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 — Groucho Marx  
  
 
 
 "In all scientific research, the researcher may or may not find what he is 
looking for — indeed, his hypothesis may be demolished — but he is 
certain to learn something new...which may be and often is more 
important than what he had hoped to learn." 
 
 — Robert A. Heinlein  
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Abstract	  
The presence of a placenta is an important synapomorphy that defines the mammal 
clade. From the fossil record we know that the first placental mammal lived 
approximately 125 million years ago, with the chorioallantoic placenta evolving not 
long after. In this thesis a set of 22 complete genomes from Eutherian, non-Eutherian 
and outgroup species are compared, the aim being to identify protein-coding and 
regulatory alterations that are likely to be implicated in the emergence of mammal 
placenta in the fossil record. To this end we have examined the roles played by 
positive selection and miRNA regulation in the evolution of the placenta. We have 
identified those genes that underwent functional shift uniquely in the ancestral 
placental mammal lineage and that are also heavily implicated in disorders of the 
placenta. Carrying out a thorough analysis of non-coding regions of the 22 genomes 
included in the study we identified a cohort of miRNAs that exist only in placental 
mammals. Many of the placenta related genes described above have multiple 
predicted “placenta-specific” miRNA binding sites. Together these results indicate a 
role for both adaptation in protein-coding regions and emergence of novel non-
coding regulators in the origin and evolution of mammal placentation. 
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Chapter	  1:	  	  	  Introduction	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1.1 Thesis	  Overview	  
This thesis describes two parallel and complementary strands of investigation into 
the origin and evolution of the placenta in mammals: a study of the role played in the 
evolution of placental genes by positive selection for gene sequence change resulting 
in a functional shift, and an analysis of the extent of regulatory innovation due to 
novel miRNA-target interactions specific to the choriallantoic placenta of Eutherian 
mammals. Before addressing the latter, it was necessary to perform an ancillary 
investigation into the relative performance of available biological sequence based 
methods for identifying miRNA-target interactions, so as to identify the miRNA-
target prediction method best able to recover known miRNA-target interactions and 
to distinguish targets from non-targets. 
 
Chapter 2 describes the analysis of functional shift and selective pressure on 
placental genes in the ancestral Eutherian lineage, while Chapter 4 reports on the 
study of regulatory miRNA innovation in the Eutherian clade. Chapter 3 outlines the 
comparison of miRNA-target predictions from different methods, which guided the 
choice of miRNA-target prediction method used in Chapter 4.  
 
Chapter 1 offers a general background treatment of the field of molecular evolution, 
while laying conceptual foundations for the analyses conducted in Chapters 2 to 4. 
Sections 1.2 through to 1.7 provide an overview of concepts underlying the methods 
and analyses throughout the thesis. However, Sections 1.6 and 1.7 — covering 
homology and phylogeny, respectively — are particularly important for 
understanding how sequences sharing a common ancestor can be, firstly, identified 
and compared, and secondly, incorporated into a dendritic model of descent with 
modification from a common ancestor.  
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Section 1.8 focuses on the analysis of selective pressure at the molecular level, and 
as such, underlies much of the work done in Chapter 2. Section 1.9 explores 
mechanisms of regulatory innovation, particularly the biogenesis and modes of 
action of miRNAs, the evolution of miRNAs and their targets, and methods used to 
predict miRNA targets. This section outlines key concepts underlying the work in 
Chapters 3 and 4 on comparing the accuracy of miRNA-target prediction methods 
and on miRNA-target interactions predicted to occur between placental miRNAs and 
placental genes.  
 
Section 1.10 describes the evolutionary history, key features and observed variety of 
the choriallantoic placenta, providing some biological context to the work described 
throughout the thesis. Finally, Section 1.11 recapitulates the overall aim and structure 
of the thesis, leading into Chapters 2 to 4. 
 
Chapters 5 and 6 explore the implications of the results obtained in Chapters 2 to 4, 
discuss the conclusions drawn from these results and outline areas that future work 
could build on the work in this thesis. The electronic appendix contained in the 
enclosed disc contains an electronic copy of this thesis, along with an electronic 
journal recording the progress of analyses, bioinformatics pipelines devised and 
implemented, scripts and modules developed, and output produced during the course 
of the work described herein.  
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1.2 Evolutionary	  Theory	  
Evolution is a process by which biological species arise and change, mediated by the 
change in heritable traits of the members of such species as they are passed from 
parents to offspring, or from one organism to another in the case of horizontal gene 
transfer (Syvanen 1985). For a given heritable trait that can take different forms in 
different individual organisms, the differential reproductive success of individuals in 
a population which possess that trait, determines the frequency of the given trait 
(Darwin 1859).  
 
In eukaryotes such as those focused on in this thesis, the vast majority of heritable 
information is stored in molecules of deoxyribonucleic acid (DNA) in the nucleus of 
each cell. The unit of inheritance is the gene, which corresponds to a region of DNA 
that, when expressed, is transcribed to a ribonucleic acid (RNA) molecule in a 
sequence-specific manner. This RNA may then be translated into a protein that 
serves a function in the organism, or may be functional in its own right. 
 
Over time, traits that are deleterious to an organism will tend to decrease in 
frequency and be removed from the population, while traits that are advantageous to 
an organism will tend to increase in frequency and become fixed in the population, in 
a process known as natural selection (Darwin 1859). A trait may also change in 
frequency due to random sampling effects by a process known as genetic drift, such 
that neutral mutations may become fixed or removed (Kimura 1968). This process 
plays a dominant role in evolution at the molecular level, according to the neutral 
theory of evolution (Kimura 1968). Depending on the effective population size of a 
species, this process can also result in a slightly advantageous trait being removed or 
a slightly deleterious trait being fixed in a process known as the nearly neutral theory 
(Ohta 1973, Ohta 1992). The process of fixation is therefore affected not only by the 
benefits or costs conferred on the organism by the trait itself, but also by other 
factors such as the size of the population within which the organism lives (see 
Section 1.4).  
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It is useful to draw a distinction between an organism's genotype (i.e. the organism's 
genetic information), and its phenotype (i.e. the observable traits of an organism) 
(Johannsen 1911). While heritable information is passed from one organism to 
another in the form of a genotype, natural selection acts on the phenotype of the 
organism, and only indirectly affects the frequency of a given gene in the population.  
 
If a mutant allele arises that causes a change in its corresponding protein or 
functional RNA molecule, this can be considered to have changed the phenotype of 
the organism. However, if the phenotypic effect is too small to appreciably affect the 
survival rate of organisms carrying the mutant trait (i.e. the organisms' fitness), then 
it is effectively invisible to natural selection. The mutant is therefore selectively 
neutral, but may be fixed at random in accordance with the neutral and nearly neutral 
theories (Kimura 1968, Ohta 1973, Ohta 1992).Where a mutant trait affects the 
fitness of an organism, this effect is usually deleterious, and is selected against. On 
the rare occasion that a mutant trait has a beneficial effect on an organism's chance of 
survival, natural selection favours this form of the trait and it will tend to become 
fixed in the population (Darwin 1859). For example, Figure 1.1 shows the 
distribution of fitness effects in diploid yeast lines in which mutations were induced 
by exposure to the mutagenic agent ethylmethane sulphonate (Wloch et al. 2001). 
About 40% of the mutations shown in Figure 1.1 were lethal, with most of the 
remainder being either neutral or deleterious.  
 
Mutation is therefore the mechanism by which novel traits are introduced to a 
species, while the fixation of selectively neutral and favoured mutations is the 
process by which a species adapts to its environment and those novel traits become 
characteristic of the species as a whole as they are swept through the population 
(Huxley 1942).  
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Figure 1.1: Distribution of fitness effects in yeast.  
In a study by Wloch et al. (2001), yeast lines were exposed to a mutagen (i.e. ethylmethane 
sulphonate) and the fitness effects of the consequent mutations were observed. The 
horizontal axis shows different levels of fitness effect in terms of the selection coefficient s 
relative to the wild type, such that yeast lines in the leftmost category underwent mutations 
that were neutral or nearly so (i.e. s ≈ 0), while all of those in the rightmost category suffered 
a lethal mutation (i.e. s = 1). Fitness was measured by relative growth of each yeast culture. 
Figure created using data from Wloch et al. (2001). 
 8 
1.3 Mutation	  
Mutation of a genotype and the consequent alteration of its phenotype can occur in a 
number of ways — leading to an alteration in the protein-coding or regulatory 
features of the genome (Wray 2007). Mutational mechanisms include mutations 
affecting a small number of nucleotides within a gene, such as point mutations, 
insertions and deletions; mutations affecting entire genes or chromosomal segments, 
such as gene duplication and deletion, as well as gene fusion and fission; and whole-
genome duplications, in which an organism's entire genome is duplicated (Eyre-
Walker and Keightley 2007, Kaessmann 2010) 
1.3.1 Point	  Mutation	  
A number of mechanisms can bring about a point mutation, and these mechanisms 
can be grouped into two general types: spontaneous and induced mutations (Patthy 
2008). Spontaneous mutations may occur, for example, due to tautomerisation of 
amino and keto groups of bases, causing the formation of nonstandard base pairs, or 
through the deamination of cytosine to form uracil (eventually replaced by thymine) 
(Patthy 2008). An induced mutation occurs in the presence of a mutagenic agent. For 
example, nitrous acid can convert cytosine to uracil, which then pairs with adenine 
instead of guanine, or it can deaminate adenine to form hypoxanthine, which pairs 
with cytosine instead of thymine (Patthy 2008). In mammals, there is a phenomenon 
known as biased gene conversion, whereby the DNA repair machinery is biased 
towards the insertion of G and C in damaged DNA, thereby increasing the GC 
content in that region (Foster and Hickey 1999). Most point mutations are identified 
and corrected by the ‘proofreading’ activity of DNA polymerases, or by mismatch 
repair enzymes (Patthy 2008). However, some mutations are not identified by these 
correction mechanisms and persist in the organism (Patthy 2008). Point mutations 
may also introduce a new stop codon when a nonsense mutation occurs (Lewin 
2008). A transition occurs when a purine mutates to another purine (i.e. an adenine 
mutates to a guanine, or vice versa), or when a pyrimidine mutates to another 
pyrimidine (i.e. a cytosine mutates to a thymine, or vice versa); while a transversion 
occurs when a purine (i.e. adenine or guanine) mutates to a pyrimidine (i.e. cytosine 
or thymine), or vice versa (Patthy 2008). 
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Not all DNA substitutions in protein-coding DNA bring about change at the amino 
acid level. Because of the degeneracy of the genetic code, most amino acids are 
coded for by multiple codons. A synonymous mutation is a change in the coding 
DNA sequence (CDS) of a gene that does not result in a changed amino acid 
sequence, whereas a non-synonymous mutation is a change in the coding sequence 
of a gene that does bring about a change at peptide level. However, not all 
synonymous mutations are without effect, as has been evidenced by bias in codon 
usage that constrains the set of codons used for a given amino acid (Akashi 1994, 
DeBry and Marzluff 1994, Kimchi-Sarfaty et al. 2007). It is believed that this codon 
usage bias is as a result of selection for more efficient transcription (Xia 1996). Other 
regions of the genome contain specific codons because they are splice sites and it is 
thought that codon usage biases in these regions may play a role in the mediation of 
alternative splicing (Abril et al. 2005). There are many examples in the literature of 
point mutations in protein-coding regions that result in altered phenotypes, a classic 
example being the melanocyte-stimulating hormone (MSH) receptor. Point 
mutations in this receptor result in variations in coat colour of mammals (Robbins et 
al. 1993). There is also a large body of evidence that point mutations in regulatory 
(non-coding) elements have important functional effects on phenotype. These 
included point mutations in the cis-regulatory regions of specific genes that have 
been shown to alter, for example, paternal care behaviour in rodents (Hammock and 
Young 2005), bristle patterning on the legs of adult fruit flies (Stern 1998) and 
obsessive compulsive behaviour in humans (Walitza et al. 2002), as reviewed 
recently by Wray et al. (2007). 
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1.3.2 Insertion	  and	  Deletion	  Mutation	  
Replication errors can also bring about an insertion or deletion mutation — also 
known as an indel. For example, replication slippage in the vicinity of short repeat 
sequences can result in the deletion or insertion of one or more nucleotides (Patthy 
2008). Replication slippage in the 5′ to 3′ direction results in a deletion, while 
slippage in the 3′ to 5′ direction causes an insertion of the repeat sequence motif 
(Patthy 2008). The presence of an intercalating agent can also bring about an 
insertion mutation by increasing the distance between adjacent nucleotides in a DNA 
sequence (Brown 2002). In mammals, deletions are somewhat more common than 
insertions, and the majority of indels are short, involving the insertion or deletion of 
three codons or less (Taylor et al. 2004). For example, given a wild type nucleotide 
sequence 'GATTACACA', an insertion after the first codon of the nucleotides 'GAA' 
would result in the mutant sequence 'GATGAATACACA', while a deletion of the 
codon 'TAC' from the original sequence would result in 'GATACA'.  
 
When the size of the insertion or deletion is a multiple of three bases, the indel is far 
less likely to disrupt the open reading frame of a gene sequence and correspondingly 
more likely to be accepted. For example, the wild type nucleotide sequence above 
would be translated as the amino acid sequence 'DYT', the example insertion mutant 
sequence would be translated into amino acid as 'DEYT', and the deletion mutant 
would be translated as 'DT'. The C-terminal threonine (T) and downstream amino 
acids are still translated from both mutant nucleotide sequences, because the reading 
frame is unaffected by the mutations. On the other hand, an indel that disrupts the 
reading frame — known as a frameshift mutation — will certainly change the 
downstream amino acid sequence, and is likely to bring a new stop codon into phase, 
which usually renders a protein non-functional. An example would be the deletion of 
the first cytosine (C) in the wild type example sequence, which would produce the 
sequence 'GATTAAACA', in turn resulting in the truncation of the protein product due 
to the newly introduced stop codon (shown in red). Because of this, such mutations 
are less likely to be accepted than in-frame indels, though it is possible for frameshift 
mutations to be accepted, as with a Flavobacterial oligomer hydrolase whose origin 
lies with a frameshift mutation in an existing gene (Ohno 1984).  
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1.3.3 Gene	  Duplication	  and	  Loss	  
Gene duplication is a significant source of evolutionary novelty (Ohno 1970) and 
can occur as a result of a number of different events, as depicted in Figure 1.2: (a) 
DNA-mediated duplication can take place as a result of unequal crossing over during 
recombination, and may cause the duplication of one or more genes (Kaessmann 
2010); (b) RNA-mediated duplication may be caused by reverse transcription of a 
messenger RNA molecule, that results in a gene duplicate lacking introns and, in 
many cases, associated regulatory regions (Kaessmann 2010).  
 
Gene duplication is estimated to occur in eukaryotes at a rate of up to 0.01% per 
gene per million years (Lynch and Conery 2000). Upon duplication, a number of 
distinct fates are possible for the duplicates, including: (i) dosage selection (retention 
of both copies due to dosage effects), (ii) escape from adaptive conflict (where the 
ancestral protein had two functions in adaptive conflict and each duplicate retains 
one of each of the conflicting functions — this is a form of subfunctionalisation), 
(iii) neofunctionalisation (acquisition of a new function by one duplicate), (iv) 
subfunctionalisation (division of the original gene function into two subfunctions, 
each performed by one duplicate), and (v), non-functionalisation (loss of function in 
one duplicate through pseudogenisation). A number of examples of gene duplication 
and associated functional divergence have been identified, including the co-option of 
an RNase gene for the purpose of extracting nutrients from bacteria in a leaf-eating 
monkey (Zhang et al. 2002), the evolution of a duplicate crystallin in zebrafish 
(Smith et al. 2006), the evolution of a galactokinase (GAL1) and co-inducer (GAL3) 
in yeast species Saccharomyces cerevisiae from a single gene with both functions 
(Hittinger and Carroll 2007), and the expansion and divergence of the opsin gene 
repertoire among ray-finned fish (Rennison et al. 2012). 
 
Non-functionalisation is the most common fate for a duplicate gene, often with 
pseudogenisation of the duplicate (Lynch and Conery 2000). Using survivorship 
rates of gene duplicates in C. elegans, D. melanogaster and S. cerevisiae, Lynch and 
Conery (2000) estimated that the average half-life of a gene duplicate is about 4 
million years. Based on this estimate, a comfortable majority of duplicated genes can 
be expected to have become a pseudogene within 10 million years.  
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Figure 1.2: Mechanisms of gene duplication.  
Mechanisms of gene duplication include: (A) DNA-mediated duplication as a result of 
unequal crossing-over during recombination; (B) RNA-mediated duplication due to reverse 
transcription and integration of mRNA. Figure taken with permission from (Kaessmann 
2010). 
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1.3.4 Gene	  Fusion	  and	  Fission	  
Partial duplication of a coding gene may sometimes result in a gene fission/fusion 
process: where the original gene undergoes ‘fission’ into two new genes, or part of 
the gene undergoes ‘fusion’ with a second gene to form a chimeric gene (Snel et al. 
2000). A classic example of a fusion event is offered by the Jingwei gene in 
Drosophila, whose origin was first studied by Long and Langley (1993). Jingwei was 
found to have formed from part of the alcohol dehydrogenase (Adh) gene and 
another, unrelated gene in the common ancestor of Drosophila yakuba and 
Drosophila teissieri (Long and Langley 1993). Again in Drosophila, specifically in 
the melanogaster subgroup, a gene fission event occurred that involved the monkey 
king gene; in this case the fission was mediated by gene duplication and subsequent 
partial degeneration (Wang et al. 2004).  
1.3.5 Whole-­‐Genome	  Duplication	  
In addition to duplication at the level of the gene, DNA sequences can be duplicated 
at the chromosomal scale, or in rare instances, at the scale of the genome — a whole-
genome duplication (WGD) (Kaessmann 2010). Ohno (1970) first suggested the "2R 
hypothesis" that two rounds of whole-genome duplication have occurred in the 
ancestral vertebrate; this has been supported by more recent genomic analysis 
(Hokamp et al. 2003, Kasahara 2007, Huminiecki and Heldin 2010).  
 
Genes in particular functional categories tend to be duplicated either in a gene 
duplication or a whole-genome duplication in a mutually exclusive manner (Maere et 
al. 2005). Genes duplicated by WGD tend to retain more interacting partner proteins 
than those duplicated in a smaller scale event (Guan et al. 2007). This may be due to 
dosage-balance effects, such that the relative expression levels of a set of genes 
affects their function (Conant and Wolfe 2008). In any case, as with gene 
duplication, many of the duplicate genes are lost over time following a whole-
genome duplication (Scannell et al. 2007). 
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1.4 Fixation	  
Whatever the nature of a mutation, its emergence as characteristic of a species as a 
whole depends on whether it increases in frequency in the population until it reaches 
fixation: a situation in which the frequency of an allele in the population reaches 
100% (Patthy 2008). As outlined above, this can happen by two general mechanisms: 
genetic drift, in which a mutation may become fixed by chance, and natural 
selection, in which a mutation may become fixed because it has a beneficial effect on 
the phenotype (positive selection) or become lost from the population because it has 
a deleterious effect (purifying or negative selection).  
 
Most mutations within a gene sequence are neutral or nearly neutral, and have a 
negligible effect at the phenotypic level; if such mutations become fixed, it is due to 
genetic drift. Whether advantageous or deleterious, such nearly neutral mutations are 
fixed more readily in populations with a small effective population size (Ne).  
 
Mutations that do impact on the phenotype of an organism (at the macroevolutionary 
level), or the function of a gene/protein (at the molecular evolutionary level), may 
also be affected by genetic drift, but natural selection plays a more significant role in 
determining their fate (Hurst 2009). Most function-altering mutations are deleterious 
and natural selection tends to remove these from a population through a process 
known as negative or purifying selection. However, a small number of mutations 
have a beneficial effect on the function and natural selection will tend to positively 
select these beneficial mutations and bring them to fixation, through a process known 
as positive selection or adaptive evolution. 
 15 
The relative effect of natural selection as opposed to genetic drift is directly 
proportional to the relative fitness of the mutant compared to the wild type. The 
relative impact of natural selection is also directly proportional to the size of a 
population: larger populations tend to be subject to stronger natural selection, while 
genetic drift plays a larger role in smaller populations (Ohta 1973). In a larger 
population, genetic drift is less likely to bring an allele to fixation before natural 
selection tends to dominate; furthermore, in such cases the sensitivity of an allele to 
the effects of natural selection is increased as the fitness of that allele deviates from 
neutrality (see Figure 1.3). Conversely, smaller populations tend to have less genetic 
variation, which in turn limits the effectiveness of natural selection and the ability of 
a species to adapt to changing circumstances (Willi et al. 2006).  
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Figure 1.3: Fixation rate and the effective population size.  
This graph shows the expected fixation rate for a novel mutation as a function of the 
effective population size (Ne). The horizontal axis shows the effective population size, while 
the vertical axis shows the fixation rate in terms of the mutation rate (µ). Different curves are 
shown for different values of the selection coefficient (s), which indicates the fitness of the 
mutation relative to the wild type. Mutations with a selection coefficient of zero are strictly 
neutral, while those with a positive or negative selection coefficient are advantageous or 
deleterious, respectively. Figure taken from (Hurst 2009). Permission obtained via the 
Copyright Clearance Center. 
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1.5 Speciation	  
Foreshadowed by Poulton (1903), Ernst Mayr in 1970 formulated the biological 
species concept: a species is a group of actually or potentially interbreeding 
populations that are reproductively isolated from other groups (Mayr 1970). This 
definition implicitly excludes organisms that reproduce asexually and is confounded 
by hybridisation between species (Mallet 2005) and horizontal gene transfer (Koonin 
et al. 2001, Keeling and Palmer 2008). Nevertheless, in animal species the vertical 
transfer of genes from parents to offspring predominates. More recent formulations 
of the biological species concept account for this by describing the reproductive 
isolation of species as substantial, if not complete (Coyne and Orr 2004). Such 
reproductive isolation can occur due to barriers in geography in allopatric speciation1 
(Mayr 1970) or in the absence of such barriers in sympatric speciation (Poulton 
1903) due to, for example, ecological or behavioural factors (Butlin et al. 2008).  
 
Once a speciation event has occurred, meaningful comparison of the descendant 
species is made possible by comparison of homologous traits, whether these be 
morphological or molecular. Homolog was defined by Richard Owen (1843) as "the 
same organ in different species under every variety of form and function". More 
recent definitions encompass both morphological and molecular homology in an 
evolutionary context, with the descent of two entities from a common ancestor 
constituting homology (Koonin 2005).  
                                                
1 Mayr (1970) defines allopatric speciation as "geographic speciation", and sympatric 
speciation as "speciation without geographic isolation by the acquisition of isolating 
mechanisms within a deme".  
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1.6 Homology	  
A homologous trait is a characteristic present in two or more species that is derived 
from a common ancestor. This is distinct from a homoplastic or analogous character, 
a trait present in two or more species that evolved separately and was not present in 
the common ancestor. The specialised beaks of the various species of Galapagos 
finch are an example of morphological homology. By comparing the different beak 
shapes (in addition to other homologous characters), it should be possible to 
reconstruct the evolutionary history of the Galapagos finches.  
 
However, the identification of homologous traits is not always so straightforward. 
For example, the homology of a horse’s hoof and the human middle finger might not 
be so immediately clear. The wings of bat and bird might appear to the naïve 
observer to be homologous, but this is not the case. Though these structures may be 
homologous as pectoral limbs, as wings they are homoplastic, having arisen by 
convergent evolution (McGhee 2011). In any case, it is clear from these examples 
that correct identification of homologous relationships is crucial if any inferences are 
to be made on the basis of those homologies. 
1.6.1 Molecular	  Homology	  
As is the case with morphological homology, so it is also true of molecular 
homology. A prerequisite for reconstructing the evolutionary history of a gene is the 
correct identification of its homologs. Pevsner (2003) outlines a number of different 
cues that are used to infer homology between two or more genes. These are as 
follows: 
 
 sequence similarity  
 bidirectional best hit (see below) 
 common sequence motifs 
 similar biological function 
 conserved microsynteny: conservation of gene order in local genomic regions  
 similarity of protein tertiary structure 
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Cues other than sequence similarity are not always available for every putative 
homologous pair and sequence similarity searches remain the predominant tool used 
for identification of homologous groups in molecular evolutionary analyses (Fuellen 
2008). The pairwise alignment software BLAST is commonly used to identify 
homologs of a query gene in a database of sequences (Camacho et al. 2009, Altschul 
et al. 1997, Altschul et al. 1990). BLAST searches may be used in a reciprocal 
manner, such that a putative homolog from an initial search is used as a query against 
the genome containing the original query gene, to obtain the bidirectional best hit 
(BBH). It is frequently used in comparative genomic analyses where the aim is to 
identify orthologous families of sequences. (Overbeek et al. 1999).  
 
The identification of homology between sequences per se is not always a sufficient 
basis to draw conclusions on the nature of their relationship from a common 
ancestor; this is because of the occurrence of gene duplication resulting in mixtures 
of orthologs and paralogs — homologs whose common ancestor diverged in a 
speciation or gene duplication event, respectively — in many gene family datasets. 
For example, Fitch and Margoliash (1967) posit a scenario in which a set of 
haemoglobin homologs are taken from a number of species — such that each species 
is represented by a single gene — and their amino acid sequences are compared and 
used to infer the evolutionary history of the haemoglobin gene family. In this 
scenario, half of the homologs are α-globins and half are β-globins. Such a scenario 
would likely produce a nonsensical result, with α-globins and β-globins clustering 
together irrespective of their species of origin (Fitch and Margoliash 1967). Indeed, 
such a situation arose — and was highlighted as an example of this issue — in the 
study by Martin and Burg (2002) of heat shock 70 (HSP70) genes in sharks. 
 
This example illustrates the necessity of ensuring that the set of homologs in a given 
gene family is as complete as possible. The advent of genome sequencing projects 
has made this a practical prospect. With complete genomes of high quality, it is 
much more plausible that all homologs for a given gene will be identified in a given 
genome, thus allowing for reconstruction of an accurate evolutionary history of the 
gene family. This example also underlines the importance of distinguishing between 
homologous genes whose most recent common ancestor (MRCA) diverged in a 
speciation event from those whose common ancestry diverged in a gene duplication.  
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I.	  Types	  of	  Homologous	  Genes	  
Fitch (1970) proposed that homologs should be divided into two subtypes. A 
homolog in a different species that evolved from a common ancestor with a given 
gene by a speciation event, such that their evolutionary history mirrors that of 
their respective species, is known as an ortholog. Where a gene duplication event 
occurs and descendants of the duplicate genes remain, each such gene is a 
paralog. 
  
Figure 1.4 (taken from Jensen 2001) depicts an evolutionary tree for three species 
A, B and C, with one, two and three genes in each species, respectively. All the 
genes in Figure 1.4 are homologs of each other, since they all share a common 
ancestor. The ancestral node of any pair of genes indicates whether those genes 
are orthologous or paralogous. For example, gene B2 is a paralog of gene C1, 
since their MRCA split in two in a gene duplication, while B2 is an ortholog of 
both C2 and C3, since their MRCA diverged into two lineages in a speciation 
event. Note also that genes C2 and C3 are paralogs of each other, while being co-
orthologs of B2 (Jensen 2001).  
 
Sonnhammer and Koonin (2002) proposed a further division of paralogs into two 
subtypes: in-paralogs and out-paralogs. An in-paralog is a paralog formed by a 
duplication that occurred after a particular speciation event. In Figure 1.4, genes 
C2 and C3 are in-paralogs with respect to Speciation 2, since they arose in Gene 
duplication 2 after Speciation 2. An out-paralog, on the other hand, is a paralog 
formed by a duplication that occurred before a particular speciation event. In 
Figure 1.4, B2 and C1 are out-paralogs with respect to Speciation 2, because they 
diverged in Gene duplication 1 before Speciation 2.  
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Figure 1.4: Types of homologous genes.  
The phylogeny shows a simplified evolutionary history for genes in species A, B and C. 
Speciation events are denoted by forking lines, while gene duplications are denoted by 
horizontal lines. The genes A1, B1, B2, C1, C2 and C3 are all homologs of each other, but 
the exact relationship of any pair of homologs differs depending on the circumstances in 
which their most recent common ancestor (MRCA) diverged. Genes whose MRCA diverged 
in a speciation event are orthologs, while genes whose MRCA diverged in a duplication 
event are paralogs. Figure taken with permission from Jensen (2001). 
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II.	  The	  Ortholog	  Conjecture	  
The hypothesis that orthologs are more functionally conserved than paralogs of 
similar sequence divergence is known as the ortholog conjecture (Koonin 2005, 
Tatusov et al. 1997). The validity of this hypothesis underlies much of the 
functional annotation of newly sequenced genomes in the absence of experimental 
validation of function (Koonin 2005).  
 
Some confusion has arisen from the ortholog conjecture, with some authors 
defining orthology in terms of conservation of function (Fàbrega et al. 2001, Gerlt 
and Babbitt 2000). Jensen (2001) argued against the incorporation of function into 
the definition of orthology (since it is possible for orthologs to diverge 
functionally and for paralogs to retain the same function), proposing that new 
nomenclature be used to classify homologs in terms of functional conservation, if 
necessary. In an accompanying comment, Gerlt and Babbitt acknowledged that 
orthology and paralogy were originally defined in terms of speciation and gene 
duplication events, respectively, but pointed out that in practice such events are 
not always inferred with certainty (Jensen 2001). Gerlt and Babbitt further 
proposed that the terms isofunctional and heterofunctional be used to denote 
homologs with similar and differing functions, respectively (Jensen 2001). 
 
Citing a discussion of the issue by Fitch (2000), Kuzniar et al. (2008) defined 
orthologs explicitly in terms of an evolutionary relationship — "homologous 
sequences derived by a speciation event from a single ancestral sequence in the 
last common ancestor of the species being compared" — but then went on to 
restate the ortholog conjecture as part of the same definition, illustrating the 
pervasiveness of the concept of the ortholog conjecture. Studer and Robinson-
Rechavi (2009) highlighted the need to test the ortholog conjecture more 
rigorously, rather than simply assuming it to be true. A number of subsequent 
studies have found evidence in support of the ortholog conjecture, in terms of 
protein structure (Peterson et al. 2009b), intron position (Henricson et al. 2010), 
domain architecture (Forslund et al. 2011) and expression patterns in mammals 
(Huerta-Cepas et al. 2011). In contrast, Qian and Zhang (2009) studied the 
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evolution of sub-cellular localisation and found no difference between orthologs 
and paralogs. Furthermore, Nehrt et al. (2011) found that paralogs tend to have 
higher functional conservation than orthologs, in a study that compared functional 
annotation from the Gene Ontology (GO) database (Ashburner et al. 2000). 
However, in a 2012 paper, members of the Gene Ontology Consortium cautioned 
against the use of GO annotation to test the ortholog conjecture, highlighting the 
incompleteness of GO annotation and in particular the species bias of GO terms, 
since different organisms are used to study different aspects of biology (Thomas 
et al. 2012). The authors further stated that this species bias in GO term frequency 
is likely to give the impression of conservation between paralogs within the same 
species. Altenhoff et al. (2012) also performed a test of the ortholog conjecture 
using GO annotation, controlling for authorship bias in GO term frequency, 
species bias in GO term frequency, variation in similarity between pairs of species 
and propagated GO annotation bias. Controlling for these biases, Altenhoff et al. 
(2012) found weak but significant support for the ortholog conjecture2: in a 
comparison of orthologs and paralogs from 13 species, the excess similarity of 
GO terms for orthologs over paralogs ranged from 0.028 for homologs with 50-
60% sequence identity (t-test, P < 2.8 × 10-9), to 0.136 for homologs with more 
than 90% sequence identity (t-test, P < 8.1 × 10-91). Therefore, orthologs do tend 
to be more conserved than paralogs, but not overwhelmingly so.  
III.	  Inference	  of	  Orthology	  and	  Paralogy	  
A gene family in which no gene duplications or losses had occurred would be 
composed entirely of orthologs and would have an evolutionary history mirroring 
that of the species. In a gene family without gene loss, a gene duplication would 
have the effect of duplicating the gene family history; in the absence of further 
duplications, both duplicates would again mirror the evolution of species after the 
initial duplication event.  
                                                
2 One exception to this trend occurred in homologs with 10-20% identity; in this case, 
paralogs were found to have an excess similarity in GO terms of 0.025 relative to orthologs 
(t-test, p < 2.2 x 10-4). However, as noted by the authors, identifying homologs can be 
challenging and error prone in the "twilight zone" of sequence similarity; distinguishing 
orthologs from paralogs even more so. 
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Tree reconciliation — comparison of the gene family history with that of the 
species — can facilitate inference of duplication events and distinguish orthologs 
from paralogs within the gene family. This classic method of identifying 
orthologs and paralogs is known as tree reconciliation because the phylogenetic 
trees of species and gene family are 'reconciled' such that — notwithstanding the 
effects of gene loss, horizontal gene transfer and incomplete lineage sorting — 
monophyletic groups of orthologs on the gene tree are congruent with the 
topology of the species phylogeny (Eulenstein et al. 1998, Page and Charleston 
1997, Maddison 1997, Mirkin et al. 1995). (See Section 1.7 for a brief 
introduction to phylogenetic trees.) 
 
In practice this process is complicated by a number of factors. Errors in inference 
of either the gene tree or species tree can be propagated to the reconciliation 
process (Koonin 2005). In addition, gene loss can make it difficult to infer 
duplication events correctly; in extreme cases of reciprocal loss in two daughter 
lineages, paralogs may be misidentified as orthologs. Furthermore, tree 
reconciliation is computationally expensive and difficult to "scale-up" for large 
numbers of gene families (Koonin 2005), with only one orthology database (i.e. 
Ensembl Compara) inferring orthology by tree reconciliation across multiple 
genomes (Vilella et al. 2009).  
 
Heuristic alternatives to tree reconciliation include the bidirectional best hit 
(BBH), in which two genes are considered orthologs if each is the best aligning 
gene to the other in their respective genomes (Overbeek et al. 1999); and the 
reciprocal smallest distance (RSD), where two genes are considered orthologs if 
each has the shortest estimated evolutionary distance to the other in their 
respective genomes (Wall et al. 2003). A disadvantage of both these methods is 
that for a given set of species, they are only able to identify one-to-one orthologs: 
a set of orthologs such that each species has no more than one ortholog. This can 
be a considerable limitation if a gene family contains one-to-many orthologs — 
a set of orthologs such that some species have multiple genes co-orthologous to a 
single gene in other species — or many-to-many orthologs — a set of orthologs 
such that some species have multiple genes co-orthologous to multiple genes in 
other species. 
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More sophisticated orthology prediction methods use sequence similarity to 
cluster groups of putative orthologs and in-paralogs across pairs of genomes, such 
as Inparanoid (Ostlund et al. 2009, Remm et al. 2001); or across multiple 
genomes, such as EggNOG (Muller et al. 2009, Jensen et al. 2008), or OrthoMCL 
(Li et al. 2003). 
1.6.2 Site-­‐wise	  Molecular	  Homology	  
Fundamentally, the identification of homologous biological sequences involves 
identifying homologous sites in those sequences. Typically, homologs are identified 
by sequence similarity to a gene of interest in a pairwise manner, such that many of 
the sites in the two genes are identical or similar, and by implication homologous. 
When a set of homologs have been identified, these are "aligned" in preparation for 
more detailed comparison. Alignment is essentially the identification of homologous 
positions within these homologous sequences. In a multiple sequence alignment 
(MSA), each sequence occupies its own row, and each column represents a site that 
is homologous across the set of aligned sequences. An MSA is effectively a 
hypothesis about sitewise homology, and maximising the alignment of truly 
homologous positions is critical to ensuring the validity of downstream analyses 
(Anisimova et al. 2010, Wong et al. 2008, Kumar and Filipski 2007). There are two 
main aspects to the process of correctly aligning homologous sequences: handling of 
(I) substitutions and (II) indels.  
I.	  Substitutions	  
When a point mutation increases in frequency in a population such that every 
member of that species has the novel form (i.e. the point mutation is fixed in the 
population), this is known as a point substitution. Comparison of character states 
at homologous sites requires that point substitutions be accounted for, and this is 
typically done with a substitution model.  
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Such a substitution model is a matrix with a row and column for each possible 
character state, with the expected frequency of a substitution from character state 
R to character state C reflected by the value of the element in row R and column 
C. With increasingly similar sequences — and correspondingly fewer 
substitutions — such a substitution model tends toward the identity matrix.  
Nucleotide	  Substitution	  Models	  
Perhaps because of the smaller number of possible states, substitution models 
were developed for DNA sequences before peptide sequences. The first such 
model was the JC69 model developed by Jukes and Cantor (1969). The JC69 
model assumes equal nucleotide base frequencies: πA = πC = πG = πT = 0.25, 
where πN represents the frequency of base N. The JC69 model also assumes that 
all substitutions are equiprobable, so this can be modelled by a single parameter, 
µ (the overall substitution rate). Felsenstein (1981) introduced the F81 model, in 
which base frequencies are allowed to vary: πA ≠ πC ≠ πG ≠ πT; and the 
substitution probability for each base is determined by the base frequency. At 
about this time it was becoming clear that transition and transversion rates could 
not always be assumed equal (Brown et al. 1982, Gojobori et al. 1982, Curtis 
and Clegg 1984); this necessitated the development of models that could account 
for different transition and transversion rates. Kimura (1980) devised the K2P 
model, which assumes base frequencies to be equal, but allows for different rates 
of transition and tranversion; this was followed by the K3P model (Kimura 
1981), which models one transition rate and two transversion rates. Hasegawa et 
al. (1985) developed the HKY85 model, which has both variable base 
frequencies and one rate for transition and transversion. The general time 
reversible (GTR) model accounts for variable base frequencies and all possible 
nucleotide substitutions using a symmetrical matrix (Lanave et al. 1984, Tavaré 
1986, Rodríguez et al. 1990). Development of nucleotide substitution models 
has continued (Tamura 1992, Tamura and Nei 1993, Zharkikh 1994), but the 
GTR is arguably the most complex nucleotide substitution model in common 
usage (Posada and Crandall 2001). In any case, the increased complexity of a 
model does not, in itself, ensure that the model is a significantly better fit to the 
data than a simpler model (see below).  
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Amino	  Acid	  Substitution	  Models	  
The first amino acid substitution model was that devised by Dayhoff et al. 
(1978). This was empirically derived from estimated mutation rates among a set 
of 34 protein superfamilies with at least 85% sequence similarity. The high 
sequence similarity used was necessary to avoid counting successive 
substitutions at the same site. Henikoff and Henikoff (1992) developed the 
BLOSUM amino acid substitution matrices from their BLOCKS database, 
which contained a larger number of aligned proteins at a range of evolutionary 
distances. This enabled a marked improvement in performance on the Dayhoff 
model, and the Blosum62 matrix (derived from sequences with 62% identity) 
was found to be the most generally useful (Henikoff and Henikoff 1992). In the 
same year, Jones et al. (1992) developed the JTT substitution matrix using a 
similar method to that of Dayhoff et al. (1978), but with the much larger set of 
protein sequences in the nascent Swiss-Prot database (Bairoch and Boeckmann 
1992).  
 
General amino acid substitution matrices continue to be developed. The VT 
model (Müller and Vingron 2000) was developed using a novel resolvent 
method — capable of estimating amino acid substitution rates from alignments 
of varying levels of divergence — with the SYSTERS database of aligned 
protein families (Krause and Vingron 1998). The WAG model (Whelan and 
Goldman 2001) used an approximate likelihood method to estimate amino acid 
substitution rates from nearly 4,000 amino acid sequences in the 180 alignments 
comprising the BRKALN database (D.T. Jones, unpublished). Like WAG, the 
LG model (Le and Gascuel 2008) was developed using a likelihood method, in 
this case implemented in the software XRATE (Holmes and Rubin 2002, 
Klosterman et al. 2006). However, for estimation of amino acid substitution 
rates, Le and Gascuel (2008) used a much larger database of amino acid 
alignments — Pfam (Bateman et al. 2002) — comprising nearly 4,000 
alignments of approximately 50,000 protein sequences.  
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Much work has also been done to try and capture the complexities of biological 
sequence evolution, such as invariant sites (Reeves 1992), among-site rate 
variation (Yang 1996), variation in sequence composition between lineages 
(Foster 2004) and variation in substitution rates across lineages (Lartillot 2004, 
Lartillot et al. 2007).  
Selection	  of	  the	  Substitution	  Model	  
The selection of the substitution model in itself is not trivial and can have a 
critical impact on downstream phylogenetic analyses (Felsenstein 1978, Bruno 
and Halpern 1999, Keane et al. 2006). For nested models (e.g. JC is a special 
case of K2P, which is in turn a special case of GTR), the likelihood ratio test 
(LRT) (Hoel 1962) may be used to select the most appropriate model to use 
(Goldman 1993). Given a series of models, the model of best fit may be selected 
using hierarchical likelihood ratio tests (hLRTs) (Huelsenbeck and Crandall 
1997). However, the applicability of hLRTs to model selection has been 
questioned (Burnham and Anderson 2002), and hLRTs can not be used to 
compare non-nested models or to assess model selection uncertainty (Posada and 
Buckley 2004). Alternative methods of model comparison include: 
 
 Akaike information criterion (AIC) (Akaike 1973, Akaike 1974), 
given in Equation 1.1. 
 
  
€ 
AIC = −2⋅ log ( ) + 2⋅ k  
Equation 1.1: Akaike information criterion.  
The AIC is given in terms of the log-likelihood of a model (i.e. log(  
€ 
 )) and a 
penalty term 2k, such that k is the number of free parameters in the model. 
 
The AIC reflects the amount of information lost when using a given 
model to approximate the underlying process. 
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 Bayesian information criterion (BIC) (Schwarz 1978), given in 
Equation 1.2. 
 
  
€ 
BIC = −2⋅ log ( ) + k⋅ log(n)  
Equation 1.2: Bayesian information criterion.  
The BIC is given in terms of log-likelihood of the model (i.e. log(  
€ 
 )) and a 
penalty term k · log(n), where k is the number of free parameters in the 
model and n is the number of data points.  
 
The BIC is equivalent to choosing the model with the maximum 
posterior probability, assuming the models have equal prior 
probabilities (Posada and Buckley 2004). 
 
 Deviance information criterion (DIC) (Spiegelhalter et al. 2002), 
given in Equation 1.3. 
 
€ 
DIC = D+ pD  
Equation 1.3: Deviance information criterion.  
The DIC is given in terms of the posterior mean deviance (
€ 
D ) and a penalty 
term (pD) defined (with respect to the relevant parameters) as the difference 
between the posterior mean of the deviance and the deviance of the posterior 
means. 
 
The DIC can be seen as a generalisation of AIC and BIC within a 
Bayesian framework; the principal drawback of the BIC is that it 
necessitates that model fitting be performed using Markov chain 
Monte Carlo methods (Burnham and Anderson 2002). 
 30 
 Hannan-Quinn information criterion (HQ) (Hannan and Quinn 
1979), given in Equation 1.4. 
 
  
€ 
HQ = −2⋅ log() + 2k⋅ log(log(n)) 
Equation 1.4: Hannan-Quinn information criterion.  
The HQ information criterion is given in terms of the log-likelihood of a 
model (i.e. log(  
€ 
 )) and a penalty term 2k · log(log(n)), such that k is the 
number of free parameters in the model and n is the number of data points. 
 
The Hannan-Quinn information criterion has been described by 
Burnham and Anderson (2002) as widely cited but little used. Perhaps 
this is partly because the effect of the penalty term — proportional to 
log(log(n)) — is low even for large n (Claeskens and Hjort 2008).  
 
Posada and Buckley (2004) suggest that the BIC should be used if the aim is to 
identify the true model, while the AIC should be used if the aim is to 
approximate reality. An advantage of the BIC is that it strongly penalises 
parameter-rich models; both the AIC and hLRT tend to favour parameter-rich 
models in large datasets (Schwarz 1978). While not explicitly conceived in 
terms of parsimony, it has been argued that the AIC achieves a parsimonious 
solution as a by-product, trading off a greater fit of the model to the data against 
the introduction of too many parameters, which could lead in turn to model 
overfitting (Anderson 2008). 
 
Amino acid sequences are considered to be better than nucleotide sequences for 
reconstructing substitution events in protein-coding genes. Synonymous 
nucleotide substitutions in particular tend to occur relatively frequently, so 
multiple substitutions and reversions introduce conflict into the phylogenetic 
signal at each site. The smaller number of possible nucleotide states — four as 
opposed to twenty for amino acids — compound this effect, since the same site 
is more likely to have the same character state by chance in distantly related taxa 
(Felsenstein 1996a, Russo et al. 1996).  
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Indels	  
Insertions and deletions (indels) in molecular sequences pose a considerable 
challenge to the identification of homologous sites, especially at greater 
evolutionary distances. Indels are most commonly represented by a gap character 
(e.g. hyphen) in sequence alignments, and are typically modelled using an affine 
gap penalty, which penalises the insertion and extension of a gap differently, since 
in practice many indels involve multiple sites. For example, ClustalW 
incorporates a gap opening penalty in addition to a gap extension penalty (Larkin 
et al. 2007, Thompson et al. 1994). Gap penalties may also be informed by 
biochemical knowledge; for example, ClustalW locally reduces gap penalties in 
peptide regions containing hydrophilic amino acids, so as to reward new gaps in 
hydrophilic loop regions where indels are expected to have less impact on protein 
structure, while discouraging their introduction in regions corresponding to 
regular secondary structure. For the same reason, MUSCLE (Edgar 2004a) locally 
increases gap penalties in hydrophobic regions. MUSCLE also incorporates an 
affine gap penalty, but includes an additional gap closing penalty, to ensure that 
the treatment of gaps is symmetrical (Edgar 2004a). Gaps are handled in an 
evolution-aware manner by PRANK (Löytynoja and Goldman 2008), which 
attempts to explicitly model insertion and deletion events over the evolutionary 
history of the sequences being aligned, such that aligned sites are presented as 
homologous. In doing so, PRANK eliminates a systematic bias present in 
previously developed methods of multiple sequence alignment, in which an 
inability to separate distinct, nearby insertions can lead to their spurious 
alignment, which can in turn cause such misaligned insertions to be misidentified 
as mutation hotspots (Löytynoja and Goldman 2008).  
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1.7 Phylogeny	  and	  Phylogenetic	  Reconstruction	  
The phylogenetic tree provides a model to describe the evolution of many extant 
species from a common ancestor through a series of speciation events. Darwin’s 
Origin of Species, published in 1859, contained one of the earliest examples of a 
phylogenetic tree (Darwin 1859). The conceptual framework of the phylogeny has 
endured, and remains widely applicable today, although not universally so (Doolittle 
1999).  
 
A rooted phylogenetic tree for the species used in this study is depicted in Figure 1.6. 
In this phylogeny, each of the rightmost nodes – the operational taxonomic units 
(OTUs) or leaves – represents an extant species, such as human or mouse. Each node 
to the left of the leaves – termed an internal node – represents the most recent 
common ancestor (MRCA) of all the species to the right of that node, and the forked 
branches leading from each internal node represent a speciation event resulting in 
two divergent lineages. The leftmost node – the root – represents the most recent 
common ancestor of all the species in the tree. The bars to the right of the phylogeny 
highlight key clades.  
 
Phylogenies are commonly represented in Newick format (Felsenstein 1996b), a text 
representation of the relationships within a phylogeny, which lists the children of a 
node in comma-separated lists enclosed in nested sets of parentheses. See Figure 1.5 
for an example. 
 
A phylogenetic relationship can also be represented in terms of a split: a partition 
(i.e. splitting) of the set of taxa into two groups, so that, for example, the species in 
one partition are more closely related to each other than to the species in the other 
partition. Any compatible set of splits can be used to construct a unique phylogenetic 
tree, and vice versa (Buneman 1971).  
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Figure 1.5: Newick format trees.  
Shown is an illustration of the Newick tree format, a text file format commonly used for 
representing phylogenies in text. A Newick tree comprises a set of taxa where siblings are 
listed in a comma-separated list, while internal nodes are represented by nested parentheses 
enclosing those taxa that descend from the given node. For example, the upper Newick text 
in (A) corresponds to the rooted phylogeny depicted in (B), with taxon 1 grouped with 2, 
taxa 1 and 2 grouped with 3, and taxa 1, 2, and 3 grouped with taxon 4. Due to the nature of 
the Newick format, all Newick trees have an implied root. A workaround used in some 
contexts is to treat Newick trees with a multifurcation at the 'root' as unrooted phylogenies. 
For example, the lower Newick text in (A) corresponds to the phylogeny depicted in (C). 
Strictly speaking, this phylogeny is rooted, with a trifurcation at its root. However, some 
phylogenetic software (e.g. PAML, see Section 1.8.3) interprets such a Newick phylogeny as 
being an unrooted phylogeny like that shown in (D).  
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Figure 1.6 Legend:  
The phylogeny shown on page 35 overleaf depicts the evolutionary relationships of the 22 
species studied in this thesis; these species relationships are uncontroversial (Benton and 
Donoghue 2007). The species shown are (from top to bottom): Human (Homo sapiens), 
Chimp (Pan troglodytes), Gorilla (Gorilla gorilla), Orangutan (Pongo abelii), Macaque 
(Macaca mulatta), Marmoset (Callithrix jacchus), Mouse (Mus musculus), Rat (Rattus 
norvegicus), Guinea Pig (Cavia porcellus), Dog (Canis familiaris), Horse (Equus caballus), 
Cow (Bos taurus), Bat (Myotis lucifugus), Elephant (Loxondonta africana), Opossum 
(Monodelphis domestica), Platypus (Ornithorhynchus anatinus), Lizard (Anolis 
carolinensis), Chicken (Gallus gallus), Zebra Finch (Taeniopygia guttata), Frog (Xenopus 
tropicalis), Fugu (Takifugu rubripes) and Zebrafish (Danio rerio). The clade bars to the right 
show the extent of clades of interest: every species within the edges of each bar is within that 
clade, and the ancestral node for each clade is marked on the phylogeny by a small circle of 
the same colour as the corresponding clade bar. Credit for all animal silhouettes goes to Dr 
Mary J. O'Connell, except for those of the bat and lizard. The bat silhouette is a public 
domain image sourced from Wikimedia Commons (http://commons.wikimedia.org), while 
the lizard silhouette was derived from an image in Fritts and Leasman-Tanner (2001). 
Permission to use the lizard image was obtained from the US Geological Survey. 
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Figure 1.6: Phylogeny of species studied in this thesis. 
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The relationships between the species used in this analysis are largely 
uncontroversial and the divergence times are well calibrated and understood 
(Murphy et al. 2001, Benton and Donoghue 2007). There has been some uncertainty 
over the Eutherian root and the placement of Chiroptera within Laurasiatheria (Asher 
et al. 2009), although Song et al. (2012) have suggested that this uncertainty can be 
resolved by using a multispecies coalescent model in conjunction with phylogenomic 
data. In any case, with respect to the species in this study, the phylogeny of Benton 
and Donoghue (2007) is congruent with that of Song et al. (2012). 
1.7.1 Molecular	  Phylogeny	  
Given a set of homologous genes or proteins, the gene family phylogeny can be 
inferred by comparison of homologous sites. There are a range of different methods 
available for this, falling into four main groups: (I) maximum parsimony, (II) 
distance methods, (III) maximum likelihood and (IV) Bayesian inference. These are 
described briefly in the following sections.  
 
Irrespective of the method used, the inference of phylogeny can be confounded by a 
number of different factors. These include horizontal gene transfer (see Section 1.5), 
gene duplication followed by differential patterns of loss (see Section 1.6.1) and 
compositional bias brought about by biased gene conversion (see Section 1.3.1). 
Other confounding factors in phylogeny reconstruction include variation of 
substitution rates among sites (Yang 1996) and over time (Lockhart et al. 2006), both 
of which violate the assumptions of homogeneous substitution models in common 
use; and incomplete lineage sorting, in which the evolutionary history of a gene 
differs from that of species because two or more speciation events took place in a 
shorter time period than it took for the given gene to reach fixation (Degnan and 
Rosenberg 2009, Philippe et al. 2011). 
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I.	  Maximum	  Parsimony	  
Felsenstein (2004) describes a maximum parsimony tree as "that phylogeny on 
which, when we reconstruct the evolutionary events leading to our data, there are 
as few events as possible." Fitch (1971) developed a maximum parsimony 
algorithm to identify the most parsimonious tree for a set of input sequences.  
 
Maximum parsimony can not make use of all sites in the input sequences; only 
those that are parsimony-informative. For a site to be parsimony-informative, 
there must be at least two character states for that site, each of which must be 
present in at least two sequences. For example, given a phylogeny with four taxa 
— human, mouse, platypus and frog — the presence of a chorioallantoic placenta 
is a parsimony-informative feature, since it is present in human and mouse and 
absent in platypus and frog. This supports a phylogeny grouping human with 
mouse and platypus with frog, at the expense of the other two possible 
phylogenies for these 4 species.  
 
On the other hand, the presence of hair is not parsimony-informative in this case: 
human, mouse and platypus possess hair, while the frog does not. None of the 3 
possible phylogenies of these 4 species are favoured by maximum parsimony with 
respect to the presence of hair. In a similar manner, the homologous character 
states at a sequence alignment site must favour one or more phylogenies as 
maximally parsimonious in order to be considered parsimony-informative.  
 
The advantages of parsimony include its simplicity and low computational 
requirements. A significant disadvantage is its lack of an explicit evolutionary 
model. With more divergent sequences, inability to account for multiple 
substitutions at the same site causes it to underestimate sequence divergence and 
can lead to long branch attraction (LBA) (Yang and Rannala 2012).  
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Long branch attraction is a phenomenon that has the effect of causing species 
with higher rates of substitution — which on a molecular phylogeny, tend to 
reside at the end of long branches — to attract each other in an inferred 
phylogeny, and occurs when the sequence identity is so low as to enter the 
Felsenstein zone (Huelsenbeck and Hillis 1993). Maximum parsimony is 
particularly vulnerable to LBA, and in the Felsenstein zone will converge on an 
incorrect topology even with the addition of more data (Felsenstein 2004). This 
contrasts with maximum likelihood (ML): while ML phylogenies were found to 
be poorly resolved in the Felsenstein zone, ML was at least statistically consistent, 
whereas maximum parsimony methods were found to be more vulnerable to long 
branch attraction artefacts, offering greater support to an incorrect phylogeny 
(Swofford et al. 2001).  
II.	  Distance	  Matrix	  Methods	  
Distance matrix methods include the least squares method (Cavalli-Sforza and 
Edwards 1967, Fitch and Margoliash 1967), the minimum evolution method 
(Rzhetsky and Nei 1994, Desper and Gascuel 2002), and neighbour-joining 
(Saitou and Nei 1987). These methods involve the construction of a matrix 
showing pairwise evolutionary distances between homologous sequences, which 
quantify the divergence between sequences. Pairwise distances can be obtained 
by, for example, a simple estimate of identity between sequences, although 
greater accuracy can be achieved using evolutionary models. For example, the 
formula for estimating the evolutionary distance per site between two sequences 
using the K2P model (Kimura 1980) is shown in Equation 1.5.  
 
€ 
DK 2P = −
1
2 ln(1− 2p − q) −
1
4 ln(1− 2q)  
Equation 1.5: Evolutionary distance under K2P model.  
Shown is the evolutionary distance per site between two sequences under the K2P model 
(DK2P), in terms of the proportion of sites with transition substitutions (p) and the 
proportion of sites with transversion substitutions (q).  
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Distance methods are more computationally efficient than other methods and can 
incorporate explicit models of evolution, but information is lost in the process of 
converting sequences to distances, and these methods are best suited to relatively 
similar sequences (San Mauro and Agorreta 2010). 
III.	  Maximum	  Likelihood	  
Maximum likelihood estimation (MLE) is a common statistical method (Edwards 
1972) that has been applied successfully to the field of phylogenetics (Felsenstein 
1981, Felsenstein 2004, Yang 2006). The likelihood of a model with respect to a 
set of data is defined as the probability of the data, given the model. Maximum 
likelihood estimates the model parameters that maximise the likelihood of the 
given model. In phylogenetics, the data set is composed of the aligned gene 
family sequences, while the model comprises a substitution model and 
phylogenetic tree.  
 
Advantages of maximum likelihood include the ability to incorporate explicit 
models of evolution, allowing these to be tested and improved over time, and the 
capability of testing hypotheses relating to the molecular clock or positive 
selective pressure, which can allow the nature of the evolution of a gene family to 
be analysed. Disadvantages of using maximum likelihood in phylogenetic 
inference include its computational complexity and its sensitivity to the use of a 
mis-specified evolutionary model (Yang and Rannala 2012). Of these two 
disadvantages, the former has been ameliorated by increases in available 
computing power in recent years, while the latter can be avoided by careful choice 
of evolutionary model.  
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IV.	  Bayesian	  Inference	  
Perhaps because of its relatively greater computational requirements, Bayesian 
inference was applied to phylogenetic inference more recently (Rannala and Yang 
1996, Mau et al. 1999, Larget and Simon 1999). Fundamental to Bayesian 
inference is Bayes' Theorem (see Equation 1.6 below), which acts as a framework 
for updating a probability in light of new evidence (Press 2007). The posterior 
probability is obtained in terms of the prior probability and the likelihood of the 
evolutionary model (i.e. substitution model and phylogeny).  
 
€ 
P(A |B) = P(A)⋅ P(B | A)P(B)  
Equation 1.6: Bayes' Theorem.  
This relates the probability of A given B (i.e. P(A|B)) to the probability of A (i.e. P(A)), 
the probability of B given A (i.e. P(B|A)) and the probability of B (i.e. P(B)). The terms 
P(A|B), P(B|A) and P(A) are called the posterior probability, likelihood and prior 
probability, respectively. Phylogenetic inference using maximum likelihood focuses on 
the likelihood of a phylogeny, while Bayesian inference of phylogeny takes account of 
the prior probability, to estimate the posterior probability of one or more phylogenies.  
 
An exhaustive Bayesian inference of phylogenies with more than a modest 
number of species is not practical even with the recent increases in available 
computing power, since the 'tree space' of possible topologies expands factorially, 
so that a tree with 50 taxa has a number of possible topologies comparable with 
the number of protons in the visible universe (Felsenstein 2004).  
 
In practice, most methods performing Bayesian inference of phylogeny use a 
sampling technique known as Markov chain Monte Carlo (MCMC) (Metropolis et 
al. 1953, Hastings 1970, Green 1995). In this approach, tree space is explored by 
a series of stochastic perturbations to phylogenies, in which the parameters of a 
given phylogeny are altered so as to sample its 'neighbours', thereby exploring the 
regions of tree space with more optimal phylogenies. A key property of MCMC is 
that the posterior probability of a phylogeny can be approximated by the 
proportion of time that the phylogeny is sampled from tree space (Tierney 1994).  
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Thus, while other methods infer a single phylogeny, the output of Bayesian 
phylogenetic methods is a distribution of trees sampled from tree space. These are 
typically sampled from a phase in the MCMC process at which the sampled 
phylogenies have converged towards an optimal region in tree space, with trees 
from the initial "burn-in" period before convergence being ignored (Felsenstein 
2004). A maximum a posteriori probability tree may be obtained from this 
distribution (Rannala and Yang 1996). An arguably more powerful approach 
expounded by Huelsenbeck et al. (2002) is to summarise the sampled trees in a 
majority rule consensus tree (Larget and Simon 1999, Huelsenbeck et al. 2001). 
This allows the estimation, for each clade in the phylogeny, of the posterior 
probability that the given clade is true (Huelsenbeck et al. 2002).  
 
Bayesian methods are similar to maximum likelihood estimation in that both 
make use of the likelihood function; hence, they share important statistical 
estimator properties like efficiency and consistency. Trees inferred by Bayesian 
methods have associated posterior probabilities that indicate in an intuitive 
manner how confident one can be in the given phylogeny. The prior probability 
can incorporate information that is known about the tree or model parameters 
(Yang and Rannala 2012). On the other hand, poor choice of prior can adversely 
impact the results of a Bayesian analysis (Rannala et al. 2012).  
 
In addition, the underlying distribution in tree space is typically unknown, so it 
can be difficult to determine when a set of MCMC chains has achieved 
convergence on an optimal region in the parameter space. One convergence 
diagnostic — used by MrBayes (Altekar et al. 2004, Ronquist and Huelsenbeck 
2003, Huelsenbeck and Ronquist 2001) — is the standard deviation of split 
frequencies, where split frequencies are estimated from the set of samples from 
tree space, and their standard deviation reflects the divergence between sampled 
trees. (See Section 1.7 for a definition of 'split' in this context.) Therefore, a lower 
value of the standard deviation of split frequencies indicates that the sampled 
phylogenies are becoming more similar, and are approaching convergence on the 
optimal region of tree space (Ronquist et al. 2007).  
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A further issue is the question of whether tree space has been sampled 
sufficiently, which is a function of the MCMC mixing behaviour: the extent to 
which optimal regions of tree space are explored in proportion to their posterior 
probability (Beaumont and Rannala 2004, Ronquist et al. 2007). As with 
convergence, our ignorance of the underlying distribution in tree space can pose a 
challenge in assessing whether that tree space has been sampled sufficiently, or 
whether, for example, the MCMC process has been 'trapped' in a region of tree 
space that is locally optimal, but not globally so (i.e. better than other trees in its 
neighbourhood, but not best overall). The use of Metropolis-coupled MCMC 
(Geyer 1991) can improve mixing behaviour and ameliorate the problem of local 
optima, and was successfully applied to Bayesian phylogenetic inference by 
Huelsenbeck et al. (2001).  
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1.8 Detecting	  Positive	  Selection	  at	  the	  Molecular	  Level	  
While neutral evolution dominates at the molecular level, natural selection can act 
both to restrict and promote change, in processes known as negative and positive 
selection, respectively. Numerous studies have found evidence for a link between 
positive selection at the molecular level and functional shift (Hughes and Nei 1988, 
Tanaka and Nei 1989, Yokoyama 1996, Messier and Stewart 1997, Levasseur et al. 
2006, Loughran et al. 2012). Freely available statistical packages such as PAML 
(Yang 2007, Yang 1997) and the more recently developed HyPhy (Pond et al. 2005) 
include software to estimate levels of positive selection and thereby infer functional 
shift. This has led to an explosion in the number of positively selected genes 
identified by these methods (Kosiol et al. 2008, Hou et al. 2009, Metzger and 
Thomas 2010, Huang et al. 2012, Loughran et al. 2012). However, the statistical 
methods employed are not without their critics (Hughes and Friedman 2010), and 
inferences of positive selection using these methods are not always borne out by 
follow-up experiments. For example, in a study of fish rhodopsins by Yokoyama et 
al. (2008), eight amino acid sites were inferred by be under positive selection by 
PAML, none of which were found to affect the wavelength of maximum absorption 
of the rhodopsins in site-directed mutagenesis experiments.  
1.8.1 Principles	  of	  Selective	  Pressure	  Analysis	  
Most positive selection inference methods are fundamentally based on the 
comparison of synonymous and non-synonymous substitutions between homologous 
protein-coding genes in different species (Miyata and Yasunaga 1980). With a 
sufficient number of aligned homologous positions, it becomes possible to estimate 
the rates of non-synonymous substitutions per non-synonymous site (Dn) and of 
synonymous substitutions per synonymous site (Ds) across the gene sequence. These 
values can then be used to estimate ω — the key statistic in codon-based selective 
pressure analysis (see Equation 1.7).  
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€ 
ω =
Dn
Ds  
Equation 1.7: Estimation of ω value.  
The value of ω is equal to the ratio of non-synonymous substitutions per non-synonymous 
site (Dn) to synonymous substitutions per synonymous site (Ds).  
 
The value of ω can be used to infer the selective pressure on a given gene, region of 
a gene, or indeed on a lineage containing that homologous sequence, in the following 
ways:  
 
 ω < 1:  indicates that the sequence is likely to be subject to negative (or 
purifying) selection; substitutions in this region that alter the peptide 
sequence are selected against, and the functional constraints on that 
region are high. 
 ω ≈ 1: indicates that the sequence is most likely undergoing neutral 
evolution; both non-synonymous and synonymous substitutions can 
accumulate in approximately equal amounts without having a 
positive or negative impact on the function of the protein. 
 ω > 1: indicates that positive selection has occurred; this happens when 
beneficial mutations are selectively retained by natural selection. 
 
See Figure 1.7 for an illustration of non-synonymous and synonymous substitutions 
and the way in which they are used to infer selective pressure.  
1.8.2 Methods	  of	  Selective	  Pressure	  Analysis	  
Early methods of selective pressure analysis were predominantly distance-based 
(Miyata and Yasunaga 1980, Li et al. 1985, Nei and Gojobori 1986, Li 1993, 
Comeron 1995). These methods generally involved counting non-synonymous and 
synonymous differences between two sequences, while correcting for multiple 
substitutions at the same site and site type, (whether this be synonymous or non-
synonymous).  
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Figure 1.7: Principles of selective pressure analysis.  
Above is a cartoon depiction of the effects of synonymous and non-synonymous 
substitutions and how this is used in selective pressure analyis. To the left of the dashed line 
are three simplified protein structures, representing (from top to bottom): the wild type 
protein, a protein produced by a mutant form of the gene with a synonymous substitution, 
and a protein produced by a mutant with a non-synonymous substitution. Because the 
synonymous substitution does not affect the resultant protein, it is much less susceptible to 
the effects of natural selection and can provide a baseline estimate of the substitution rate. 
This forms the basis for selective pressure analysis by comparison of the rate of non-
synonymous substitution per non-synonymous site (Dn) with the rate of synonymous 
substitution per synonymous site (Ds). The ratio of these two values (Dn/Ds or ω) can be 
used to identify the action of positive selection: a value of ω less than 1 is indicative of 
negative or purifying selection; a value of ω equal to 1 points to neutral evolution; and a 
value of ω greater than 1 indicates that the gene has undergone positive selection for 
functional shift. Figure taken with permission from Morgan (2012). 
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Confounding factors include transition-transversion rate ratios, which can cause 
overestimation of Ds and consequently underestimation of ω, (Li et al. 1985), and 
codon usage bias, which can cause underestimation of Ds and consequently 
overestimation of ω, (Bielawski et al. 2000). Later methods attempted to account for 
transition-transversion rate ratios, (Li et al. 1985, Nei and Gojobori 1986, Li 1993, 
Comeron 1995), and codon usage bias (Yang et al. 2000).  
 
However, Yang and Nielsen (2000) found maximum likelihood methods of selective 
pressure analysis using explicit codon evolutionary models to have superior 
performance over distance-based methods: using a simulated dataset of codon 
sequences, the authors estimated the mean square error (MSE) of ω as estimated by 
three distance methods and maximum likelihood, finding that maximum likelihood 
had overall lowest MSE; especially so in the case of a strong transition-transversion 
bias.  
 
Another popular method of selective pressure analysis makes use of sliding windows 
to identify sites under positive selection, (Endo et al. 1996, Hurst and Pál 2001, Fares 
et al. 2002). Software incorporating sliding window analysis include K-Estimator 
(Comeron 1999) and SWAPSC (Fares 2004). However, sliding window analysis is 
prone to artefactual positive selection: Schmid and Yang (2008) used sliding window 
analysis with simulated data and found that variation in Ds was greater than that of 
Dn, even in cases where the simulated Dn and Ds were constant along the full length 
of the sequence. This was attributed to multiple testing of codon sites as the sliding 
window moves along the sequence (Schmid and Yang 2008). Lin et al. (2011) have 
performed a sliding window analysis that does correct for multiple testing, using at 
gene level a Bonferroni correction for the number of windows tested in the given 
gene, and at genome level the Benjamini and Hochberg false discovery rate 
controlling method (Benjamini and Hochberg 1995). Nevertheless, the question of 
the most appropriate window size and offset to use remains an issue, since this can 
have a significant impact on the outcome of the sliding window analysis (Schmid 
and Yang 2008).  
 
Due to their significant issues, neither sliding window nor averaging-based methods 
(i.e. methods that calculate a single Dn/Ds value for the entire gene/protein) are in 
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common use in contemporary analyses of selective pressure variation. An example of 
the averaging method is the simplest model in the Codeml package, known as Model 
0 (Goldman and Yang 1994, Yang 1998). This model calculates a single ω ratio for 
the entire protein-coding sequence (i.e. an averaging-based method). This is the 
model with the fewest estimated parameters that is implemented in Codeml, and is 
very unlikely to identify positive selection: this is because positive selection in a few 
sites in a sequence can be swamped by neutral evolution and/or negative selection in 
the majority of sites (Anisimova et al. 2001). Only very rarely will the signal of 
positive selection be strong enough for the value of ω to exceed 1 over the whole 
length of the gene sequence.  
1.8.3 Selective	  Pressure	  Analysis	  with	  Codeml	  
More sophisticated models than Model 0 are therefore required to detect most cases 
of positive selection. Codeml from the PAML package (Yang 2007, Yang 1997) is 
arguably the most widely-used maximum likelihood method for selective pressure 
analysis. It supports a variety of models, each representing a particular class of 
evolutionary scenarios. The site-specific and branch-site specific models of Codeml 
allow for heterogeneity in ω by having multiple rate ratio (ω) categories across sites 
and across both branches and sites, respectively.  
Codon	  Models	  of	  Evolution	  and	  Their	  Comparison	  
The site-specific models implemented in Codeml (Nielsen and Yang 1998, Yang 
et al. 2000, Wong et al. 2004) detect selective pressure variation on a site-specific 
basis: codon sites are grouped into site classes, each of which is associated with a 
particular ω value. Model 1a has two site classes with values ω < 1 and ω = 1. 
Model 2a has three site classes with values ω < 1, ω = 1 and ω > 1. The discrete 
models Model 3 (k=2) and Model 3 (k=3), where k refers to the number of site 
classes in each model, allow for varying ω values to be estimated from the data. 
Model 7 (β), Model 8 (β&ω > 1) and Model 8a (β&ω = 1) each have ten site 
classes with ω ≤ 1. Models 8 and 8a both have an extra site class, with ω > 1 and 
ω = 1, respectively. For each of these models the likelihood of the model, given 
the data, is estimated, as is the proportion of sites (p) in the aligned homologous 
sequences that fit into each of these site classes. 
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The branch-site models implemented in Codeml (Yang and Nielsen 2002, Zhang 
et al. 2005) detect rate heterogeneity occurring in specific sites on particular 
lineages, or branches, of the phylogeny. Lineages of interest are chosen by the 
user a priori and each is labelled as a foreground lineage, with unlabelled 
lineages each serving as a background lineage. For example, if one wanted to 
test for positive selection in the Eutherian lineage, that is the lineage that should 
be labelled as foreground and all non-Eutherian species (e.g. chicken, platypus, 
opossum) would be considered as background taxa. Model A and Model A Null 
both have 3 ω value estimates across 4 site classes — see Zhang et al. (2005). 
Model A has constrained ω values as follows: ω0 < 1, ω1 = 1 and ω2 ≥ 1, while 
Model A Null is the null model of Model A, with ω values: ω0 < 1, ω1 = 1 and   
ω2 = 1. The four site classes are 0, 1, 2a and 2b. The ω estimates for site classes 0 
and 1 are respectively ω0 and ω1, in both foreground and background lineages. 
For site class 2a, the background lineage is constrained to ω0, while the 
foreground lineage is constrained to ω2. For site class 2b, the background lineage 
is constrained to ω1, while the foreground lineage is again constrained to ω2. 
Model B is similar to Model A, but differs in that the ω values are free to vary and 
are estimated entirely based on the data (Yang and Nielsen 2002); this is therefore 
the most parameter rich of all models. See Figure 1.8 for a graphical depiction of 
each of the currently available Codeml models and their parameters. 
 
The models are then analysed using a likelihood ratio test (LRT) to compare the 
null hypothesis of neutral evolution and/or negative selection against the 
alternative hypothesis allowing for positive selection. The test statistic (D) of the 
LRT is calculated as shown in Equation 1.8.  
 
  
€ 
D = c⋅ (ln1 − ln 0)  
Equation 1.8: Likelihood ratio test statistic.  
The likelihood ratio test statistic D is shown in terms of the log-likelihood of the null and 
alternative models (ln  
€ 
 0 and ln  
€ 
 1, respectively), as well as a constant factor c specific to 
each pair of Codeml models.  
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For a pair of nested models, D follows a χ2 distribution with degrees of freedom 
(ν) equal to the difference in the number of free parameters in the two models. 
The goodness-of-fit of the null and alternative models can be compared using a χ2 
test. See Table 1.1 for a summary of the LRTs that can be performed on currently 
available Codeml models.  
 
Where Codeml infers that positive selection has occurred and the LRT confirms 
this, the positive selection model estimates may be used to estimate the posterior 
probability (PP) that a given site belongs to the category of positively selected 
sites. This can be done using a Naïve empirical Bayes (NEB) approach (Nielsen 
and Yang 1998) or a Bayes empirical Bayes (BEB) method (Yang et al. 2005). 
However, the Naïve empirical Bayes fails to account for uncertainties in 
parameter estimates and may infer sites to be positively selected with a high rate 
of false-positives, while on the other hand Bayes empirical Bayes can identify 
amino acid sites under positive selection more accurately. Indeed, in a simulation 
study by Yang et al. (2005), using 100 replicate datasets with a 30 taxon tree, in 
which half of the sites had an ω value of 1 and half were given an ω value of 1.5, 
BEB positively selected sites under Model 8 captured 9% of true-positives and 
5% of false-positives, while NEB inference under the same model identified 16% 
of positively selected sites, but had a false-positive rate of 14%. The authors of 
this study concluded that where possible, positively selected sites inferred under 
Bayes empirical Bayes should be used in preference to those inferred by Naïve 
empirical Bayes.  
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Figure 1.8: Models of codon substitution implemented in Codeml.  
Above is a graphical depiction of the codon substitution models used for selective pressure 
analysis by Codeml from the PAML package (Yang 2007, Yang 1997). Each model is 
shown with the set of possible values for ω under that model. These models are described in 
detail in Section 1.8.3. (A) Model 0 and the site-specific codon models in order of increasing 
complexity, with Model 0 being the simplest model implemented by Codeml and Model 8 
being the most complex site-specific model used in this thesis. (B) Branch-site specific 
models are shown, with a phylogenetic tree illustrating the foreground lineage in red. Figure 
adapted with permission from Morgan (2012). 
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Table 1.1: Likelihood ratio tests used in Codeml analysis. 
Null Model Alternative Model ν χ2 Critical Value 
Model 0 Model 3 (k=2) 2 5.99 
Model 3 (k=2) Model 3 (k=3) 1 1.00 
Model 1a Model 2a 2 5.99 
Model 7 (β) Model 8 (β&ω>1) 2 5.99 
Model 8a (β&ω=1) Model 8 (β&ω>1) 2 2.71 
Model 1a Model A 2 5.99 
Model A Null Model A 2 3.84 
Model 3 (k=2) Model B 2 5.99 
 
Table 1.1 Legend:  
This table shows the key statistics for each of the likelihood ratio tests used in the selective 
pressure analysis with Codeml in this thesis. The Null Model and Alternative Model 
columns show, respectively, the null and alternative models being tested in each LRT. The 
column marked ν shows the degrees of freedom in the χ2 distribution being used for each 
LRT, while the χ2 Critical Value column indicates the critical value that must be exceeded 
by the LRT test statistic D (see Equation 1.8) in order for the null model to be rejected at a 
5% significance level.  
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Accuracy	  and	  Power	  of	  Codeml	  
Although the models implemented in Codeml have been found to be both accurate 
and powerful, (Anisimova et al. 2001, Zhai et al. 2012), a number of factors can 
confound the identification of positively selected genes and amino acid sites. In 
some cases, biased gene conversion may give the appearance of positive selection, 
(Galtier and Duret 2007). For example, Galtier et al. (2009) found the proportion 
of AT→GC substitutions to be significantly greater in lineages undergoing 
accelerated amino acid evolution (43.6%), than in non-accelerating lineages 
(39.6%). Recombination itself can cause spurious signals of positive selection, 
although Codeml is robust to lower levels of recombination, (Anisimova et al. 
2003). Population bottlenecks can also lead to false-positive identification of 
positive selection, because slightly deleterious substitutions are more likely to 
become fixed in a smaller population (Ohta 1973). Relaxation of selective 
constraint could similarly lead to spurious identification of positive selection, 
since such a relaxation can affect the non-synonymous substitution rate. Indeed, a 
selective pressure analysis was performed by Crandall and Hillis (1997) to 
determine whether selective pressure had been relaxed on rhodopsin genes in 
cave-dwelling crayfish. (No significant relaxation was inferred in that case, 
leading the authors to suggest that the rhodopsins in question may have some 
additional function other than phototransduction.) In addition to these factors, a 
reduced rate of adaptation in species with lower effective populations, combined 
with a higher proportion of neutral (or nearly neutral) substitutions, conspire to 
make adaptive change more difficult to accurately detect in such species 
(Gossmann et al. 2012, Lartillot 2012). 
 
There are some aspects of selective pressure analysis that can be controlled more 
easily. The power of selective pressure analysis with Codeml is known to be low 
with less than 7 sequences (Anisimova et al. 2001) or with less than 100 codon 
sites (Bielawski and Yang 2003). In order to avoid the local optimum problem, 
Codeml should be run multiple times with different initial ω values, with at least 
one initial ω value below one, and one inital ω value above one (Bielawski and 
Yang 2003). 
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Schneider et al. (2009) identified three areas of selective pressure analysis in 
which avoidable errors can occur, as follows:  
 
 sequence quality: genes with less than 3X sequencing coverage were found 
to have inferred rates of positive selection more than 3 times greater than 
those genes with more than 3X coverage. 
 
 annotation quality: positive selection was inferred for 7.6% of Ensembl 
"known" genes, as opposed to 14.6% of those genes inferred by the Ensembl 
gene prediction pipeline. 
 
 sequence alignment: genes in multiple sequence alignments with a 100% 
Heads or Tails (HoT) score (Landan and Graur 2007) were inferred to have 
positive selection in 9.5% of cases, as opposed to 15% of those gene families 
with a HoT score less than 100%. 
 
Such errors can be minimised by using high-quality, high-coverage sequence data, 
by favouring more confidently annotated sequences and by careful choice of 
alignment method, respectively (Schneider et al. 2009). Increases in the quantity 
and quality of available genomic sequences in recent years (Flicek et al. 2012) 
can ameliorate the first two issues, while the active development of alignment 
methods (Edgar 2004b, Löytynoja and Goldman 2008), and alignment 
performance comparisons (Fletcher and Yang 2010, Markova-Raina and Petrov 
2011), can help with the third issue.  
 
The codon-based methods of Codeml have come under criticism, however, with a 
number of studies demonstrating false-positive inferences of positive selection 
using Codeml (Friedman and Hughes 2007, Suzuki 2008, Nozawa et al. 2009). 
For example, Friedman and Hughes (2007) found that inference of positive 
selection was correlated significantly (α = 0.05) with the GC content in the third 
codon position (GC3), mean synonymous substitution rate and the length of input 
gene sequences, but found no significant correlation (at a 5% significance level) 
of positive selection with either mean non-synonymous substitution rate or mean 
estimated ω value. As a rationale for these results, the authors suggested that the 
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correlation with sequence length may simply be due to the greater power of the 
LRT with more data; that the synonymous substitution rate was affected in their 
dataset by the presence of paralogous groups, in addition to the neutral 
substitution rate; and that the correlation with GC3 content reflected a more 
general GC bias in mammalian genomes. Zhai et al. (2012) sought to address the 
concerns of Friedman and Hughes (2007) in particular by repeating their analysis. 
However, Zhai et al. (2012) could not replicate the results of Friedman and 
Hughes (2007), finding instead that inference of positive selection was correlated, 
as expected, with mean estimated ω value and gene sequence length. Zhai et al. 
(2012) found no significant correlation between inference of positive selection 
and mean non-synonymous substitution rate, mean synonymous substitution rate 
or GC content.  
 
Hughes and Friedman (2005) criticised the use of codon-based methods such as 
Codeml to infer positive selection, arguing that a certain proportion of sites are 
expected to have an ω value estimate greater than one, due to chance variation in 
the rate of synonymous and non-synonymous substitution. Indeed, the authors 
found that proportions of non-synonymous (pN) and synonymous (pS) substitution 
substitutions in nearly 2 million codons across more than 4 thousand genes from 
the aligned genomes of S. cerevisiae and S. paradoxus, found that 6.47% of 
codons had an excess of pN over pS, significantly greater than 6.31% — the rate 
expected by chance in that dataset (P < 0.001). Zhai et al. (2012) agreed that in 
many cases variation in synonymous and non-synonymous substitution rate 
affects the estimation of ω, but argued that in most such cases the LRT will not 
achieve significance in testing alternative models as a result of this variation.  
 
Hughes (2007) argued that many of the models used lack a prior biological 
hypothesis. Zhai et al. (2012) countered that LRTs with site models do indeed 
have a set of prior statistical hyphotheses based on biological understanding of the 
effect of natural selection on nucleotide and amino acid sequences.  
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As an example, the authors cite codon models Model 1a (having two site classes 
with ω0 < 1 and ω1 = 1) and Model 2a (including an additional site class such that      
ω2 > 1). If an LRT rejects the null model, Model 1a, in this case, such a result 
constitutes statistical evidence that non-synonymous substitutions are 
preferentially fixed at some codon sites in the gene. The prior statistical 
hypothesis — that the ratio of non-synonymous to synonymous substitutions is 
greater than unity in some codons of a gene — can therefore be tested without 
reference to the specific process of adaptive substitution at play, or indeed prior 
knowledge of which sites are under positive selective pressure (Zhai et al. 2012). 
 
While Zhai et al. (2012) appear to have addressed the narrow methodological 
concerns raised by Friedman and Hughes in their 2005 and 2007 studies, a 
broader epistemic question was raised by Hughes and Friedman (2010): the 
comparison of non-synonymous and synonymous substitutions is only suited to a 
scenario in which repeated amino acid substitution in the same gene has been 
favoured by natural selection. Further to this, they proposed several alternative 
scenarios of adaptive novelty that can not be modelled by codon-based 
comparisons of non-synonymous and synonymous substitutions. For a given gene 
these can include a single amino acid substitution, an insertion or deletion, a loss 
of splice signals that in turn leads to exon loss, gene fusion and a change in the 
regulation of the gene that affect its expression. It is to this last source of 
evolutionary novelty — gene regulation — that we turn next.  
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1.9 Gene	  Regulation	  
Sequence evolution plays a key role in creating evolutionary novelty, but the picture 
is inevitably incomplete without considering the role played by the regulation of 
gene expression (Hughes and Friedman 2010). Mechanisms of gene regulation are 
many and varied, including chromatin remodelling (Saha et al. 2006), cell signalling 
(Shin and Manley 2004), transcriptional regulation by transcription factors (Spitz and 
Furlong 2012), alternative splicing (Barash et al. 2010, Roy and Gilbert 2006), 
alternative polyadenylation (Di Giammartino et al. 2011), post-transcriptional 
regulation by miRNA (Pasquinelli 2012), DNA methylation (Suzuki and Bird 2008) 
and genomic imprinting (Ferguson-Smith 2011).  
 
Transcription factors and miRNAs are arguably better studied than other forms of 
gene regulation (Chen and Rajewsky 2007). Both modes of gene regulation are 
believed to be critical for the development of multicellular eukaryotes. On one hand, 
transcription factors are known to play a role in co-ordination of body plans, (Levine 
and Tjian 2003, Davidson and Erwin 2006, Peter and Davidson 2011), while on the 
other, miRNAs have been shown to maintain phenotypic precision through tight 
control of the expression of target genes, (Cohen et al. 2006, Hornstein and Shomron 
2006, Peterson et al. 2009a). The sequence-specific nature of regulatory binding sites 
for transcription factors and miRNAs might be seen as supporting a prima facie 
argument for the identification of such binding sites using bioinformatics. However, 
the reality is more complex — neither transcriptional nor miRNA regulation are 
completely understood — and the in silico identification of binding sites remains 
challenging both for transcription factors and for miRNAs. For example, high 
turnover of individual transcription factor binding sites can hinder their identification 
with conservation footprinting (Wasserman and Sandelin 2004), while miRNA-target 
interactions, being incompletely understood, cannot be modelled accurately without 
introducing some false-positives (Bartel 2009).  
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1.9.1 Transcription	  Factors	  
A transcription factor is a protein that binds to a specific DNA sequence to regulate 
the expression of its target gene(s). This can include general transcription factors 
(GTFs) that bind to core promoter elements, as well as activators and repressors that 
respectively enhance and repress target gene expression (Lee and Young 2000). By 
controlling the timing and extent of gene expression, transcription factors facilitate 
the development of complex structures in multicellular eukaryotes, such as the 
choriallantoic placenta (Cross et al. 2002, Rawn and Cross 2008).  
 
Significant challenges remain with in silico identification of transcription factor 
binding sites (Wasserman and Sandelin 2004, Tompa et al. 2005). Such methods 
typically make use of sequence motifs and phylogenetic footprinting (i.e. positive 
weighting of conserved orthologous sequence) to identify putative transcription 
factor binding sites, but false-positive prediction rates remain intolerably high, such 
that the majority of predicted transcription factor binding sites are not biologically 
meaningful — due perhaps to the difficulties in modelling the relevant interactions, 
the high turnover of individual binding sites, or difficulties in validating interactions 
in vivo (Wasserman and Sandelin 2004, Tompa et al. 2005).  
1.9.2 MicroRNAs	  
MicroRNAs are a class of short non-coding molecules of RNA of ~22 nucleotides in 
length that regulate genes post-transcriptionally by binding to their expressed 
transcripts (Lewin 2008). MiRNAs are believed to have widespread influence on 
gene expression levels (Bartel and Chen 2004), and estimates of the proportion of 
human genes regulated by these short RNA molecules range from 25% (Lewis et al. 
2005) to 50% of the transcriptome (Shomron et al. 2009).  
 
Among regulatory mechanisms, miRNA regulation lends itself to bioinformatics 
studies because these short non-coding RNA molecules are more highly conserved 
and more amenable to computational binding site prediction than transcription 
factors (Chen and Rajewsky 2007). Furthermore, miRNAs have a characteristic that 
is highly desirable in evolutionary biology — they are unique and rarely secondarily 
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lost (Sperling and Peterson 2009). Once a miRNA emerges in a lineage it is rarely 
subsequently lost, therefore the patterns of presence and absence themselves reveal 
an appreciable amount of robust information on evolutionary history (Sperling and 
Peterson 2009). 
 
MiRNAs were initially discovered by Lee et al. (1993), who found that the C. 
elegans gene lin-4 produced a short RNA that was complementary to a number of 
sites in the 3′ untranslated region (3′ UTR) sequence of lin-14. These sites had 
previously been identified as mediating the regulation of lin-14 by lin-4 (Wightman 
et al. 1991). It was proposed that the binding of lin-4 to the 3′ UTR of lin-14 
repressed the translation of that gene, reducing levels of LIN-14 protein without 
significantly affecting lin-14 mRNA levels (Lee et al. 1993, Wightman et al. 1993).  
 
It appeared as if this regulatory mechanism was specific to this one region in C. 
elegans until Reinhart et al. (2000) demonstrated that the C. elegans gene let-7 
regulated several genes in a similar manner, and Pasquinelli et al. (2000) identified 
homologous sequences in multiple species including human, raising the prospect that 
this mode of regulation was more widespread than previously believed. This new 
class of regulators was termed miRNAs (Lagos-Quintana et al. 2001) and within a 
few years miRNAs were recognised as playing a significant role in gene regulation 
and development (Bartel 2004). MiRNAs are present in both animals (Brennecke et 
al. 2003, Johnston and Hobert 2003, Chen 2004a) and plants (Aukerman and Sakai 
2003, Emery et al. 2003, Chen 2004b), although there are differences in miRNA 
biogenesis and modes of action between the two kingdoms (Millar and Waterhouse 
2005, Axtell et al. 2011). The miRNA database miRBase (Griffiths-Jones 2004, 
Griffiths-Jones 2006, Griffiths-Jones et al. 2008, Kozomara and Griffiths-Jones 
2011) now has over a thousand annotated miRNAs in human, and more than 20,000 
entries in total.  
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1.9.3 Biogenesis	  of	  MicroRNAs	  
Vertebrate miRNA biogenesis can occur through a number of pathways, as shown in 
Figure 1.9. The primary miRNA transcript (pri-miRNA) may be derived from an 
intron (Calin et al. 2002) or exon (Tam 2001) of a non-coding transcript. Pri-
miRNAs may also be derived from the intron (Bortolin-Cavaille et al. 2009) or exon 
(Lu et al. 2008) of a protein-coding transcript, although the latter is controversial 
(Berezikov et al. 2010) and is not believed to be a significant source of miRNAs 
(Berezikov 2011). MiRNAs are typically transcribed by RNA Polymerase II (Lee et 
al. 2004). Borchert et al. (2006) found evidence that the chromosome 19 microRNA 
cluster (C19MC) is transcribed by RNA polymerase III, but this was challenged by 
Bortolin-Cavaillé (2009), who demonstrated that this miRNA cluster lies within the 
introns of a non-coding gene that is transcribed by RNA Polymerase II.  
 
In canonical miRNA biogenesis, the pri-miRNA is processed by the Microprocessor 
complex, to produce one or more hairpin loop precursor miRNAs (pre-miRNAs) of 
around 70 bases in length (Denli et al. 2004, Gregory et al. 2004). The 
Microprocessor complex contains Drosha (Lee et al. 2003) and its cofactor DiGeorge 
syndrome critical region gene 8 (DGCR8) in human, or Pasha in C. elegans and D. 
melanogaster (Han 2004, Landthaler et al. 2004).  
 
Alternatively, pre-miRNAs may arise in a Drosha-independent manner as mirtrons. 
These are pre-miRNAs that form from spliced introns that undergo Lariat 
debranching (Ldbr) before progressing along the canonical miRNA biogenesis 
pathway (Kim et al. 2009). Mirtrons were first observed in D. melanogaster and C. 
elegans (Okamura et al. 2007, Ruby et al. 2007a) and shortly afterwards in mammals 
(Berezikov et al. 2007, Sibley et al. 2011). 
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Figure 1.9: Pathways of microRNA biogenesis in vertebrates.  
Three main miRNA biogenesis pathways are known in vertebrates: canonical miRNA 
biogenesis in which the primary miRNA is processed by the Drosha in the Microprocessor 
complex, the resulting precursor miRNA is exported from the nucleus, spliced by the Dicer 
complex and recruited by Argonaute; conventional mirtron biogenesis, in which a spliced 
intron undergoes Lariat debranching (Ldbr) before progressing along the canonical miRNA 
biogenesis pathway; and a Dicer-independent pathway, in which the pre-miRNA is both 
spliced and recruited by Argonaute-2. Figure adapted with permission from Axtell (2011). 
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Whatever the mechanism by which it arises, the pre-miRNA is exported from the 
nucleus to the cytoplasm in a process mediated by Exportin-5 (Kim 2004). Typically 
the pre-miRNA is then spliced by the Dicer complex, removing the hairpin loop and 
leaving only a miRNA duplex of about 22 bases in length (Bernstein et al. 2001, 
Ketting 2001, Hutvagner et al. 2001). Following cleavage by Dicer, the miRNA 
duplex is recruited by Argonaute, (Liu et al. 2004, Meister et al. 2004) and 
incorporated into the RNA-induced silencing complex (RISC), (Gregory et al. 2005). 
One strand — known as the guide strand — is retained in the RISC as a single-
stranded mature miRNA, while its complementary strand — the passenger strand 
— is degraded (Schwarz et al. 2003, Khvorova et al. 2003). It is important to note 
that this bias in strand retention is by no means universal, and functional activity has 
been reported for many so-called passenger strands (Yang et al. 2011). A Dicer-
independent pathway has also been observed in vertebrates, in which Argonaute-2 
(Ago2) in particular serves a dual purpose of recruiting the pre-miRNA and 
mediating its cleavage (Cheloufi et al. 2010, Cifuentes et al. 2010, Yang et al. 2010). 
Once the mature miRNA is incorporated into the RISC, it is then available to assist 
the RISC in regulating mRNA transcripts (Axtell et al. 2011).  
1.9.4 MicroRNA-­‐Target	  Interactions	  
Although it was known from their initial discovery that miRNAs modulate the 
expression of their targets in a sequence-specific manner (Lee et al. 1993, Wightman 
et al. 1993), our understanding of the nature of miRNA-target interactions has 
evolved since that time to form a picture that is more rich, more complex, and in 
some ways more incomplete, (Bartel 2004, Brennecke et al. 2005, Breving and 
Esquela-Kerscher 2010, Bartel 2009, Berezikov 2011). The precise mechanisms by 
which miRNAs regulate their targets remain incompletely understood and are the 
subject of debate, although the most commonly reported mode of action remains 
post-transcriptional repression of the target mRNA by the mature miRNA in 
conjunction with RISC (Morozova et al. 2012).  
 
The canonical function of a miRNA is to downregulate expression of a specific 
mRNA target by inducing cleavage or translational repression, where base pairing of 
the miRNA to the target mRNA is extensive or partial, respectively (Bartel 2009). 
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Cleavage of the target is more commonly observed in plants (Rhoades et al. 2002), 
while in animals extensive complementarity of miRNA and target is believed to be 
comparatively rare, and consequently translational repression is considered the more 
dominant mode of action, (Yekta et al. 2004, Davis et al. 2005). The repressive 
action of miRNAs is supported by the observation by Farh et al. (2005) that mRNAs 
that are conserved targets of a given miRNA tend to be expressed in the same tissue 
as the cognate miRNA, but that such miRNA-target pairs tend to have inverse 
expression patterns. For example, an accumulation of miR-1 and miR-133, after cell 
cycle arrest in differentiating myoblasts, was found to be associated with reduced 
expression of genes predicted to be targets of these two miRNAs (Farh et al. 2005).  
 
In addition to repression activity, miRNAs have also been observed to upregulate 
expression (Vasudevan et al. 2007, Ørom et al. 2008) and to be linked to direct 
tuning of gene expression rather than outright repression (Poy et al. 2004, Karres et 
al. 2007). This expands the role of miRNA to both that of an expression switch and 
an expression fine-tuner, in a threshold-dependent manner (Mukherji et al. 2011). 
Reflecting this potentially broader set of functions, it has been proposed that 
miRNAs allow for more precise control of gene expression (Bartel and Chen 2004, 
Peterson et al. 2009a). The latter hypothesised that miRNAs effectively offer greater 
phenotypic precision (and therefore greater heritability) by exercising tight control 
over the level of target protein produced, without which elaborate morphological 
structures might not be possible. 
MicroRNA-­Target	  Site	  Features	  
Perhaps the most important feature of miRNA-target interactions — and probably 
the most utilised in early miRNA-target prediction (Lewis et al. 2003, John et al. 
2004, Grün et al. 2005) — is binding of the microRNA seed region to the target 
site. The microRNA seed was defined by Lewis et al. (2003) as comprising bases 
2-8 of the miRNA, numbering from the 5′ end. A seed match site is a region of a 
miRNA-target sequence that is complementary to the miRNA seed sequence. By 
identifying seed match sites that were conserved in orthologous sequences across 
human, mouse and rat, Lewis et al. (2003) predicted miRNA-target sites with a 
signal-to-noise ratio of 7:2, demonstrating that conserved seed match sites were a 
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good indication of a functional miRNA-target site. Subsequent studies confirmed 
the importance of seed binding to miRNA-target interactions (Doench and Sharp 
2004, Kloosterman et al. 2004, Krützfeldt et al. 2005), and its utility in predicting 
such interactions (Lewis et al. 2005, Krek et al. 2005, Brennecke et al. 2005). 
 
Figure 1.10 shows the known types of seed match miRNA-target site and their 
relative proportions among conserved vertebrate miRNA targets as observed by 
Friedman et al. (2009). Both Figure 1.10 and the nomenclature used for seed 
match miRNA-target sites are taken from Bartel (2009). The canonical miRNA-
target site types include 8mer, 7mer-m8 and 7mer-A1 sites (Lewis et al. 2005). 
The 8mer and 7mer-m8 sites both have Watson-Crick (WC) complementarity to 
sites 2-8 of the miRNA, while the 7mer-A1 site only has WC complementarity to 
miRNA sites 2-7. Both the 8mer and the 7mer-A1 sites are flanked by an 
adenosine opposite miRNA site 1, while a 7mer-m8 site lacks this. The 8mer is 
considered to be more indicative of a functional miRNA-target site than the 7mer 
site types, while a 7mer-m8 site is considered to have more efficacy than a 7mer-
A1 site. The 6mer target sites pairing to miRNA sites 2-7 and 3-8 are considered 
to be a marginal miRNA-target site type and by themselves are not considered 
to be particularly discriminative (Grimson et al. 2007, Nielsen et al. 2007). 
Preferential conservation of miRNA-target site types reflects this, with the 
canonical and marginal site types, ordered by decreasing conservation signal-to-
background ratios, as follows: 8mer, 7mer-m8, 7mer-A1 and 6mer (Friedman et 
al. 2009). 
 
In some seed match sites, supplementary WC base pairing occurs between sites 
12-17 of the miRNA and the target, in what is known as a 3′-supplementary site 
(Brennecke et al. 2005, Lim et al. 2005). Base pairing between sites 12-17 can 
also compensate for imperfect binding of the seed region in a 3′-compensatory 
site (Yekta et al. 2004), although these are believed to be relatively rare 
(Friedman et al. 2009).  
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Although seed match miRNA targets remain the most easily discriminated using 
sequence data, due to their (often conserved) high sequence complementarity to 
the miRNA seed sequence, binding of the miRNA seed region to the target is not 
always required for miRNA regulation. Functional miRNA targets have been 
observed that lack a seed region (Vella 2004, Hammell et al. 2008, Lal et al. 
2009, Chi et al. 2009), and in some cases G:U base pairing in the seed region is 
tolerated (Didiano and Hobert 2006). Indeed, up to 27% of Ago-mRNA clusters 
in murine brain are orphan clusters: regions bound by Ago-miRNA complexes 
but lacking a canonical seed match site for the set of top Ago-bound miRNAs 
(Chi et al. 2009). A reliance on seed match sites is also widely acknowledged to 
introduce many false-positive miRNA-target predictions (Bartel 2009, Peter 
2010), with as many as two-thirds of predicted targets by some seed match 
methods being found to be non-responsive to knockout of the cognate miRNA 
(Baek et al. 2008). This has led some authors to conclude that despite its success 
in identifying a significant class of functional miRNA-target sites, seed region 
binding is neither necessary nor sufficient for miRNA-target interactions 
generally (Hammell et al. 2008, Chi et al. 2012).  
 
To complicate the picture further, at least two other classes of miRNA-target site 
type have been observed: the centred site and the bulge site. The centred 
miRNA-target site was observed by Shin et al. (2010) using pooled microarray 
data from miRNA and short interfering RNA (siRNA) transfection experiments 
(Lim et al. 2005, Birmingham et al. 2006, Jackson 2006, Jackson et al. 2006, 
Schwarz et al. 2006, Grimson et al. 2007, Anderson et al. 2008). This site type is 
characterised by WC base-pairing of 11 contiguous sites towards the centre of the 
miRNA (i.e. miRNA sites 4-14 or 5-15) and a lack of substantial pairing at either 
end of the miRNA (see Figure 1.11, part A). Centred miRNA-target sites were 
shown not to be an artefact of extended base pairing of canonical seed match sites, 
and were estimated to be about as common as 3′-compensatory sites (Shin et al. 
2010). Friedman et al. (2009) estimated the proportion of conserved seed match 
miRNA-target sites that are 3′-compensatory to be about 2%, so while centred 
sites are an important new class of miRNA-target site, they are likely to be quite 
rare.  
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Figure 1.10: MicroRNA-target site types.  
Above is a depiction of a number of known miRNA-target site types with seed binding. The 
canonical site types include (A) 7mer-A1, (B) 7mer-m8 and (C) 8mer, while the more 
marginal 6mer and offset 6mer are shown in (D) and (E). Watson-Crick binding of the 
miRNA to its target may occur towards the 3′ end of the miRNA, either to supplement seed 
binding (F) or to compensate for imperfect seed binding (G). The pie chart in (H) shows the 
proportions of each site type as estimated by Friedman et al. (2009). Figure taken from 
Bartel (2009). Permission obtained via the Copyright Clearance Center. 
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Figure 1.11: Alternative miRNA-target site types.  
Shown are two observed miRNA-target site types that differ from those shown in Figure 
1.10: (A) centred sites, in which base pairing of miRNA to target sequence is observed 
principally towards the centre of the miRNA (Shin et al. 2010), and (B) miRNA bulge sites, 
in which a functional miRNA-target interaction with a target sequence of imperfect 
complementarity to the miRNA seed is facilitated by a transitional nucleation bulge, such 
that miRNA sites 2-6 then bind to their corresponding nucleotides in the target sequence, the 
nucleotide opposite miRNA site 6 forms the bulge, and site 6 binds to the nucleotide on the 
target sequence immediately 5′ of the bulge nucleotide (Chi et al. 2012). Part (A) is taken 
from Shin et al. (2010), while part (B) is taken from Chi et al. (2012). Both figures are 
reproduced with permission obtained from the Copyright Clearance Center. 
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The miRNA-target bulge site was reported by Chi et al. (2012), who made use 
of a genome-wide Argonaute HITS-CLIP survey of Ago-miRNA binding sites in 
mouse brain cells (Chi et al. 2009). In a bulge site, miRNA sites 2-5 and 6-8 are 
bound to the target, but the target mRNA has a bulge between miRNA sites 5 and 
6. Chi et al. (2012), proposed that binding of a miRNA to a bulge site is preceded 
by a transitional nucleation bulge, such that miRNA sites 2-6 bind to their 
corresponding nucleotides in the target sequence. The nucleotide opposite miRNA 
site 6 then forms the bulge, while site 6 binds to the target sequence immediately 
5′ of the bulge nucleotide (Chi et al. 2012), see Figure 1.11, part B.  
 
Using data from a meta-analysis by (Khan et al. 2009) of several miRNA 
transfection microarray experiments, Chi et al. (2012) showed that repression of 
genes mediated by bulge sites was significant (Kolmogorov-Smirnov test, P = 
0.03), although less significant than that of genes containing canonical seed match 
sites (Kolmogorov-Smirnov test, P = 1.05 × 10−24). These authors pointed out that 
bulge sites have been observed before (Ha et al. 1996, Vella 2004), but were not 
recognised as a widespread miRNA-target site type. At least 15% of targets in 
mouse brain were found to contain miRNA-target bulge sites, which suggests that 
this site type is relatively common (Chi et al. 2012). 
MicroRNA-­Target	  Site	  Context	  
Perhaps the most significant aspect of miRNA-target site context is its location on 
the target mRNA. The 3′ untranslated region (UTR) of the target mRNA has 
historically been considered to host the majority of functional miRNA-target sites 
in animals, although whether this is due to mechanistic effects or historical 
contingency has been questioned (Bartel 2004). Most, if not all, of the earliest 
examples of animal miRNA-target sites were found in the 3′ UTR of their target 
gene (Bartel 2004). In addition, many of the early methods of miRNA-target 
prediction made use of conservation filters, and conserved miRNA-target sites 
would be more easy to detect against the relatively unconserved background of 3′ 
UTRs, compared to the more constrained coding sequence regions. Their relative 
ease of detection in 3′ UTRs would have exacerbated any initial acquisition bias, 
if one existed (Rigoutsos 2009, Peter 2010).  
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One suggested mechanistic explanation for enrichment of miRNA targets in 3′ 
UTR sequences is that ribosomal activity in coding regions prevents the miRISC 
from binding effectively (Bartel 2004). A mechanistic explanation is supported by 
Gu et al. (2009), who modified the stop codon of a reporter gene to effectively 
extend the expressed region of the transcript so as to include a miRNA-target site 
located in the 3′ UTR. This had the effect of eliminating repression of the reporter 
gene by the cognate miRNA. By addition of rare codons upstream of the miRNA-
target site, ribosome stalling was induced and miRNA translational inhibition was 
restored (Gu et al. 2009). 
 
Nevertheless, evidence has accumulated that at least some miRNA targets are to 
be found in coding regions (Duursma et al. 2008, Forman et al. 2008, Tay et al. 
2008, Zhou et al. 2009, Elcheva et al. 2009, Huang et al. 2010, Fang and 
Rajewsky 2011) and in 5′ UTRs (Lytle et al. 2007, Ørom et al. 2008, Lee et al. 
2009, Zhou et al. 2009). Schnall-Levin et al. (2011), in particular, noted a 
tendency for targeting by miR-181 to be unusually effective in the repeat-rich 
coding regions of its target genes retinoblastoma 1 (RB1) and RB-associated 
KRAB zinc finger (RBAK) (Schnall-Levin et al. 2011). The efficacy of miRNA-
target sites in coding regions has been found to be marginal relative to those in 3′ 
UTRs; in a miRNA transfection experiment, the mean log2 fold change of target 
mRNA expression was -0.08 for genes with a miRNA-target site in their coding 
region, and -0.175 for genes with a miRNA-target site in their 3′ UTR (Baek et al. 
2008). It has been proposed that miRNA-target sites in coding regions will be 
more effective for mRNAs that are not efficiently translated (Bartel 2009).  
 
More local target features associated with functional miRNA-target sites include 
high local AU content of the target sequence and proximity of the miRNA-target 
site to either end of the 3′ UTR (Grimson et al. 2007, Majoros and Ohler 2007).3  
                                                
3 Grimson et al. 2007 did note one exception to this: miRNA-target sites in a 3′ UTR that are 
within ~15 base pairs of the stop codon were less preferentially conserved and were also 
found to be less effective than other target sites in the 3′ UTR at mediating downregulation.  
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The 3′ UTR length of a gene indicates whether it is likely to be the target of a 
miRNA, such that highly targeted genes tend to have longer 3′ UTRs (Stark et al. 
2005). Indeed, even isoforms of the same gene with a longer 3′ UTR are more 
likely to be subjected to miRNA regulation (Sandberg et al. 2008). Structural 
accessibility of the mRNA in the vicinity of the putative target site has been 
shown to have a positive effect on miRNA-target interactions (Long et al. 2007, 
Kertesz et al. 2007). The presence of multiple miRNA-target sites on the same 
target sequence was found to have an additive effect on target repression, with 
synergistic effects being observed when miRNA-target sites were in close 
proximity (i.e. 8-40 bases) (Grimson et al. 2007, Saetrom et al. 2007, Hon and 
Zhang 2007).  
 
A broader aspect of a given miRNA-target interaction is the cellular context in 
which it takes place, and the relative abundance of competing targets in the cell. 
The competing target abundance (TA) — defined by Garcia et al. (2011) as the 
number of nonoverlapping canonical miRNA-target sites in the available 3′ UTR 
sequences of the given transcriptome — has been shown to affect individual 
miRNA-targeting efficacy and specificity (Anderson et al. 2008, Arvey et al. 
2010). For example, in a bioinformatics analysis following a set of miRNA 
transfection experiments, Arvey et al. (2010) found a significant correlation 
between difference in TA and difference in levels of downregulation (Spearman's 
rank correlation coefficient, ρ=0.59; P < 10-15). Target abundance has also been 
shown to be a discriminative feature for identifying miRNA-target sites (Garcia et 
al. 2011, Ragan et al. 2011). Garcia et al. (2011) estimated TA from genomic data 
and weighted these according to the relative abundance of each mRNA in the cell 
of interest, but noted that in practice the genomic TA and cell-specific TA were 
highly correlated (Spearman's R2 = 0.9813), suggesting that for practical purposes 
genomic TA may be informative for identifying genuine miRNA targets (Garcia 
et al. 2011).  
 70 
MicroRNA	  Anti-­Targets	  and	  MicroRNA	  Sponges	  
Given the short length of many miRNA seeds, it is not unreasonable to expect that 
many mRNAs in any given transcriptome will contain miRNA seed match sites 
by chance.4 Where repression of a given gene would be deleterious, natural 
selection will favour the avoidance of seed matches in the gene sequence — since 
such deleterious repression would affect the survival of the organism — and the 
gene will become an anti-target (Bartel and Chen 2004). Genes that are more 
broadly expressed tend to have shorter 3′ UTRs and lower density of predicted 
miRNA-target sites than genes with more specific expression patterns (Farh et al. 
2005, Stark et al. 2005).  
 
In a given cellular context, the abundance of alternative targets has a negative 
effect on the efficacy of individual miRNA-target interactions. This has been 
exploited by the use of artificial miRNAs, known as microRNA sponges, that 
compete with a specific miRNA and effectively reverse repression of its targets 
(Franco-Zorrilla et al. 2007, Ebert et al. 2007). It has also been suggested that 
many putative miRNA-target genes are natural competitive inhibitors of specific 
miRNA-target interactions, i.e. natural miRNA sponges (Seitz 2009, Ebert and 
Sharp 2010).  
1.9.5 Evolution	  of	  MicroRNAs	  
MiRNAs are believed to have emerged more or less continuously throughout the 
metazoa, with substitutions and secondary loss occurring only rarely (Wheeler et al. 
2009). Significant expansions of the genomic complement of miRNAs are believed 
to have coincided with the ancestral lineage in Bilateria (Prochnik et al. 2006, Hertel 
et al. 2006), vertebrates (Heimberg et al. 2008, Hertel et al. 2006, Wang et al. 2010), 
Eutheria (Hertel et al. 2006) and primates (Wang et al. 2010).  
                                                
4 Assuming a miRNA seed 7mer and a random target DNA sequence in which each 
nucleotide is one of the 4 possible bases (i.e. A, C, G or T), one should expect to find a 
complementary match of the 7mer on average once every 47 = 16,384 bases, simply by 
chance.  
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In animals, de novo emergence of functional miRNAs is considered to be more likely 
than for protein-coding genes, since a functional miRNA need only be a transcribed 
locus that, when expressed, forms a hairpin that is recognised by the Microprocessor 
complex (Chen and Rajewsky 2007). A preliminary analysis by Chen and Rajewsky 
(2007) found that the set of miRNAs were distributed quite randomly in sequence 
space, which tentatively indicates that de novo emergence is a non-trivial source of 
new miRNAs. The presence in the human genome of large numbers of sequences 
capable of forming a hairpin structure (Bentwich et al. 2005) lends further support to 
a model of random emergence of miRNAs (Svoboda and Di Cara 2006, Tanzer and 
Stadler 2004). 
 
A new miRNA can also emerge from the antisense strand of an existing miRNA 
(Stark et al. 2008, Tyler et al. 2008). This could be facilitated by the fact that the 
different arms of a miRNA hairpin are not always completely complementary to each 
other, so the emerging miRNA sequence could differ from that of the original 
miRNA (Berezikov 2011).  
 
Duplication of existing miRNAs is also considered to be a significant source of 
novelty (Hertel et al. 2006); in plants, an inverted duplication model has been 
proposed — in which an inverted duplication event creates the upstream and 
downstream arms of the novel precursor sequence in each strand of DNA, forming a 
hairpin structure with the complementary sequences formed by the inverted 
duplication — that would account for the emergence of a hairpin structure with high 
WC complementarity between the hairpin arms (Allen et al. 2004). Yuan et al. 
(2011) reported that transposable elements and segmental duplications both play a 
role in the origin of new miRNAs. 
 
Animal miRNAs have been noted for their tendency to form clusters (Lagos-
Quintana 2003, Altuvia 2005, Yu et al. 2006), and the presence of a significant 
number of paralogs among these clusters points to the effect of segmental duplication 
in their expansion — of 326 human miRNAs in miRBase 7.1 (then known as the 
miRNA registry), 148 were found in 52 clusters, which contained 9 paralogous 
groups (Yu et al. 2006).  
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Shomron et al. (2009) has suggested that such clustering allows novel miRNAs to 
hitchhike on existing transcriptional mechanisms; this is supported by the finding 
that clustered miRNAs tend to be co-expressed with each other (Liang et al. 2007). 
Another way in which newly evolved miRNAs might hitchhike with existing 
transcriptional machinery is as an intronic miRNA: a miRNA residing within the 
intron of a host gene (Lin et al. 2006). About 25-40% of known miRNA genes reside 
within introns (Rodriguez et al. 2004, Shomron et al. 2009). However, not all 
intronic miRNAs are dependent on their host gene for expression; some have their 
own promoter regions (Martinez et al. 2008, Ozsolak et al. 2008). Introns may be a 
significant source of new miRNAs, mediated by a process called intronic 
exaptation, in which the miRNA emerges within a pre-existing intron and acquires 
independent functionality, with or without the retention of the original host gene 
(Campo-Paysaa et al. 2011). 
 
Once a novel miRNA has emerged, there are several documented mechanisms by 
which it can undergo evolutionary change (Berezikov 2011).  
 
 Nucleotide substitutions within miRNAs are rare, but when they do occur, 
they tend to happen away from the functionally critical seed region (Wheeler 
et al. 2009). 
 
 Seed shifting occurs if the location of the seed has changed in either the 5′ or 
3′ direction (Wheeler et al. 2009), and is relatively common between distantly 
related species (Grimson et al. 2008, Marco et al. 2010). 
 
 Arm switching involves a swap in roles between the guide strand and 
passenger strand, such that the former passenger strand becomes the new 
guide strand (Okamura et al. 2008, de Wit et al. 2009). Recent studies have 
shown that the roles of guide and passenger strands are more plastic than 
previously thought: the passenger strand has been observed to accumulate to 
physiologically relevant levels (Ruby et al. 2007b), to associate with 
Argonaute and regulate targets (Okamura et al. 2008), and, for relative 
expression of the nominal guide and passenger strands to vary considerably 
between tissues (Kuchenbauer et al. 2011).  
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 Hairpin shifting is a more drastic mode of miRNA evolution, in which a 
new miRNA hairpin evolves from one arm of an existing hairpin and adjacent 
upstream or downstream sequence (de Wit et al. 2009). 
1.9.6 Evolution	  of	  MicroRNA	  Targets	  
A novel miRNA needs novel binding sites through which to exert its effects. Given 
the relatively short length of complementarity between miRNAs and their target 
sites, novel binding sites can arise relatively quickly on an evolutionary timescale. 
Chen and Rajewsky (2007) reviewed several studies on the emergence of new 
binding sites (Stone and Wray 2001, Berg et al. 2004, MacArthur and Brookfield 
2004, Durrett and Schmidt 2007). Chen and Rajewsky (2007) concluded that neutral 
evolution of new binding sites is most likely too slow — of the order of millions 
years for a 7mer to evolve from a null binding sequence — to constitute an 
appreciable source of novel miRNA binding sites, but that positive selection on 'pre-
sites' (i.e. sites with one seed mismatch) could generate a new miRNA-target site in 
~375,000 years (Chen and Rajewsky 2007). Shomron et al. (2009) estimated that a 
kilobase of 3′ UTR sequence would typically contain several such pre-sites, and gave 
an estimate for the emergence of a functional miRNA-target site of ~200,000 years. 
 
Chen and Rajewsky (2007) further proposed a model of miRNA emergence followed 
by the evolution of miRNA-target interactions. In this model, the miRNA is initially 
expressed at low levels in a tissue-specific manner. The miRNA then exerts selective 
pressure on its targets (Chen and Rajewsky 2006, Saunders et al. 2007) and anti-
targets5 (Bartel and Chen 2004, Farh et al. 2005, Stark et al. 2005), while these in 
turn subject the miRNA itself to selective pressure (Sempere et al. 2006). As the 
miRNA, targets and anti-targets co-evolve, the miRNA increases in expression and 
may become more broadly expressed (Chen and Rajewsky 2007). This is supported 
by evidence that many miRNAs have tissue-specific expression patterns, (e.g. hsa-
miR-516-5p, which was found, in a microarray experiment, to have placenta-specific 
expression) (Liang et al. 2007); while more broadly conserved miRNAs tend to be 
expressed at higher levels, (e.g. among miRNA genes in 6 Drosophila species, those 
                                                
5 A microRNA anti-target was defined by Bartel and Chen (2004) as a mRNA that is a non-
target of a microRNA and is under selective pressure to remain a non-target. 
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miRNAs conserved in at least 5 species were more highly expressed than miRNAs 
conserved in fewer species) (Lu et al. 2008), an attribute associated with less tissue-
specific expression (e.g. hsa-miR-98, which was found to have high expression but 
low tissue-specificity) (Landgraf et al. 2007).  
1.9.7 MicroRNA-­‐Target	  Prediction	  
As the mechanisms of interaction of miRNAs with their binding sites are not 
completely understood, miRNA-target prediction (miTP) remains incomplete. Table 
1.2 lists some currently available miRNA-target prediction methods. Although it is 
by no means an exhaustive listing, it is representative of current methods, and 
includes the most popular general-purpose miRNA-target prediction algorithms. 
Many of the miRNA-target interaction features discussed in Section 1.9.4 are used 
by one or more of these methods. The problem of miRNA-target prediction is mainly 
approached from three general directions: evolutionary conservation, sequence 
features and thermodynamic considerations (Hammell 2010).  
MicroRNA-­Target	  Prediction	  using	  Evolutionary	  Conservation	  
With many early miRNA-target prediction studies, conservation of putative 
miRNA-target sites was extensively used as a filter for miRNA-target predictions, 
and many conserved candidate miRNA targets were identified as a result (Lewis 
et al. 2003, Brennecke et al. 2005, Krek et al. 2005, Lewis et al. 2005). It was 
reasoned that preferential conservation of the sequence of a putative binding site 
— and particularly that of the region complementary to the miRNA seed — 
indicates that the site is undergoing negative selection to preserve its function 
(Lewis et al. 2003). Conservation of the region flanking the putative miRNA-
target site has also been shown to have some predictive value (Wen et al. 2011).  
 
Requiring all species of interest to have an aligned orthologous miRNA-target site 
reduces the power of this method, since in many cases such a miRNA-target site 
may be absent due to lineage-specific duplication or loss, or simply due to lack of 
sequencing coverage or errors in alignment (Friedman et al. 2009). For example, 
in the 28-way genomic alignment by Miller et al. (2007) that was used for 
conservation analysis by Friedman et al. (2009), 10 genomes had a sequence 
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coverage of 2X or less, which theoretically entails the lack of at least 10% of 
genomic sequence (Lander and Waterman 1988). Along with the challenging 
process of genomic alignment undertaken by Miller et al. (2007), this would have 
inevitably reduced the number of orthologous sequences included in the final 28-
way alignment, even in the ideal case of perfectly conserved one-to-one orthologs. 
The effects of duplication and loss would compound this issue, to the extent that 
requiring perfect conservation of miRNA-target sites across all 28 species would 
markedly reduce the ability of this method to identify conserved miRNA-target 
sites (Friedman et al. 2009). 
 
In response to this, methods developed more recently estimate instead the branch 
length over which a predicted miRNA-target site has been conserved using a 
phylogenetic tree of the species of interest, such that a longer branch length 
indicates greater probability of preferential conservation (Kheradpour et al. 2007, 
Friedman et al. 2009, Vejnar and Zdobnov 2012). Furthermore, Rajewsky (2006) 
distinguishes between conservation of miRNA-target sites and conservation of 
miRNA-target genes. While a miRNA-target site may be lost in one region of the 
target gene and arise in another region, the regulatory interaction itself is 
conserved. On the basis of this distinction, Rajewsky (2006) further suggests a 
strategy for conservation analysis of miRNA-targets: requiring conservation of 
miRNA-target sites for more closely related species, while requiring only the 
conservation of a miRNA-target interaction for more distantly related species.  
 
While conservation filters have been very good at identifying miRNA targets, a 
large proportion of non-conserved miRNA-target sites are functional (Farh et al. 
2005), so continuing to rely on conservation filters would severely limit the 
potential to identify novel miRNA targets (Bartel 2009). 
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MicroRNA-­Target	  Prediction	  using	  Thermodynamics	  
In addition to identifying miRNA-target sites using primary sequence features, a 
parallel but complementary approach has explored the effect of RNA secondary 
structure thermodynamics on miRNA binding site efficacy (Long et al. 2007). 
Many early miRNA-target prediction (miTP) methods incorporated estimation of 
the differential of Gibbs free energy (ΔG) of miRNA-target hybridisation (Enright 
et al. 2003, Lewis et al. 2003, Stark et al. 2003), and some miTP methods rely 
predominantly on considerations of miRNA-target binding energy (Rehmsmeier 
et al. 2004, Krüger and Rehmsmeier 2006, Thadani and Tammi 2006).  
 
The ViennaRNA suite of programs (Gruber et al. 2008, Hofacker et al. 1994, 
Hofacker 2003) has been widely used in miRNA-target prediction methods for 
estimation of folding energy of miRNA-target duplexes (Enright et al. 2003, 
Lewis et al. 2003, Rehmsmeier et al. 2004, Krüger and Rehmsmeier 2006, 
Thadani and Tammi 2006) and for modelling target site accessibility in addition 
to hybridisation energy (Kertesz et al. 2007, Sturm et al. 2010, Vejnar and 
Zdobnov 2012). The ViennaRNA package in turn makes use of the minimum 
free energy (MFE) algorithm devised by Zuker and Stiegler (1981), the ensemble 
partition function created by McCaskill (1990), the suboptimal folding algorithm 
described by Wuchty et al. (1999), and the RNA energy parameters in Mathews et 
al. (2004). 
 
Unfortunately, large-scale studies of the effect of miRNAs on their targets have 
found the overall hybridisation energy of a miRNA and its putative target to be a 
poor indicator of a functional miRNA-target interaction (Grimson et al. 2007, 
Baek et al. 2008). In contrast, thermodynamic stability of the seed duplex has 
been shown to be a significant factor in siRNA interactions (Ui-Tei et al. 2008); 
siRNA modes of action include seed binding similar to that observed in miRNAs 
(Lim et al. 2005). Subsequently, estimated seed-pairing stability (SPS) of the 
miRNA-target duplex was shown to be a determinant of strength and specificity 
of repression in miRNA-target interactions (Garcia et al. 2011).  
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MicroRNA-­Target	  Prediction	  using	  Sequence	  Features	  
As discussed in Section 1.9.4, the importance of miRNA seed binding to the 
prediction of miRNA-target sites was clear from its use in many early methods 
(Lewis et al. 2003, John et al. 2004, Grün et al. 2005). This importance is 
underscored by its continued use in more recently developed miRNA-target 
prediction methods (Liu et al. 2010, Sturm et al. 2010, Marín and Vaníček 2011 
and 2012, Vejnar and Zdobnov 2012).  
 
Binding of the miRNA in miRNA sites 12-17 to the target has been used to 
identify 3′-supplementary sites (Brennecke et al. 2005, Lim et al. 2005) and 3′-
compensatory sites (Yekta et al. 2004). However, 3′-supplementary pairing is of 
relatively limited use, since these types of sites can be identified by a simple seed 
match analysis (Grimson et al. 2007), while 3′-compensatory sites are believed to 
be a relatively rare occurrence (Friedman et al. 2009). Some methods omit these 
site types (Lewis et al. 2005, Gaidatzis et al. 2007), while others incorporate them 
with such strict criteria that they have only marginal impact on miRNA-target 
predictions (Krek et al. 2005, Grimson et al. 2007). 
 
To the knowledge of this author, no miRNA-target prediction method has yet 
incorporated bulge sites (Chi et al. 2012) or centred sites (Shin et al. 2010). 
Whether they are used in future methods will probably depend more on their 
predictive value than on their importance to miRNA-target binding. For example, 
the 6mer seed match site is considered to be very common among functional 
miRNA-target sites, but is not regarded as useful for miRNA-target prediction 
because of the preponderance of false-positive 6mer seed matches (Bartel 2009, 
Ellwanger et al. 2011). This emphasises the limitations of our current 
understanding of miRNA-target interactions, and shows that much remains to be 
done to improve that understanding (Bartel 2009). As miRNAs continue to be 
actively studied, progressively greater knowledge of these features is being used 
to improve the quality of miRNA binding site predictions. 
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Table 1.2: Current microRNA-target prediction methods.  
miTP Method Availability 
Web 
Interface 
Data 
Download 
Standalone 
Software 
References 
DIANA-microT diana.cslab.ece.ntua.gr/DianaTools/ Yes Yes No Reczko et al. (2012), Reczko et al. (2011),                                     Maragkakis et al. (2009a), Maragkakis et al. (2009b) 
EIMMo www.mirz.unibas.ch/ElMMo3/ Yes Yes No Gaidatzis et al. (2007) 
Hitsensor Available on request No No Yes Zheng and Zhang (2010) 
MicroTar tiger.dbs.nus.edu.sg/microtar/ No No Yes Thadani and Tammi (2006) 
miRanda www.microrna.org/ Yes Yes Yes Betel et al. (2010), Betel et al. (2008),                                                       John et al. (2004), (Enright et al. 2003) 
mirEE didattica-online.polito.it/eda/miREE/ Yes No No Reyes-Herrera et al. (2011) 
miRmap cegg.unige.ch/mirmap/ Yes Yes Yes Vejnar and Zdobnov (2012) 
MirTarget2 mirdb.org/miRDB/ Yes Yes No 
Wang (2008), Wang and El Naqa (2008),  
Wang and Wang (2006) 
MultiMiTar www.isical.ac.in/~bioinfo_miu/ Yes Yes Yes 
Mitra and Bandyopadhyay (2011),  
Bandyopadhyay and Mitra (2009) 
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Table 1.2: Current microRNA-target prediction methods. (continued) 
miTP Method Availability 
Web 
Interface 
Data 
Download 
Standalone 
Software 
References 
PACCMIT lcpt.epfl.ch/ No Yes No 
Marín and Vaníček (2012),  
Marín and Vaníček (2011) 
PicTar pictar.mdc-berlin.de Yes Yes No Chen et al. (2006), Lall et al. (2006),                                                        Grün et al. (2005), Krek et al. (2005) 
PITA genie.weizmann.ac.il/pubs/mir07/ Yes Yes Yes Kertesz et al. (2007) 
RNA22 cm.jefferson.edu/rna22v1.0/ Yes Yes No Miranda et al. (2006) 
RNAhybrid bibiserv.techfak.uni-bielefeld.de/ Yes No Yes 
Krüger and Rehmsmeier (2006),  
Rehmsmeier et al.(2004) 
SVMicrO compgenomics.utsa.edu/svmicro.html No Yes Yes Liu et al. (2010) 
TargetScan www.targetscan.org/ Yes Yes Yes Garcia et al. (2011), Friedman et al. (2009),                                      Grimson  et al.(2007), Lewis et al. (2005) 
TargetSpy www.targetspy.org/ Yes Yes Yes Sturm et al. (2010) 
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1.10 Placenta	  
It is believed that the earliest Eutherian mammals evolved about 125 million years 
ago (MYA), and that the chorioallantoic placenta typical of Eutheria evolved (in 
evolutionary terms) shortly thereafter (Ji et al. 2002). See Figure 1.12 for a summary 
of placental characteristics across the species studied here. Formed from both foetal 
and maternal tissues, the chorioallantoic placenta forms an intimate connection 
between mother and offspring, mediating the transfer of nutrients, gases and waste 
products during gestation.  
1.10.1 Evolution	  of	  the	  Placenta	  
The evolution of the placental structures appears to be intimately associated with the 
evolution of viviparity. As outlined by Crespi and Semeniuk (2004), viviparity 
carries several advantages: increases in offspring survival rates, birth weight and 
offspring vigour, as well as increased efficiency and flexibility in resource allocation 
by the mother.  
 
Figure 1.12 Legend:  
A phylogeny of the 14 placental mammal species in this study is shown overleaf, along with 
a breakdown of placental types by maternofaetal barrier, placental interdigitation and 
placental shape for each species. Species lacking a chorioallantoic placenta have been 
excluded. As with Figure 1.6, the phylogeny used is that of Benton and Donoghue (2007). 
The branches of the phylogeny are to scale except within the encircled area, where branch 
lengths are dilated to clarify the branching order used. The species in this phylogeny are as 
follows (from top to bottom): Human (Homo sapiens), Chimp (Pan troglodytes), Gorilla 
(Gorilla gorilla), Orangutan (Pongo abelii), Macaque (Macaca mulatta), Marmoset 
(Callithrix jacchus), Mouse (Mus musculus), Rat (Rattus norvegicus), Guinea Pig (Cavia 
porcellus), Horse (Equus caballus), Dog (Canis familiaris), Cow (Bos taurus), Bat (Myotis 
lucifugus) and Elephant (Loxondonta africana). Credit for all animal silhouettes goes to Dr 
Mary J. O'Connell, except for that of the bat, which is a public domain image sourced from 
Wikimedia Commons (http://commons.wikimedia.org). The information about placental 
types was taken from Kurt Benirschke's 'Comparative Placentation' website (Benirschke 
2007) as cited in Elliot and Crespi (2009), except for that of the bat species Myotis lucifugus, 
which was taken from Gopalakrishna and Karim (1979). 
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Figure 1.12: Placental characteristics of Eutherian species studied in this thesis. 
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That the chorioallantoic placenta has some compelling advantages is further 
supported by examples of viviparity and placental structures that have evolved 
independently in clades other than mammals, including some sharks (Hamlett 2005) 
and lizards (Flemming and Blackburn 2003). 
 
The choriovitelline (or yolk-sac) placenta provides for limited exchange of nutrients 
in marsupials and monotremes, before the young are ensconced in a marsupium or 
laid in an egg, respectively. Eutherian mammals retain this yolk-sac placenta as a 
complement to the chorioallantoic placenta. In humans, it is responsible for nutrient 
exchange from the exocoelomic cavity in early pregnancy (Freyer and Renfree 
2009), as well as playing a role in early haematopoiesis (King and Enders 1993). 
Rodents are a notable exception among Eutheria because, as in marsupials and 
monotremes, they retain a functional yolk-sac placenta in direct contact with the 
maternal endometrium until term (Freyer and Renfree 2009). 
 
Notable exceptions to the yolk sac placenta among marsupials include the bandicoot, 
which has evolved a chorioallantoic placenta analogous to that found in Eutherian 
mammals (Tyndale-Biscoe and Renfree 1987). The bandicoot is an instructive 
example of the evolutionary rationale for the chorioallantoic placenta: accounting for 
its relatively short gestation period, neonates are more developed than comparable 
marsupials lacking the tissue, (Tyndale-Biscoe and CSIRO Publishing. 2005). 
 
Despite this compelling rationale for its existence, aspects of the evolution of the 
chorioallantoic placenta remain incompletely understood, not least the form that the 
ancestral tissue would have taken. Chorioallantoic placentas are often grouped 
according to three general attributes: (i) the extent of the interhaemal barrier, (ii) the 
interdigitation between maternal and foetal tissues, and (iii) the shape of the placenta, 
as scored in Figure 1.12. In this analysis we have pursued a comparative genomics 
approach to elucidating the processes involved in placenta evolution. The 14 
Eutherian species we have included in our analyses are shown in the phylogeny in 
Figure 1.12, each species being labelled with its placental attributes. The species 
were strategically selected, based on genome quality and phylogenetic placement.  
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Figure 1.13: Variety of placental interhaemal barrier.  
There are three general types of maternofoetal barrier found in the Eutherian chorioallantoic placenta: epitheliochorial, endotheliochorial and haemochorial 
(left, middle and right respectively in the diagram). Labelled in the epitheliochorial example above are a) maternal blood, b) maternal endothelium, c) 
endometrial connective tissue, d) endometrial epithelium, e) trophoblast, f) foetal connective tissue, g) foetal endothelium and h) foetal blood. Note that the 
endometrial epithelium is absent from the endotheliochorial example (middle), bringing trophoblast into contact with the maternal endothelium. Note further 
that the maternal endothelium is absent from the haemochorial example, bringing the trophoblast into direct contact with maternal blood. For examples from 
the species under study in this thesis, an epitheliochorial placenta is found in horse, an endotheliochorial placenta is found in dog, and a haemochorial placenta 
is found in human. Figure adapted with permission from Benirschke and Kaufmann (2000). 
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Figure 1.14: Variety of placental interdigitation.  
The five main types of interdigitation in the chorioallantoic placenta are shown. From left to right, they are: folded, lamellar, trabecular, villous and 
labyrinthine. Labelled in the folded example above are: (M) maternal tissue or blood, (T) foetal trophoblast and (C) foetal capillaries. For all examples shown, 
dotted volumes represent maternal tissue/blood, dashed volumes represent foetal tissue and foetal trophoblast is shown in black. For examples from the 
species under study in this thesis, the macaque has trabecular interdigitation, the human has villous interdigitation, and that of mouse is labyrinthine. Figure 
adapted with permission from Benirschke and Kaufmann (2000). 
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Figure 1.15: Variety of placental shape.  
The chorioallantoic placenta has a variety of shapes in different mammalian clades. From left to right, these include: discoid, diffuse, cotyledonary and zonary. 
For examples from the species under study in this thesis, the discoid placenta is found in human, the diffuse placenta is found in horse, cotyledonary placenta 
is found in cow, and zonary is found in elephant. Figure adapted with permission from Benirschke and Kaufmann (2000). 
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Under the former criterion, a species was included only if it had genome sequencing 
coverage above 6X. According to the latter requirement, and within the constraints of 
genome sequence availability, species were sampled as thoroughly as possible from 
across Eutheria in particular, and from vertebrates more generally. Thorough 
sampling of Eutheria was essential to ensure that as much as possible of the diversity 
of placental attributes could be represented. The attributes themselves are described 
in the following section. 
1.10.2 Placental	  Variety	  
The interhaemal barrier is the barrier separating the foetal placental tissue from that 
of the mother, and different types involve different degrees of placental invasiveness. 
In order of increasing invasiveness, the main types are epitheliochorial, 
endotheliochorial and haemochorial (see Figure 1.13). Epitheliochorial placentation 
occurs when the trophoblast is in contact with the uterine epithelium, and offers 
relatively little oxygen diffusing capacity. Endotheliochorial placentation is where 
the trophoblast is in contact with the endothelial cells of the maternal blood vessels. 
 
Haemochorial placentation is brought about by the trophoblast from the developing 
embryo that invades sufficiently into maternal tissue to provide direct access to the 
maternal blood — other things being equal, this offers the greatest oxygen diffusing 
capacity. 
 
There is currently a lack of consensus as to what type of interhaemal barrier the 
ancestral Eutherian would have possessed, with some studies favouring 
endotheliochorial placentation (Vogel 2005, Mess and Carter 2007, Martin 2008), 
and others supporting a haemochorial placenta (Wildman et al. 2006, Elliot and 
Crespi 2009). However, Elliot and Crespi (2009) do make a somewhat compelling 
case that the ancestral placental mammal had a haemochorial placenta, based on 
evidence from maximum likelihood analysis of data on placenta and body mass for 
340 species: 334 extant and 6 extinct. They note that the haemochorial form 
correlates with smaller body size, which would be consistent with the tendency to 
have a relatively small body size among early Eutherian mammals (Elliot and Crespi 
2009). Although recent evidence suggests that these early Eutherian mammals were 
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somewhat larger than previously believed (Romiguier et al. 2013), this would not be 
expected to affect the overall pattern of early Eutheria having had smaller body sizes.  
 
The other two general attributes that are known to vary among placental mammals 
are maternofoetal interdigitation (the way in which maternal and foetal tissues 
interconnect, see Figure 1.14) and placental shape (see Figure 1.15).  
 
Types of interdigitation in Eutheria include folded, lamellar, trabecular, villous or 
labyrinthine; while the shape of Eutherian placentae are similarly varied in different 
lineages, with diffuse, cotyledonary, zonary and discoid placentas being observed 
(Elliot and Crespi 2009). There is more consensus about the ancestral state of these 
attributes, with the earliest chorioallantoic placenta believed to be discoid and 
labyrinthine (Elliot and Crespi 2009).  
 
This great variability among chorioallantoic placental forms adopted by different 
species of Eutherian mammals underlines the flexibility it affords the mother in 
delivering nutrients to, and removing waste from, the developing young. Although 
the exact mechanisms by which different placental structures are adapted to different 
constraints have yet to be completely understood, it is a good illustration of the 
benefit of the tissue itself, and perhaps a clue to why placental mammals have met 
with such success.  
 
We have sought to study indirectly the process by which the placenta evolved by 
studying genes known to be critical for the function of placenta; the assumption 
being that genes that are critical for placental development are more likely to have 
played a critical role in early placental evolution.  
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1.11 Aim	  of	  Thesis	  
This project addresses a fundamental question about the origin and evolution of 
novel tissues in the animalia. We have attempted to address two complementary 
questions about the placental miRNAs and genes in our study. The first stage of the 
project has attempted to address the question: what role has been played by positive 
selection and functional shifts in the evolution of placental genes? The second stage 
of the project has involved a comparative benchmark study of current miRNA-target 
prediction methods, in order to identify the miRNA-target method best able to 
recover known miRNA-target interactions and to distinguish between known 
miRNA targets and non-targets. This was in preparation for the third stage of the 
project — and the second question to be addressed: what role has regulatory 
innnovation, with respect to miRNAs and their targets, played in the evolution of 
placenta? From a greater understanding of the evolution of these placental miRNAs 
and genes, it is possible to make reliable inferences about the evolution of the 
placenta itself and the molecular building blocks that have contributed to its origin. 
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Chapter	  2:	  	  	  Selective	  Pressure	  Analysis	  of	  Placental	  Genes	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2.1 Introduction	  
In this chapter the focus is specifically on placental genes, encompassing genes that 
are known to be critical to placental development and function, as well as genes that 
are known to have placenta-specific expression. However, it is worthwhile to 
consider the genomic backdrop against which these genes have been evolving. In a 
genome-wide study of 16,529 orthologous gene alignments across six mammalian 
genomes, a total of 544 genes were identified as containing the classical signatures of 
positive selection, 144 of these genes showed evidence of positive selection in the 
ancestral Eutherian lineage alone (Kosiol et al. 2008).  
 
Although the study by Kosiol et al. (2008) was limited to six mammal species, this 
gives a conservative estimate of the level of positive selection in mammalian 
genomes: positive selection was detected in about 2% of genes overall, but this rose 
to about 6% in testes. On examination of the functional categories of genes most 
likely to have undergone positive selection, there is enrichment for functions such as 
sensory perception, reproduction and immune defense. This study also found, in a 
microarray experiment, that positively selected genes are expressed at significantly 
lower levels than their non-positively selected counterparts (one-sided Mann-
Whitney U test, P < 7 × 10-25), and in a more tissue-specific manner. This is 
consistent with the finding, in the same study, of a negative correlation of Dn/Ds or 
ω with overall expression level in all 11 tissues sampled (Spearman’s rank 
correlation coefficient, -0.25 ≤ ρ ≤ -0.43), and a positive correlation of ω with tissue-
specific expression (Spearman’s rank correlation coefficient, ρ = 0.24) (Kosiol et al. 
2008).  
 
A positive correlation of ω with tissue-specific expression of course implies that a 
study of placental genes is likely to find a large number of positively selected genes. 
Indeed, a prior study of genes with placenta-specific expression confirms this trend 
(Hou et al. 2009). Although the Hou 2009 study was restricted to genes with one-to-
one orthologs, the genes show significant evidence of ancient adaptations, with a 
larger number of positively selected genes on the Eutherian stem lineage than on 
descendant branches, indicating that functional shift mediated by changes in protein 
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sequence was taking place in placental genes in the ancestral Eutherian. Of 222 
genes studied, 94 (~42%) showed evidence of positive selection — 62 of which were 
under positive selection in the Eutherian stem lineage (Hou et al. 2009). As 
described in Section 1.3.3, gene duplication is a known mechanism by which new 
sequences emerge in genomes (Ohno 1970). The analysis carried out in this chapter 
differs from that of Hou et al. (2009) in that it does not exclude those gene families 
with one-to-many ortholog relationships. Such gene families add to the complexity 
of the analysis but comprise a large proportion of gene families; their inclusion here 
should consequently offer, for the first time, a more complete analysis of the 
evolution of placental genes.  
 
In another detailed study of genes preferentially expressed in placenta, Knox and 
Baker (2008) performed genome-wide expression profiling of the murine placenta. 
Samples of murine placenta were taken at nine different stages of gestation and a 
microarray analysis was performed on the resulting tissue samples. The microarray 
analysis identified a set of genes preferentially expressed in placenta (i.e. magnitude 
of fold change ≥ 1.5, placental PEM ≥ 4), many of which undergo a transition: being 
expressed, at higher levels, later in gestation than earlier, or vice versa. Estimating 
the time of origin of these preferentially expressed genes using homology 
relationships, it was shown that older, pre-existing genes were over-represented in 
the cohort of genes preferentially expressed early in gestation, while newer, duplicate 
genes were more likely to be expressed later in pregnancy (Knox and Baker 2008). 
From these results, Knox and Baker (2008) formed the hypothesis that early 
placental evolution was facilitated by the co-option of existing genes, while later 
placental evolution involved gene duplication and divergence. Three of the 
preferentially expressed placental genes identified by Knox and Baker (2008) were 
also identified as placental genes in this chapter: adrenomedullin (ADM), cyclin E1 
(CCNE1) and placenta-specific 1 (PLAC1); all three were found to be preferentially 
expressed in developing placenta, as opposed to at term. While the study by Knox 
and Baker (2008) highlighted the importance of gene duplications in placental 
evolution, it stopped short of performing an evolutionary analyis of the selective 
pressures at work on these genes. An important part of understanding the process of 
new tissue formation, maintenance and regulation is to examine how each of the 
genes in the process evolved.  
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In this chapter we have performed evolutionary analyses of selective pressure on 110 
placental genes, 73 of which are known to be critical to placental function and 40 of 
which are preferentially expressed in placenta. Our aim in doing so was to: (a) 
determine if protein functional shift (positive selection) is evident in these genes, (b) 
to what extent and in what lineages (with a particular focus on the ancestral 
Eutherian lineage), and (c) to determine if the sites inferred to be positively selected 
are related to specific protein functions.  
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2.2 Materials	  
Two complementary sets of placental genes were assembled: those known to be 
critical to the function of the placenta and those known to be specifically or 
exclusively expressed in placenta. The genomes of 22 species — 14 Eutherian and 6 
outgroup species — were selected, from which gene family members were to be 
obtained (see Table 2.1). The gene family sequence data of each placental gene was 
then downloaded from the Ensembl genomic database server (Flicek et al. 2012) 
through the BioMart interface (Smedley et al. 2009). All scripts used during this 
process can be accessed from the following location in the electronic appendix: 
Appendix / home / code / scripts.html. 
 
(Please note that throughout this thesis, unless otherwise specified, Ensembl data has 
been obtained from Ensembl release 65. Note also that Ensembl release 65 provides 
access to the human genome assembly version GRCh37.p5 (Church et al. 2011). 
This includes patch release 5 — genome patches are minor changes made to a 
genome assembly between major assembly releases. Patch release 5 includes 40 fix 
patches (a fix patch contains an alternative genomic assembly sequence that corrects 
genome assembly errors in the standard genome release), 65 novel patches (a novel 
patch contains a genomic assembly sequence that adds new alternate loci to the 
standard genome release), and 9 haplotype sequences that are mainly located in the 
major histocompatibility complex region of chromosome 6 (Flicek et al. 2012).  
2.2.1 Selection	  of	  Species	  of	  Interest	  
An interspecies analysis of selective pressure requires homologs from multiple 
species by definition. Selective pressure analysis by maximum likelihood should 
ideally involve 7 or more taxa (Anisimova et al. 2001). Indeed, good taxon sampling 
can affect many aspects of phylogenetic analysis, with increased taxon sampling 
improving phylogenetic reconstruction (Philippe et al. 2011), and conferring 
resistance to artefacts such as long branch attraction (Yang and Rannala 2012), so it 
is important to sample as many taxa (i.e. species) as possible.  
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On the other hand, higher sequencing coverage and its positive impact on alignment 
quality is critical to avoid detection of spurious signals of positive selection 
(Schneider et al. 2009) — see Section 1.8.3. This constraint limits the set of species 
genomes that can be selected, since genome data is inevitably heterogeneous across 
species in the Ensembl genomic database, ranging from less than 2X coverage in, for 
example, hedgehog (specifically Erinaceus europaeus), to the high coverage 
assemblies of human and mouse (Flicek et al. 2012). Of the 54 full genome 
assemblies available in the standard Ensembl release 65, 22 species — each with a 
genome sequencing coverage of 6X or greater — were used in this thesis (see Table 
2.1). These 22 genomes were chosen so as to strike a balance between sequence 
coverage and annotation quality on one hand, and taxon sampling on the other.  
2.2.2 Placental	  Gene	  Set	  Assembly	  
To identify a set of placental genes, two complementary approaches were taken: (I) 
genes critical to the development and/or function of placenta were identified using a 
keyword search of Online Mendelian Inheritance in Man (OMIM) (Hamosh et al. 
2005), and (II) genes specifically expressed in placenta were identified using tissue-
specificity filters on microarray expression data, as consolidated by Russ and 
Futschik (2010). These two sets of genes were then merged into one combined set of 
(III) placental genes. The processes involved are shown in the bioinformatics 
pipeline in Figure 2.1.  
I.	  Placenta-­Critical	  Genes	  
To obtain a set of placenta-critical genes — genes critical to placental function 
and/or development — using Online Mendelian Inheritance in Man (OMIM) 
(Hamosh et al. 2005), the full set of OMIM entries was searched for the following 
keywords that are associated with placental tissue or cell types: 'placenta', 
'trophoblast', 'syncytium', 'blastocyst', 'chorioallantoic', 'chorion' and 'allantois'. 
This was done using the Perl script FilterOMIMbyKeywords.pl, which filters 
OMIM with respect to user-specified keywords. This script then outputs a table in 
a tab-separated variable (TSV) file — a text format for representing tables in 
which rows are on different lines and columns are separated by tab characters — 
showing information for the set of OMIM entries with a keyword match.  
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Table 2.1: Ensembl genome assemblies used in this thesis. 
Species Scientific Name Genome Assembly 
Genome 
Coverage 
Assembly 
Type 
Bat Myotis lucifugus myoLuc2 7X NC 
Chicken Gallus gallus WASHUC2 ~6X C 
Chimp Pan troglodytes CHIMP2.1.4 6X C 
Cow Bos taurus UMD3.1 7.1X C 
Dog Canis familiaris CanFam2.0 7.6X C 
Elephant Loxodonta africana loxAfr3 7X NC 
Frog Xenopus tropicalis JGI_4.2 7.65X NC 
Fugu Takifugu rubripes FUGU4.0 8.5X NC 
Gorilla Gorilla gorilla gorGor3.1 35X C 
Guinea Pig Cavia porcellus cavPor3 6.79X NC 
Horse Equus caballus EquCab2 6.79X C 
Human Homo sapiens GRCh37.p5 High C 
Lizard Anolis carolinensis AnoCar2.0 7.1X C 
Macaque Macaca mulatta MMUL_1.0 ~5.1X C 
Marmoset Callithrix jacchus C_jacchus3.2.1 6X C 
Mouse Mus musculus NCBIM37 High C 
Opossum Monodelphis domestica monDom5 7.33X C 
Orangutan Pongo abelii PPYG2 6X C 
Platypus Ornithorhynchus anatinus OANA5 6X C 
Rat Rattus norvegicus RGSC3.4 7X C 
Zebra Finch Taeniopygia guttata taeGut3.2.4 ~6X C 
Zebrafish Danio rerio Zv9 ~7.5X C 
 
Table 2.1 Legend:  
This table lists the common name, species name, genome assembly, genome coverage and 
assembly type. Assemblies are grouped into chromosomal (C) and non-chromosomal (NC).  
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Figure 2.1: Placental gene set assembly pipeline.  
Shown is a bioinformatics pipeline depicting the steps involved in placental gene set assembly. Arrows indicate the direction of process flow. For information 
on symbols used, see the pipeline key in Figure 2.2. 
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Figure 2.2: Bioinformatics pipeline key.  
Shown is a key for the symbols used in bioinformatics pipelines throughout this study. Note 
that, since it is rare for a process to be purely automated or manual, an automated process is 
labelled as such if the process is mainly automated, while manual processes are labelled so if 
they are predominantly manual.  
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For each of the 2,368 filtered OMIM entries, the output table shows the OMIM 
ID, gene ID, number of keyword matches and the context of each keyword match. 
Only OMIM entries for which the relevant gene locus is known were checked for 
keyword matches. 
 
The set of OMIM entries with keyword matches was then manually reviewed by 
this author, and retained only if a placental phenotype was verified. Three broad 
categories of phenotype were accepted: human allelic variants that are associated 
with a placental disease state (e.g. pre-eclampsia), genes that are upregulated or 
downregulated in a placental disease state and genes that have been observed to 
have a null phenotype in animal experiments.  
 
For each retained entry, a brief description of the phenotype was added to the 
dataset. Also, gene symbols were checked against Ensembl and, where necessary, 
replaced by the correct HGNC symbol. A total of 73 placenta-critical genes 
remained after manual review. A table of these can be found in the appendix at 
the following location: Appendix / home / projects / placenta / data / placental-
genes / pcgs.html. 
II.	  Placenta-­Specific	  Genes	  	  
Placenta-specific genes — those genes specifically expressed in placenta — were 
identified using microarray expression data as consolidated from four separate 
studies by Russ and Futschik (2010). Following the nomenclature of Russ and 
Futschik (2010), the four microarray datasets were Rosetta1 (Johnson et al. 2003), 
Rosetta2 (Schadt et al. 2004), Stanford (Shyamsundar et al. 2005) and Geneatlas 
(Su et al. 2002). Four criteria of tissue-specific gene expression were reviewed for 
possible use in this process, all of which take tissue expression data as input.  
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Minimum Akaike Information Criterion Estimate (MAICE) identifies a set of 
tissues with outlying expression values. Given a set of expression values of a 
given gene across multiple tissues, the set of tissue expression values chosen as 
outliers (i.e. outlier candidates) that minimises the statistic U (see ) is taken as the 
set of tissues in which the gene is specifically expressed (Kadota et al. 2003, Ueda 
1996, Akaike 1973).  
 
€ 
U = 12 AIC = n log σ( ) + 2 ⋅ s⋅
log(n!)
n  
Equation 2.1: MAICE statistic.  
The Minimum Akaike Information Criterion Estimate (MAICE) is obtained by 
minimising U, shown here in terms of the AIC and also in terms of the number of outlier 
candidates s, the number of tissues that are designated non-outliers n, and the standard 
deviation (σ) of expression values in those tissues that are designated non-outliers.  
 
The outcome of the MAICE process is simply a list of outlier tissues: those for 
which the gene of interest is relatively over-expressed. With respect to a specific 
tissue, this can be codified in binary form, such that 1 and 0 indicate, respectively, 
that the gene is and is not specifically expressed in the given tissue.  
 
For example, Table 2.2 shows the estimates of MAICE derived from 4 microarray 
datasets with respect to the expression of the gene pregnancy-associated plasma 
protein A, pappalysin 1 (PAPPA) in the placenta, corresponding to the expression 
profile shown in Figure 2.3. PAPPA has highly placenta-specific expression, and 
this is reflected in the MAICE outcomes for each dataset, which show that 
expression of PAPPA in placenta is an outlier in the distribution of tissue 
expression values for that gene. 
 
The MAX statistic developed by Russ and Futschik (2010) was devised to 
identify genes that are almost exclusively expressed in a unique tissue. Given a 
vector of n tissue expression levels for the gene of interest in order of decreasing 
expression T=(t1, t2,..., tn-1, tn), such that ti is the expression level in the tissue of 
interest, the MAX statistic is obtained as in Equation 2.2.  
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€ 
MAX = t1 / t2 if ti = t10 if ti ≠ t1
⎧ 
⎨ 
⎩ 
 
Equation 2.2: MAX tissue-specificity measure.  
The MAX tissue-specificity measure is shown for the tissue of interest with expression 
level ti in two cases. If the tissue of interest is that in which the given gene is most highly 
expressed (ti = t1), then MAX is the ratio of expression in the tissue in which a gene has 
highest expression (t1) to that of the tissue with next highest expression of the gene (t2). 
Otherwise, the value of MAX is zero. 
 
MAX effectively indicates the extent to which the expression of a given gene is 
specific to a tissue of interest; its value can conceivably range from 1 to ∞, where 
higher values indicate more preferential expression in the tissue of interest. For 
example, the placenta-specific expression of PAPPA (see Figure 2.3) is reflected 
in the MAX values shown in Table 2.2. In each dataset examined, expression 
levels of PAPPA in placenta were at least twice those in any other tissue.  
 
Huminiecki et al. (2003) devised the Preferential Expression Measure (PEM), 
which scores expression of a gene in a given tissue relative to its average 
expression in all tissues (see Equation 2.3). 
 
€ 
PEM = log2(o /e)  
Equation 2.3: Preferential Expression Measure.  
The Preferential Expression Measure (PEM) is shown in terms of the observed 
expression level of a gene of interest in a given tissue (o) and the expected expression 
level of the gene of interest (e).  
 
PEM is perhaps most useful for assessing both under- and over-expressed genes 
in the tissue of interest: values below 0 indicate that a gene is under-expressed in 
the given tissue, while values above 0 indicate that the given is over-expressed in 
the tissue of interest. For example, the placenta-specific expression of PAPPA 
(see Figure 2.3) is reflected in the PEM values shown in Table 2.2. In each dataset 
examined, expression of PAPPA in placenta was many times greater than the 
levels that would be expected for a gene that is not expressed in a tissue-specific 
manner. 
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Xiao et al. (2010) defined a specificity measure (SPM) to estimate the tissue-
specificity of gene expression, which is evaluated as in Equation 2.4.  
 
€ 
SPM = PT  
Equation 2.4: SPM specificity measure.  
Given a vector of expression levels for a gene in different tissues T=(t1, t2,..., tn-1, tn), such 
that ti is the expression level in the tissue of interest, a second vector T′=(0, 0,..., ti,...,0), 
in which all tissue expression values except ti have been set to zero, and ||P||, the scalar 
projection of T′ on T, the SPM is evaluated as the ratio of ||P|| to the magnitude of the 
overall expression vector T (i.e. ||T||). 
 
SPM effectively indicates the proportion of total expression of a gene that is 
observed in the tissue of interest. SPM can range from 0 to 1, such that a value of 
0 indicates that no expression was observed for that gene in the tissue of interest, 
and a value of 1 implies that the gene is expressed exclusively in that tissue. For 
example, the SPM values in Table 2.2 effectively capture the impression given by 
Figure 2.3 that the vast majority of detected expression of PAPPA occurs in the 
placenta.  
 
An ideal criterion in this instance is one that would select only genes that are 
exclusively (or almost exclusively) expressed in placenta. Because of this strict 
requirement, MAICE and PEM were not used. The stringency of MAICE can not 
be easily adjusted, while PEM does not differentiate sufficiently between those 
genes with over-expression in a subset of tissues and those with highly specific 
expression in one tissue. Genes with placenta-specific expression were identified 
using the Perl script IdentifyTSGs.pl. This script identifies genes with tissue-
specific expression based on user-selected tissue-specificity criteria (i.e. one or 
more of MAICE, MAX, PEM or SPM) and using the dataset provided by Russ 
and Futschik (2010). MAX and SPM were set to strict cutoff values of 2 and 0.9, 
respectively. To satisfy both these criteria, 90% of the expression of a particular 
gene would have to take place in the placenta, and its expression level in placenta 
would have to be 4-fold higher than in any other tissue (MAX is on a log2 scale).  
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Figure 2.3: PAPPA tissue expression profile.  
The above figure is a tissue expression profile for pregnancy-associated plasma protein A, 
pappalysin 1 (PAPPA), showing normalised expression of PAPPA in 19 tissues across 4 
microarray datasets consolidated by Russ and Futschik (2010) — the dataset nomenclature 
used in that study is used again here. For each tissue, the normalised expression level 
indicates the proportion of all PAPPA expression that was detected in that tissue. It can be 
seen from this graph — and from Table 2.2 — that PAPPA has a highly placenta-specific 
expression pattern. 
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Table 2.2: PAPPA expression tissue-specificity. 
 MAICE MAX PEM SPM 
Geneatlas 1 2.83 3.91 0.9784 
Rosetta1 1 5.94 4.07 0.9987 
Rosetta2 1 5.09 3.83 0.9933 
Stanford 1 3.82 3.50 0.9715 
 
Table 2.2 Legend:  
Shown are values of 4 tissue-specificity measures with respect to placenta, across 4 
microarray expression datasets, for pregnancy-associated plasma protein A, pappalysin 1 
(PAPPA). The 4 microarray datasets used were those consolidated by Russ and Futschik 
(2010) — the dataset nomenclature used in that study is used again here. The 4 tissues 
specificity measures shown are the Minimum Akaike Information Criterion Estimate 
(MAICE), MAX, Preferential Expression Measure (PEM) and specificity measure 
(SPM). It can be seen from the specificity measures shown — and from Figure 2.3 — 
that PAPPA has a highly placenta-specific expression pattern. Note that the value of 
MAICE takes a value of either 1 or 0, depending respectively on whether or not the 
expression of PAPPA in placenta constitutes an outlier in the distribution of tissue 
expression values.   
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A gene was deemed placenta-specific if the tissue-specificity criteria in at least 2 
of the 4 component datasets were satisfied. It is important to note that a gene 
might be accepted as placenta-specific even if it did not satisfy the tissue-
specificity criteria in all datasets, as long as the median value of the tissue-
specificity measure across datasets exceeded the threshold. Effectively, if the gene 
was present in 2 or 3 datasets, it would have to meet the threshold in at least 2 
datasets. If the gene was present in all 4 datasets, it was required to meet the 
threshold in at least 3 datasets. The output file was manually reviewed to check all 
HGNC symbols and insert the correct symbol where necessary.  
 
A total of 44 genes were identified by this process as having placenta-specific 
expression. Figure 2.3 shows the expression profile of one of these genes — 
pregnancy-associated plasma protein A, pappalysin 1 (PAPPA) — while Table 
2.2 shows the tissue-specificity estimates for PAPPA as derived from each 
dataset. A table of these can be found in the appendix at the following location: 
Appendix / home / projects / placenta / data / placental-genes / psgs.html. 
III.	  Placental	  Genes	  
The set of placenta-critical genes and the set of placenta-specific genes were 
combined to form a dataset of "placental genes": those that are known to be 
critical to the development and/or function of placenta, or have placenta-specific 
expression. The combined placental gene set comprised 114 genes. Three genes 
were both placenta-critical and placenta-specific: glial cells missing homolog 1 
(GCM1), leptin (LEP) and pregnancy specific beta-1-glycoprotein 1 (PSG1). 
Seven genes were also present in the study by Hou et al. (2009) that examined 
rates of positive selection in one-to-one orthologous gene families on the 
Eutherian lineage. These were: ADAM metallopeptidase domain 12 (ADAM12), 
adrenomedullin (ADM), kisspeptin (KISS1), leptin (LEP), met proto-oncogene 
(MET), nuclear receptor coactivator 6 (NCOA6) and protein C receptor, 
endothelial (PROCR). These will serve as points of comparison for results 
generated in this analysis. Gene names and identifiers for all 114 placental genes 
are shown in Table 2.3. 
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Table 2.3: Placental genes. 
Gene Symbol Gene Name Ensembl Gene ID Representative Transcript Ensembl ID Swiss-Prot ID 
ADAM12 ADAM metallopeptidase domain 12 ENSG00000148848 ENST00000368679 O43184 
ADM adrenomedullin ENSG00000148926 ENST00000278175 P35318 
ADRA2A adrenoceptor alpha 2A ENSG00000150594 ENST00000280155  
AGT angiotensinogen ENSG00000135744 ENST00000366667 P01019 
ALB albumin ENSG00000163631 ENST00000295897 P02768 
ALPP alkaline phosphatase, placental ENSG00000163283 ENST00000392027 P05187 
ALPPL2 alkaline phosphatase, placental-like 2 ENSG00000163286 ENST00000295453 P10696 
AQPEP aminopeptidase Q ENSG00000172901 ENST00000357872 Q6Q4G3 
ASCL2 achaete-scute complex homolog 2 ENSG00000183734 ENST00000331289 Q99929 
BIRC6 baculoviral IAP repeat containing 6 ENSG00000115760 ENST00000421745 Q9NR09 
CAPN6 calpain 6 ENSG00000077274 ENST00000324068 Q9Y6Q1 
CCBP2 chemokine binding protein 2 ENSG00000144648 ENST00000273145 O00590 
CCNE1 cyclin E1 ENSG00000105173 ENST00000262643 P24864 
CCNE2 cyclin E2 ENSG00000175305 ENST00000308108 O96020 
CDX2 caudal type homeobox 2 ENSG00000165556 ENST00000381020 Q99626 
CGA glycoprotein hormones, alpha polypeptide ENSG00000135346 ENST00000369582 P01215 
COMT catechol-O-methyltransferase ENSG00000093010 ENST00000361682 P21964 
CRH corticotropin releasing hormone ENSG00000147571 ENST00000276571 P06850 
CRHR1 corticotropin releasing hormone receptor 1 ENSG00000120088 ENST00000398285 P34998 
CSF3R colony stimulating factor 3 receptor ENSG00000119535 ENST00000361632 Q99062 
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Table 2.3: Placental genes. (continued) 
Gene Symbol Gene Name Ensembl Gene ID Representative Transcript Ensembl ID Swiss-Prot ID 
CSH1 chorionic somatomammotropin hormone 1 ENSG00000136488 ENST00000316193 P01243 
CSH2 chorionic somatomammotropin hormone 2 ENSG00000213218 ENST00000392886 P01243 
CSHL1 chorionic somatomammotropin hormone-like 1 ENSG00000204414 ENST00000309894 Q14406 
CUL7 cullin 7 ENSG00000044090 ENST00000265348 Q14999 
CYP19A1 cytochrome P450, family 19, subfamily A, polypeptide 1 ENSG00000137869 ENST00000260433 P11511 
CYR61 cysteine-rich, angiogenic inducer, 61 ENSG00000142871 ENST00000451137 O00622 
DLX3 distal-less homeobox 3 ENSG00000064195 ENST00000434704 O60479 
EBI3 Epstein-Barr virus induced 3 ENSG00000105246 ENST00000221847 Q14213 
EDN1 endothelin 1 ENSG00000078401 ENST00000379375 P05305 
EED embryonic ectoderm development ENSG00000074266 ENST00000263360 O75530 
EGFL6 EGF-like-domain, multiple 6 ENSG00000198759 ENST00000361306 Q8IUX8 
ELF5 E74-like factor 5 ENSG00000135374 ENST00000312319 Q9UKW6 
EOMES eomesodermin ENSG00000163508 ENST00000295743 O95936 
ERF Ets2 repressor factor ENSG00000105722 ENST00000222329 P50548 
ERN1 endoplasmic reticulum to nucleus signaling 1 ENSG00000178607 ENST00000433197 O75460 
ESRRB estrogen-related receptor beta ENSG00000119715 ENST00000380887 O95718 
ESX1 ESX homeobox 1 ENSG00000123576 ENST00000372588 Q8N693 
ETS2 v-ets erythroblastosis virus E26 oncogene homolog 2 ENSG00000157557 ENST00000360214 P15036 
FBN2 fibrillin 2 ENSG00000138829 ENST00000262464 P35556 
FOSL1 FOS-like antigen 1 ENSG00000175592 ENST00000312562 P15407 
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Table 2.3: Placental genes. (continued) 
Gene Symbol Gene Name Ensembl Gene ID Representative Transcript Ensembl ID Swiss-Prot ID 
GCM1 glial cells missing homolog 1 ENSG00000137270 ENST00000259803 Q9NP62 
GH1 growth hormone 1 ENSG00000259384 ENST00000323322 P01241 
GH2 growth hormone 2 ENSG00000136487 ENST00000423893 P01242 
GINS1 GINS complex subunit 1 ENSG00000101003 ENST00000262460 Q14691 
GSTP1 glutathione S-transferase pi 1 ENSG00000084207 ENST00000398606 P09211 
HAND1 heart and neural crest derivatives expressed 1 ENSG00000113196 ENST00000231121 O96004 
HGF hepatocyte growth factor ENSG00000019991 ENST00000222390 P14210 
HRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog ENSG00000174775 ENST00000311189 P01112 
HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 ENSG00000176387 ENST00000326152 P80365 
IGF2 insulin-like growth factor 2 ENSG00000167244 ENST00000300632 P01344 
INSL4 insulin-like 4 ENSG00000120211 ENST00000239316 Q14641 
ISM2 isthmin 2 homolog ENSG00000100593 ENST00000342219 Q6H9L7 
ITGAV integrin, alpha V ENSG00000138448 ENST00000261023 P06756 
KISS1 kisspeptin ENSG00000170498 ENST00000367194 Q15726 
KRT8 keratin 8 ENSG00000170421 ENST00000293308 P05787 
LEP leptin ENSG00000174697 ENST00000308868 P41159 
LGALS13 lectin, galactoside-binding, soluble, 13 ENSG00000105198 ENST00000221797 Q9UHV8 
LGALS14 lectin, galactoside-binding, soluble, 14 ENSG00000006659 ENST00000392052 Q8TCE9 
MAP2K1 mitogen-activated protein kinase kinase 1 ENSG00000169032 ENST00000307102 Q02750 
MAP3K3 mitogen-activated protein kinase kinase kinase 3 ENSG00000198909 ENST00000361733 Q99759 
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Table 2.3: Placental genes. (continued) 
Gene Symbol Gene Name Ensembl Gene ID Representative Transcript Ensembl ID Swiss-Prot ID 
MAPK14 mitogen-activated protein kinase 14 ENSG00000112062 ENST00000229794 Q16539 
MET met proto-oncogene ENSG00000105976 ENST00000397752 P08581 
MFN2 mitofusin 2 ENSG00000116688 ENST00000235329 O95140 
MTHFD1 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 ENSG00000100714 ENST00000555709 P11586 
NCOA2 nuclear receptor coactivator 2 ENSG00000140396 ENST00000452400 Q15596 
NCOA6 nuclear receptor coactivator 6 ENSG00000198646 ENST00000359003 Q14686 
NLRP7 NLR family, pyrin domain containing 7 ENSG00000167634 ENST00000340844 Q8WX94 
NOS3 nitric oxide synthase 3 ENSG00000164867 ENST00000297494 P29474 
NR2F2 nuclear receptor subfamily 2, group F, member 2 ENSG00000185551 ENST00000394166 P24468 
PAGE4 P antigen family, member 4 ENSG00000101951 ENST00000218068 O60829 
PAPPA pregnancy-associated plasma protein A, pappalysin 1 ENSG00000182752 ENST00000328252 Q13219 
PAPPA2 pappalysin 2 ENSG00000116183 ENST00000367662 Q9BXP8 
PBRM1 polybromo 1 ENSG00000163939 ENST00000296302 Q86U86 
PCSK4 proprotein convertase subtilisin/kexin type 4 ENSG00000115257 ENST00000300954 Q6UW60 
PEG10 paternally expressed 10 ENSG00000242265 ENST00000482108 Q86TG7-2 
PHLDA2 pleckstrin homology-like domain, family A, member 2 ENSG00000181649 ENST00000314222 Q53GA4 
PISD phosphatidylserine decarboxylase ENSG00000241878 ENST00000439502 Q9UG56 
PLAC1 placenta-specific 1 ENSG00000170965 ENST00000359237 Q9HBJ0 
PNPLA6 patatin-like phospholipase domain containing 6 ENSG00000032444 ENST00000221249 Q8IY17-2 
POU5F1 POU class 5 homeobox 1 ENSG00000204531 ENST00000259915 Q01860 
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Table 2.3: Placental genes. (continued) 
Gene Symbol Gene Name Ensembl Gene ID Representative Transcript Ensembl ID Swiss-Prot ID 
PPARG peroxisome proliferator-activated receptor gamma ENSG00000132170 ENST00000287820 P37231 
PROCR protein C receptor, endothelial ENSG00000101000 ENST00000216968 Q9UNN8 
PSG1 pregnancy specific beta-1-glycoprotein 1 ENSG00000231924 ENST00000436291 P11464 
PSG11 pregnancy specific beta-1-glycoprotein 11 ENSG00000243130 ENST00000320078 Q9UQ72 
PSG2 pregnancy specific beta-1-glycoprotein 2 ENSG00000242221 ENST00000329509 P11465 
PSG3 pregnancy specific beta-1-glycoprotein 3 ENSG00000221826 ENST00000327495 Q16557 
PSG4 pregnancy specific beta-1-glycoprotein 4 ENSG00000243137 ENST00000405312 Q00888 
PSG5 pregnancy specific beta-1-glycoprotein 5 ENSG00000204941 ENST00000342951 Q15238 
PSG6 pregnancy specific beta-1-glycoprotein 6 ENSG00000170848 ENST00000292125 Q00889 
PSG7 pregnancy specific beta-1-glycoprotein 7 ENSG00000221878 ENST00000406070  
PSG9 pregnancy specific beta-1-glycoprotein 9 ENSG00000183668 ENST00000270077 Q00887 
ROCK2 Rho-associated, coiled-coil containing protein kinase 2 ENSG00000134318 ENST00000315872 O75116 
RTL1 retrotransposon-like 1 ENSG00000254656 ENST00000534062  
S100P S100 calcium binding protein P ENSG00000163993 ENST00000296370 P25815 
SENP1 SUMO1/sentrin specific peptidase 1 ENSG00000079387 ENST00000004980 Q9P0U3 
SERPINE1 serpin peptidase inhibitor, clade E, member 1 ENSG00000106366 ENST00000223095 P05121 
SLC2A1 solute carrier family 2 (facilitated glucose transporter), member 1 ENSG00000117394 ENST00000426263 P11166 
SLC40A1 solute carrier family 40 (iron-regulated transporter), member 1 ENSG00000138449 ENST00000261024 Q9NP59 
SOCS3 suppressor of cytokine signaling 3 ENSG00000184557 ENST00000330871 O14543 
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Table 2.3: Placental genes. (continued) 
Gene Symbol Gene Name Ensembl Gene ID Representative Transcript Ensembl ID Swiss-Prot ID 
STK11 serine/threonine kinase 11 ENSG00000118046 ENST00000326873 Q15831 
SULT1E1 sulfotransferase family 1E, estrogen-preferring, member 1 ENSG00000109193 ENST00000226444 P49888 
TAC3 tachykinin 3 ENSG00000166863 ENST00000415231 Q9UHF0 
TFAP2C transcription factor AP-2 gamma  ENSG00000087510 ENST00000201031 Q92754 
TFPI2 tissue factor pathway inhibitor 2 ENSG00000105825 ENST00000222543 P48307 
TGFBR1 transforming growth factor, beta receptor 1 ENSG00000106799 ENST00000374994 P36897 
THBD thrombomodulin ENSG00000178726 ENST00000377103 P07204 
TJP1 tight junction protein 1 ENSG00000104067 ENST00000346128 Q07157 
UBP1 upstream binding protein 1 (LBP-1a) ENSG00000153560 ENST00000283628 Q9NZI7 
VEGFA vascular endothelial growth factor A ENSG00000112715 ENST00000523873 P15692 
VGLL1 vestigial like 1 ENSG00000102243 ENST00000370634 Q99990 
VHL von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase ENSG00000134086 ENST00000256474 P40337 
XAGE2 X antigen family, member 2 ENSG00000185751 ENST00000330906 Q96GT9 
XAGE3 X antigen family, member 3 ENSG00000171402 ENST00000346279 Q8WTP9 
ZFP36L1 ZFP36 ring finger protein-like 1 ENSG00000185650 ENST00000336440 Q07352 
 
Table 2.3 Legend:  
Shown on pages 105 to 110 inclusive are tables showing gene names and identifiers for all 114 placental genes studied in this thesis. Aside from each gene 
symbol and gene name, the corresponding Ensembl Gene ID is given, as is the Ensembl Transcript ID of the representative transcript used, in addition to the 
corresponding entry in Swiss-Prot, if available.  
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2.2.3 Placental	  Gene	  Data	  Assembly	  
Gene family homologs and their representative transcript coding sequences were 
obtained for each placental gene — the steps taken in doing so are shown in the 
bioinformatics pipeline in Figure 2.4. For all 22 species of interest, the set of 
homologs of each placental gene — as inferred by the Ensembl Compara pipeline 
(Vilella et al. 2009) — were obtained from Ensembl (Flicek et al. 2012). The process 
undertaken by Vilella et al. (2009) to identify these homologous families is outlined 
here and shown in Figure 2.5. 
 
1. Gene sequence download: a set of representative gene sequences are loaded 
from all Ensembl genomes. For each gene, the longest available coding 
sequence is taken as representative.  
 
2. Homology search: Protein homology relationships are inferred using 
WUBLASTP 2.0, in an all-against-all homolog search for the set of 
representative gene sequences. 
 
3. Homology network construction: a sparse graph is constructed of protein 
homology relationships identified during the homolog search, in which each 
node represents a protein and each edge represents a homology relationship 
between two proteins. 
 
4. Gene family alignment: Gene families are formed from clusters in the 
homology graph, and the amino acid sequences of every protein in each gene 
family are aligned using MUSCLE (Edgar 2004b).  
 
5. Gene family phylogeny: TreeBeST (Li 2007) makes use of the aligned 
homologous genes to infer the phylogeny of the gene family, which is 
reconciled with a species phylogeny.  
 
6. Orthology/paralogy inference: the reconciled gene tree is used to infer 
orthology and paralogy relationships in each gene family (Vilella et al. 2009).  
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Figure 2.4: Placental gene data assembly pipeline.  
Shown is a bioinformatics pipeline depicting the steps involved in placental gene data assembly. Arrows indicate the direction of process flow. For 
information on symbols used, see the pipeline key in Figure 2.2. 
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A key aspect of the Ensembl Compara pipeline is the use of a duplication 
consistency score (DCS) developed by Vilella et al. (2009) to resolve ambiguous 
proposed duplications. Given two daughter lineages descending from a proposed 
duplication event, the DCS is calculated from the number of species represented in 
both lineages divided by the number of species represented in either lineage. A 
duplication without subsequent gene loss results in all species being represented in 
both daughter lineages, this example would attain a perfect DCS of 1. A worst-case 
scenario with a duplication and reciprocal complementary gene loss in the daughter 
lineages attains a DCS of 0 — this is considered unlikely (Vilella et al. 2009). 
 
For each of the 114 placental human genes described in Section 2.2.2, a set of pre-
defined Ensembl Compara homologs was obtained from Ensembl as follows: each 
gene was used as a query in a BioMart 'Homologs' search on the Ensembl server. 
The following attributes were requested from the server: (1) the Ensembl Gene ID 
— a unique identifier associated with each gene in the Ensembl genome database; 
(2) the Human Paralog Ensembl Gene ID — this is the Ensembl Gene ID of a human 
gene paralogous to one of the placental genes; and (3) the Ancestor — the most 
recent common ancestor of the placental gene and its paralog (as inferred by the 
Ensembl Compara pipeline). The result of this query was a paralog table that showed 
the pre-defined Ensembl Compara human paralogs of each placental gene and the 
inferred ancestor of each paralogous pair. This table was filtered to retain only 
paralogs whose common ancestor with a placental gene was within Eutheria. This 
ensured that only paralogs resulting from duplications within the clade of interest 
(i.e. Eutheria) would be retained for further analyses.  
 
With the set of placental genes and their paralogs in human, a series of Ensembl 
BioMart 'Homologs' queries were made to obtain the orthologs of each placental 
gene and paralog in every other species under study. The attributes sought in each 
such query were: (1) the Ensembl Gene ID, and (2) either Ortholog or Possible 
Ortholog. Both of these return the Ensembl Gene ID of an ortholog of the query 
gene, but possible orthologs are from a part of the gene family phylogeny with a 
duplication consistency score equal to or less than 0.25 (Vilella et al. 2009).  
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Figure 2.5: Ensembl Compara pipeline.  
Shown is an outline of the Ensembl Compara pipeline (Vilella et al. 2009). This involves 6 
main steps: (1) loading a set of representative gene sequences from every Ensembl genome; 
(2) performing a genome-wise all-against-all search, to identify homology relationships 
between the set of representative genes in all genomes; (3) constructing a sparse graph of 
homology relationships between representative genes, such that clusters of genes represent 
gene families; (4) aligning the sequences of all the genes in each homology cluster; (5) 
constructing a gene tree for each homology cluster, while reconciling that gene tree with a 
known species phylogeny; and (6) inferring orthology and paralogy relationships for each 
pair of homologs using the gene phylogeny.  
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In summary, the result of these Ensembl BioMart queries was a set of tables, each 
with two columns: one with the Ensembl Gene ID of the gene of interest, the other 
with the Ensembl Gene ID of an Ensembl Compara ortholog. Using the Perl script 
MergeTables.pl, these were combined into one ortholog table, such that every row 
showed the orthologs of a given placental gene or paralog, and every column showed 
all orthologs for a given species. With the paralog table and merged ortholog table as 
input, the script CreateEnsemblGeneFamilyTable.pl was used to construct a gene 
family table, in which the leftmost column contained the 114 placental genes, and the 
other columns contained gene family members — including the placental genes 
themselves — in all 22 species of interest, including human. Figure 2.6 shows an 
example of such a gene family table. 
 
It is optimal when performing analysis of selective pressure using maximum 
likelihood that a minimum of 7 species are represented in the dataset. Anisimova et 
al. (2001) found that with a lower number of sequences, selective pressure analysis 
with maximum likelihood lacks power: in two comparable simulated datasets of 
length 100 codons, one of which had 6 taxa, the other having 17 sequences, the LRT 
had a power of 66% and 92%, respectively (α = 0.05).  
 
Only 110 gene families were found to have genes in 7 or more species. The other 4 
gene families were: pregnancy specific beta-1-glycoprotein 7 (PSG7), X antigen 
family members 2 and 3 (XAGE2 and XAGE3) and insulin-like 4 (INSL4). These 
gene families were not analysed for selective pressure variation as the test would 
lack power. Of the remaining 110 placental gene families, 58 genes had one-to-one 
orthologs within Eutheria, and 25 genes had one-to-one orthologs throughout all 22 
species. 
 
Gene sequences were downloaded for the placental gene families as follows. All 
annotated coding DNA sequences of each placental gene, paralog and ortholog were 
obtained using an Ensembl BioMart 'Sequences' query, with the following FASTA 
header attributes requested: (1) Ensembl Gene ID; and (2) Ensembl Transcript ID 
— a unique identifier associated with each gene transcript in the Ensembl genome 
database.  
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Figure 2.6: Gene family table example.  
Shown is an example gene family table, in which each row shows the gene identifiers of members of a particular gene family across all species, while each 
column shows the identifiers of genes in a particular species across all gene families. In this example, the gene families are named for the gene of interest, 
while the individual gene identifiers are Ensembl Gene IDs. Where multiple homologs are present for a given gene in a given species, these are separated by 
commas. Where no homologs are known for a given gene in a given species, the table entry is left blank. 
 117 
Where multiple alternative transcripts were present for a single gene, a 
representative transcript was chosen for each gene, such that the sequence of that 
transcript was used for the given gene throughout the analyses in this thesis. Data 
quality is critical for selective pressure analysis, so the best quality transcript should 
be selected where possible (Schneider et al. 2009).  
 
A single representative transcript was chosen for each gene using the Perl script 
GetRepresentativeTranscripts.pl in conjunction with a local copy the Swiss-Prot 
sequence data file and a table of Ensembl transcript annotation data. This script takes 
as input a FASTA file containing a set of sequences such that for every gene 
represented in the file, the coding DNA sequence (CDS) of every transcript of that 
gene available in the Ensembl genomic database (Flicek et al. 2012) is included in 
the file. It then outputs a FASTA file containing a single representative transcript 
CDS for each gene included in the input FASTA file. The process of representative 
transcript selection is shown in Figure 2.7 and outlined below. 
 
1. Quality check: the set of transcripts for each gene is first quality checked to 
ensure that the CDS has a complete reading frame and no internal stop 
codons. Any transcript that fails this quality check (e.g. by having multiple 
internal stop codons) is removed. If every available transcript of a gene fails 
this quality check, then it is not possible to select a valid protein coding 
transcript for that gene, so the gene is removed from consideration entirely. 
Where only one transcript is available for a gene, it is automatically taken as 
the representative transcript. Otherwise, this script filters the candidate 
transcripts by Ensembl annotation. 
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2. Ensembl annotation: transcripts are filtered by their Ensembl annotated 
'Transcript Biotype' and 'Status (transcript)', respectively. First, if there are 
protein-coding transcripts for a gene, all transcripts that are not protein-
coding are removed. Then, the transcripts are grouped by Ensembl-annotated 
evidence status (i.e. 'KNOWN', 'NOVEL' or 'PUTATIVE'), and only the set 
of transcripts with the best status level are retained. Known transcripts are 
given preference over novel transcripts, while both are given preference over 
putative transcripts. This is done on the basis that a transcript with more 
experimental support is less likely to produce an unreliable alignment and 
downstream spurious signals of positive selection (Schneider et al. 2009). If 
this filter selects only one candidate transcript, that transcript is taken as 
representative. Otherwise, this script filters the remaining candidate 
transcripts by Swiss-Prot annotation. 
 
3. Swiss-Prot annotation: if a given gene has a corresponding entry in Swiss-
Prot (UniProt Consortium 2011), the transcripts are filtered for sequence 
similarity to that of the corresponding Swiss-Prot entry. Only those 
transcripts with the best match to the corresponding Swiss-Prot sequence are 
kept. If this filter selects only one candidate transcript, that transcript is taken 
as representative. Otherwise, this script filters the remaining candidate 
transcripts by transcript length. 
 
4. Transcript length: transcripts with the longest CDS are retained. If one 
candidate transcript has a longer transcript than all others, it is taken as 
representative. Otherwise, this script arbitrarily selects a transcript as 
representative from among those with the longest CDS. 
 
5. Arbitrary selection: the remaining transcripts are sorted by Ensembl 
Transcript ID and the first transcript in the list is arbitrarily selected as the 
representative transcript.  
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For each species, a gene-transcript mapping table was output, showing the identifiers 
of each gene and its corresponding representative transcript, in addition to the details 
of the representative transcript selection process. Where a representative transcript 
was successfully mapped to a Swiss-Prot entry, the Swiss-Prot accession was 
included in the information for that representative transcript.  
 
Swiss-Prot annotation informed representative transcript selection in only 17 of the 
22 species under study. The following genomes had no corresponding Swiss-Prot 
entries for Ensembl Compara homologs: Bat (Myotis lucifugus), Fugu (Takifugu 
rubripes), Lizard (Anolis carolinensis) and Platypus (Ornithorhynchus anatinus). 
Furthermore, Ensembl release 65 lacked Swiss-Prot accession mapping information 
for Gorilla (Gorilla gorilla).  
 
Three genes had no transcript with a valid coding sequence, so these were removed 
from the dataset. This included the human placental gene pregnancy specific beta-1-
glycoprotein 7 (PSG7), which despite the highly placenta-specific expression pattern 
of its mRNA in 3 of the 4 microarray experiments consolidated by Russ and Futschik 
(2010), is a polymorphic pseudogene and is designated an orphan (no annotated 
orthologs) in Ensembl release 65. (In any case, PSG7 was excluded from further 
analysis because it lacked the requisite number of homologs.) The two other genes 
found to lack a valid coding sequence were Danio rerio genes 
ENSDARG00000092174 and ENSDARG00000093343. Both these genes were 
found to have annotated coding sequences whose length is not a multiple of 3, so 
these were removed from the gene family table created previously.  
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Figure 2.7: Representative transcript selection pipeline.  
Shown is a bioinformatics pipeline depicting the steps involved in representative transcript selection. Arrows indicate the direction of process flow. For 
information on symbols used, see the pipeline key in Figure 2.2. 
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2.3 Methods	  
This section describes the procedures followed in a selective pressure analysis 
pipeline conducted for 114 placental genes. The phylogeny of each gene family was 
reconstructed, as was a nucleotide alignment (see Figure 2.8, part A). These were to 
be used as input to Codeml for selective pressure analysis (Yang 2007, Yang 1997) 
(see Figure 2.8, part B). All scripts used during this process can be accessed from the 
following location in the electronic appendix: Appendix / home / code / scripts.html. 
2.3.1 Phylogeny	  Reconstruction	  
The reconstruction of the phylogeny of each gene family involved three main steps: 
(I) the alignment of the sequences of all gene family members, so that homologous 
amino acid sites could be compared, (II) the selection of the model of best fit for 
each gene family, and (III) the reconstruction of a phylogenetic tree of the gene 
family, using the gene family multiple sequence alignment and the model of best fit.  
I.	  Multiple	  Sequence	  Alignment	  
Coding DNA sequences for each gene family were translated to amino acid 
sequences using the Perl script TranslateFASTA.pl, which takes as input a 
FASTA file containing protein-coding nucleotide sequences and outputs a 
FASTA file containing the translated amino acid sequences corresponding to the 
input nucleotide sequences. All stop codons were removed, and where possible 
ambiguous codons were resolved and translated (e.g. 'ACN' would be translated 
as 'T'). The amino acid sequences of each gene family were then aligned using 
PRANK (Löytynoja and Goldman 2008).  
 
Many different programs are available to perform multiple sequence alignment 
(MSA) (e.g. Clustal, MUSCLE, PRANK, see Section 1.6.2). PRANK was chosen 
in this instance because it was found to outperform other methods when used in 
selective pressure analysis on both simulated data (Fletcher and Yang 2010) and 
empirical datasets (Markova-Raina and Petrov 2011).  
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Figure 2.8: Selective pressure analysis pipeline.  
Shown is a bioinformatics pipeline depicting the steps involved in selective pressure 
analysis. Part (A) depicts the process of creating a gene family phylogeny and nucleotide 
sequence alignment, while part (B) shows the process of preparing and using this data in 
selective pressure analysis. Arrows indicate the direction of process flow. For information on 
symbols used, see the pipeline key in Figure 2.2. 
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For example, in a ROC analysis of selective pressure analysis outcomes in a 
simulation study by Fletcher and Yang (2010), the true alignment — known from 
the simulated data — had an area under the ROC curve6 (AUC) of 0.63, the AUC 
of PRANK ranged from 0.61-0.63, while AUC did not exceed 0.6 for other 
methods such as ClustalW (Larkin et al. 2007, Thompson et al. 1994) and 
MUSCLE (Edgar 2004b). These other, worse performing methods were found to 
align non-homologous sites together in the same column, resulting in an 
alignment that is more compact but less correct with respect to modelling sitewise 
homology across a set of sequences. However, both studies warn that high false-
positive rates remain a potential issue even when using PRANK, with false-
positive estimates of selective pressure analysis with a PRANK alignment ranging 
from 2% to 29%, depending on the foreground lineage, synonymous substitution 
rate and sequence type (Fletcher and Yang 2010). To reduce this risk, all results 
from the selective pressure analysis have been carefully monitored (see Section 
2.3.2).  
 
There are a number of different versions of the PRANK software, with each 
iteration incorporating more features and fixing bugs. As mentioned above, 25 of 
the 110 gene families comprised one-to-one orthologs and lacked paralogs 
throughout all species sampled. PRANK v.100802 was used to create amino acid 
MSAs for these 25 gene families, using a guide tree taken from a recent 
authoritative species phylogeny for these species (Benton and Donoghue 2007). 
 
For these 25 gene families comprising one-to-one orthologs, each guide tree was 
created with the Perl script CreateGuideTree.pl, using the species phylogeny of 
Benton and Donoghue (2007) as a template (see Figure 2.9). This script takes as 
input a FASTA file containing the members of a gene family comprising one-to-
one orthologs, a template species tree and a regex (i.e. regular expression) key file 
                                                
6 ROC curves can be used to compare method performance where the true-positive rate and 
false-positive rate can be estimated. Essentially, the ROC curve of a method is drawn by 
plotting a graph of the true-positive rate and false-positive rate of the algorithm at different 
levels of stringency. The area under the ROC curve (AUC) of each method can then provide 
a measure of the performance of that method, such that a higher AUC is associated with a 
higher true-positive rate and lower false-positive rate. A prediction method that identifies all 
true-positives and rejects all true negatives will have an AUC of 1, while a random method 
will have an AUC of 0.5. 
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mapping gene identifier regular expressions to species (e.g. an Ensembl Gene ID 
containing 'ENSG0' would correspond to 'Human'). For each species with a 
corresponding gene identifier in the FASTA file, this script replaces the species 
name with the gene identifier. The resulting guide tree containing gene identifiers 
is then saved to file and can be used as a pre-specified guide tree for multiple 
sequence alignment. Version 100802 of PRANK was used in this case because it 
includes a pruning option: the full species tree can be input as a guide tree to 
PRANK, which prunes the tree dynamically to retain only those taxa for which an 
input sequence is present. 
 
For the remaining 85 gene families with paralogs, this Perl script could not be 
used to create a guide tree, because genes could not be unambiguously placed on 
the template species tree in those cases. In those cases, PRANK v.081202 was 
used to create amino acid MSAs with a PRANK-generated guide tree. All 
PRANK jobs were run on the Ampato high performance computing (HPC) cluster 
in Dublin City University, operated under the aegis of the Sci-Sym Research 
Center (http://sci-sym.dcu.ie/).  
 
There is currently no parallel implementation of PRANK, so in order to make 
optimal use of the parallel architecture of Ampato, a Sun Grid Engine array job 
script was used to manage the parallel computation of serial PRANK jobs. Array 
jobs are useful for embarrassingly parallel jobs such as this: parallel 
computation jobs with multiple serial tasks that lack interdependency, such that 
parallelising the workload is trivial. The array job allocated each individual 
PRANK job to one of 32 individual computer processors, both at the start of the 
array job and on completion of each PRANK task. See Figure 2.10 for an 
illustration. 
 125 
 
Figure 2.9: Guide tree creation.  
Shown is an illustration of the input and output of the process of creation of guide trees for 
use by PRANK alignment software. Guide trees were created only for those gene families 
with no more than one gene per species, so that each member of the gene family could be 
matched to its corresponding species. Taking the set of gene sequences and their 
corresponding identifiers, a species tree derived from that of Benton and Donoghue (2007), 
and a regex key mapping gene identifiers to species names, a guide tree was created in which 
each species name had been replaced by the relevant gene identifier. Credit for animal 
silhouette images is due to Dr Mary J. O'Connell. 
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Figure 2.10: Array job example.  
Shown is an illustration of an array job performed under the Sun Grid Engine (SGE) batch 
system on the '4node' queue of the Ampato computing cluster. The array job script (upper 
left) instructs the batch system to run each serial task from a task list (lower left) on the 
Ampato 4node queue (at right), which comprises 4 nodes, each with 8 processing cores. A 
cartoon representation of each core in the 4node queue is shown, numbered by node and 
core, so that for example, the 3rd core on the 4th node is numbered 4.3. The arrows shown 
indicate that serial tasks are each allocated to a single core in the parallel architecture, and 
thus run in an 'embarrassingly parallel' manner. 
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While the phylogenetic reconstruction for each gene family required an amino 
acid MSA, the downstream selective pressure analysis would require an alignment 
at the nucleotide level as the nucleotides contain data about synonymous 
substitution rates. To generate the precise nucleotide alignment for each gene 
family, the Perl script MapGapsFASTA.pl was used to map alignment gaps from 
the amino acid MSA onto the corresponding position in the unaligned nucleotide 
sequences, such that each single amino acid gap maps to a triplet of gaps in the 
nucleotide coding sequence. This ensured that the sitewise homology represented 
in the resulting nucleotide multiple sequence alignment corresponded to that of 
the gene family amino acid alignment. These nucleotide alignments were retained 
for use in selective pressure analysis.  
II.	  Phylogenetic	  Model	  Optimisation	  
For each gene family, the evolutionary model of best fit was chosen using the 
software ProtTest 3.2 (Darriba et al. 2011), which proceeds through two main 
stages: 
 
1. Model parameter optimisation using PhyML (Guindon and Gascuel 
2003). The following models were included as candidates in this process: 
JTT, Dayhoff, Blosum62, VT, WAG and LG (see Section 1.6.2). For each 
model, parameters were optimised using the gene family alignment and a 
neighbour-joining guide tree created by BIONJ (Gascuel 1997). Parameter 
optimisation was also performed for variants of each model that account 
for invariant sites (Reeves 1992), among-site rate variation using a discrete 
approximation to a gamma distribution (Yang 1996), or a combination of 
the two. These 3 model variants were denoted by the suffixes '+I', '+G' and 
'+I+G', respectively.  
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2. Model selection using a suitable criterion. The criterion used in this case 
was the Bayesian information criterion (BIC) (Schwarz 1978) — see 
Section 1.6.2. Since none of the models being compared are nested, 
comparison of a sequence of models by hierarchical LRTs was not a 
suitable approach. The set of models and model variants were ranked 
according to increasing BIC, and the posterior probability of each model 
(conditional on the model of best fit being among those tested) was 
estimated in a manner analagous to that for 'Akaike weights' (Burnham 
and Anderson 2002).  
 
In each case, the model with the lowest BIC — and by implication the closest to 
the 'true' model — was taken to be the model of best fit. If a model variant, such 
as JTT+G — i.e. Jones, Taylor and Thornton model incorporating a discrete 
gamma distribution to account for among-site rate variation — was selected, then 
this model variant was of course chosen for use in the subsequent phylogenetic 
reconstruction. The results of model selection are shown in Table 2.4. 
 
For 105 of 110 gene families, the model of best fit was found to be JTT 
incorporating a discrete gamma distribution to account for substitution rate 
variation among sites (i.e. JTT+G). This was in line with expectations, as a 
previous study had found JTT to be the model of best fit for a majority (i.e. 57%) 
of vertebrate genes studied (Keane et al. 2006).  
 
Of the remaining 5 gene families, JTT without a gamma distribution was found to 
be the model of best fit for 3 genes of interest: kisspeptin (KISS1), P antigen 
family member 4 (PAGE4) and tachykinin 3 (TAC3). The other two genes were 
albumin (ALB) and caudal type homeobox 2 (CDX2), for which the models of 
best fit were WAG+G and Dayhoff+G, respectively. 
 
Table 2.4 Legend:  
Shown on pages 129 to 131 inclusive are tables listing each gene family for which a 
phylogenetic model was selected, showing the model, its log-likelihood (lnL), the 
value of the Bayesian Information Criterion (BIC) and the posterior probability of the 
given model P(M), given the set of models tested.  
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Table 2.4: Results of phylogenetic model selection. 
Gene Model lnL BIC P(M) 
ADAM12 JTT+G -13045.63 26372.85 0.97 
ADM JTT+G -4103.18 8439.42 0.94 
ADRA2A JTT+G -10707.31 21784.97 0.97 
AGT JTT+G -12552.62 25371.82 0.96 
ALB WAG+G -12429.58 25118.98 0.77 
ALPP JTT+G -21819.53 44345.64 0.98 
ALPPL2 JTT+G -21819.53 44345.64 0.98 
AQPEP JTT+G -17811.7 35889.66 0.97 
ASCL2 JTT+G -3296.02 6786.95 0.95 
BIRC6 JTT+G -35250.53 70897.43 0.99 
CAPN6 JTT+G -8910.84 18096.17 0.96 
CCBP2 JTT+G -4863.3 9921.74 0.95 
CCNE1 JTT+G -7103.86 14555.78 0.96 
CCNE2 JTT+G -5467.83 11226.95 0.95 
CDX2 Dayhoff+G -2583.62 5389.19 0.93 
CGA JTT+G -1797.23 3801.09 0.92 
COMT JTT+G -6155.38 12628.92 0.95 
CRH JTT+G -3603.15 7441.9 0.94 
CRHR1 JTT+G -3985.18 8232.03 0.96 
CSF3R JTT+G -22808.21 45939.01 0.97 
CSH1 JTT+G -7546.85 15592.77 0.96 
CSH2 JTT+G -7546.85 15592.77 0.96 
CSHL1 JTT+G -7546.85 15592.77 0.96 
CUL7 JTT+G -26510.77 53311.76 0.98 
CYP19A1 JTT+G -8943.27 18208.75 0.96 
CYR61 JTT+G -7344.22 15012.94 0.96 
DLX3 JTT+G -2443.22 5094.55 0.93 
EBI3 JTT+G -5165.21 10534.79 0.95 
EDN1 JTT+G -3819.05 7850.12 0.94 
EED JTT+G -2982.04 6219.28 0.96 
EGFL6 JTT+G -10049.77 20399.76 0.96 
ELF5 JTT+G -2712.21 5634.15 0.95 
EOMES JTT+G -8044.87 16403.91 0.97 
ERF JTT+G -3402.48 6998.84 0.96 
ERN1 JTT+G -14434.52 29254.85 0.98 
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Table 2.4: Results of phylogenetic model selection. (continued) 
Gene Model lnL BIC P(M) 
ESRRB JTT+G -6991.44 14302.47 0.97 
ESX1 JTT+G -12749.19 26034.44 0.97 
ETS2 JTT+G -7925.78 16168.1 0.96 
FBN2 JTT+G -51376.83 103360.12 0.99 
FOSL1 JTT+G -4040.9 8327.4 0.96 
GCM1 JTT+G -7167.25 14582.03 0.96 
GH1 JTT+G -7456.62 15404.78 0.96 
GH2 JTT+G -7456.31 15404.16 0.96 
GINS1 JTT+G -1733.16 3702.02 0.94 
GSTP1 JTT+G -3878.51 8023.18 0.94 
HAND1 JTT+G -1701.08 3586.91 0.88 
HGF JTT+G -11893.49 24139.74 0.97 
HRAS JTT+G -1803.2 3898.15 0.95 
HSD11B2 JTT+G -6451.23 13162.02 0.96 
IGF2 JTT+G -3714.76 7649.19 0.95 
ISM2 JTT+G -9581.59 19424.91 0.97 
ITGAV JTT+G -13194.57 26707.9 0.97 
KISS1 JTT -2057.37 4223.44 0.93 
KRT8 JTT+G -13603.36 27731.63 0.97 
LEP JTT+G -2062.78 4279.46 0.93 
LGALS13 JTT+G -4448.02 9198.08 0.94 
LGALS14 JTT+G -4448.02 9198.08 0.94 
MAP2K1 JTT+G -2427.93 5113.46 0.96 
MAP3K3 JTT+G -9767.95 19929.32 0.97 
MAPK14 JTT+G -2699.09 5685.28 0.93 
MET JTT+G -18987.2 38282 0.97 
MFN2 JTT+G -6590.03 13500.36 0.97 
MTHFD1 JTT+G -9378.37 19053.43 0.97 
NCOA2 JTT+G -17842.86 36016.09 0.98 
NCOA6 JTT+G -31619.31 63620.44 0.98 
NLRP7 JTT+G -26532.64 53435.58 0.98 
NOS3 JTT+G -10318.46 20881.99 0.97 
NR2F2 JTT+G -4129.63 8584.32 0.96 
PAGE4 JTT -2876.25 6104.41 0.93 
PAPPA JTT+G -21160.01 42694.91 0.98 
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Table 2.4: Results of phylogenetic model selection. (continued) 
Gene Model lnL BIC P(M) 
PAPPA2 JTT+G -30904.49 62148.46 0.98 
PBRM1 JTT+G -18000.31 36472.71 0.98 
PCSK4 JTT+G -12665.66 25577.57 0.97 
PEG10 JTT+G -15190.18 31563.42 0.97 
PHLDA2 JTT+G -2168.64 4511.16 0.94 
PISD JTT+G -5736.34 11766.7 0.97 
PLAC1 JTT+G -6213.59 12823.11 0.95 
PNPLA6 JTT+G -15321.1 30941.65 0.98 
POU5F1 JTT+G -10564.45 21533.73 0.96 
PPARG JTT+G -4097.35 8478.31 0.96 
PROCR JTT+G -4820.75 9831.97 0.94 
PSG1 JTT+G -19096.19 39240.29 0.98 
PSG2 JTT+G -19129.79 39307.49 0.98 
ROCK2 JTT+G -16117.21 32715.58 0.98 
RTL1 JTT+G -13612.97 27362.27 0.98 
S100P LG+G -1269.37 2661 0.88 
SENP1 JTT+G -9884.51 20066.37 0.97 
SERPINE1 JTT+G -6358.33 12947.62 0.95 
SLC2A1 LG+G -7861.2 16073.05 0.96 
SLC40A1 JTT+G -8992.59 18274.91 0.96 
SOCS3 JTT+G -4156.7 8616.01 0.95 
STK11 JTT+G -3847.11 7955.82 0.96 
SULT1E1 JTT+G -7026.28 14367.76 0.96 
TAC3 JTT -1966.82 4075.17 0.91 
TFAP2C JTT+G -5788.75 11908.65 0.96 
TFPI2 JTT+G -11229.44 22940.64 0.96 
TGFBR1 JTT+G -4752.34 9837.39 0.97 
THBD JTT+G -12025.87 24285.03 0.96 
TJP1 JTT+G -24467 49323.82 0.98 
UBP1 JTT+G -5989.95 12279.1 0.96 
VEGFA JTT+G -5161.85 10621.49 0.96 
VGLL1 JTT+G -6745.56 13753.94 0.96 
VHL JTT+G -3221.18 6675.74 0.94 
ZFP36L1 JTT+G -7896.97 16109.29 0.97 
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The 8 pregnancy-specific beta-1-glycoproteins (PSGs) that remained in the 
dataset at this point form part of a PSG superfamily with multiple gene 
duplications within the Eutherian clade — according to the Ensembl Compara 
data. The PSG superfamily members were as follows: PSG1, PSG2, PSG3, PSG4, 
PSG5, PSG6, PSG9 and PSG11. Model selection for the PSG superfamily was 
performed only with the MSAs for PSG1 and PSG2 as representatives of the PSG 
superfamily. Because both alignments contained all 8 members of the PSG 
superfamily, and JTT+G was the model of best fit in both cases, this was taken as 
the model of best fit for all PSGs.  
 
For the subsequent Bayesian phylogeny reconstruction (see below), PSG1 and 
PSG2 were taken as representative of the PSG superfamily, and analysis for the 
PSGs was performed only on the data for PSG1 and PSG2. Exclusion of the other 
6 PSG gene families reduced the total number of phylogenetic trees to be 
reconstructed to 104. However, each of the remaining 6 PSGs are included in the 
PSG superfamily phylogeny, so for example, PSG3 is represented in the 
phylogeny of both PSG1 and PSG2. 
III.	  Bayesian	  Phylogeny	  Reconstruction	  
The parallel implementation of the Bayesian phylogeny software, MrBayes 
version 3.2, was used to reconstruct the phylogeny of each gene family (Altekar et 
al. 2004, Ronquist and Huelsenbeck 2003, Huelsenbeck and Ronquist 2001). For 
every gene family, MrBayes was run on the Stokes HPC cluster operated by the 
Irish Centre for High-End Computing (ICHEC), in 2 runs of 6 chains each for 5 
million generations. Trees were sampled every 1000 generations, and the relative 
burn-in was set to 0.25. For example, at 1 million generations, the burn-in would 
be 250,000 generations. The convergence diagnostic in MrBayes is the standard 
deviation of split frequencies (see Section 0). This convergence diagnostic reflects 
the divergence between sampled trees, so that as the MCMC process converges on 
an optimal region of tree space, sampled trees become increasingly similar and the 
differences in splits of the phylogenies are reduced. When the convergence 
diagnostic reached 0.01, the analysis was stopped and a majority rule consensus 
tree was generated using the trees from the phase of the run after burn-in. 
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For 26 gene families for which the phylogenies failed to converge after 5 million 
generations, MrBayes was rerun for 7 million generations; for the 13 of these that 
failed to converge, MrBayes was rerun for 20 million generations with chain 
temperatures adjusted, where the temperature of an MCMC chain determines the 
probability with which a less optimal phylogeny will be accepted. The 
adjustments of temperature and MCMC chain length were made in order to 
improve mixing within tree space, so that the distribution of optimal trees were 
more effectively sampled. After these reruns of MrBayes, the phylogenies of all 
but 5 gene families attained a convergence diagnostic of 0.01. For the remaining 5 
gene families (i.e. ESX1, FBN2, PEG10, PSG1, PSG2), the convergence 
diagnostic was not below 0.01. However, for ESX1, FBN2, PEG10 and PSG1, the 
convergence diagnostic was below 0.05 for at least one run. This was regarded as 
acceptable and these phylogenies were used in selective pressure analysis, with 
the caveat that their respective phylogenies were less well resolved and supported 
than those that achieved a convergence diagnostic below 0.01, and that the results 
of selective pressure analysis for these gene families should be interpreted with 
caution, since the tree topology is a key element of selective pressure analysis. 
The phylogeny of PSG1 was taken as representative for the entire PSG 
superfamily, reducing the number of gene families to be analysed further to 103. 
2.3.2 Selective	  Pressure	  Analysis	  using	  Maximum	  Likelihood	  
Codeml takes as input a gene family phylogeny and a multiple alignment of protein 
coding DNA sequences, such that the set of genes in the phylogeny matches those in 
the alignment. This process involves three main steps: (I) removal of phylogenies 
with poor resolution and a priori selection of foreground lineages of interest, (II) 
removal from nucleotide alignments of those sites with a high proportion of gaps that 
contribute little to the analysis of selective pressure, and (III) selective pressure 
analysis and likelihood ratio tests. For an overview, see Figure 2.8, part B. 
I.	  Phylogeny	  Preparation	  and	  Lineage	  Selection	  
The gene family phylogeny must satisfy the following requirements in order for a 
Codeml analysis to produce sensible results: (a) the phylogeny must be reasonably 
well resolved, at minimum splitting the foreground and background lineages; (b) 
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the phylogeny should be unrooted, if a molecular clock is not assumed; (c) the 
foreground lineage should be labelled for branch-site models, so that Codeml can 
distinguish foreground and background taxa. Codeml reads the input phylogeny in 
Newick format and regards a lineage as foreground if the part of the Newick tree 
representing that lineage is followed by the text '#1'. (See Figure 1.5 for an 
illustration of the Newick tree format.) For Model 0 and site-specific models, 
branch labels are ignored, such that identical trees could be used for both site- and 
lineage-specific models for each specific alignment. 
 
The resolution of each gene family phylogeny was checked using the nw_stat 
program from the Newick utilities (Junier and Zdobnov 2010). The maximum 
number of dichotomies (i.e. internal nodes with two children) in a phylogeny with 
n leaves is n-1. Phylogenies with less than half this number of dichotomies were 
considered to be poorly resolved and were not retained for selective pressure 
analysis; in this case out of 103 phylogenies in total, 17 were deemed to be poorly 
resolved and were not retained for Codeml analysis. In many cases, the gene 
family phylogeny was poorly resolved due to high conservation of the gene 
family member sequences, so in these cases at least, one would not expect to 
detect positive selection even if they were retained for Codeml analysis.  
 
As is required by Codeml when a molecular clock is not assumed, all phylogenies 
were unrooted. However, due to the nature of the Newick format, Newick trees 
have an implied root (see Figure 1.5). To assist automated labelling of 
phylogenies, for the 28 gene family phylogenies in which ingroup taxa were 
placed at the implied root, the tree was rerooted around a known outgroup species 
and then unrooted again. This was done using the known species phylogeny as a 
guideline (Benton and Donoghue 2007). 
 
The foreground lineages of interest in this analysis can be seen in Figure 1.6. 
These are the apes, primates, Murinae, rodents, dog, Fereuungulata and Eutheria. 
For each gene family, the Perl script CreateLabelledTrees.pl was used to 
automatically generate an appropriately labelled phylogeny for every foreground 
lineage of interest. This script labels the foreground of a phylogeny in the trivial 
case where the foreground taxa form one or more distinct paralagous groups, each 
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forming a clear monophyletic clade separated by background taxa. The script 
takes as input an unlabelled tree template file and one or more files listing tree 
foreground regexes (i.e. regular expressions). For example, the ape lineage might 
be labelled with the regexes 'ENSG0', 'ENSPTRG', 'ENSGGOG' and 'ENSPPYG', 
where these are regular expressions found in the Ensembl Gene IDs of all genes in 
human, chimp, gorilla and orangutan, respectively. Using the input tree and 
foreground regexes, this script generates a set of labelled Codeml tree files, one 
for each foreground clade.  
 
With 7 lineages of interest and 86 gene families, there was a maximum of 602 
possible labelled phylogenies. Of these, 430 labelled trees were created by 
CreateLabelledTrees.pl automatically. Of the remaining 172 possible labelled 
phylogenies, 15 lacked sequences in the given foreground lineage; 4 lacked 
background taxa with which to compare the foreground gene sequences; and 153 
did not have a clear set of monophyletic clades separated by background taxa. The 
153 trees with ambiguous foreground clades were labelled manually. For the 19 
trees without either foreground or background taxa, no sensible labelled tree could 
be produced. In 4 cases, due to nested clades having identical foreground genes, 
automatic tree labelling produced phylogenies with identically labelled 
foreground lineages. Where this occurred, the redundant labelled tree was 
identified and removed manually.  
II.	  Nucleotide	  Coding	  Sequence	  Alignment	  Preparation	  
It is not uncommon for regions of a gene family nucleotide MSA to be found in 
which the majority of codon sites are composed of gaps (i.e. '---') or ambiguous 
nucleotides (e.g. 'NNN'), typically reflecting missing data or indel events. For 
example, with a species-specific insertion in a human gene, the human gene 
sequence will align with no other sequence, so all other alignment sequences will 
contain gaps at that position in the MSA. Although these may reflect interesting 
evolutionary events in their own right (e.g. positive selection for indels was 
observed by Podlaha et al. (2005), in the first exon of the rodent sperm protein 
Catsper1), they are not very informative in a Codeml analysis, since Codeml 
primarily models substitution rates within homologous sites across species.  
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Therefore, for each of the 86 remaining well-resolved gene family phylogenies, 
the corresponding gene family nucleotide alignment was trimmed using the Perl 
script CreateTrimmedAlignment.pl. Alignments were trimmed as follows: sites 
were removed if the number of sequences with gap characters exceeded n-7, 
where n was the total number of sequences in the gene family alignment. Sites 
with such a large number of gaps were trimmed because these would not add any 
useful information to the analysis. This number was chosen because 7 is 
considered to be the minimum number of sequences that should be used in a 
selective pressure analysis using ML methods (Anisimova et al. 2001).  
 
In addition to outputting a trimmed version of the gene family alignment, 
CreateTrimmedAlignment.pl also created a masked alignment in HTML format, 
such that gap sites were masked by a black background instead of being trimmed. 
This masked alignment served as a record of both the original alignment and its 
trimmed counterpart; this is often requested by reviewers of manuscripts. See 
Figure 2.11 for an example.  
III.	  Selective	  Pressure	  Analysis	  and	  Likelihood	  Ratio	  Tests	  
A total of eleven models of selective pressure were used in this analysis: the site 
homogeneous model 0; seven site-heterogeneous models, Model 1a (Neutral), 
Model 2a (Selection), Model 3 (k=2), Model 3 (k=3), Model 7, Model 8 and 
Model 8a; and three branch-site heterogeneous models, Model A, Model A Null 
and Model B. These models were described in detail in Section 1.8.3. 
 
Each individual Codeml run requires its own directory, with its own Codeml 
control file (stating all parameters and settings to be used, specific to each model) 
and input gene family phylogeny and nucleotide alignment files. Each Codeml 
control file specifies settings for a codon model and an initial ω value, as well as 
file paths to the relevant input files. It was therefore necessary to create a Codeml 
workspace directory for each gene family using GenerateCodemlWorkspace.pl, 
which takes as input the gene family alignment file and labelled phylogenies, and 
creates a Codeml workspace directory for the given gene family containing all the 
required Codeml control and input files in an ordered directory structure. 
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Figure 2.11: Alignment trimming example.  
Shown is an example of the process of trimming gapped sites from a codon alignment. At 
left is an excerpt of the original alignment, containing 18 sites from 17 sequences. Trimming 
sites with gaps in more than 10 sequences results in the trimmed alignment excerpt at top 
right, which is identical to the original alignment except for the removal of unwanted codon 
sites 9, 13, 14, and 15. A masked alignment can also be produced (bottom right), in which 
the unwanted codon sites are masked instead of removed. Note that codon site 2 has exactly 
10 sequences with gaps and so remains in the output alignments in this example.  
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Codeml from PAML version 4.4e (Yang 2007) was run for 86 gene families. This 
was carried out on the ICHEC Stokes HPC cluster, which took an estimated 
13,500 core hours to complete 8,408 Codeml runs. As with PRANK, Codeml 
currently lacks a parallel implementation, so in order to make optimal use of the 
parallel architecture of the Stokes cluster, Codeml tasks were run using the 
ICHEC Taskfarm utility. Three taskfarms were run on Stokes, each using 7-8 
nodes (with 12 processors per node), in an embarrasingly parallel manner (i.e. 
serial tasks run separately on parallel architecture). Codeml tasks were sorted in 
each taskfarm in order of decreasing estimated execution time — based on the 
model used, as well as the sequence count and sequence length of the alignment 
— so that as each taskfarm neared completion, smaller tasks were executed on the 
processors left idle by differences in the execution time of larger tasks.  
 
The set of raw Codeml output files was processed with the Perl script 
CreateCodemlReports.pl, with 'FOREGROUND' specified as the sequence of 
interest. This script processed raw Codeml output, performed the necessary 
likelihood ratio tests (LRTs), and created a set of reports for each gene family. A 
summary report and LRT table file were output for all gene families. For those 
gene families in which positive selection was inferred, the following files were 
output: a positively selected site (PSS) alignment — an alignment highlighting the 
inferred positively selected sites; and one or more positively selected site (PSS) 
reports — complete reports on the positively selected sites in each foreground 
sequence.  
 
A summary of the overall Codeml output was created using the Perl script 
CreateCodemlAggregateReport.pl. This script processes the raw Codeml output 
files, performs all necessary LRTs and identifies the model of best fit for each 
specific dataset. It then outputs an aggregate report showing a summary of results 
across all the input Codeml workspace directories; this aggregate report allows the 
overall results of a Codeml selective pressure analysis to be seen at a glance. 
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For each gene family with positive selection in one or more lineages, the Perl 
script GetPosSiteOverview.pl was used to create a positively selected site (PSS) 
overview diagram of each gene in the foreground lineage gene that had a 
corresponding Swiss-Prot entry. This script takes as input the relevant positively 
selected site (PSS) report and positively selected site (PSS) alignment, a gene-
transcript mapping file and functional annotation data from a local copy of the 
Swiss-Prot data file (UniProt Consortium 2011). If a corresponding Swiss-Prot 
entry exists for the gene of interest, this script produces a diagram showing the 
Swiss-Prot annotation for the cognate protein, overlaid by positively selected 
sites, as inferred by Codeml (see Figure 2.13 for an example).  
 
Each PSS overview thus produced showed the inferred, positively selected sites 
overlaid on a representation of the gene/protein showing Swiss-Prot annotation of 
functionally relevant features. These PSS overviews were reviewed and for those 
genes in which one or more positively selected sites were in close proximity to a 
Swiss-Prot annotated feature, possible functional shifts were assessed.  
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2.4 Results	  
Following the various filtering and quality control steps outlined in Section 2.3.2, a 
total of 93 gene families remained for selective pressure analysis — this total 
includes each of the individual pregnancy specific beta-1-glycoprotein (PSG) gene 
families, although these were analysed as a superfamily. These 93 gene families met 
the specific criteria of alignment length, alignment quality, phylogenetic 
informativeness, taxon number and suitable outgroup data. Positive selection was 
detected in the Eutherian lineage in 41 of these 93 gene families, or around 44% of 
cases. Table 2.5 shows the overall results of selective pressure analysis in each gene 
family and lineage of interest, while Table 2.6 shows functional information for the 
41 genes found to be positively selected in the ancestral Eutherian. Figure 2.12 
summarises the results of selective pressure analysis with respect to specific lineages. 
Signals of positive selection were also detected within the Eutheria, with 17 and 24 
gene families undergoing positive selection in apes and primates, respectively; 15 
and 22 gene families showing signals of positive selection in Murinae and rodents, 
respectively; and 18 and 28 gene families exhibiting evidence of positive selection in 
the canid and fereuungulate lineages, respectively. The full set of selective pressure 
analysis results is accessible from the electronic appendix at the following file path: 
Appendix / home / projects / placenta / pipelines / selection-analysis / selection-
analysis-results.html. 
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Table 2.5 Legend:  
Shown on pages 142 to 144 inclusive are tables of the overall results of the selective pressure 
analysis of placental genes conducted in this chapter. The first table, with single column S 
(for Sites), shows results for each gene family under site-specific models of selective 
pressure. The second table, with columns A, P, M, R, D, F and E, shows the results for each 
gene family under a specific lineage: apes, primates, Murinae, rodents, dog, Fereuungulata 
and Eutheria, respectively. Each row shows the results for a particular gene. A plus sign (+) 
indicates that positive selection was detected in the lineage in question, while a minus sign (-
) indicates that positive selection was not inferred. Note that in the latter case, this is not a 
positive statement that such positive selection has not occurred, but rather indicates a failure 
to detect positive selection, such that this failure may or may not be due to the absence of 
positive selection. Thus, for example, site-specific models failed to infer positive selection in 
the case of ADAM12, even though branch-site models did infer positive selection in 
Murinae. For the lineage specific results, an underscore (_) is used for cases in which the 
given gene family lacked either foreground or background taxa in the given lineage. 
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Table 2.5: Results of selective pressure analysis. 
 S  A P M R D F E 
ADAM12 -  - - + - + - - 
ADM -  - - - + - - - 
ADRA2A -  - + - - + + - 
AGT -  + + - + - - - 
ALB -  - + + - - - - 
ALPP +  - - - - + + + 
ALPPL2 +  - - - + + + + 
AQPEP +  - - - + + - - 
ASCL2 -  - - - - - - - 
BIRC6 -  - - - - - - - 
CAPN6 -  + - - - - - + 
CCBP2 +  - - - - + + + 
CCNE1 -  - - - - - - + 
CCNE2 -  - - - - + - - 
CGA -  + + - - - - - 
COMT -  - + - + + + - 
CRH -  - - - - _ + + 
CSF3R +  - - + - + + + 
CSH1 +  + - - + - - - 
CSH2 +  + - - + - - - 
CSHL1 +  + - - + - - - 
CUL7 +  - - + - - - + 
CYP19A1 -  - - - + - + - 
CYR61 -  - - - - - - - 
EBI3 -  - + + - - - - 
EDN1 -  - - - - - - + 
EGFL6 -  - - - + - - - 
EOMES -  - - - - - - - 
ERF -  - - - + - - + 
ERN1 -  - - - - + - - 
ESX1 +  - - + + - - _ 
ETS2 -  - - - - - - - 
FBN2 -  - - - - - - + 
FOSL1 -  - - - - - - + 
GCM1 -  - - - - - - - 
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Table 2.5: Results of selective pressure analysis. (continued) 
 S  A P M R D F E 
GH1 +  - - - + - - - 
GH2 +  - - - + - - - 
GINS1 -  - - - - - - - 
GSTP1 -  - - - + - - + 
HGF -  - - - - - - - 
HSD11B2 -  - - - - - - + 
ISM2 -  + + - - - + + 
ITGAV -  - - - - - - - 
KRT8 -  + - - - + - + 
LGALS13 +  - - - - - + + 
LGALS14 +  - - - - - - + 
MAP3K3 -  - - - - - - - 
MET -  - + - - - - - 
MFN2 -  + + - - - - - 
MTHFD1 -  - - - - - - + 
NCOA2 -  - - - - - - + 
NCOA6 -  - - + - - - + 
NLRP7 +  - + + + + + + 
NOS3 -  + + - - - - - 
PAGE4 +  - - _ _ _ - _ 
PAPPA -  + - - - - - + 
PAPPA2 +  - - - - - + + 
PBRM1 -  - - - - + - - 
PCSK4 -  + + + - + - + 
PEG10 -  - - + + - + + 
PHLDA2 -  - - + - _ - + 
PISD -  - - - - - - - 
PLAC1 +  - - + + - + _ 
PNPLA6 -  - - - - - - + 
POU5F1 -  - - - - - - - 
PPARG -  - - - - - - - 
PROCR +  - - - + - - - 
PSG1 +  - + _ _ _ + + 
PSG11 +  + + _ _ _ + + 
PSG2 +  - + _ _ _ + + 
PSG3 +  - + _ _ _ + + 
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Table 2.5: Results of selective pressure analysis. (continued) 
 S  A P M R D F E 
PSG4 +  - + _ _ _ + + 
PSG5 +  + + _ _ _ + + 
PSG6 +  - + _ _ _ + + 
PSG9 +  - + _ _ _ + + 
ROCK2 -  - - - - - - - 
RTL1 +  - + + + - + _ 
S100P -  - - _ + + - - 
SENP1 +  - - - - - - - 
SERPINE1 -  - + - - - - + 
SLC2A1 -  + - - - + + + 
SLC40A1 -  - - - - - - - 
SOCS3 -  - - - - + - - 
STK11 -  - + - - - - - 
SULT1E1 -  - - - - - + + 
TAC3 +  - + - - + - - 
TFAP2C -  - - - - - - - 
TFPI2 +  - - + - - + - 
THBD -  + - - - - - + 
TJP1 -  - - - - - + - 
VEGFA -  + - - - - - - 
VGLL1 +  - - - + - + - 
ZFP36L1 -  - - + - - - + 
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Figure 2.12: Lineage specific positive selection.  
Shown is a phylogeny of Eutheria, overlaid by pie charts on specific lineages showing the 
proportion of gene families in which positive selection was found in the given lineage. For 
example, in the Eutherian stem lineage (on the left hand side at the root of the tree), positive 
selection was identified in 41 of the 89 gene families (i.e. 46.1%) for which selective 
pressure analysis was performed. For information on species, see Figure 1.6. 
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Table 2.6: Functions of positively selected genes. 
 Cellular Component Molecular Function 
ALPP plasma membrane,              cell surface 
phosphatase activity, hydrolase activity,          
metal ion binding 
ALPPL2 plasma membrane,              cell surface 
phosphatase activity, hydrolase activity,          
metal ion binding 
CAPN6 intracellular, cytoplasm, cytoskeleton, microtubule 
endopeptidase activity, protein binding, 
microtubule binding 
CCBP2 plasma membrane signal transducer activity, receptor activity,    protein binding 
CCNE1 nucleus, cytoplasm, centrosome 
transcription coactivator activity, protein binding, 
kinase activity, androgen receptor binding 
CRH extracellular region receptor binding, hormone activity, protein binding 
CSF3R extracellular region, plasma membrane receptor activity, protein binding 
CUL7 nucleus, cytoplasm, mitochondrion protein binding 
EDN1 extracellular region, cytoplasm 
cytokine activity, hormone activity, receptor 
binding, protein binding 
ERF nucleus transcription factor activity 
FBN2 
microfibril,  
extracellular region 
extracellular matrix structural constituent,    
calcium ion binding, protein binding 
FOSL1 nucleus, microsome, cytosol, presynaptic membrane 
transcription factor activity, protein binding, 
protein dimerization activity 
GSTP1 nucleus, cytoplasm, plasma membrane 
protein binding, transferase activity,               
kinase regulator activity, glutathione binding, 
nitric oxide binding 
HSD11B2 cytoplasm, microsome, endoplasmic reticulum 
steroid binding, oxidoreductase activity,          
NAD binding 
ISM2 extracellular region  
KRT8 keratin filament, nucleus, cytoplasm, nuclear matrix structural molecule activity, protein binding 
LGALS13  carboxylesterase activity, sugar binding, lysophospholipase activity, hydrolase activity 
LGALS14 nucleus sugar binding 
MTHFD1 mitochondrion 
formate-tetrahydrofolate ligase activity, 
formyltetrahydrofolate dehydrogenase activity, 
catalytic activity 
NCOA2 
nucleus, cytoplasm,          
rough endoplasmic reticulum, 
Golgi apparatus  
transcription coactivator activity, protein binding,  
nuclear hormone receptor binding,                  
signal transducer activity 
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Table 2.6: Functions of positively selected genes. (continued) 
 Cellular Component Molecular Function 
NCOA6 nucleus, intracellular membrane-bounded organelle 
transcription coactivator activity, protein binding,  
nuclear hormone receptor binding,                  
signal transducer activity 
NLRP7  nucleotide binding, ATP binding 
PAPPA extracellular region, cytoplasm, membrane 
peptidase activity, metallopeptidase activity, 
metal ion binding 
PAPPA2 extracellular region, cytoplasm, membrane 
peptidase activity, metallopeptidase activity, 
metal ion binding 
PCSK4 acrosomal membrane peptidase activity 
PEG10  nucleic acid binding, zinc ion binding 
PHLDA2 cytoplasm, membrane protein binding 
PNPLA6 endoplasmic reticulum lysophospholipase activity, hydrolase activity 
PSG1 extracellular region protein binding 
PSG2 extracellular region protein binding 
PSG3 extracellular region protein binding 
PSG4 extracellular region protein binding 
PSG5 extracellular region protein binding 
PSG6 extracellular region protein binding 
PSG9 extracellular region protein binding 
PSG11 extracellular region protein binding 
SERPINE1 
extracellular region,        
plasma membrane, 
extracellular matrix 
protease binding, receptor binding,              
protein binding, peptidase inhibitor activity 
SLC2A1 female pronucleus, cytoplasm, plasma membrane 
protein binding, kinase binding,         
transmembrane transporter activity 
SULT1E1 nucleus, cytoplasm,        nuclear membrane steroid binding, transferase activity 
THBD extracellular space,             cell surface 
transmembrane signaling receptor activity, 
calcium ion binding, protein binding 
ZFP36L1 nucleus, cytoplasm 
transcription factor activity, DNA binding,    
protein binding, zinc ion binding,                   
metal ion binding 
 
Table 2.6 Legend:  
Shown here and on page 146 overleaf are tables listing the set of genes that are positively 
selected in the Eutherian stem lineage, along with functional information for each gene. 
Gene Ontology (GO) annotation for both cellular component and molecular function were 
obtained from Ensembl (Flicek et al. 2012) through BioMart (Smedley et al. 2009). 
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To assess the functional implications of positive selection, it is necessary to review 
the positively selected gene in the context of its available functional information. In 
summary, functional annotation from Swiss-Prot (UniProt Consortium 2011) was 
integrated with Codeml output on positively selected sites. Of the 75 gene families in 
which positive selection was inferred on at least one lineage, 61 had a corresponding 
Swiss-Prot entry for at least one gene family member. Of these 61 gene families, 
there were 21 gene families in which one or more positively selected sites were in 
close proximity to a Swiss-Prot annotated functional site or feature. There were 18 
such gene families among those positively selected in the ancestral Eutherian 
lineage. Six of these gene families are discussed further in the following sections, 
reflecting a spectrum of differing degrees of functional impact in different cases.  
2.4.1 Positive	  Selection	  of	  Genes	  in	  the	  Eutherian	  Lineage	  
As examples of the 41 gene families under positive selection in the ancestral 
Eutherian lineage, Table 2.7, Table 2.8 and Table 2.9 each show a summary of the 
Codeml model parameters and LRT results for the genes chemokine binding protein 
2 (CCBP2), sulfotransferase family 1E, estrogen-preferring, member 1 (SULT1E1), 
and colony stimulating factor 3 receptor (CSF3R), respectively. For CCBP2 and 
SULT1E1, the results shown are those for which the Eutherian lineage was the 
foreground, while for CSF3R, results are shown for selective pressure analyses with 
Murinae and Eutheria respectively labelled as foreground. In all three cases, positive 
selection was detected in the Eutherian lineage under both branch-site models A and 
B, with a value of ω much greater than 1. For CSF3R, positive selection was also 
inferred along the lineage leading to mouse and rat. These results are indicative of 
strong positive selection, or at the very least a relaxation of selective constraint, on 
these proteins in the ancestral placental mammal. These three genes and several 
others are discussed in more detail in the next section. 
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Table 2.7 Legend:  
Shown on page 150 overleaf is a table summarising the results of selective pressure analysis 
on CCBP2 with the Eutheria as foreground lineage. The Model column shows the name of 
the model used. The p column shows the number of free parameters in the ω distribution that 
are estimated under the given model. The ω  (t=0) column shows the initial ω value used in 
the Codeml run from which results were taken. The lnL column shows the log-likelihood of 
the given model. The LRT Result column shows the result of LRTs (if any) for the given 
model — this shows the null model unless the null was rejected, in which case the 
alternative model is shown. For example, the LRT Result column shows Model A because 
likelihood ratio tests rejected both Model 1a and Model A Null in favour of their alternative 
hypothesis (i.e. Model A). Had either of the likelihood ratio tests failed to reject the null 
hypothesis, this column would instead display the relevant null model(s) (e.g. Model 1a or 
Model A Null). The Parameter Estimates column shows the parameter estimates of each 
given model for the current dataset. The ω value estimates for each model are as described in 
Section 1.8.3. The parameters of the form pi (where i is an integer) indicate the proportion of 
codon sites in site class i — note that the branch-site model parameters p2 and p3 refer to the 
proportion of codon sites in site classes 2a and 2b, respectively. In Models 7, 8 and 8a, the 
parameters p and q are the shape parameters of the β distribution used to model sites 
undergoing neutral evolution and negative selection. The Positive Selection column 
indicates whether positive selection was predicted under the given model. Finally, the 
rightmost column shows the number of positively selected sites, if any. The LRT Result 
column indicates that both Model 1a and Model A Null were rejected, and that the 
foreground ω value (ω2) is much greater than 1, indicating that positive selection has 
occurred in the Eutherian lineage. Note the very high values for Models A and B of the 
foreground statistic ω2. As highlighted by Zhai et al. (2012), such high ω estimates may 
occur at sites with low rates of synonymous substitution (estimates of ω can theoretically 
range up to infinity, although in practice are typically bounded at a high number, such as 
999). However, as these authors point out, such low synonymous substitution rates do not in 
any case affect the results of the likelihood ratio test (Zhai et al. 2012).  
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Table 2.7: Results of selective pressure analysis on CCBP2 with respect to the Eutherian lineage. 
Model p ω  (t=0) lnL LRT Result Parameter Estimates 
Positive 
Selection 
Positive Sites 
 P(ω>1) > 0.5 
Model 0 1 2 -8113.608629 N/A ω=0.23127 No  
Model 1a 2 2 -8006.859619 N/A p0=0.74987 p1=0.25013                                         
ω0=0.14114 ω1=1.00000 
N/A  
Model 2a 4 2 -8006.859619 Model 1a 
p0=0.74987 p1=0.17041 p2=0.07972  
ω0=0.14114 ω1=1.00000 ω2=1.00000 
No  
Model 3 (k=2) 3 2 -7978.71558 Model 3 (k=2) 
p0=0.49120 p1=0.50880  
ω0=0.05694 ω1=0.47667 
No  
Model 3 (k=3) 5 2 -7964.470545 Model 3 (k=3) 
p0=0.38201 p1=0.51736 p2=0.10063  
ω0=0.03548 ω1=0.31856 ω2=1.12623 
Yes 36 NEB sites 
Model 7 2 2 -7969.190514 N/A p=0.60548 q=1.55420 N/A  
Model 8 4 2 -7966.59623 
Model 7,  
Model 8a 
p=0.70232 q=2.14966  
p0=0.95867 p1=0.04133 ω=1.42868 
No  
Model 8a 4 1 -7967.44171 N/A 
p=0.74527 q=2.56519  
p0=0.92276 p1=0.07724 ω=1.00000 
N/A  
Model A 3 2 -7983.917314 Model A p0=0.58422 p1=0.16254 p2=0.19812 p3=0.05512   
ω0=0.13840 ω1=1.00000 ω2=76.57178 
Yes 66 BEB sites 
Model A Null 3 1 -7992.406621 N/A p0=0.56296 p1=0.16366 p2=0.21181 p3=0.06157  ω0=0.12948 ω1=1.00000 ω2=1.00000 
N/A  
Model B 5 2 -7969.955336 Model B p0=0.45178 p1=0.37464 p2=0.09489 p3=0.07869  ω0=0.06506 ω1=0.52181 ω2=76.61156 
Yes 33 NEB sites 
 151 
Table 2.8 Legend:  
Shown on page 152 overleaf is a table summarising the results of selective pressure analysis 
on SULT1E1 with the Eutheria as foreground lineage. The Model column shows the name 
of the model used. The p column shows the number of free parameters in the ω distribution 
that are estimated under the given model. The ω  (t=0) column shows the initial ω value used 
in the Codeml run from which results were taken. The lnL column shows the log-likelihood 
of the given model. The LRT Result column shows the result of LRTs (if any) for the given 
model — this shows the null model unless the null was rejected, in which case the 
alternative model is shown. For example, the LRT Result column shows Model A because 
likelihood ratio tests rejected both Model 1a and Model A Null in favour of their alternative 
hypothesis (i.e. Model A). Had either of the likelihood ratio tests failed to reject the null 
hypothesis, this column would instead display the relevant null model(s) (e.g. Model 1a or 
Model A Null). The Parameter Estimates column shows the parameter estimates of each 
given model for the current dataset. The ω value estimates for each model are as described in 
Section 1.8.3. The parameters of the form pi (where i is an integer) indicate the proportion of 
codon sites in site class i — note that the branch-site model parameters p2 and p3 refer to the 
proportion of codon sites in site classes 2a and 2b, respectively. In Models 7, 8 and 8a, the 
parameters p and q are the shape parameters of the β distribution used to model sites 
undergoing neutral evolution and negative selection. The Positive Selection column 
indicates whether positive selection was predicted under the given model. Finally, the 
rightmost column shows the number of positively selected sites, if any. The LRT Result 
column indicates that both Model 1a and Model A Null were rejected, and that the 
foreground ω value (ω2) is much greater than 1, indicating that positive selection has 
occurred in the Eutherian lineage. Note the very high values for Models A and B of the 
foreground statistic ω2. As highlighted by Zhai et al. (2012), such high ω estimates may 
occur at sites with low rates of synonymous substitution (estimates of ω can theoretically 
range up to infinity, although in practice are typically bounded at a high number, such as 
999). However, as these authors point out, such low synonymous substitution rates do not in 
any case affect the results of the likelihood ratio test (Zhai et al. 2012).  
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Table 2.8: Results of selective pressure analysis on SULT1E1 with respect to the Eutherian lineage. 
Model p ω  (t=0) lnL LRT Result Parameter Estimates 
Positive 
Selection 
Positive Sites 
P(ω>1) > 0.5 
Model 0 1 2 -10075.09816 N/A ω=0.25900 No  
Model 1a 2 2 -9945.250437 N/A p0=0.69879 p1=0.30121                                         ω0=0.17240 ω1=1.00000 
N/A  
Model 2a 4 2 -9945.250437 Model 1a 
p0=0.69879 p1=0.22096 p2=0.08025  
ω0=0.17240 ω1=1.00000 ω2=1.00000 
No  
Model 3 (k=2) 3 2 -9893.906718 Model 3 (k=2) 
p0=0.48245 p1=0.51755  
ω0=0.07814 ω1=0.48420 
No  
Model 3 (k=3) 5 2 -9874.524571 Model 3 (k=3) 
p0=0.27743 p1=0.51244 p2=0.21014  
ω0=0.02808 ω1=0.26382 ω2=0.72949 
No  
Model 7 2 2 -9872.756688 N/A p=0.70625 q=1.66399 N/A  
Model 8 4 2 -9872.083947 
Model 7,  
Model 8a 
p=0.75471 q=1.91925  
p0=0.97875 p1=0.02125 ω=1.24002 
No  
Model 8a 4 1 -9872.33275 N/A 
p=0.76376 q=2.00360  
p0=0.96786 p1=0.03214 ω=1.00000 
N/A  
Model A 3 2 -9926.70281 Model A p0=0.59513 p1=0.19542 p2=0.15767 p3=0.05177  ω0=0.17847 ω1=1.00000 ω2=152.19959 
Yes 42 BEB sites 
Model A Null 3 1 -9939.577474 N/A p0=0.60012 p1=0.23004 p2=0.12278 p3=0.04706  
ω0=0.16848 ω1=1.00000 ω2=1.00000 
N/A  
Model B 5 2 -9883.394406 Model B p0=0.41858 p1=0.41387 p2=0.08425 p3=0.08330   
ω0=0.08010 ω1=0.49403 ω2=68.60378 
Yes 33 NEB sites 
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Table 2.9 Legend:  
Shown on page 154 overleaf is a table summarising the results of selective pressure analysis 
on CSF3R with Murinae and Eutheria as foreground lineages. The Model column shows the 
name of the model used. The p column shows the number of free parameters in the ω 
distribution that are estimated under the given model. The ω  (t=0) column shows the initial 
ω value used in the Codeml run from which results were taken. The lnL column shows the 
log-likelihood of the given model. The LRT Result column shows the result of LRTs (if 
any) for the given model — this shows the null model unless the null was rejected, in which 
case the alternative model is shown. For example, the LRT Result column shows Model A 
for both Murinae and Eutheria because in both cases, likelihood ratio tests rejected both 
Model 1a and Model A Null in favour of their alternative hypothesis (i.e. Model A). Had any 
of the likelihood ratio tests failed to reject the null hypothesis, this column would instead 
display the relevant null model(s) (e.g. Model 1a or Model A Null). The Parameter 
Estimates column shows the parameter estimates of each given model for the current 
dataset. The ω value estimates for each model are as described in Section 1.8.3. The 
parameters of the form pi (where i is an integer) indicate the proportion of codon sites in site 
class i — note that the branch-site model parameters p2 and p3 refer to the proportion of 
codon sites in site classes 2a and 2b, respectively. In Models 7, 8 and 8a, the parameters p 
and q are the shape parameters of the β distribution used to model sites undergoing neutral 
evolution and negative selection. The Positive Selection column indicates whether positive 
selection was predicted under the given model. Finally, the rightmost column shows the 
number of positively selected sites, if any. The LRT Result column indicates that both 
Model 1a and Model A Null were rejected in both Murinae and Eutheria, and that the 
foreground ω value (ω2) is greater than 1, indicating that positive selection has occurred in 
both Murinae and Eutheria. Note the very high values for Models A and B of the foreground 
statistic ω2 when Eutheria is the foreground. As highlighted by Zhai et al. (2012), such high 
ω estimates may occur at sites with low rates of synonymous substitution (estimates of ω can 
theoretically range up to infinity, although in practice are typically bounded at a high 
number, such as 999). However, as these authors point out, such low synonymous 
substitution rates do not in any case affect the results of the likelihood ratio test (Zhai et al. 
2012). 
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Table 2.9: Results of selective pressure analysis on CSF3R with respect to Murinae and Eutheria. 
 Model p 
ω 
(t=0) lnL LRT Result Parameter Estimates 
Positive 
Selection 
Positive Sites 
P(ω>1) > 0.5 
Model 0 1 2 -34810.28977 N/A ω=0.25389 No  
Model 1a 2 2 -34446.25255 N/A p0=0.69403 p1=0.30597 ω0=0.19121 ω1=1.00000 N/A  
Model 2a 4 10 -34443.296 Model 1a p0=0.69 p1=0.306 p2=0.0043 ω0=0.192 ω1=1.0 ω2=4.535 No  
Model 3 (k=2) 3 2 -34296.02441 Model 3 (k=2) p0=0.42397 p1=0.57603 ω0=0.09420 ω1=0.43098 No  
Model 3 (k=3) 5 2 -34227.56711 Model 3 (k=3) p0=0.248 p1=0.526 p2=0.225 ω0=0.055 ω1=0.252 ω2=0.709 No  
Model 7 2 2 -34219.04323 N/A p=1.02382 q=2.37416 N/A  
Model 8 4 2 -34208.10102 Model 8 p=1.08158 q=2.6637 p0=0.98619 p1=0.01381 ω=2.21891 Yes 13 BEB sites 
Si
te
s 
Model 8a 4 1 -34211.60249 N/A p=1.18879 q=3.34611 p0=0.93917 p1=0.06083 ω=1.00000 N/A  
Model A 3 2 -34435.75334 Model A p0=0.64990 p1=0.28453 p2=0.04561 p3=0.01997             
ω0=0.18589 ω1=1.00000 ω2=3.58641 
Yes 16 BEB sites 
Model A Null 3 1 -34438.22543 N/A p0=0.58931 p1=0.25579 p2=0.10802 p3=0.04688               
ω0=0.18481 ω1=1.00000 ω2=1.00000 
N/A  
M
ur
in
ae
 
Model B 5 2 -34286.27731 Model B p0=0.41128 p1=0.53010 p2=0.02561 p3=0.03301             
ω0=0.09402 ω1=0.42904 ω2=4.37461 
Yes 22 NEB sites 
Model A 3 2 -34430.92685 Model A p0=0.66857 p1=0.27940 p2=0.03670 p3=0.01534              
ω0=0.19033 ω1=1.00000 ω2=53.71444 
Yes 11 BEB sites 
Model A Null 3 1 -34445.03703 N/A p0=0.65546 p1=0.28497 p2=0.04152 p3=0.01805             
ω0=0.18935 ω1=1.00000 ω2=1.00000 
N/A  
E
ut
he
ri
a 
Model B 5 2 -34279.40456 Model B p0=0.39449 p1=0.54387 p2=0.02591 p3=0.03573                
ω0=0.09238 ω1=0.42512 ω2=35.70343 
Yes 29 NEB sites 
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2.4.2 Functional	  Implications	  of	  Positively	  Selected	  Sites	  
This section will focus on three broad categories of positively selected site identified 
by Codeml across six genes: chemokine binding protein 2 (CCBP2), colony 
stimulating factor 3 receptor (CSF3R), Ets2 repressor factor (ERF), pleckstrin 
homology-like domain, family A, member 2 (PHLDA2), sulfotransferase family 1E, 
estrogen-preferring, member 1 (SULT1E1), and ZFP36 ring finger protein-like 1 
(ZFP36L1). These broad categories of positively selected site — (I) sites undergoing 
functional shift, (II) sites under relaxed selective constraint, and (III) sites 
erroneously inferred to be positively selected — differ in the degree to which the 
inferred positive selection could be viewed as being indicative of a functional shift.  
I.	  Signals	  of	  Positive	  Selection:	  Functional	  Shift	  
Four genes are discussed here that have signals of positive selection indicative of 
functional shift: (i) CCBP2, (ii) CSF3R, (iii) ERF, and (iv) ZFP26L1. In each 
case, the positively selected sites are discussed with reference to a positively 
selected site (PSS) overview diagram and alignment excerpt, and in light of the 
expected effect of observed substitutions, at each positively selected site, on the 
conformation and/or function of the relevant protein.  
(i)	  CCBP2	  
The positively selected site (PSS) overview diagram in Figure 2.13 shows the 
Swiss-Prot annotation for chemokine binding protein 2 (CCBP2) — and in 
particular for an enlarged region from sites 115-200 — overlaid by codon sites 
undergoing positive selection in the Eutherian lineage as inferred using Codeml. 
Under each overview diagram is a breakdown of the Swiss-Prot annotation for 
CCBP2 (Swiss-Prot accession O00590). The overall structure of the CCBP2 
protein can be seen from the alternating topological and transmembrane domains 
(i.e. TOPO_DOM and TRANSMEM, respectively); CCBP2 is a transmembrane 
protein that is threaded repeatedly through the membrane, alternating between 
cytosolic and extracellular domains.  
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The enlarged region highlights the cysteine sites at positions 117 and 195 (see 
sites annotated as DISFULID in Figure 2.13), which form an intramolecular 
disulfide bond between two extracellular domains. Five positively selected sites 
flank these two cysteines: the first cysteine is adjacent to two positively selected 
sites at positions 118 and 119, while the second cysteine is flanked by positively 
selected sites at positions 193, 196 and 197.  
 
It is important to consider the impact of the amino acid substitutions in terms of 
the physicochemical properties/changes incurred at each positively selected site. 
Figure 2.14 shows the relevant sites of the nucleotide alignment for CCBP2. Site 
118 is a lysine (K) in Eutheria and a proline (P) in the background, while site 
119 is either a methionine (M) or valine (V) in Eutheria and either a 
phenylalanine (F) or valine (V) in the background. The substitutions at site 119 
are somewhat neutral, but the substitution of proline with lysine would not be 
considered neutral and may have altered the local conformation of CCBP2 
(Betts and Russell 2003).  
 
With respect to the positively selected sites at 193, 196 and 197: site 193 is an 
isoleucine (I) in background taxa but a tryptophan (W) in Eutheria; site 196 is an 
alanine (A) or threonine (T) in background taxa but a histidine (H) or tyrosine 
(Y) in Eutheria; and site 197 is a histidine (H) or glutamine (Q) in background 
taxa but an alanine (A) or proline (P) in the Eutherian foreground taxa. Of these, 
the substitutions at site 196 would likely introduce the biggest change in local 
conformation of CCBP2, since this site has hydrophobic amino acids in 
background species and hydrophilic amino acids in Eutherian taxa; this 
hydrophilic property might locally draw the peptide out of the membrane into 
extracellular space (Betts and Russell 2003). Taken together, these substitutions 
and their propensity to change the local physicochemical properties of CCBP2 
may indicate that these sites were under positive selection to alter the way that 
the cysteines at sites 117 and 195 of CCBP2 are presented for the formation of a 
disulphide bridge.  
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Figure 2.13: Overview of positively selected sites in CCBP2 with respect to the Eutherian lineage.  
Above is a cartoon representation of CCBP2, showing sites positively selected with respect to Eutheria overlaid on functional annotation for the CCBP2 
protein as obtained from Swiss-Prot (UniProt Consortium 2011). Each positively selected site is represented by a plus sign (+); the horizontal position of each 
positively selected site in the overview indicates its position within CCBP2, while its vertical position indicates the posterior probability (PP) that the site is 
undergoing positive selection, as inferred by Codeml (Yang 2007, Yang 1997). Below both the main and enlarged overview is a breakdown of the relevant 
Swiss-Prot annotation.  
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Figure 2.14: Positively selected sites in CCBP2 with respect to the Eutherian lineage.  
Excerpts are shown from the positively selected site alignment for CCBP2 with respect to the Eutherian lineage. Positively selected sites are shown in 
red (for foreground sequences) and blue (for background sequences), while all other sites are shown in grey. Provisional gene names (based on species 
of origin) for the members of the CCBP2 gene family are shown to the left of the figure, with alignment excerpts shown to the right of these. The 
numbers below each alignment excerpt show the codon positions within the human CCBP2 gene (i.e. ENSG00000144648). Note that because of the gap 
in human CCBP2 in the fourth codon of the first alignment excerpt, there is a discrepancy between the number of alignment positions shown and the 
position of alignment columns relative to human CCBP2.  
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(ii)	  CSF3R	  
The positively selected site (PSS) overview diagrams in Figure 2.15 and Figure 
2.16 show the Swiss-Prot annotation for colony stimulating factor 3 receptor 
(CSF3R) in human and mouse, respectively, overlaid by codon sites undergoing 
positive selection in the Eutherian lineage as inferred using Codeml. Figure 2.15 
shows an overview for human CSF3R with respect to positively selected sites in 
ancestral Eutheria, focusing on sites 600-620. Figure 2.16 shows an overview for 
mouse CSF3R with respect to positively selected sites in ancestral Murinae, 
focusing on sites 405-585. Under each of the overview diagrams is a breakdown 
of the relevant Swiss-Prot annotation: the corresponding Swiss-Prot accessions 
are Q99062 for human CSF3R and P40223 for mouse CSF3R. 
 
As can be seen from these overviews, CSF3R is a transmembrane protein, with a 
transmembrane domain (i.e. TRANSMEM) close to its C-terminal end. This 
transmembrane domain is flanked on the N-terminal side by an extracellular 
domain and on the C-terminal side by a cytoplasmic domain (i.e. TOPO_DOM). 
Positively selected sites in both human and mouse CSF3R are found close to 
glycosylation sites in the extracellular domain, pointing to a possible effect on 
the conformation or binding characeristics of this protein (Varki et al. 2009).  
 
The rightmost alignment excerpt in Figure 2.17 shows the site at position 608 in 
human CSF3R that is positively selected in Eutheria, along with sites 609-612. 
This Eutherian-specific positively selected site lies close to an N-linked 
glycosylation site at 610 (see site annotated as CARBOHYD in Figure 2.15). The 
N-glycosylation site itself is a conserved asparagine (N) in Eutherian and most 
non-Eutherian species, where homologous sequence is present. Where present, 
this asparagine is followed by a serine (S) or glycine (G), then a threonine (T) or 
serine (S). This follows a known sequence motif associated with N-linked 
glycosylation sites (i.e. NX[ST], where N is asparagine, X is any amino acid, 
and the amino acid at the third position may be a serine or threonine) (Gavel and 
von Heijne 1990).  
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In most Eutherian species, site 608 is a hydrophobic alanine (A). In mouse and 
rat, site 608 is a polar serine (S). In non-Eutherian species, site 608 is one of the 
polar residues serine (S), cysteine (C) or threonine (T). This may point to a 
change in the local conformation of CSF3R in the ancestral Eutherian lineage 
due to the juxtaposition of a hydrophobic amino acid with a glycosylation site, 
which perhaps underwent a reversion to a polar residue in Murinae.  
 
In addition to the potentially functionally relevant reversion of this positively 
selected site in Murinae, an instance of directional selection is shown in the 
central alignment excerpt in Figure 2.17. The codon site at 583 in mouse CSF3R 
is positively selected in Murinae, and is adjacent to an N-linked glycosylation 
site at position 582 (see site annotated as CARBOHYD in Figure 2.16). The N-
glycosylation site itself is a conserved asparagine (N) in Eutherian and most 
non-Eutherian species, where homologous sequence is present. In mouse and rat, 
site 583 is an isoleucine (I). In all but one of the other species with the conserved 
asparagine (N) at 582, site 583 is an alanine. In frog, site 583 is a serine (S). This 
may indicate that functionally relevant changes in the local conformation of 
CSF3R have occurred that have affected the local conformation of CSF3R and 
in turn the positioning of the N-glycosylation site at 582. 
 
Another instance of functionally relevant sequence change in ancestral Murinae 
is shown in the leftmost alignment excerpt in Figure 2.17. Codon site 408 in 
mouse CSF3R was positively selected in the mouse-rat ancestor, and coincides 
with an N-linked glycosylation site (see site annotated as CARBOHYD in Figure 
2.16). This N-glycosylation site contains an asparagine (N) in mouse and rat 
only. Both mouse and rat CSF3R have an asparagine (N) at this site, followed by 
a valine (V) and threonine (T); a sequence motif characteristic of N-
glycosylation sites (Gavel and von Heijne 1990). This may indicate that this 
glycosylation site arose anew in the ancestral Murinae lineage, therefore 
representing a novel glycosylation site in Murinae, and an instance of functional 
shift due to sequence change.  
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Figure 2.15: Overview of positively selected sites in human CSF3R with respect to the Eutherian lineage.  
Above is a cartoon representation of human CSF3R, showing sites positively selected with respect to Eutheria overlaid on functional annotation for the human 
CSF3R protein as obtained from Swiss-Prot (UniProt Consortium 2011). Each positively selected site is represented by a plus sign (+); the horizontal position 
of each positively selected site in the overview indicates its position within human CSF3R, while its vertical position indicates the posterior probability (PP) 
that the site is undergoing positive selection, as inferred by Codeml (Yang 2007, Yang 1997). Below both the main and enlarged overview is a breakdown of 
the relevant Swiss-Prot annotation.  
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Figure 2.16: Overview of positively selected sites in mouse CSF3R with respect to the lineage Murinae.  
Above is a cartoon representation of mouse CSF3R, showing sites positively selected with respect to Eutheria overlaid on functional annotation for the mouse 
CSF3R protein as obtained from Swiss-Prot (UniProt Consortium 2011). Each positively selected site is represented by a plus sign (+); the horizontal position 
of each positively selected site in the overview indicates its position within mouse CSF3R, while its vertical position indicates the posterior probability (PP) 
that the site is undergoing positive selection, as inferred by Codeml (Yang 2007, Yang 1997). Below both the main and enlarged overview is a breakdown of 
the relevant Swiss-Prot annotation. 
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Figure 2.17: Positively selected sites in CSF3R with respect to stem lineages of Murinae and Eutheria.  
Excerpts are shown from the positively selected site alignments for CSF3R with respect to Murinae (at left and centre) and Eutheria (at right). The numbers 
below the alignment excerpts at left and centre show the codon positions within the mouse CSF3R gene (i.e. ENSMUSG00000028859), while the numbers 
below the alignment excerpt at right show the codon positions within the human CSF3R gene (i.e. ENSG00000119535). Positively selected sites are shown in 
red (for foreground sequences) and blue (for background sequences), while all other sites are shown in grey. Provisional gene names (based on species of 
origin) for the members of the CSF3R gene family are shown to the left of the figure, with the alignment excerpts shown to the right of these. 
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(iii)	  ERF	  
The positively selected site (PSS) overview diagram in Figure 2.18 shows the 
Swiss-Prot annotation for Ets2 repressor factor (ERF) — in particular for two 
enlarged regions from sites 140-160 and 425-450 — overlaid by codon sites 
undergoing positive selection in the Eutherian lineage as inferred using Codeml. 
Under each overview diagram is a breakdown of the Swiss-Prot annotation for 
ERF (Swiss-Prot accession P50548). Similarly, Figure 2.19 shows alignment 
excerpts for two regions of ERF, from sites 146-150 and 433-437, respectively. 
Both the alignment excerpts and the PSS overviews highlight two particular 
positively selected sites at positions 147 and 435. Both of these positively 
selected sites lie close to modified residues: site 147 is adjacent to a 
phosphothreonine at position 148, while site 435 is annotated as a 
phosphoserine. (See sites annotated as MOD_RES in Figure 2.18.) 
 
Regarding the Eutherian positively selected site at position 147: all homologous 
sequences have a threonine at site 148, in both Eutherian and non-Eutherian 
species, while the positively selected site at 147 is a serine (S) in Eutherian 
species and a cysteine (C) in the non-Eutherian species studied.  
 
The positively selected site 435 of this intracellular protein coincides with a 
phosphoserine residue. Each Eutherian sequence contains a serine (S) at this site, 
while the homologous site of non-Eutherian sequences from zebrafish and frog 
contain a glutamine and glutamic acid, respectively. This may point to the 
emergence of this phosphorylation site in the ancestral Eutherian lineage, 
therefore representing a novel phosphorylation site in Eutheria, which may 
affect the signalling behaviour of this transcription factor. 
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Figure 2.18: Overview of positively selected sites in human ERF with respect to the Eutherian lineage.  
Above is a cartoon representation of human ERF, showing sites positively selected with respect to Eutheria overlaid on functional annotation for the human 
ERF protein as obtained from Swiss-Prot (UniProt Consortium 2011). Each positively selected site is represented by a plus sign (+); the horizontal position of 
each positively selected site in the overview indicates its position within human ERF, while its vertical position indicates the posterior probability (PP) that the 
site is undergoing positive selection, as inferred by Codeml (Yang 2007, Yang 1997). Below both the main and enlarged overview is a breakdown of the 
relevant Swiss-Prot annotation.  
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Figure 2.19: Positively selected sites in ERF with respect to the Eutherian lineage.  
Excerpts are shown from the positively selected site alignment for ERF with respect to the 
Eutherian lineage. Positively selected sites are shown in red (for foreground sequences) and 
blue (for background sequences), while all other sites are shown in grey. Provisional gene 
names (based on species of origin) for the members of the ERF gene family are shown to the 
left of the figure, with alignment excerpts shown to the right of these. The numbers below 
each alignment excerpt show the codon positions within the human ERF gene (i.e. 
ENSG00000105722). 
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(iv)	  ZFP36L1	  
The positively selected site (PSS) overview diagram in Figure 2.20 shows the 
Swiss-Prot annotation for ZFP36 ring finger protein-like 1 (ZFP36L1) — with a 
particular focus on the enlarged region at sites 71-107 — overlaid by codon sites 
undergoing positive selection in the Eutherian lineage as inferred using Codeml. 
Under each overview diagram is a breakdown of the Swiss-Prot annotation for 
ZFP36L1 (Swiss-Prot accession Q07352). The region focused on in the PSS 
overview diagram notably includes all ZFP36L1 sites that are positively selected 
in the ancestral Eutherian lineage. One positively selected site — at position 94 
in human ZFP36L1 — lies close to a modified residue at position 92 (see site 
annotated as MOD_RES in Figure 2.20). 
 
Figure 2.21 shows an alignment excerpt for a region of ZFP36L1 from sites 90-
94. The Eutherian-specific positively selected site at position 94 lies two sites 
away from a phosphoserine site at 92. The phosphoserine site itself appears to be 
conserved in all homologous sequences, including some non-Eutherian species. 
Site 94 is a glycine (G) in Eutherian species and a threonine (T) or asparagine 
(N) in all non-Eutherian species. These substitutions are generally disfavoured 
and thus unlikely to occur unless they are under positive selective pressure to do 
so (Betts and Russell 2003). This may therefore indicate a functionally relevant 
change in the local conformation of ZFP36L1, due to a sequence substitution in 
the ancestral Eutherian lineage, which affects the positioning — and in turn the 
function — of the neighbouring phosphoserine.  
III.	  Signals	  of	  Positive	  Selection:	  Relaxed	  Selective	  Constraint	  
Two genes are discussed here that have signals of positive selection that may be 
indicative of functional shift, but may also reflect relaxed selective constraint: (i) 
PHLDA2 and (ii) SULT1E1. In each case, positively selected sites are discussed 
with reference to a positively selected site (PSS) overview diagram and alignment 
excerpt, and in light of the expected effect of observed substitutions at each 
positively selected site. 
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Figure 2.20: Overview of positively selected sites in human ZFP36L1 with respect to the Eutherian lineage.  
Above is a cartoon representation of human ZFP36L1, showing sites positively selected with respect to Eutheria overlaid on functional annotation for the 
human ZFP36L1 protein as obtained from Swiss-Prot (UniProt Consortium 2011). Each positively selected site is represented by a plus sign (+); the horizontal 
position of each positively selected site in the overview indicates its position within human ZFP36L1, while its vertical position indicates the posterior 
probability (PP) that the site is undergoing positive selection, as inferred by Codeml (Yang 2007, Yang 1997). Below both the main and enlarged overview is 
a breakdown of the relevant Swiss-Prot annotation. 
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Figure 2.21: Positively selected sites in ZFP36L1 with respect to the Eutherian lineage.  
Excerpts are shown from the positively selected site alignment for ZFP36L1 with respect to 
the Eutherian lineage. Positively selected sites are shown in red (for foreground sequences) 
and blue (for background sequences), while all other sites are shown in grey. Provisional 
gene names (based on species of origin) for the members of the ZFP36L1 gene family are 
shown to the left of the figure, with alignment excerpts shown to the right of these. The 
numbers below each alignment excerpt show the codon positions within the human 
ZFP36L1 gene (i.e. ENSG00000185650). 
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(i)	  PHLDA2	  
The positively selected site (PSS) overview diagram in Figure 2.22 shows the 
Swiss-Prot annotation for pleckstrin homology-like domain, family A, member 2 
(PHLDA2) — in particular for an enlarged region at sites 1-50 — overlaid by 
codon sites undergoing positive selection in the Eutherian lineage as inferred 
using Codeml. Under each overview diagram is a breakdown of the Swiss-Prot 
annotation for PHLDA2 (Swiss-Prot accession Q53GA4).  
 
As can be seen from the alignment excerpts in Figure 2.23, two Eutherian-
specific positively selected sites at 2 and 43 are each adjacent to a phosphoserine 
residue at sites 3 and 42, respectively. (See sites annotated as MOD_RES in 
Figure 2.22.) 
 
Both phosphoserine residues are serine (S) throughout primates. Site 3 is also a 
serine in cow and lizard, and is a threonine (T) in the remaining Eutherian 
species. In Eutherian species, site 2 is a lysine (K) or arginine (R). In non-
Eutherian species, site 2 is a serine (S), threonine (T) or glycine (G). The amino 
acids present at this site in the foreground would be relatively less favoured to 
substitute the amino acids in the background sequences (Betts and Russell 
2003). Site 43 is one of proline (P), lysine (K), asparagine (N) or alanine (A) in 
Eutherian species, but is either lysine (K) or arginine (R) in non-Eutherian 
species. The substitutions at this site would be considered to be relatively neutral 
(Betts and Russell 2003). While the positive selection at site 2 involves 
somewhat disfavoured substitutions potentially indicative of functional shift, the 
substitutions at site 43 are relatively neutral — i.e. close to being functionally 
equivalent (Betts and Russell 2003) — and therefore may simply indicate a 
relaxation of selective constraint. 
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Figure 2.22: Overview of positively selected sites in human PHLDA2 with respect to the Eutherian lineage.  
Above is a cartoon representation of human PHLDA2, showing sites positively selected with respect to Eutheria overlaid on functional annotation for the 
human PHLDA2 protein as obtained from Swiss-Prot (UniProt Consortium 2011). Each positively selected site is represented by a plus sign (+); the horizontal 
position of each positively selected site in the overview indicates its position within human PHLDA2, while its vertical position indicates the posterior 
probability (PP) that the site is undergoing positive selection, as inferred by Codeml (Yang 2007, Yang 1997). Below both the main and enlarged overview is 
a breakdown of the relevant Swiss-Prot annotation. 
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Figure 2.23: Positively selected sites in PHLDA2 with respect to the Eutherian lineage.  
Excerpts are shown from the positively selected site alignment for PHLDA2 with respect to 
the Eutherian lineage. Positively selected sites are shown in red (for foreground sequences) 
and blue (for background sequences), while all other sites are shown in grey. Provisional 
gene names (based on species of origin) for the members of the PHLDA2 gene family are 
shown to the left of the figure, with alignment excerpts shown to the right of these. The 
numbers below each alignment excerpt show the codon positions within the human 
PHLDA2 gene (i.e. ENSG00000181649). 
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(ii)	  SULT1E1	  
The PSS overview diagram in Figure 2.24 shows the Swiss-Prot annotation for 
sulfotransferase family 1E, estrogen-preferring, member 1 (SULT1E1), overlaid 
by codon sites undergoing positive selection in the Eutherian lineage as inferred 
using Codeml. Under the overview diagram is a breakdown of the Swiss-Prot 
annotation for SULT1E1 (Swiss-Prot accession P49888). The protein produced 
by SULT1E1 is an enzyme with three 3′-Phosphoadenosine-5′-phosphosulfate 
(PAPS) binding sites at positions 129, 137 and 192 (see sites annotated as 
BINDING in Figure 2.24).  
 
Figure 2.25 shows the nucleotide alignment of SULT1E1 with its homologs 
from site 127 to 129, inclusive. Adjacent to the binding site at position 129 are 
sites 127 and 128, which are positively selected in the Eutherian lineage. Site 
127 is a leucine (L) or isoleucine (I) in Eutheria, but a valine (V) in background 
taxa, while site 128 is a cysteine (C) in Eutherian taxa but an alanine (A) in non-
Eutherian taxa. The proximity of these positively selected sites to the binding 
site at position 129 may indicate that these sites have been under positive 
selection to alter the local conformation of SULT1E1 and the presentation of the 
binding site. However, the substitutions at sites 127 and 128 would be 
considered neutral or perhaps slightly favourable, because the amino acids 
before and after the relevant substitutions are close to being functionally 
equivalent (Betts and Russell 2003), so the prospect of relaxation of selective 
constraint can not be ruled out in this case. 
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Figure 2.24: Overview of positively selected sites in SULT1E1 with respect to the Eutherian lineage.  
Above is a cartoon representation of SULT1E1, showing sites positively selected with respect to Eutheria overlaid on functional annotation for the SULT1E1 
protein as obtained from Swiss-Prot (UniProt Consortium 2011). Each positively selected site is represented by a plus sign (+); the horizontal position of each 
positively selected site in the overview indicates its position within SULT1E1, while its vertical position indicates the posterior probability (PP) that the site is 
undergoing positive selection, as inferred by Codeml (Yang 2007, Yang 1997). Below both the main and enlarged overview is a breakdown of the relevant 
Swiss-Prot annotation. 
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Figure 2.25: Positively selected sites in SULT1E1 with respect to the Eutherian lineage.  
Excerpts are shown from the PSS alignment for SULT1E1 with respect to the Eutherian 
lineage. Provisional gene names (based on species of origin) for the members of the 
SULT1E1 gene family are shown to the left of the figure, with alignment excerpt shown to 
the right of these. The numbers below the alignment excerpt show the codon positions within 
the human SULT1E1 gene (i.e. ENSG00000101193). Positively selected sites are shown in 
red (for foreground sequences) and blue (for background sequences), while all other sites are 
shown in grey. 
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III.	  Signals	  of	  Positive	  Selection:	  Alignment	  Error	  
A final point of interest —relevant to the category of erroneously predicted 
positively selected sites — lies in sites 21-22 of CCBP2, which were inferred as 
positively selected in the ancestral Eutherian lineage by Codeml under Model A. 
Alignment sites corresponding to codons 19-23 of CCBP2 are shown in Figure 
2.14. It can be seen from this subsection of the CCBP2 alignment that the positive 
selection inferred for sites 21-22 in human (corresponding to three sites in some 
other species) is quite likely due to a misalignment of the codon 'AAT', which has 
been positioned in site 19 of the foreground sequences and site 20 of the 
background sequences. An alternative alignment of these sites might align the 
'AAT' codon in site 19 across all sequences, then place a gap codon in the 3 
background sequences at position 22: this would imply that a codon was inserted 
at site 22 in Eutheria and deleted in primates. In any case, it is quite likely that the 
inferred positive selection of substitutions at sites 21-22 were precipitated by an 
alignment error. This confirms the importance of vigilance in the construction of 
multiple sequence alignments, and the impact of alignment errors on downstream 
analyses. In any case, the specific proposed alignment error outlined here does not 
affect the overall result for CCBP2: selective pressure analysis was repeated with 
the errors corrected, and positive selection was inferred, as before, in the same 
sites and in the same lineages (i.e. dog, Fereuungulata, Eutheria). 
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2.5 Discussion	  
The aim of this chapter was to estimate levels of positive selection that can be 
detected by comparative sequence analysis of placental genes and their gene 
families, and to assess the extent to which such inferred positive selection can be 
attributed to protein functional shift. In addition to this purely biological aim, we also 
set out to design and implement the associated software and pipelines for the 
automation of large-scale selective pressure analyses. 
 
While for some placental genes in our carefully assembled dataset it was not possible 
to address this question with selective pressure analysis using maximum likelihood 
— due either to an insufficient number of homologs or inadequate resolution of the 
gene family phylogeny — it was at least possible in the majority of cases (93 gene 
families) to conduct complete analyses across all models in Codeml (Yang 1997, 
Yang 2007).  
 
Whether positive selection inferred by a selective pressure analysis per se can 
constitute evidence of functional shift is another question that remains the subject of 
some debate (Anisimova and Liberles 2007, Hughes 2007, Nozawa et al. 2009, Zhai 
et al. 2012). It is really only through the combined efforts of in silico prediction and 
in vitro validation that the link between positive selection and functional shift can be 
confirmed. Studies in the literature that have carried out such cross-disciplinary 
analyses are relatively rare, but provide strong and conclusive support for the 
relationship between positive selection and functional shift in those proteins that 
have been tested (Levasseur et al. 2006, Huang et al. 2012, Loughran et al. 2012). 
 
In the absence of the ability to perform large-scale rational mutagenesis experiments, 
the consideration of functional annotation through resources such as Swiss-Prot can 
inform an assessment of the functional implications of positive selection on a gene of 
interest. However, it is important to note that this information was available for only 
a third of the genes that were identified in this chapter as positively selected.  
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Indeed, the increase in experimentally supported information on protein function in 
databases such as Swiss-Prot will most likely fail to keep pace with the considerable 
growth in genome sequence data in recent years, so this situation is unlikely to 
change for the foreseeable future (Koonin 2005).  
 
In any case, those genes for which functional annotation was available illustrated the 
different degrees to which inferred positive selection can be attributed to functional 
shift: from cases in which a functional shift has been mediated by non-synonymous 
substitution, to those situations where the observed non-synonymous substitutions 
are likely to be selectively neutral or nearly so, to misaligned sites that appear to be 
positively selected due to erroneous inference of sitewise homology. Where positive 
selection is inferred, care must be taken to ensure that this is not due to a relaxation 
of selective constraint (Hughes 2007) or to an alignment error (Schneider et al. 
2009). 
 
It is worth noting that the three placental genes identified as preferentially expressed 
in murine placenta by Knox and Baker (2008) — adrenomedullin (ADM), cyclin E1 
(CCNE1) and placenta-specific 1 (PLAC1) — were found to be positively selected: 
ADM and PLAC1 in the rodent lineage, CCNE1 in the Eutherian stem lineage. This 
is perhaps an indication that these genes have undergone a functional shift in these 
lineages, becoming critical to development of placenta in mice; indeed, two of the 
three — ADM and CCNE1 — were initially chosen as placenta-critical genes 
because they had been found to have lethal null phenotypes in mouse knockout 
studies (Li et al. 2006, Geng et al. 2003).  
 
The results of this chapter are in broad agreement with the previous study by Hou et 
al. (2009), in which 222 genes with preferential expression in term placenta were 
analysed for selective pressure using Codeml. Focusing only on genes with one-to-
one orthologs throughout Eutheria, Hou et al. (2009) found that about 27.9% of these 
placenta-specific genes had undergone positive selection in the ancestral Eutherian 
lineage (62 of 222 gene families analysed). The genes analysed in this chapter have 
undergone gene duplication in many cases and so the fact that the overall level of 
positive selection differs somewhat in this analysis is not entirely surprising.  
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Under the neofunctionalisation model (Lynch and Conery 2000), an increased rate of 
positive selection would be expected among gene families with gene duplications in 
the Eutherian lineage. The overall level of positive selection at the Eutherian stem 
detected in this chapter, across all gene families, is 44.1% (41 of 93 gene families 
analysed). This is significantly greater than the rate of positive selection inferred by 
Hou et al. (2009) (two-tailed Fisher's exact test, P < 0.01).  
 
However, it should be noted that this does not remain the case when the dataset 
excludes the 11 gene families with a phylogeny sampled from a distribution with a 
standard deviation of split frequencies greater than 0.01 (see Section 2.3.1), all but 
one of which were inferred to be positively selected in the Eutherian lineage. 
Excluding these gene families, positive selection was found in 37.8% of cases (31 of 
82 gene families for which Bayesian inference of phylogeny converged); this is still 
higher than the proportion of positively selected genes identified by Hou et al. 
(2009), but no longer significantly so (two-tailed Fisher's exact test, P = 0.1225).  
 
Considering only those gene families with one-to-one orthologs within Eutheria from 
our dataset, the selective pressure analysis in this chapter identified positive selection 
in 16 of 44, or 36.4% of cases — somewhat greater than the rate inferred by Hou et 
al. (2009). However, the difference in rate of positive selection between our one-to-
one gene families and those of the Hou study was not statistically significant (two-
tailed Fisher's exact test, P = 0.2794). The discrepancy between the two datasets in 
terms of the level of positive selection detected on one-to-one orthologs is most 
likely due to the specific genes in each dataset differing, so we return to those 7 gene 
families that were in common between the two datasets to determine why this 
discrepancy may exist.  
 
A comparison of the 7 specific genes analysed here and by Hou et al. (2009) follows 
a similar pattern, with a lower level of positive selection detected in our analysis — 1 
gene in our analysis compared to 3 in that of Hou et al. (2009). Here we infer the 
presence of positive selection signatures for nuclear receptor coactivator 6 (NCOA6), 
while Hou et al. (2009) inferred positive selection for NCOA6 as well as ADAM 
metallopeptidase domain 12 (ADAM12), and kisspeptin (KISS1).  
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The higher number of genes inferred to be under positive selection by Hou et al. 
(2009) may be due to the multiple sequence alignment method used in that study: 
ClustalW (Larkin et al. 2007, Thompson et al. 1994). ClustalW has been found to 
perform poorly in comparison to other multiple sequence alignment methods — 
including PRANK, the method used in this chapter — when used to prepare a gene 
family alignment for use in selective pressure analysis (Fletcher and Yang 2010), see 
Section 2.3.1.  
 
In any case, when compared to the conservative estimates of positive selection 
produced by Kosiol et al. (2008), the levels of positive selection inferred by both this 
study and by Hou et al. (2009) indicate that a considerable amount of positive 
selection has occurred in the ancestral placental mammal. With over 40% of 
placental genes inferred to be undergoing positive selection by this study, it is 
difficult to escape the conclusion that significant levels of functional shift occurred in 
these proteins at a time coincident with the emergence of the Eutherian lineage, and 
it is possible that this may have played a significant role in the emergence of this 
novel tissue. 
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3.1 Introduction	  
Since their tentative discovery nearly twenty years ago (Lee et al. 1993, Wightman et 
al. 1993) and the realisation of their broader implications (Reinhart et al. 2000, 
Pasquinelli et al. 2000), miRNAs have been intensively studied, resulting in an 
explosion in the number of known miRNAs and miRNA-target interactions (Alexiou 
et al. 2009).  
 
The evolution of methods for miRNA-target prediction (miTP) has been intimately 
linked with research on miRNAs, and with our growing knowledge of miRNAs has 
come a concomitant growth in the number of available miRNA-target prediction 
methods, (Reyes-Herrera and Ficarra 2012). The large number of miTP methods, in 
itself, presents a challenge to non-expert users who must choose which method to use 
from a range of options with differing strategies and, (all too often), differing 
predictions (Alexiou et al. 2009).  
 
Treating miRNA-target prediction as a binary classification task (i.e. classifying 
genes as either a target or non-target of a given miRNA), an ideal miTP method 
would maximise the following attributes, among others: 
 
 sensitivity: proportion of actual miRNA-target genes correctly identified. 
 specificity: proportion of non-target genes correctly rejected.  
 precision: proportion of predicted target genes that are actual miRNA targets. 
 
In practice, no miTP method can attain perfection in this regard, and the choice of 
miTP method and level of stringency will frequently require choosing which of these 
attributes is more important for the task at hand. For example, if a miRNA-target 
prediction method were to be used to identify a target gene for a miRNA of interest, 
and if the costs of validating miRNA-target interactions were such that only one 
miRNA-target interaction could be tested, then precision would take precedence over 
sensitivity in that case.  
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An intuitive strategy is to combine the predictions of two or more miTP methods, 
and several strategies have been proposed for the optimal integration of miRNA-
target predictions from different methods (Zhang and Verbeek 2010). However, this 
strategy has been shown to perform poorly, with increases in specificity more than 
offset by decreases in sensitivity, and vice versa; the use of a single, accurate 
miRNA-target prediction method being frequently preferable (Alexiou et al. 2009, 
Ritchie et al. 2009, Peter 2010).  
 
For example, in the study by Alexiou et al. (2009), sets of predictions from several 
miTP methods were checked against the results of the protein repression survey 
conducted by Selbach et al. (2008). The prediction sets for different miTP methods 
were also combined, in both intersection and union sets, so that the performance of 
method combinations could be compared with individual methods. TargetScan 5.0 
was the most precise individual method, with precision and sensitivity of 50.6% and 
12.34%, respectively, while miRanda was the most sensitive individual method 
(albeit at some cost to precision), with precision and sensitivity of 28.77% and 
19.83%, respectively. While the union set of all methods surveyed achieved 
sensitivity of 51.66%, this was at some cost to precision, with only 25.17% of 
predictions corresponding to actual targets. At the other extreme, the intersection set 
of predictions by several methods — DIANA-microT, EIMMo, miRanda, miRBase 
Targets and RNA22 — achieved precision of 75%, but at a sensitivity of 0.37% 
(Alexiou et al. 2009).  
 
This chapter will compare the performance of the 9 miRNA-target prediction 
programs described in Section 3.1.2. In this benchmark comparison, each miRNA-
target prediction program was run on a set of miRNAs and target genes and their 
predictions compared to a set of known miRNA-target interactions. Because of the 
predominance of miRNA-target interactions mediated through target sites in the 3′ 
UTR (Grimson et al. 2007, Baek et al. 2008, Vergoulis et al. 2012) miRNA-target 
predictions were focused on the 3′ UTR region of the target mRNA sequences for the 
purposes of this benchmark study.  
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3.1.1 MicroRNA-­‐Target	  Prediction	  Benchmark	  Studies	  
Several studies have sought to compare the performance of contemporary miRNA-
target prediction methods in terms of their ability to identify genuine miRNA-target 
interactions (Sethupathy et al. 2006, Baek et al. 2008, Selbach et al. 2008, Alexiou et 
al. 2009). Typically, these studies compare miRNA-target predictions to a set of 
experimentally validated miRNA-target interactions. Not all studies take the same 
approach to comparison of miRNA-target prediction methods, and so the results of 
these studies are not necessarily directly comparable. Four such studies are outlined 
below. 
 
The first such benchmark was performed by Sethupathy et al. (2006), which 
compared five methods available at that time: DIANA-microT (Kiriakidou et al. 
2004), miRanda (Enright et al. 2003), PicTar (Krek et al. 2005), TargetScan (Lewis 
et al. 2003) and TargetScanS — a revised and simplified form of TargetScan that 
was the foundation for TargetScan as it is now known (Lewis et al. 2005). Using a 
combination of de novo and pre-compiled miRNA-target predictions, Sethupathy et 
al. (2006) compared these with 84 validated miRNA-target interactions from the 
nascent TarBase (Sethupathy et al. 2006). TargetScanS, PicTar and miRanda — 
recently developed methods at that time — achieved sensitivity levels of 47.6%, 
47.6% and 48.8%, respectively. This was an order of magnitude more sensitive than 
DIANA-microT and the original TargetScan, which had sensitivity levels of 9.5% 
and 20.8%, respectively. Although it had the highest sensitivity, miRanda also made 
the largest number of miRNA-target predictions (i.e. 18,289); while TargetScanS and 
PicTar achieved a comparable level of sensitivity to miRanda despite making 
relatively fewer predictions (i.e. 10,351 and 11,259, respectively) (Sethupathy et al. 
2006).  
 
Baek et al. (2008) used stable isotope labelling with amino acids in cell culture 
(SILAC) (Ong et al. 2002) to measure the effect on protein expression caused by the 
introduction of miR-124, miR-1 or miR-181 into HeLa cells in separate experiments, 
and a gene knockout of mir-223 in mouse neutrophils. Using the results of these 
experiments, Baek et al. (2008) compared sets of miRNA-target predictions against 
the observed repressive effects of miRNA-target interactions on protein expression in 
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their SILAC experiment. The prediction sets compared were those of: miRanda 
(Betel et al. 2008, John et al. 2004, Enright et al. 2003), PicTar (Lall et al. 2006, 
Krek et al. 2005), PITA (Kertesz et al. 2007), miRBase Targets, now known as 
MicroCosm Targets (Griffiths-Jones et al. 2008) and TargetScan, which had initially 
been known as TargetScanS to distinguish it from earlier iterations of the program 
(Grimson et al. 2007, Lewis et al. 2005). Unlike Sethupathy et al. (2006), which 
assessed the performance of miTP methods as binary classifiers of miRNA targets 
and non-targets, this study assessed the degree to which genes predicted as miRNA 
targets were downregulated at protein level.  
 
TargetScan and PicTar were noted as having the best performance in this benchmark: 
on knockout of mir-223, the observed mean log2 fold change of protein expression 
was 0.32 for the protein products of genes predicted to be miRNA targets by 
TargetScan, 0.27 for PicTar, and 0.15 for the next best performing method, miRanda. 
TargetScan was the only method for which the ranking of predictions was 
significantly correlated with protein downregulation (Mann-Whitney U test, P < 
0.01), with a lower context score indicating greater protein repression. Nevertheless, 
with two thirds of targets predicted by TargetScan and PicTar being false-positive 
predictions whose expression remained unresponsive to mir-223 knockout, these 
methods could be estimated to have a precision of about one third (Baek et al. 2008).  
 
A similar survey of protein repression was performed by Selbach et al. (2008), 
involving the transfection and overexpression of let-7b, miR-1, miR-16, miR-30a or 
miR-155 in separate cultures of HeLa cells. Pulsed SILAC (pSILAC) was used to 
measure the effect of overexpression of each individual miRNA on protein 
expression. As part of their study, Selbach et al. (2008) tested the correlation of 
miRNA-target predictions with their miRNA repression data for the following pre-
compiled miTP datasets: DIANA-microT v3.0 (Maragkakis et al. 2009a), 
TargetScan, then still known as TargetScanS (Grimson et al. 2007, Lewis et al. 
2005), PicTar (Lall et al. 2006, Krek et al. 2005), RNA22 (Miranda et al. 2006), 
PITA (Kertesz et al. 2007), miRanda (Betel et al. 2008, John et al. 2004, Enright et 
al. 2003) and miRBase Targets (Griffiths-Jones et al. 2008).  
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For each miTP method, Selbach et al. (2008) calculated the proportion of predicted 
targets for which protein fold change exceeded -0.1 on a log2 scale (i.e. 
approximately 10% or greater reduction in expression from basal levels). About 27% 
of proteins in the survey by Selbach et al. (2008) were downregulated by at least this 
amount, so a miTP method that predicts miRNA-target interactions at random would 
be expected to identify ~27% of the downregulated proteins simply by chance. In 
addition, Selbach et al. (2008) considered the performance of a simple seed match 
heuristic — by which the presence in the target mRNA of a site complementary to 
the miRNA seed constitutes a miRNA-target prediction — and found that 44% of the 
downregulated proteins had such a seed match in their mRNA sequence. TargetScan, 
PicTar and DIANA-microT had the greatest precision in identifying genes whose 
protein product was downregulated, with precision levels of 61.3%, 61.4% and 66%, 
respectively. Other miTP datasets had lower precision, ranging in performance 
between those of the random predictor and seed match heuristic (i.e. 27% and 44%, 
respectively). The performance of DIANA-microT v3.0 was particularly noteworthy, 
since its precision exceeded that of TargetScan and PicTar while making 294 
miRNA-target predictions — less than half the number predicted by either 
TargetScan (622 predictions) or PicTar (629 predictions) (Selbach et al. 2008).  
 
Alexiou et al. (2009) performed a benchmark that made use of validated miRNA-
target interactions from three sources: the aforementioned pSILAC study by Selbach 
et al. (2008), a microarray study of the effects on mRNA expression of transfection 
of miR-1 and miR-124 in separate cultures of HeLa cells (Lim et al. 2005) and a set 
of over 1300 validated miRNA-target interactions from the most recent update of 
TarBase at that time, TarBase v5.0 (Papadopoulos et al. 2009).  
 
This study compared a broader range of methods than previous benchmarks: 
DIANA-microT v3.0 (Maragkakis et al. 2009a), TargetScan v5.0 (Friedman et al. 
2009, Grimson et al. 2007, Lewis et al. 2005), EIMMo (Gaidatzis et al. 2007), 
PicTar (Lall et al. 2006, Krek et al. 2005), miRanda (Betel et al. 2008, John et al. 
2004, Enright et al. 2003), PITA (Kertesz et al. 2007), RNA22 (Miranda et al. 2006) 
and miRBase Targets (Griffiths-Jones et al. 2008). As with Selbach et al. (2008), 
Alexiou et al. (2009) compared these methods with a simple seed match heuristic.  
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For all three validated miTI datasets, four miTP methods performed comparably 
better: DIANA-microT v3.0, TargetScan v5.0, EIMMo and PicTar. In the 
comparison based on the proteomic data of Selbach et al. (2008), these methods had 
estimated precision ranging from 48-51%, while their estimated sensitivity ranged 
from 8-12%. (For comparison, a simple seed match heuristic attained precision of 
30% and sensitivity of 45%.) The remaining four methods had precision about equal 
to the seed match heuristic, although miRanda was notable among these for attaining 
the highest sensitivity of all the programs tested (i.e. 20%), while also attaining a 
reasonably high level of precision (i.e. 29%) (Alexiou et al. 2009). 
 
From these studies, it would be reasonable to select as a miRNA-target prediction 
method one of TargetScan, PicTar, DIANA-microT v3.0, EIMMo or possibly 
miRanda. However, miRNA-target prediction software continues to be actively 
developed, including: SVMicrO (Liu et al. 2010), TargetSpy (Sturm et al. 2010), 
miREE (Reyes-Herrera et al. 2011), TargetMiner (Bandyopadhyay and Mitra 2009) 
and its successor MultiMiTar (Mitra and Bandyopadhyay 2011), PACCMIT (Marín 
and Vaníček 2012) (Marín and Vaníček 2011) and the miRmap Python package 
(Vejnar and Zdobnov 2012). In addition, new versions of three existing methods 
have been published since the benchmark studies discussed above: miRanda v3.3 
(Betel et al. 2010), TargetScan 6 (Garcia et al. 2011) and DIANA-microT v4.0 
(Reczko et al. 2012, Reczko et al. 2011). A comparison of the miTP methods now 
available would therefore be timely and useful for those seeking to identify candidate 
miRNA target genes in silico.  
 
Such a comparison would nevertheless be challenging, as it is difficult to compare, in 
a fair way, miRNA-target prediction methods that are based on different principles 
(Sturm et al. 2010), have different input data (Sethupathy et al. 2006) and different 
miTP output (Betel et al. 2010).  
 
Because of their reliance on pre-compiled miRNA-target predictions that would 
inevitably be based on different input data, all of the benchmarks outlined above 
could potentially have been affected by data heterogeneity (Sethupathy et al. 2006, 
Baek et al. 2008, Selbach et al. 2008, Alexiou et al. 2009). Running each method on 
consistent data would mitigate this issue and could allow for a more consistent 
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comparison of different miTP methods. A standalone version of the miTP program 
would be required for a miRNA-target prediction method to be compared in this 
way, so that the program can be run with the test data on a local computer. 
Therefore, in this chapter we compare the miRNA-target prediction performance of 
only those 9 currently available methods that have a standalone version. These are 
described in detail in the following section. 
3.1.2 Standalone	  MicroRNA-­‐Target	  Prediction	  Methods	  
There are 9 currently available miRNA-target prediction (miTP) programs with a 
standalone program: (I) RNAhybrid, (II) MicroTar, (III) PITA, (IV) miRanda, (V) 
TargetSpy, (VI) Hitsensor, (VII) MultiMiTar, (VIII) TargetScan, and (IX) miRmap. 
The features of each are described in turn below and summarised in Table 3.1. 
I.	  RNAhybrid	  
RNAhybrid extends the RNA secondary structure algorithm proposed by Zuker 
and Stiegler (1981), obtaining the optimal energy of hybridisation between a 
miRNA and its potential target sequence (Krüger and Rehmsmeier 2006, 
Rehmsmeier et al. 2004). Because of the short sequence length of the miRNA 
relative to its target and RNAhybrid's constraint on the formation of 
intramolecular loops in either miRNA or target mRNA, the execution time of 
RNAhybrid is estimated to be linearly proportional to the target RNA sequence 
length. The hybridisation energy calculation can also be constrained so that the 
miRNA seed sites are bound to the corresponding target site on the target. 
RNAhybrid outputs two metrics for each predicted miTI (Krüger and Rehmsmeier 
2006, Rehmsmeier et al. 2004):  
 
 the RNAhybrid Energy metric reflects the minimum free energy 
(MFE) of hybridisation between the miRNA and its target. 
 
 the p-value of the miTI: the probability that the given miRNA-target 
interaction would have that MFE or better by chance. 
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Table 3.1 Legend:  
Shown on page 190 overleaf is a table of the key features used by the 9 miTP methods being 
compared in this chapter. A plus sign (i.e. +) denotes that a feature is incorporated into a 
miTP method; if it is followed by a question mark (i.e. +?), then that feature is optional for 
the given miRNA-target prediction program. Three miRNA binding features are shown: the 
miRNA column indicates whether overall miRNA-target binding information is used, the 
Seed column indicates whether seed binding information is used, and the 3′ column indicates 
whether binding of the 3′ region of the miRNA to its target sequence is a feature of the miTP 
method. Two thermodynamics features are shown: the Hybridisation column shows 
whether the give method estimates the free energy of hybridisation of the miRNA to its 
target, while the Accessibility column indicates whether thermodynamic accessibility of the 
target site is accounted for. (Note that for TargetScan, assessment of hybridisation is limited 
to the seed sequence.) Six target site features are included: use of conservation to identify 
conserved functional miRNA-target sites (Conservation), assessment of sequence 
composition (e.g. AU content) in the target site (Composition), position of miRNA-target 
sites relative to each other (Relative Position), position of miRNA-target sites within the 
target sequence (Absolute Position), the proportion of base pair bonds between the miRNA 
and its target site (Compactness), and the probability of chance occurrence of a given target 
site sequence (Probability). The rightmost column shows a feature used only by 
TargetScan: target abundance, the estimated quantity of competing target sites in the 
transcriptome (TA). 
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Table 3.1: Key features of microRNA-target prediction benchmark methods. 
miRNA Binding  Thermodynamics  Target Site  
miTP 
Method miRNA Seed 3′  Hybridisation Accessibility  Conservation Composition Relative Position 
Absolute 
Position Compactness Probability  
TA 
RNAhybrid  +?   +           
MicroTar  +   +           
PITA  +   + +          
miRanda + +?   +           
TargetSpy + +? +      +   +    
Hitsensor  +? +      + + +     
MultiMiTar  +       +       
TargetScan  + +  +   + +  +    + 
miRmap  + +  + +  + +  +  +   
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II.	  MicroTar	  
MicroTar was developed by Thadani and Tammi (2006), and is similar to 
RNAhybrid, in that it calculates the binding energy of the miRNA and its target 
sequence using the algorithm described by Zuker and Stiegler (1981). However, 
MicroTar takes a more thorough approach — the secondary structure and MFE of 
the entire target mRNA is first estimated using RNAfold from the ViennaRNA 
package (Gruber et al. 2008, Hofacker 2003, Hofacker et al. 1994); the 3′ UTR of 
the target mRNA is then checked for miRNA seed matches; and for each seed 
match site, the secondary structure and MFE of the mRNA and its bound miRNA 
are estimated using the ViennaRNA cofold program. Predicted miTIs are output 
with an associated negative normalized MFE of the bound miRNA-target pair 
(Thadani and Tammi 2006). 
III.	  PITA	  
PITA focuses on the miRNA-target accessibility within the folded 3′ UTR 
(Kertesz et al. 2007). Sequences in the target 3′ UTR that are complementary to 
the miRNA seed site are taken to be miRNA-target sites and are each given an 
accessibility score ΔΔG (see Equation 3.1).  
 
€ 
ΔΔG = ΔGduplex − ΔGopen  
Equation 3.1: Accessibility score in PITA.  
The accessibility score (ΔΔG) used by PITA is shown in terms of the free energy gained 
by miRNA-target hybridisation (ΔGduplex) and the energetic cost of unpairing the miRNA-
target site nucleotides (ΔGopen). Both are calculated by PITA using the ViennaRNA 
package (Gruber et al. 2008, Hofacker 2003, Hofacker et al. 1994). 
 
 192 
Where there is more than one target site for a given miRNA-target pair, the 
accessibility scores are integrated into one target score as in Equation 3.2. 
 
€ 
TS = −log e−ΔΔGi
i=1
n
∑
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟  
Equation 3.2: Target score in PITA.  
The PITA target score (TS) is shown in terms of the individual ΔΔG values of n putative 
miRNA-target sites for the given miRNA-target pair.  
 
The lower the value of the target score for a given miTI is, the more accessible the 
miRNA-target sites are considered to be for the given gene. PITA also includes 
the coding DNA sequence and target site flanking sequence in its energy 
calculations for each miRNA-target site, if these are specified by the user (Kertesz 
et al. 2007).  
IV.	  miRanda	  
miRanda calculates the optimal sequence complementarity between the miRNA 
and the target sequence using a modified form of the Smith-Waterman algorithm 
(Smith and Waterman 1981), which gives greater weight to complementarity in 
the region of the target site complementary to the miRNA seed, allows for G-U 
'wobble' pairs, and applies empirical rules constraining mismatches between the 
miRNA and its target (Betel et al. 2010, Betel et al. 2008, John et al. 2004, 
Enright et al. 2003). For target regions of high sequence complementarity, the 
ViennaRNA package (Gruber et al. 2008, Hofacker 2003, Hofacker et al. 1994) is 
then used to calculate the minimum free energy (MFE) of formation of the 
miRNA-target duplex. miRanda therefore outputs two metrics for each miTI:  
 
 the miRanda Score metric reflects the weighted complementarity of 
the miRNA and target sequences, estimated according to its dynamic 
programming algorithm.  
 
 the miRanda Energy metric reflects the MFE of formation of the 
hybridised miRNA-target duplex.  
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Note that miRanda miRNA-target predictions are available to download from the 
website microRNA.org (Betel et al. 2008). Here the miRNA-target predictions are 
ranked using mirSVR (Betel et al. 2010) — a support vector regression trained 
using the miRNA transfection experiments conducted by Grimson et al. (2007). 
mirSVR ranks miTPs by their estimated downregulation level, and was reported 
to perform well by Betel et al. (2010): mirSVR-ranked predictions — along with 
those of TargetScan's standard Context score (Grimson et al. 2007), as opposed to 
the Context+ score (Garcia et al. 2011) — were checked against the observed 
downregulation of gene expression in a miRNA transfection experiment by 
Linsley et al. (2007). In a ROC analysis of their relative performance, mirSVR 
had a higher area under the ROC curve in 21 out of 25 test sets, indicating a 
statistically significant improvement on the standard Context score (signed rank 
test, P < 0.002). However, mirSVR is not currently available either as standalone 
software or integrated in miRanda.  
V.	  TargetSpy	  
TargetSpy was developed by Sturm et al. (2010) with machine learning methods, 
using the Ago HITS-CLIP data set of Chi et al. (2009) as a training data set. The 
learning scheme MultiBoost (Webb 2000) — as implemented in WEKA (Witten 
and Frank 2005) — was used with a wide range of miTI features including the 
extent of miRNA-target binding, G:U base pairing, duplex bulges, position-
specific features, compositional features, 'compactness', and the accessibility of 
the target site. After training, the set of features were ranked using the ReliefF 
algorithm (Kononenko 1994) and the most discriminative features were selected 
by Correlation-Based Feature Selection. (Hall and Smith 1997). A novel feature 
introduced by these authors is compactness, which is defined as the mean of two 
ratios: the number of base pairings divided by the length of the miRNA, and the 
number of base pairings divided by the length of the target site. 
 
TargetSpy uses RNAduplex from the ViennaRNA package (Gruber et al. 2008, 
Hofacker 2003, Hofacker et al. 1994) to identify all possible duplex structures for 
the miRNA-target pair. Regions of the target that have a large number of 
energetically favourable miRNA-target duplexes are selected as candidate zones.  
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TargetSpy outputs a ranked list of candidate miRNA-target sites, each with two 
metrics: 
 
 the TargetSpy Score metric, which takes account of discriminative 
features found by machine learning methods to be associated with 
known miRNA-target sites. 
 
 the TargetSpy Energy metric: the estimated Gibbs free energy of 
hybridisation of the miRNA-target duplex (i.e. ΔGduplex).  
VI.	  Hitsensor	  
The Hitsensor algorithm was developed by Zheng and Zhang (2010). This 
program first uses a modified form of the Smith-Waterman algorithm (Smith and 
Waterman 1981) that, similarly to the dynamic programming algorithm 
incorporated in miRanda, finds regions of high complementarity in the target 
sequence, allowing for G-U pairs and mismatches. These highly complementary 
regions are then scored according to five specific features of known miRNA-
target sites: local AU content, base pairing of miRNA nucleotides 12–17, optimal 
intersite spacing, miRNA-target site position in the 3′ UTR sequence, and seed 
pairing in the 3′ part of the miRNA. In this benchmark, for each miRNA-target 
gene with one or more miRNA-target sites, the Hitsensor score is taken from that 
of the highest scoring miRNA-target site. For example, Hitsensor predicts 5 
miRNA-target sites of cel-lin-4 in the 3′ UTR of the C. elegans gene lin-14, with 
Hitsensor scores ranging from 111.4 to 291.3. In this benchmark, the highest 
scoring miRNA-target site is taken as representative for a given miRNA-target 
pair; in the example given, this would be the miRNA-target site with Hitsensor 
score 291.3.  
 195 
VII.	  MultiMiTar	  
MultiMiTar (Mitra and Bandyopadhyay 2011, Bandyopadhyay and Mitra 2009) is 
also based on machine learning — in this case using an SVM integrated with 'a 
simulated annealing based multi-objective optimization algorithm' (AMOSA) 
(Bandyopadhyay et al. 2008). This is an integration of a support vector machine 
(SVM) used as a classifier, and a simulated annealing based multi-objective tool, 
AMOSA, used for feature selection. Features assessed by the SVM include the 
presence of a miRNA seed match and local AU content, frequency of single 
nucleotides and dinucleotides in the seed match and in the remainder of the target 
site, miRNA-target base-pairing in the seed region and dinucleotide base-pairing 
in the seed region. MultiMiTar outputs a result for each miRNA-target pair with 
an associated score — known as a decision value — taking account of all 
predicted miRNA-target sites in that miRNA-target pair. Predictions of miRNA-
target interactions with a higher decision value may be considered to be more 
reliable. For example, the MultiMiTar decision value for a miTI involving hsa-
miR-16-5p and cyclin T2 (CCNT2) is 0.869, indicating that such an interaction is 
highly probable. 
VIII.	  TargetScan	  
TargetScan is a package of Perl scripts that identify miRNA-target sites by 
searching for discriminative features of experimentally verified miTIs (Garcia et 
al. 2011, Friedman et al. 2009, Grimson et al. 2007, Lewis et al. 2005). The 
standard TargetScan script searches for canonical miRNA seed matches in the 
target sequence. The set of seed matches can then be further analysed by the 
complementary TargetScan context and conservation scripts.  
 
The TargetScan context script checks for contextual features of the target site that 
are associated with functional sites: seed match site type, base pairing at the 3′ end 
of the miRNA, local AU content, position of the target site in the target sequence 
(Grimson et al. 2007). Garcia et al. (2011) added two further context features: the 
seed-pairing stability and the target abundance within the genome under study. 
The Context+ score returned by TargetScan 6.2 takes account of all these features 
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and tends to decrease from zero, with a lower Context+ score being indicative of a 
stronger miRNA-target prediction; the Context+ score for a miRNA and its target 
gene is obtained by summing all negative Context+ scores for that miRNA-target 
pair (Garcia et al. 2011, Grimson et al. 2007). For example, TargetScan predicts a 
miRNA-target interaction between hsa-let-7a and LIN28B, involving 5 miRNA-
target sites. The individual miRNA-target sites have the following Context+ 
scores: -0.442, -0.184, -0.152, -0.075 and -0.056; the total Context+ score for hsa-
let-7a and LIN28B is the sum of these: -0.909.  
 
The TargetScan conservation script compares putative target sites across multiple 
orthologous target sequences, and returns a probability of preferentially conserved 
targeting. Rather than require conservation throughout all species, the TargetScan 
conservation script estimates the branch length across which a predicted target site 
is conserved, on a phylogeny of 28 species. This "TargetScan phylogeny" was 
created by Friedman et al. (2009) using the topology given by Miller et al. (2007), 
estimating branch lengths from comparison of the orthologous 3′ UTRs aligned by 
the same study (Miller et al. 2007). In assessing the conservation of a miRNA-
target site, the background conservation of the target 3′ UTR is accounted for, so 
that, other things being equal, a conserved target site is scored more highly if it's 
located in a poorly conserved 3′ UTR (Friedman et al. 2009).  
 
A slightly modified version of TargetScan was used in the analysis in this chapter 
and in Chapter 4, such that the following two changes were made to TargetScan 
by this author: 
 
 in the conservation script, the reference species (from which branch 
lengths are calculated) can be set at the command line.  
 
 in the context script, a user-specified TA/SPS file can be set at the 
command line, and if this is done, variables within the context script 
tracking the minimum and maximum TA values are updated using the 
TA values in the specified TA/SPS file.  
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Figure 3.1: TargetScan TA/SPS file sample.  
Shown is a sample of a TA/SPS file used by TargetScan to calculate the Context+ score 
(Garcia et al. 2011). Four columns are included: a Seed Region column that includes every 
possible 7mer seed region, an SPS (8mer and 7mer-m8) column that contains the estimated 
seed-pairing stability (SPS) for seed match sites of type 8mer and 7mer-m8, an SPS (7mer-
1a) column that shows SPS estimates for seed match sites of type 7mer-1a, and a TA column 
showing the estimated target abundance for the given miRNA seed region. 
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Figure 3.2: TargetScan phylogeny.  
Shown is the "TargetScan phylogeny" created by Friedman et al. (2009) based on the topology and aligned 3′ UTR sequences of Miller et al. (2007). 
TargetScan infers preferentially conserved targeting based on the estimated branch length on this phylogeny that a miRNA-target site is conserved (Friedman 
et al. 2009). The 6 species in bold are the benchmark test species for this chapter. 
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IX.	  miRmap	  
miRmap is an open-source Python library that integrates features previously used 
only by different miTP methods (Vejnar and Zdobnov 2012). Using the 
ViennaRNA package (Gruber et al. 2008, Hofacker 2003, Hofacker et al. 1994), 
miRmap assesses the thermodynamic stability of the miRNA-target duplex (i.e. 
ΔG), taking account of the accessibility of the target site (i.e. ΔΔG) in a manner 
similar to PITA (see above). It estimates the probability of chance occurrence of 
the proposed target site sequence (e.g. for miRNA hsa-let-7b-5p, with seed 
sequence 'GAGGUAG', this might be 'CUACCUC'), using an approximation 
following the binomial distribution as in Marín and Vaníček (2011), as well as an 
exact probability calculated in the manner described by Nuel et al. (2010). It 
estimates target site conservation by summing over the branch lengths of a species 
phylogeny (Stark et al. 2007, Friedman et al. 2009), using DendroPy (Sukumaran 
and Holder 2010) for tree manipulations; it can also test for conservation due to 
negative selection using the Siepel, Pollard and Haussler (SPH) test (Pollard et al. 
2010) as implemented in the PhyloP program of the PHAST suite (Hubisz et al. 
2011). In addition, it takes account of the miRNA-target site features outlined by 
Grimson et al. (2007): seed match type, local AU content, proximity of target 
sites to either end of the 3′ UTR sequence and binding of miRNA bases 12-17 to 
the putative target site.  
 
These features were incorporated into miRmap and tested against a number of 
validated miTI datasets: Grimson et al. (2007), Linsley et al. (2007), Selbach et 
al. (2008), and Hendrickson et al. (2009). The relative importance of these 
features were computed by the CAR method — with the strained acronym 
Correlation Adjusted marginal coRrelation — which helps determine which 
variables of a model account most for the observed data (Zuber and Strimmer 
2011). For each miRNA-target prediction, miRmap outputs a score combining 
these features. Like the TargetScan context score, this tends to decrease from zero 
so that lower scores are considered to be better. 
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3.2 Materials	  
A set of validated miRNA-target interactions (miTIs) was assembled using the 
TarBase 6.0 database. For each of the miRNAs with at least one miTI validation, the 
miRNA sequence was obtained from miRBase release 187 (Kozomara and Griffiths-
Jones 2011, Griffiths-Jones 2004, Griffiths-Jones 2006, Griffiths-Jones et al. 2008). 
For each benchmark test species, all annotated 3′ UTR sequences were downloaded 
from the Ensembl server (Flicek et al. 2012) through the BioMart interface (Smedley 
et al. 2009); from these, a representative 3′ UTR was selected for each gene, against 
which miRNA-target prediction was to be performed. All scripts used during this 
process can be accessed from the following location in the electronic appendix: 
Appendix / home / code / scripts.html. 
3.2.1 Validated	  MicroRNA-­‐Target	  Interaction	  Data	  Assembly	  
In order to compare the performance of different miRNA-target prediction methods, 
it is necessary to have validated miRNA-target interactions with which to compare 
their predictions. This involved several stages as follows: (I) identifying a good 
quality source of validated miRNA-target interaction data, (II) downloading 
validated miRNA-target interaction data, (III) curating that data to eliminate 
redundancy and remove any errors, (IV) preparing the validated miRNA-target 
interaction data by resolving miRNA-target validations and interactions, (V) filtering 
the set of validated miTIs for quality purposes, and (VI) dividing the set of miRNA-
target validations into two different data subsets more appropriate to their use in the 
subsequent miRNA-target prediction benchmark process. This process is outlined 
below, and summarised in the bioinformatics pipeline in Figure 3.3. 
                                                
7 Please note that throughout this thesis, unless otherwise specified, Ensembl data has been 
obtained from Ensembl release 65 and miRBase data has been obtained from miRBase 
release 18. 
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Figure 3.3: Validated microRNA-target interaction data assembly pipeline.  
Shown is a bioinformatics pipeline depicting the steps involved in validated miRNA-target interaction data assembly. Arrows indicate the direction of process 
flow. For information on symbols used, see the pipeline key in Figure 2.2. 
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I.	  Selecting	  a	  Validated	  MicroRNA-­Target	  Interaction	  Database	  
Several databases of validated miRNA-target interactions were reviewed. These 
were: miR2Disease (Jiang et al. 2009), miRecords (Xiao et al. 2009), 
miRTarBase (Hsu et al. 2010), miRWalk (Dweep et al. 2011) and TarBase 6.0 
(Vergoulis et al. 2012). These were reviewed with regard to the breadth of species 
coverage within vertebrates and the number and quality of validated miRNA-
target interactions. From this review, it was apparent that TarBase 6.0 was the 
best currently available source of miRNA-target interactions, so this database was 
selected as a source of validated miRNA-target interactions (see Table 3.2). 
TarBase 6.0 has been recently updated and includes the highest number of 
validated miTIs across the broadest range of vertebrate species (Vergoulis et al. 
2012). TarBase 6.0 also integrates entries from three other databases: 
miR2Disease (Jiang et al. 2009), miRecords (Xiao et al. 2009) and miRTarBase 
(Hsu et al. 2010).  
II.	  Downloading	  Validated	  MicroRNA-­Target	  Interaction	  Data	  
Validated miRNA-target interaction data is available from TarBase 6.0 for a total 
of 9 vertebrate species (Vergoulis et al. 2012). The vertebrate species given as 
available in TarBase 6.0 are: Human (Homo sapiens), Mouse (Mus musculus), Rat 
(Rattus norvegicus), Cow (Bos taurus), Sheep (Ovis aries), Chicken (Gallus 
gallus), African Clawed Frog (Xenopus laevis), Western Clawed Frog (Xenopus 
tropicalis) and Zebrafish (Danio rerio). Each validated miRNA-target interaction 
(miTI) is associated with one or more supporting studies, and validation data are 
given both for the miTI and for each supporting study. Validations are grouped by 
experiment type (see Table 3.3). Validation outcomes are given as either positive 
or negative. A positive validation indicates that the miTI was validated by the 
given experiment, while a negative validation indicates that the miTI was not 
validated by the given experiment. With respect to the integrated external 
databases, both miRecords and miR2Disease report only positive validations, 
while miRTarBase reports both positive and negative miTI validations.  
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Table 3.2: Databases of validated miRNA-target interactions. 
Database Name Number of Validations Availability References 
miRecords 6653 mirecords.umn.edu/miRecords Xiao et al. (2009) 
miR2Disease 809 www.mir2disease.org Jiang et al. (2009) 
miRTarBase 4867 mirtarbase.mbc.nctu.edu.tw Hsu et al. (2010) 
miRWalk Unknown www.umm.uni-heidelberg.de/apps/zmf/mirwalk/ Dweep et al.(2011) 
TarBase 6.0 65814 diana.cslab.ece.ntua.gr/DianaToolsNew/index.php?r=tarbase/index Vergoulis et al.(2012) 
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Table 3.3: Categories of miTI validation experiment used in TarBase 6.0. 
Symbol Name Description 
R Reporter Gene Assay 
A reporter gene (e.g. luciferase) is used to test for changes in 
expression of the putative target mRNA in response to 
miRNA transfection or knockout.  
N Northern Blot Tests changes in expression of the putative target mRNA in response to miRNA transfection or knockout. 
W Western Blot Tests changes in expression of the putative target protein in response to miRNA transfection or knockout. 
Q PCR 
Quantitative PCR is used to test for changes in expression of 
the putative target mRNA in response to miRNA transfection 
or knockout. 
P Proteomics 
A high-throughput proteomics method (e.g. pSILAC) is used 
to test changes in expression of multiple proteins in response 
to miRNA transfection or knockout. 
M Microarray A microarray is used to test changes in expression of multiple mRNAs in response to miRNA transfection or knockout. 
A Sequencing Sequencing of miRNA-target sites, often associated with Argonaute immunoprecipitation (e.g. HITS-CLIP). 
D Degradome MicroRNA cleavage sites in a putative target mRNA are identified using degradome sequencing. 
O Other 
An experimental method was used that does not fit into any of 
the other categories, or the experimental method used is 
unknown. 
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For each of these vertebrate species given as available in TarBase 6.0 (Vergoulis 
et al. 2012), all available mature miRNA IDs were obtained from a local copy of 
miRBase release 13 (Griffiths-Jones 2004, Griffiths-Jones 2006, Griffiths-Jones et 
al. 2008), using the Perl script GetMirbaseInfo.pl with the given species name as 
a filter and with the attribute ‘Mature miRNA ID'. The set of mature miRNA IDs 
for each species were then input to the Perl script TarBaseQueryAgent.pl — a 
web query robot script that makes use of the web user agent Perl module 
LWP::UserAgent (Aas 2012) — which queried the TarBase 6.0 web interface and 
output a TSV file with a set of validated miRNA-target interactions for the given 
species, each with its own supporting study. No results were returned for the set 
of query miRNAs submitted for the Western Clawed Frog (Xenopus tropicalis), 
so this species could not be included in the dataset. The raw validated miTI data 
files were then curated, prepared and filtered as described below.  
III.	  Curating	  Validated	  MicroRNA-­Target	  Interaction	  Data	  
The raw miTI validation data downloaded from TarBase 6.0 required manual 
curation due to issues with some entries: (a) a miRNA being derived from a 
different species to that in which its target gene is present; (b) a miRNA lacking a 
corresponding miRBase accession; (c) inconsistent and occasionally 
uninformative gene identifiers — the same gene could be given different 
identifiers depending on the supporting study and source database. The last issue 
presented the greatest challenge: because a gene could have multiple identifiers, 
redundant entries exist for the same miTI validation. This redundancy — 
especially apparent between entries sourced from different databases — was 
eliminated by mapping each miRNA target to a unique Ensembl gene entry by 
automated processes and, in cases where these failed, manual curation. See Figure 
3.4 for an overview of this process.  
 
For those TarBase entries in which the species of the target gene was different 
from that of the miRNA: if the supporting study indicated clearly that the target 
gene was in the same species as the given miRNA, the entry was edited to reflect 
this; otherwise, the entry was removed from the dataset.  
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Figure 3.4: Validated microRNA-target interaction curation pipeline.  
Shown is a bioinformatics pipeline depicting the steps involved in curating validated 
miRNA-target interaction data. Arrows indicate the direction of process flow. For 
information on symbols, see the pipeline key in Figure 2.2. 
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For those TarBase entries in which the miRNA was listed without a miRBase 
accession: if the relevant supporting study identified the miRNA unambiguously, 
the miRBase accession was obtained and the entry was edited to included this. 
Otherwise, the entry was removed from the dataset. 
 
For those TarBase entries in which the gene identifier was given as 'unknown' or a 
similarly uninformative name: if possible, the name of the gene was obtained 
from the supporting study. Otherwise, the entry was removed.  
 
Because the gene symbol used in each TarBase entry may differ depending on the 
symbol used in the supporting study and on the source database, the gene 
identifiers used in the relevant TarBase 6.0 entries were each mapped to a 
corresponding Ensembl entry to eliminate redundancy. This was done as follows: 
a non-redundant list of the gene identifiers in TarBase 6.0 was obtained for each 
species. This non-redundant gene symbol set was separated into two: one 
containing RefSeq symbols and one containing all other symbols. Both sets of 
symbols were mapped to their corresponding Ensembl Gene ID using an Ensembl 
BioMart query with filters of type 'RefSeq mRNA' and 'HGNC symbol' (or 
equivalent for that species), respectively.  
 
With those genes for which the BioMart query failed to return a result, a 
corresponding Ensembl Gene ID was obtained manually, where possible. This 
was done with reference to authoritative databases — such as Ensembl (Flicek et 
al. 2012), HGNC (Seal et al. 2011) and MGI (Eppig et al. 2012) — and if 
necessary, by consulting the relevant supporting study. In cases where there was 
conflicting information about a target gene, the original supporting study took 
precedence. For example, the miR2Disease-sourced TarBase entry validating an 
interaction between miRNA hsa-miR-17 and human gene 'FBX031' lists Tan et al. 
(2009) as its supporting study. Unfortunately, there is no record of a human gene 
with symbol 'FBX031' in either HGNC or Ensembl. However, the original 
supporting study (Tan et al. 2009) refers to this target gene by the symbol 
'FBXO31' as well as 'FBX031'; giving its GenBank accession as NM_024735. The 
gene 'FBXO31', with gene name 'F-box only protein 31' has Ensembl Gene ID 
'ENSG00000103264'. Indeed, a miRTarBase-sourced TarBase entry exists for a 
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validated interaction between hsa-miR-17 and human 'FBXO31', listing Tan et al. 
(2009) as its supporting study. Because of their redundancy, these two TarBase 
entries — one sourced from miR2Disease and one from miRTarBase — were 
subsequently merged into one entry.  
 
For genes that are part of a genome fix patch — indicating an error in the 
reference sequence of the genome — the patched version was chosen if there was 
no reference sequence version of the gene, or if the annotated 3′ UTR sequences 
of the gene in question differed between the patch and the reference sequence. 
Otherwise, the reference sequence entry was given preference. For miRNA target 
symbols that referred to a clone or EST as a validated miRNA target, the 
alignment of the clone/EST to the relevant genome assembly in Ensembl release 
65 was used to identify a specific target gene, where that alignment contained a 
single annotated gene.  
 
If a target symbol — for whatever reason — could not be mapped unambiguously 
to a single Ensembl Gene ID, all TarBase entries relating to that validated miRNA 
target were removed from the dataset. Table 3.4 shows the number of target 
symbols in the raw TarBase data, the number of such symbols mapped 
unambiguously to an Ensembl Gene ID, and a breakdown of the numbers of target 
symbols that could not be mapped to Ensembl for different reasons. These reasons 
could include unrecognised target identifiers without an associated gene symbol 
(e.g. Contig10441_RC), an invalid GenBank ID, an unsuccessful query of all 
relevant databases, the failure of a clone or EST to align to a unique gene, or the 
target symbol referring to a conjoined gene. Athough a considerable number of 
miRNA targets could not be mapped successfully to Ensembl, it is unlikely that 
their exclusion would bias the resulting set of validated miRNA-target 
interactions: their exclusion was due in many cases to the lack of information 
about validated miRNA targets (e.g. unavailable symbol, invalid GenBank ID, 
unsuccessful query), and in most cases to the inability to determine, from the 
available evidence, which of a set of genes is the miRNA target (e.g. failure to 
align clone sequences to a unique gene, conjoined genes).  
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The end result of this curation process was a set of raw TarBase 6.0 entries for 
which each entry had a corresponding miRNA accession in miRBase and a 
corresponding target gene accession in Ensembl. (Table 3.5 shows the number of 
TarBase entries modified, inserted and deleted in this processs, as well as the total 
number of curated TarBase entries for each species.) However, redundant entries 
remained that referred to the same miRNA-target interaction — these entries had 
different gene identifiers but mapped to the same Ensembl Gene ID. It was 
necessary to eliminate this redundancy and to shift the miRNA-target validation 
data from the perspective of miRNA-target validation to the perspective of the 
miRNA-target interaction. This preparation of the TarBase 6.0 data is described in 
the following section.  
IV.	  Preparing	  Validated	  MicroRNA-­Target	  Interaction	  Data	  
The set of curated, validated miRNA-target interactions for each species were 
prepared for use with the Perl script PrepTarBaseData.pl. Taking as input a raw 
TarBase data file as output by TarBaseQueryAgent.pl, this script output two TSV 
files: one containing the non-redundant set of miRNA-target interaction 
validations (miTVs) and one containing the non-redundant set of validated 
miRNA-target interactions (miTIs). The number of miTVs and miTIs for each 
species is shown in Table 3.5. See Figure 3.5, part A for an overview of this 
process. 
 
The files output by PrepTarBaseData.pl contain much the same data as the input, 
but with redundancies resolved and conflicting evidence or interpretations noted, 
and reoriented to the perspective of a miRNA-target validation and of a miRNA-
target interaction, respectively. In this context, a miRNA-target validation is 
regarded as a validation of a miRNA-target interaction supported by a specific 
study, while a validated miRNA-target interaction refers specifically to the 
interaction between the given miRNA and target, which may be supported by 
more than one study. Each miRNA and target gene was referred to by its miRBase 
accession and Ensembl Gene ID, respectively, so as to eliminate redundancy 
caused by the use of different gene symbols in different databases and supporting 
studies.  
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Table 3.4: Mapping target genes to the Ensembl database. 
Species 
Targets in  
TarBase 
Symbol 
Unavailable 
GenBank ID  
Invalid 
Query       
Failure 
Alignment   
Failure 
Conjoined     
Gene 
Targets in  
Ensembl 
Bos taurus 8 0 0 0 0 0 8 
Danio rerio 111 0 0 0 0 0 111 
Gallus gallus 11 0 0 0 0 0 11 
Homo sapiens 12,919 138 65 287 457 5 11,967 
Mus musculus 4,589 0 0 62 48 0 4,479 
Rattus norvegicus 186 0 1 6 0 0 179 
 
Table 3.4 Legend:  
Shown is a summary of the process of mapping TarBase miRNA-target gene identifiers to their corresponding Ensembl gene entry, across 6 species of 
interest. The leftmost column but one, Targets in TarBase, shows the total number of unique miRNA-target gene identifiers in the raw TarBase data for the 
given species. The rightmost column, Targets in Ensembl, shows the number of such miRNA-target gene identifiers for which a corresponding Ensembl 
Gene ID was obtained. Each of the intermediate columns shows the number of miRNA-target identifiers that could not be mapped to an Ensembl Gene ID for 
a particular reason. The column Symbol Unavailable shows the number of miRNA targets for which the supporting study provided an identifier for the target, 
but not a corresponding gene symbol (e.g. Contig10441_RC). The column GenBank ID Invalid shows the number of miRNA targets for which the given 
GenBank ID is under review, suppressed, replaced or removed. The column Query Failure shows the number of miRNA targets for which a query to a 
database failed to return a unique gene identifier. The column Alignment Failure shows the number of miRNA-target identifiers referring to a clone or EST, 
for which alignment to Ensembl genomic sequence encompassed multiple genes, or none. The Conjoined Gene column shows the number of conjoined genes 
in each species — these were removed, since it was unknown which of the two component genes harboured target sites for the cognate miRNA.  
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Table 3.5: Assembly of validated microRNA-target interactions from TarBase data. 
Curation Filters 
Species 
Raw  
TarBase 
Entries E I D 
Curated  
TarBase  
Entries 
miTVs miTIs 
Conflict 3′ UTR  
Filtered  
Validated 
miTIs 
Bos taurus 8 0 0 0 8 4 4 0 0 4 
Danio rerio 143 6 1 4 140 106 106 1 3 102 
Gallus gallus 12 0 0 0 12 11 11 0 1 10 
Homo sapiens 22,828 81 5 1,397 21,436 19,345 18,424 167 324 17,933 
Mus musculus 9,475 79 0 264 9,211 9,034 8,950 10 85 8,855 
Rattus norvegicus 421 9 0 55 366 269 267 0 16 251 
 
Table 3.5 Legend:  
Shown is a summary of the process of curating, preparing and filtering TarBase-sourced validated miRNA-target interaction data for 6 species of interest. The 
leftmost column but one, Raw TarBase Entries, shows the number of raw miRNA-target validation entries obtained from TarBase. Each such raw TarBase 
entry corresponds to an individual validation of a given miRNA-target interaction, as supported by a specific study. The subsequent three columns summarise 
the semi-automated curation of the raw TarBase data. The columns E, I and D respectively show the number of edits, insertions and deletions performed on 
the TarBase data, while the column Curated TarBase Entries shows the number of TarBase entries remaining after the curation process was complete. The 
columns miTVs and miTIs show the output of TarBase data preparation, and contain the number of non-redundant miRNA-target validations and the number 
of non-redundant validated miRNA-target interactions, respectively. The filtering process is summarised by two columns, Conflict and 3′ UTR, which show 
the number of miRNA-target interactions removed by the 'Conflicting Evidence' and 'Annotated 3′ UTR' filters, respectively. The rightmost column, Filtered 
Validated miTIs, shows the final tally of miRNA-target interactions in each species.  
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Where multiple source databases referred to the same miTI validation, the 
outcome reported by each source database was checked against the others. Each 
validation sourced from miR2Disease (Jiang et al. 2009) and miRecords (Xiao et 
al. 2009) was taken to be a positive validation: the outcome of the validation 
experiment supported the cognate miRNA-target interaction. If a validation was 
sourced from miRTarBase (Hsu et al. 2010), the outcome of the validation was 
taken directly from the miRTarBase data files. If the same validation outcome was 
reported by all source databases, the miTI validation was marked as positive or 
negative as appropriate. If different outcomes were reported, the miTI validation 
was marked as having a conflicting interpretation.  
 
The set of miTI validations were then used to create the set of validated miTIs. 
For each miRNA-target pair, all relevant miTI validations were checked against 
each other. If the outcome of every validation was positive, the miRNA-target 
interaction was marked as positively validated. If the outcome of every validation 
was negative, the miRNA-target interaction was marked as negatively validated. 
If differing validation outcomes were reported for a given miRNA-target 
interaction, the miRNA-target interaction validation status was set to conflicting 
evidence. The only exception to this was where the set of validations appeared to 
support a miRNA-target interaction mediated by translational repression: where 
validations based on mRNA expression (i.e. N, Q or M in Table 3.3) were 
negative, validations based on protein expression (i.e. W or P in Table 3.3) were 
positive, and no other validation outcome contradicted this interpretation. 
 
The key result of this preparation process was a non-redundant set of validated 
miRNA-target interactions. However, miRNA-target interactions with conflicting 
evidence or conflicting interpretations of the evidence remained. Additionally, 
target genes lacking an annotated 3′ UTR in Ensembl release 65 could not be used 
in the miTP benchmark, so validated miRNA-target interactions involving such 
unannotated genes would have to be removed.  
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Figure 3.5: Validated microRNA-target interaction preparation and filtering pipelines.  
Shown are two bioinformatics pipelines depicting the steps involved in (A) preparing and 
(B) filtering validated miRNA-target interaction data. Arrows indicate the direction of 
process flow. For information on symbols used, see the pipeline key in Figure 2.2. 
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Both types of problematic miRNA-target interaction were filtered from this non-
redundant set of validated miRNA-target interactions, as described in the 
following section. The number of miTIs removed by these filters in each species 
is shown in Table 3.5, as well as the number of filtered, validated miTIs 
remaining after this process. It is not expected that this filtering process would 
bias the set of validated miRNA-target interactions considerably, since they were 
removed due to either conflicting experimental results or lack of annotation; 
neither factor is known to be associated with any feature of miRNA-target 
interactions to the extent that their removal would bias the resulting dataset.  
V.	  Filtering	  Validated	  MicroRNA-­Target	  Interaction	  Data	  
Non-redundant validated miRNA-target interactions were filtered using the Perl 
script FilterTable.pl to remove all miRNA-target interactions subject to 
conflicting evidence or conflicting interpretations of the evidence, then filtered to 
retain only miTIs for which the target gene had an annotated 3′ UTR in Ensembl. 
See Figure 3.5, part B for an overview of this process.  
 
To filter for Ensembl 3′ UTR annotation, the target gene of each miRNA-target 
interaction was submitted in a query of Ensembl BioMart (Flicek et al. 2012, 
Smedley et al. 2009) to obtain all available 3′ UTR sequences. For each gene, a 
representative 3′ UTR sequence was selected using the Perl script 
GetRepresentativeUTRs.pl. The representative 3′ UTR sequence was taken to be 
the longest annotated 3′ UTR sequence for the given gene. If a target gene lacked 
a representative 3′ UTR, or had a representative 3′ UTR shorter than 37 
nucleotides, all miRNA-target interactions involving that target gene were 
removed from the dataset of validated miTIs. The minimum 3′ UTR length was 
set to 37 bases as this is the sum of the average length of a mature miRNA (i.e. 22 
bases) and the distance downstream of the open reading frame (i.e. 15 bases) in 
which miRNA-target interactions have been found to have reduced effectiveness, 
comparable with that found in coding regions (Grimson et al. 2007).  
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No annotated 3′ UTR sequences could be obtained for the Ovis aries target gene 
Rtl1 (the only target gene in that species), or for any of the 4 target genes in 
Xenopus laevis, so all miRNA-target interactions for both of these species were 
removed from the dataset. This left 6 remaining species of interest for the 
benchmark test: Human (Homo sapiens), Mouse (Mus musculus), Rat (Rattus 
norvegicus), Cow (Bos taurus), Chicken (Gallus gallus) and Zebrafish (Danio 
rerio).  
 
In addition to the aforementioned filters, to control for bias introduced by the 
presence of validated miRNA-target interactions that were used as training data 
— directly or indirectly — by any of the miTP methods being benchmarked, the 
validated miTI dataset was filtered for any studies or specific miRNA-target 
interactions that had been used as training data by any of the 9 miTP methods 
described in Section 3.1.2. A total of 36 papers and 521 specific miRNA-target 
interactions were identified as possible sources of training data bias. TarBase 
entries supported by these 36 studies, or involving one of the 521 specific 
miRNA-target interactions, were removed from the validated miTI dataset using 
the Perl script FilterTarBaseData.pl. The removed miTI validations were not 
analysed further, due to the possible bias introduced by their use as training data. 
The effect of filtering training data is outlined briefly during the next section.  
VI.	  Dividing	  Validated	  MicroRNA-­Target	  Interaction	  Data	  
The dataset of validated miRNA-target interactions was split into two subsets for 
the benchmark: (i) a set of positively validated miRNA-target interactions, and (ii) 
a high-quality subset of positively and negatively validated miRNA-target 
interactions.  
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(i)	  Positively	  Validated	  MicroRNA-­Target	  Interactions	  
The positively validated miTIs were to be used to compare the recovery rates of 
each miTP method in a graph similar to that used by Alexiou et al. (2009), 
showing the number recovered miRNA-target interactions per miRNA against 
the number of predicted miRNA-target interactions per miRNA. This would 
involve testing every miRNA of interest against every 3′ UTR in the cognate 
species. These were obtained by filtering the main validated miTI dataset to 
remove all negatively validated miRNA-target interactions. There were 17,699 
positively validated human miTIs; exclusion of training data removed 3,384 of 
these, leaving a total of 14,315 validated miRNA-target interactions in Homo 
sapiens. This set of positively validated miTIs is accessible in the electronic 
appendix at this file path: Appendix / home / projects / benchmark / pipelines / 
mitp-benchmark / files / Benchmark-POSITIVE-XTD.zip. 
(ii)	  High-­Quality	  Validated	  MicroRNA-­Target	  Interactions	  
The high-quality validated miRNA-target interactions were to be used to 
construct a receiver operating characteristic (ROC) graph (Egan 1975). In 
general terms, a ROC curve graphs the true-positive rate against the false-
positive rate of a binary classifier at different levels of stringency. This was to be 
used to compare the ability of each miTP method to distinguish known 
positively validated miRNA-target interactions from known negatively validated 
miRNA-target interactions. Unlike the estimation of recovery rates, the 
construction of a ROC graph would only involve testing the miRNA-target pairs 
in the set of high-quality validated miTIs.  
 
High-quality positively validated miRNA-target interactions were taken to be 
those validated miTIs that had been annotated in TarBase 6.0 as having been 
directly validated (Vergoulis et al. 2012). There were 479 such directly and 
positively validated miRNA-target interactions in Homo sapiens. 
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High-quality negatively validated miRNA-target interactions were taken to be 
those validated miTIs that had been annotated in TarBase 6.0 as having been 
directly validated or validated in a gene reporter assay (Vergoulis et al. 2012). 
These high-quality negatively validated miTIs were augmented by those 
miRNA-target interactions annotated as non-functional in the most recent 
release 3.5 of miRTarBase (Hsu et al. 2010). These validated miTIs were 
manually reviewed: if there was reason to suspect that the miRNA-target 
interaction was functional, the validation was removed from consideration. At 
the end of this process, there were 45 high-quality negatively validated miRNA-
target interactions in Homo sapiens.  
 
Due to the low number of high-quality validations in species other than Homo 
sapiens, a high-quality validated miTI dataset could only be assembled for 
human. This set of high-quality miTI validations originally included 1092 
positively validated miTIs and 46 negative validations. Exclusion of training 
data reduced these to 479 positive and 45 negative validations. The resulting set 
of high-quality miTI validations is accessible in the electronic appendix at the 
path: Appendix / home / projects / benchmark / pipelines / mitp-benchmark / 
files / Benchmark-DIRECT-END2.zip. 
3.2.2 MicroRNA	  Sequence	  Download	  
The Perl script GetMirbaseSequences.pl was used to access a local copy of miRBase 
release 18 (Griffiths-Jones 2004, Griffiths-Jones 2006, Griffiths-Jones et al. 2008, 
Kozomara and Griffiths-Jones 2011), obtaining sequences for all 586 mature 
miRNAs involved in one or more validated miRNA-target interactions. The result for 
each species was a FASTA sequence file containing all mature miRNA sequences 
involved in a validated miRNA-target interaction. 
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3.2.3 Target	  Sequence	  Download	  
For the miRNA-target prediction method benchmark, a set of representative 3′ UTRs 
was required for each of the 6 benchmark test species: Human (Homo sapiens), 
Mouse (Mus musculus), Rat (Rattus norvegicus), Cow (Bos taurus), Chicken (Gallus 
gallus) and Zebrafish (Danio rerio). For each of these species, the 3′ UTR of every 
transcript was downloaded from Ensembl BioMart (Flicek et al. 2012, Smedley et al. 
2009), using a 'Sequences' query with the attributes 'Ensembl Gene ID', 'Ensembl 
Transcript ID' and '3′ UTR'. A set of representative transcripts was obtained using the 
script GetRepresentativeUTRs.pl, which took the longest annotated 3′ UTR for each 
gene, and removed genes that lacked an annotated 3′ UTR longer than the minimum 
37 nucleotides. This was set as the minimum 3′ UTR length as it is the sum of the 
average length of a mature miRNA (i.e. 22 bases) and 15 bases downstream of the 
open reading frame, a region in which miRNA-target interactions have been found to 
have reduced effectiveness (Grimson et al. 2007). The result was a FASTA file 
containing all representative 3′ UTRs for the given species.  
 219 
3.3 Methods	  
This section describes the procedures followed in a benchmark study of 9 current 
miRNA-target prediction methods. Each miTP method was tested against a common 
dataset, with the results then compared to a set of known miRNA-target interactions. 
All scripts used during this process can be accessed from the following location in 
the electronic appendix: Appendix / home / code / scripts.html. 
3.3.1 MicroRNA-­‐Target	  Prediction	  Benchmark	  Run	  
A miRNA-target prediction benchmark run was performed for all 9 miTP methods 
on a common dataset, in three main stages: (I) preparation of benchmark run input 
data files, (II) the benchmark run itself, and (III) processing of benchmark run output 
files. See the bioinformatics pipeline in Figure 3.7 for an overview. 
I.	  Benchmark	  Run	  Input	  Preparation	  
All miTP methods made use of the miRNA and target 3′ UTR sequences in some 
way. However, only miRanda, Hitsensor and TargetSpy took the standard FASTA 
miRNA and target sequence files as input. Specific input data preparation 
measures were required for the remaining programs: (i) MicroTar, (ii) 
MultiMiTar, (iii) PITA, (iv) RNAhybrid, (v) TargetScan, and (vi) mirMap. These 
were as follows. 
(i)	  MicroTar	  
Because it calculates the folding energy of the entire messenger RNA molecule, 
MicroTar requires the full mRNA sequence as input, with the 3′ UTR region set 
to lowercase. The Ensembl Transcript IDs of the representative 3′ UTRs were 
submitted to an Ensembl BioMart 'Sequences' query with sequence attribute 
'cDNA'. With the resulting mRNA sequence and the previously obtained 3′ UTR 
sequence as input, the Perl script SetCaseFASTA.pl identified the 3′ UTR of the 
full mRNA sequence and set it to lowercase. For ENSGALG00000013959 and 
ENSGALG00000022194 (Gallus gallus genes), the 3′ UTR matched multiple 
regions in their mRNA sequences. Both were separated from the main dataset, 
used to set the mRNA sequence case manually, and then returned to the dataset.  
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(ii)	  MultiMiTar	  
MultiMiTar has very specific requirements for its data input (Mitra and 
Bandyopadhyay 2011). In consultation with the authors (Mitra 2012, personal 
correspondence), the following changes were made to the input data prior to 
running MultiMiTar. These are illustrated in Figure 3.6. 
 
 A 'test' file was compiled, listing each miRNA-target pair to be tested. 
 
 All miRNA headers were changed to follow the format '>miRNA_ID 
miRBase18', where 'miRNA_ID' was the ID of the miRNA and 
'miRBase18' was a required non-whitespace string. 
 
 All target 3′ UTR headers must follow the format '>Ensembl65 
target_ID', where 'Ensembl65' was a required non-whitespace string 
and 'target_ID' was the Ensembl ID of the target 3′ UTR. 
 
 All target 3′ UTR sequences were set to lowercase. 
 
 All input files, whether miRNA sequence, target sequence or test list, 
were appended with a line containing nothing but a greater-than 
symbol (i.e. '>'). 
(iii)	  PITA	  
PITA requires that for each 3′ UTR sequence tested, the corresponding coding 
sequence (CDS) is also input (Kertesz et al. 2007). To obtain these, the Ensembl 
Transcript IDs of the representative 3′ UTRs were submitted to an Ensembl 
BioMart 'Sequences' query with sequence attribute 'CDS'. Each target 3′ UTR 
was then input to PITA along with its corresponding CDS.  
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Figure 3.6: MultiMiTar input preparation.  
Shown is an outline of the process of preparing input files for MultiMiTar. (A) An example 
conversion of a miRNA FASTA sequence file to the format required by MultiMiTar. At top 
is the original FASTA file and at bottom the resulting MultiMiTar input miRNA file. At 
centre are the bash commands used to insert the text 'miRBase18' into each FASTA header 
and to append a greater-than symbol to the end of the file. (B) An example conversion of a 
target 3′ UTR FASTA file to the format required by MultiMiTar. At top is the original 
FASTA file and at bottom the resulting MultiMiTar input target sequence file. At centre are 
the bash commands used to convert all sequences to lowercase, restore Ensembl Gene IDs to 
uppercase, insert the text 'Ensembl65' into each FASTA header and to append a greater-than 
symbol to the end of the file. Note that for the purposes of this example, FASTA files are 
given the extension '.fa', while files ready for input to MultiMiTar are given the extension 
'.mm'.  
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(iv)	  RNAhybrid	  
The input parameters of RNAhybrid must be calibrated using RNAcalibrate, 
which takes as input a file listing dinucleotide frequency (DiF) information for 
the target genome (Rehmsmeier et al. 2004, Krüger and Rehmsmeier 2006). For 
each benchmark test species, the dinucleotide frequencies of its representative 3′ 
UTRs were obtained using the Perl script GetDinucleotideFrequencies.pl. These 
dinucleotide frequencies were used by RNAcalibrate to estimate parameter 
values for RNAhybrid (Rehmsmeier et al. 2004, Krüger and Rehmsmeier 2006). 
(v)	  TargetScan	  
TargetScan requires an orthologous 3′ UTR alignment (where possible) for each 
3′ UTR sequence (Garcia et al. 2011, Friedman et al. 2009, Grimson et al. 2007, 
Lewis et al. 2005). TargetScan 6 also requires a TA/SPS file containing a table 
of target abundance (TA) and seed-pairing stability (SPS) estimates for all 
possible 7mer miRNA seed sequences (Garcia et al. 2011).  
 
A human TA/SPS file is bundled with TargetScan: SPS estimates can be used 
across species, but TA estimates are species-specific and were obtained 
separately for each benchmark test species. The set of representative 3′ UTRs for 
each genome were input to the Perl script GetTargetAbundance.pl, which 
estimates the miRNA target abundance (TA) of the sequences in an input 
FASTA file and outputs these to a target abundance table file. Following the 
procedure described in Garcia et al. (2011), this script searches for non-
overlapping canonical miRNA target sites in the set of input sequences and 
estimates target abundance based on this. TargetScan 6 expects, and 
GetTargetAbundance.pl produces, log-transformed (to base 10) TA estimates. 
These were then included with the SPS data in the 'TA' column of a species-
specific TA/SPS file.  
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To assess miRNA-target site conservation, TargetScan requires an alignment of 
a 3′ UTR across two or more species. Other than the 6 benchmark test species, 
there are 22 species in the TargetScan phylogeny (the phylogeny used by 
TargetScan to assess the extent of conservation). Of these, 14 have annotated 3′ 
UTR sequences in Ensembl release 65. A group of representative transcripts 
were obtained for these 14 species. These were then incorporated in orthologous 
3′ UTR alignments as follows. For each of the six benchmark test species, a list 
was compiled of the Ensembl Gene IDs of all representative 3′ UTRs. This was 
used as a filter in a series of Ensembl BioMart 'Homologs' queries — one for 
each other species in the TargetScan phylogeny — with the 'Ortholog' attribute. 
The resulting two-column ortholog tables were merged into one raw ortholog 
table for the given species using the Perl script MergeTables.pl. 
 
This raw ortholog table contained the Ensembl Gene IDs of all Ensembl 
orthologs for each representative 3′ UTR in the given species. In the alignment 
of orthologous 3′ UTR sequences, TargetScan only allows for one ortholog per 
species, so it was necessary to choose a representative ortholog in each species 
for each gene. Given a gene of interest in one species that has many co-orthologs 
in a second species, a representative ortholog is a single ortholog chosen as 
representative from among those co-orthologs.  
 
The Perl script GetRepresentativeOrthologs.pl was used for each key species to 
remove orthologs lacking a representative 3′ UTR and to select a representative 
ortholog in cases where multiple orthologs exist for a given gene in the same 
species. The representative ortholog was taken to be the orthologous 3′ UTR that 
aligned best to the 3′ UTR of the given gene. The pairwise alignment between 
each gene and its orthologs was performed by Needle from the EMBOSS 
package (Rice et al. 2000), an implementation of the Needleman-Wunsch 
algorithm (Needleman and Wunsch 1970). 
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The resulting representative ortholog table was used to create an ortholog 
sequence file for each representative 3′ UTR in the six benchmark test species: 
Human (Homo sapiens), Mouse (Mus musculus), Rat (Rattus norvegicus), Cow 
(Bos taurus), Chicken (Gallus gallus) and Zebrafish (Danio rerio). For each 
representative 3′ UTR with one or more orthologs, a guide tree was created 
using the Perl script CreateGuideTree.pl with the TargetScan phylogeny as a 
template tree (see Figure 3.2). The ortholog sequence file and guide tree were 
then input to PRANK v.100802.  
 
TargetScan does not accept miRNA or target gene input sequence files in 
FASTA format, but in a custom TSV format. Given the set of miRNA and target 
3′ UTR alignment FASTA files, the TargetScan input files were created using 
the Perl scripts PrepTargetScanMirFiles.pl and PrepTargetScanTarFile.pl, 
respectively. Once these TargetScan input TSV files were prepared, TargetScan 
input was ready. 
(vi)	  miRmap	  
The input requirements for miRmap are similar to those of TargetScan: an 
orthologous alignment is required where ortholog sequences are available. 
Because of this, the 3′ UTR ortholog sequence/alignment files created for 
TargetScan were used again for miRmap. To allow conservation to be estimated 
for orthologous 3′ UTR ortholog sequences, miRmap also requires a 
phylogenetic model fit to the 3′ UTR ortholog alignment. This was created for 
each 3′ UTR ortholog alignment using phyloFit (Siepel and Haussler 2004, Yang 
1994, Yang et al. 1994) with the TargetScan phylogeny (Friedman et al. 2009), 
using the GTR model (see Section 1.6.2). With the evolutionary model prepared, 
miRmap input was ready. 
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II.	  Benchmark	  Run	  
For each of the benchmark test species, the miRNA-target prediction benchmark 
itself involved running each miRNA-target prediction program on all miRNAs 
against every representative 3′ UTR in the given species.  
 
All 9 miRNA-target prediction methods were run with default settings. Hitsensor, 
miRanda, TargetSpy and RNAhybrid all have a miRNA seed binding filter or 
feature option. These were all run both with and without a seed option. PITA was 
additionally run both with and without its site flank option. Where used, the PITA 
site flank was set to 15 nucleotides upstream and downstream. In total, 15 miTP 
benchmark runs were performed (see Table 3.6).  
 
As the benchmark run for each miRNA-target prediction method was being run in 
an embarrassingly parallel manner, the set of tasks for each program was run 
using the ICHEC Taskfarm utility on the Stokes HPC cluster.  
 
Every miTP method except MicroTar performed all miRNA-target predictions 
within the expected time frame of less than one second per miRNA-target 
prediction. Possibly because of its more thorough structural analysis, MicroTar 
failed to perform the full miRNA-target prediction analysis in a timely manner, in 
some cases taking more than 12 hours to test a single miRNA-target interaction. 
This called into question the applicability of this method for large-scale miRNA-
target predictions, so it was only tested on the comparatively smaller number of 
high-quality validated miTIs.  
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Figure 3.7: MicroRNA-target prediction benchmark run pipeline.  
Shown is a bioinformatics pipeline depicting the steps involved in running each of the 9 
miTP methods to be compared in the miRNA-target prediction benchmark. Arrows indicate 
the direction of process flow. For information on symbols used, see the bioinformatics 
pipeline key in Figure 2.2. 
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Table 3.6: MicroRNA-target prediction benchmark runs. 
Name Description 
HITSENSOR  Hitsensor with default settings 
HITSENSORs  Hitsensor with increased weighting for seed match sites 
MICROTAR  MicroTar 
MIRANDA  miRanda without strict seed 
MIRANDAs  miRanda with strict seed binding 
MIRMAP  miRmap 
MULTIMITAR  MultiMiTar 
PITA  PITA with default settings 
PITAf  PITA accounting for target site flanking sequence 
RNAHYBRID  RNAhybrid with default settings 
RNAHYBRIDs  RNAhybrid constrained by seed binding 
TARGETSPY  TargetSpy with default settings 
TARGETSPYs  TargetSpy with seed match requirement 
TSCONSERV  TargetScan conservation script 
TSCONTEXT  TargetScan context script 
 
Table 3.6 Legend:  
Shown are names and descriptions of the 15 miRNA-target prediction methods and variants 
run in the miTP benchmark.  
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III.	  Benchmark	  Run	  Output	  Processing	  
Having run each miTP program on its benchmark data, the raw output of each 
program was processed by the Perl script ProcessMicrornaTargetPredictions.pl. 
This script takes as input the name of a miRNA target prediction program and a 
set of raw output files from that program, then outputs a single processed output 
TSV file, which shows for each miRNA-target prediction the miRNA, target gene 
and associated prediction score value; these predictions are ranked in the output 
file from best to worst score value. For an example of this process, see Figure 3.8. 
 
Some miTP programs output predictions at the level of individual miRNA-target 
sites (e.g. TargetScan, MicroTar), while others output prediction predictions for 
both each individual target site and for the target gene as a whole (e.g. miRanda, 
PITA). The script ProcessMicrornaTargetPredictions.pl follows the convention of 
the previous benchmark studies discussed above, such that miRNA-target site 
predictions are aggregated to miRNA-target gene predictions where necessary 
(Sethupathy et al. 2006, Baek et al. 2008, Selbach et al. 2008, Alexiou et al. 
2009). 
 
TargetSpy, RNAhybrid and miRanda all give two metrics for each miRNA-target 
prediction. TargetSpy gives a hybridisation energy and score value. RNAhybrid 
gives a hybridisation energy and p-value. miRanda gives a hybridisation energy 
and score value. The miTP output files for all three programs were processed for 
each score type in turn. The score type was then chosen in the manner described 
in Section 3.3.2. 
3.3.2 MicroRNA-­‐Target	  Prediction	  Benchmark	  Comparison	  
The different methods were assessed by comparing the miRNA-target predictions of 
each method with known validated miRNA-target interactions in a miRNA-target 
prediction benchmark comparison (see Figure 3.9). There were three stages: (I) score 
types were selected for those methods with more than one, (II) a ROC graph was 
created to compare true- and false-positive rates of all 9 methods, and (III) a 
recovery graph was made to compare the recovery rates of 8 of the miTP methods. 
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Figure 3.8: miRNA-Target prediction output processing pipeline.  
Shown is a simple bioinformatics pipeline depicting the input and output of the processing of 
raw miRNA-target prediction output from different miTP programs and conversion to a 
standard layout. Arrows indicate the direction of process flow. For information on symbols, 
see the bioinformatics pipeline key in Figure 2.2. 
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Figure 3.9: miRNA-target prediction benchmark comparison pipeline.  
Shown is a bioinformatics pipeline depicting the steps involved in comparing the output of the 9 miTP methods against known miRNA targets and non-
targets. Arrows indicate the direction of process flow. For information on symbols, see the pipeline key in Figure 2.2. 
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I.	  Score	  Type	  Selection	  
For TargetSpy, RNAhybrid and miRanda, score types were compared with each 
other using a ROC graph. The web tool StAR (Vergara et al. 2008) — available 
from: http://protein.bio.puc.cl/star/home.php — was used to create a ROC graph 
for each miTP program. In addition to constructing a ROC graph, the StAR web 
utility performs statistical analysis, implementing the method described by 
Delong et al. (1988) for comparing the AUC values of different ROC curves 
using a Mann-Whitney U test.  
 
Input files for StAR were prepared using PrepRocStarInput.pl, which reads one or 
more TSV files containing processed miRNA target prediction output and a TSV 
file containing directly validated miRNA target interactions (miTIs). This script 
then creates three output files: a complete data file listing each directly validated 
miTI, its associated scores according to each miTP method of interest and whether 
it is positively or negatively validated; a positive target data file containing 
normalised scores of positively validated targets for each miTP method; and a 
negative target data file containing normalised scores of negatively validated 
targets for each miTP method. For each method, scores are normalised to the 
range -1.0 to 0.0, such that the score of the top-ranking miRNA-target prediction 
for that method is mapped to -1.0, the minimum possible score for the given 
method is mapped to 0.0, and the scores of all other miRNA-target predictions by 
that method are mapped onto an intermediate scale between these two extremes. 
The positive and negative target data files could then be used as input to the StAR 
web utility.  
 
For each method, the area under the ROC curve (AUC) of each score type was 
compared so as to guide selection of a score type for that method, such that if one 
score type had a significantly higher AUC than another score type, it was given 
preference. In the absence of a significant difference in AUC, the score type with 
the better AUC was arbitrarily selected for that method, with the caveat that the 
selected score type was not significantly better than the alternative.  
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Two ROC graphs were created for miRanda: one showing the results with a strict 
seed requirement, the other showing results without this. Both ROC graphs 
showed two ROC curves: one for the miRanda results ranked by increasing 
'Energy', the other for miRanda results ranked by decreasing 'Score'. In both ROC 
graphs, the area under the ROC curve (AUC) for miRanda's 'Score' ranked output 
was slightly higher than that for the 'Energy' ranked output, although not 
significantly so (at a 5% significance level), with a difference in AUC of 0.0115 
for miRanda with a strict seed requirement (Mann-Whitney U test, P = 0.085), 
and a difference in AUC of 0.00935 otherwise (Mann-Whitney U test, P = 0.162). 
Because the AUC of miRanda was so similar between score types, 'Score' was 
arbitrarily chosen as the metric for miRanda.  
 
Two ROC graphs were similarly created for RNAhybrid: one showing the results 
with a seed binding constraint, the other showing results without this. Both ROC 
graphs showed two ROC curves: one for the RNAhybrid results ranked by 
increasing 'Energy', the other for RNAhybrid results ranked by increasing 'p-
value' (where p-value ranges from zero to one, and a lower p-value represents a 
better score). In the ROC graph for RNAhybrid without a seed binding constraint, 
the overall AUC for 'Energy' was 0.672, which was significantly greater than that 
for 'p-value' miTPs: 0.5639 (Mann-Whitney U test, P = 0.026). In the ROC graph 
for RNAhybrid with a seed binding constraint, the overall AUC for 'Energy' was 
0.665, which was slightly greater that that achieved by 'p-value' miTPs — 0.663 
— but not significantly so (Mann-Whitney U test, P = 0.953). However, a visual 
assessment indicated that the 'p-value' miTPs appeared to have a considerably 
higher AUC at lower false-positive rates (FPRs) in both ROC graphs (i.e. FPR ≤ 
0.15), see Figure 3.10. This seems to indicate that p-value is a better way to 
distinguish true from false-positives when p-values are low, but that this is a poor 
classifier at high p-values. Because 'Energy' performed so well overall but 'p-
value' appeared to perform better at low false-positive rates, RNAhybrid results 
with both score types were included in the final ROC graph.  
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Two ROC graphs were created for TargetSpy: one showing results with a seed 
requirement, the other showing results without this. Both ROC graphs showed 
two ROC curves: one for the TargetSpy results ranked by increasing 'Energy', the 
other for TargetSpy results ranked by decreasing 'Score'. In the ROC graph for 
TargetSpy without a seed requirement, the AUC for 'Energy' was 0.663, while that 
for 'Score' was 0.657; the difference in AUC between the two score types was not 
significant (Mann-Whitney U test, P = 0.408). In the ROC graph for TargetSpy 
with a seed requirement, the AUC for 'Score' was 0.642, while that of 'Energy' 
was 0.639; as before, the difference in AUC between the two score types was not 
significant (Mann-Whitney U test, P = 0.84476). Because no significant 
difference was found between the AUC of the two TargetSpy score types, 'Score' 
was arbitrarily chosen as the metric for TargetSpy. 
 
 
 
 
 
 
 
 
 
 
Figure 3.10 Legend:  
Shown on page 234 overleaf are two ROC graphs created during score type selection for 
RNAhybrid, in which miRNA-target predictions are shown as ranked by increasing 
minimum free energy ('Energy') — shown in blue — and by increasing p-value — shown in 
red. (A) Included is a ROC graph of RNAhyrid miRNA-target predictions without a seed 
binding constraint. The overall AUC of the 'Energy' metric is 0.672, significantly greater 
than the AUC of 0.5639 achieved by p-value (P = 0.026). (B) Shown is a ROC graph of 
RNAhybrid miRNA-target predictions with a seed binding constraint. The overall AUC of 
the 'Energy' metric is 0.665, slightly greater than the AUC of 0.663 achieved by p-value, but 
not significantly so (P = 0.953). Note from graphs A and B that although RNAhybrid 
miRNA-target predictions ranked by the Energy metric have a higher AUC overall, the AUC 
of p-value ranked miTPs is greater at low false-positive rates (i.e. FPR ≤ 0.15).  
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Figure 3.10: ROC graphs for RNAhybrid score type selection.  
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II.	  Generating	  a	  ROC	  Graph	  
Taking processed results from all miRNA-target prediction programs, StAR input 
was prepared using the Perl script PrepRocStarInput.pl. This included miRanda 
'Score' results, RNAhybrid 'Energy' and 'p-value' results, and TargetSpy 'Energy' 
results. A ROC graph was created using the StAR web tool (Vergara et al. 2008), 
including 17 ROC curves corresponding to 15 sets of miRNA-target predictions 
for 9 miTP methods. (See Figure 3.11.)  
 
For each miRNA-target prediction method, predictions were compared to the 
high-quality validated miRNA-target interaction dataset. The ROC curve data 
files output by StAR were input to the Perl script PlotStarRocCurveChart.pl, 
which plotted the final ROC graph in Microsoft Excel format using Perl modules 
Spreadsheet::WriteExcel (McNamara 2012), OLE::Storage_Lite (Takanori and 
McNamara 2012) and Parse::RecDescent (Braun and Conway 2012). 
III.	  Generating	  a	  Recovery	  Graph	  
The processed results from all miRNA-target prediction programs were input to 
the Perl script CreateMitpRecoveryGraph.pl, which compared these to the 
positively validated miRNA-target interaction dataset. Using this input, this script 
creates a Microsoft Excel file displaying a miTP recovery graph, with the help of 
the Perl modules Spreadsheet::WriteExcel (McNamara 2012), OLE::Storage_Lite 
(Takanori and McNamara 2012) and Parse::RecDescent (Braun and Conway 
2012). 
 
For each miRNA-target prediction that has identified a known miRNA-target 
gene, a miTP recovery graph plots the number of validated miTIs (per miRNA) 
recovered by the miTP method against the total number of miRNA-target 
predictions (per miRNA); the recovery curve joining these points conveys the 
relationship between the number of miRNA targets predicted by each method and 
the number of known targets identified. As a point of comparison, a random 
predictor line is estimated using the formula shown in Equation 3.3. 
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Lrand =
Rmax
Pmax
=
RT µ
PT  
Equation 3.3: Estimated recovery rate of random microRNA-target predictor.  
Shown is the equation of the 'random predictor line' in a miTP recovery graph (Lrand), 
which reflects the performance of a miTP method predicting miRNA targets at random. 
This is equal to the ratio of the maximum number of miRNA targets that can be 
recovered per miRNA (Rmax) to the maximum number of miRNA-target predictions that 
can be made per miRNA (Pmax). The value of Rmax is calculated as the ratio of the number 
of positively validated miRNA targets (RT) — i.e. the number of 'recoverable' miRNA 
targets — to the number of unique miRNAs in the set of positively validated miRNA 
targets (µ). The value of Pmax is taken as being equivalent to the number of annotated 
target 3′ UTR sequences being tested (PT) — i.e. the maximum number of targets that can 
be predicted for any miRNA. It is not necessary to divide PT by the number of miRNAs 
µ, since all annotated 3′ UTR sequences being tested are regarded, at least in principle, as 
potential targets of each miRNA.  
 
The results of the TargetScan context and conservation scripts were merged in 
each recovery graph (forming the TSUNION recovery curve, see Figure 3.12 and 
Figure 3.13) to facilitate a fairer comparison between TargetScan and other 
methods. 
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3.4 Results	  
For the human data, a ROC graph was produced comparing miRNA-target 
predictions against known miRNA targets and non-targets (true- and false-positives, 
respectively). For each of the 6 benchmark test species, a recovery graph was 
produced showing the number of known miRNA targets recovered by each miTP 
method, graphed against the number of miTP predictions made. These results are 
described in the following sections. 
3.4.1 MicroRNA-­‐Target	  Prediction	  ROC	  Graph	  
The ROC graph in Figure 3.11 shows a comparison of the ranked output of 9 
different miTP programs, while the bar graph displays the area under the ROC 
curve (AUC) for each miTP method. ROC curves can be used to compare method 
performance where the true-positive rate and false-positive rate can be estimated. 
The AUC of each method can provide a measure of the performance of that method, 
such that a higher AUC is associated with a higher true-positive rate and lower false-
positive rate. The TargetScan context script has the highest AUC (i.e. 0.753), 
followed by the TargetScan conservation script (i.e. 0.723), and miRanda with and 
without a seed requirement (i.e. 0.716 and 0.71, respectively). The TargetScan 
context script has a significantly higher AUC than 9 of the bottom 10 ranked ROC 
curves, none of which had an AUC greater than 0.67 (Mann-Whitney U test, P ≤ 
0.035), see Table 3.7. The AUC values of the bottom 5 ranked ROC curves — none 
of which had an AUC higher than 0.639 — are significantly exceeded by those of the 
TargetScan conservation script (Mann-Whitney U test, P ≤ 0.00184), miRanda with a 
strict seed requirement (Mann-Whitney U test, P ≤ 0.0113), and miRanda without a 
strict seed (Mann-Whitney U test, P ≤ 0.0384). Neither TargetScan nor miRanda has 
an AUC that is significantly better than those of miRmap or Hitsensor at a 5% 
significance level. This suggests that TargetScan is the miTP program best able to 
distinguish between miRNA targets and non-targets, followed closely by miRanda 
and more distantly by miRmap and Hitsensor. Having said that, all methods except 
MultiMiTar were found to have an AUC greater than that of a random predictor 
(where a random predictor is expected to have an AUC of 0.5). 
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With an area under the ROC curve of 0.461, MultiMiTar was the only miRNA-target 
prediction program with an AUC below that of a random classifier. This may be due 
to the low number of predictions output by MultiMiTar — nine involving the miTIs 
used in the ROC graph — so it may not be a good reflection of MultiMiTar's true 
performance. Similarly, although the TargetScan conservation script identified 
44.7% (i.e. 214 of 479) of known miRNA targets while predicting no false-positives, 
to attain an AUC of 0.7234, this lack of false-positives can be seen as a disadvantage 
with respect to assessing its performance, since its ROC curve may not give a full 
picture of exactly how well it distinguishes miRNA targets from non-targets. The 
ROC curve data files are accessible in the electronic appendix at: Appendix / home / 
projects / benchmark / pipelines / mitp-benchmark / roc-curve.html.  
3.4.2 MicroRNA-­‐Target	  Prediction	  Recovery	  Graph	  
Figure 3.12 shows the overall recovery graph for human. For each miRNA-target 
prediction method, this graph plots the number of recovered known miRNA-target 
interactions against the number of miRNA-target predictions. The recovery graphs 
for mouse, rat and zebrafish broadly recapitulate those of human. There were a very 
small number of validated miTIs for cow and chicken, so the recovery graphs for 
these organisms was a step function. All six recovery graphs are accessible in the 
electronic appendix at the following file path: Appendix / home / projects / 
benchmark / pipelines / mitp-benchmark / validated-target-recovery-graph.html. 
 
The recovery graph shows, for each miTP method, the number of known targets 
identified for a given number of miRNA-target predictions, or conversely, the 
number of predictions required to recover a given number of known miRNA targets. 
In a manner analogous to the ROC curve, a recovery curve with a larger area 
indicates a better performance.  
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Figure 3.11 Legend:  
The figure on page 240 overleaf shows (A) results of a ROC analysis comparing 17 ROC 
curves corresponding to 15 sets of miRNA-target predictions by 9 miRNA-target prediction 
methods; and (B) a ranking of AUC values for the ROC curves. The colour of the bar for 
each ROC curve in the AUC ranking matches the colour of the corresponding ROC curve in 
the ROC graph. Given a set of ranked predictions by a miRNA-target prediction method and 
a set of known miRNA targets and non-targets, the true-positive and false-positive rates can 
be estimated for different levels of stringency and plotted on a curve; this produces a 
receiver operating characteristic (ROC) curve (Egan 1975). The area under the ROC curve 
(AUC) of each miTP method can then provide a measure of the performance of the method, 
such that a higher AUC is associated with a higher true-positive rate and lower false-positive 
rate. A prediction method that identifies all true-positives and rejects all true-negatives will 
have an AUC of 1, while a random classifier will have an AUC of 0.5 (corresponding to the 
dashed diagonal line in the ROC graph). In order of decreasing AUC values, the ROC curves 
represent miRNA-target predictions from: the TargetScan context script (TSCONTEXT), the 
TargetScan conservation script (TSCONSERV), miRanda with strict seed binding 
(MIRANDAs), miRanda without strict seed (MIRANDA), Hitsensor with increased 
weighting for seed match miRNA-target sites (HITSENSORs), miRmap (MIRMAP), 
Hitsensor with default settings (HITSENSOR), PITA with default settings (PITA), 
RNAhybrid predictions ranked by MFE (RNAHYBRID-E), RNAhybrid predictions 
constrained by seed binding and ranked by MFE (RNAHYBRIDs-E), RNAhybrid 
predictions constrained by seed binding and ranked by p-value (RNAHYBRIDs-P), 
TargetSpy with default settings (TARGETSPY), TargetSpy with seed match requirement 
(TARGETSPYs), PITA accounting for target site flanking sequence (PITAf), MicroTar 
(MICROTAR), RNAhybrid predictions ranked by p-value (RNAHYBRID-P) and 
MultiMiTar (MULTIMITAR). 
 
Table 3.7 Legend:  
Shown on page 241 is a table summarising statistical analysis performed on the miTP 
benchmark ROC graph, taken from the output of the StAR web utility (Vergara et al. 2008). 
(For the benchmark run names, see Table 3.6. For the AUC values, see Table 3.8.) The 
values in the upper triangle show the difference in AUC between miTP methods (ΔAUC), 
while the values in the lower triangle give the p-value of the ΔAUC in a Mann-Whitney U 
test. Those p-values less than 5% are shown in green, while p-values greater than 5% are 
shown in red. Note that because the AUC of MultiMiTar was less than 0.5, results are given 
for an inverted ROC curve for this miTP program. 
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Figure 3.11: Benchmark ROC graph of 9 miTP programs.  
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Table 3.7: ROC StAR statistical analysis. 
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TSCONTEXT — 0.0299 0.03716 0.04322 0.04765 0.05414 0.07532 0.08103 0.08161 0.08868 0.09047 0.09058 0.11401 0.14843 0.18103 0.18938 0.21424 
TSCONSERV 0.39146 — 0.00726 0.01331 0.01775 0.02424 0.04542 0.05113 0.05170 0.05878 0.06057 0.06068 0.08411 0.11853 0.15113 0.15948 0.18434 
MIRANDAs 0.06844 0.84044 — 0.00605 0.01048 0.01698 0.03816 0.04386 0.04444 0.05152 0.05331 0.05342 0.07685 0.11127 0.14387 0.15222 0.17708 
MIRANDA 0.09468 0.74871 0.71942 — 0.00443 0.01093 0.03210 0.03781 0.03839 0.04547 0.04725 0.04737 0.07080 0.10522 0.13781 0.14616 0.17103 
HITSENSORs 0.30021 0.69441 0.80178 0.91430 — 0.00650 0.02767 0.03338 0.03396 0.04103 0.04282 0.04294 0.06637 0.10079 0.13338 0.14173 0.16660 
MIRMAP 0.32842 0.6062 0.74854 0.83452 0.83914 — 0.02118 0.02688 0.02746 0.03454 0.03633 0.03644 0.05987 0.09429 0.12689 0.13524 0.16010 
HITSENSOR 0.10897 0.34527 0.38780 0.45889 0.20812 0.57369 — 0.00571 0.00629 0.01336 0.01515 0.01526 0.03869 0.07312 0.10571 0.11406 0.13892 
PITA 0.03532 0.29104 0.24657 0.30019 0.35821 0.55683 0.88029 — 0.00058 0.00765 0.00944 0.00956 0.03299 0.06741 0.10000 0.10835 0.13322 
RNAHYBRID-E 0.06786 0.29288 0.26673 0.35057 0.47967 0.64090 0.90018 0.98902 — 0.00707 0.00886 0.00898 0.03241 0.06683 0.09942 0.10777 0.13264 
RNAHYBRIDs-E 0.01352 0.20332 0.12031 0.17675 0.36879 0.53627 0.77739 0.83210 0.81190 — 0.00179 0.00190 0.02533 0.05975 0.09235 0.10070 0.12556 
RNAHYBRIDs-P 0.01240 0.17051 0.18230 0.21855 0.42985 0.53850 0.78754 0.84377 0.86058 0.95261 — 0.00012 0.02354 0.05797 0.09056 0.09891 0.12378 
TARGETSPY 0.03195 0.12118 0.15587 0.21209 0.21290 0.39173 0.63480 0.81520 0.84294 0.96634 0.99827 — 0.02343 0.05785 0.09044 0.09879 0.12366 
TARGETSPYs 0.00115 0.00170 0.01129 0.03835 0.08457 0.14804 0.33606 0.45370 0.50402 0.56654 0.61075 0.39514 — 0.03442 0.06701 0.07537 0.10023 
PITAf 0.00001 0.00184 0.00096 0.00225 0.00966 0.05057 0.06561 0.01926 0.08699 0.11038 0.20237 0.08210 0.34400 — 0.03259 0.04094 0.06581 
MICROTAR 0.00001 0.00010 0.00150 0.00581 0.02226 0.04302 0.07955 0.07340 0.05932 0.05538 0.05811 0.10198 0.17319 0.46951 — 0.00835 0.03322 
RNAHYBRID-P 0.00006 0.00026 0.00248 0.00502 0.03580 0.05231 0.09897 0.07695 0.02633 0.05743 0.04221 0.10504 0.15981 0.41595 0.86794 — 0.02487 
MULTIMITAR 0.00002 0.00000 0.00032 0.00137 0.00145 0.00166 0.01096 0.02414 0.03055 0.03615 0.02716 0.00590 0.00165 0.16611 0.47709 0.64035 — 
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As can be seen from Figure 3.12, TargetScan again performs well compared to other 
miRNA-target prediction methods, having a relatively high area under its curve 
despite low overall sensitivity — see the recovery curves for TSCONSERV and 
TSCONTEXT — the TargetScan conservation and context scripts, respectively — 
to the left of Figure 3.12. (Each miTP method is named here in the same colour as its 
corresponding recovery curves in Figure 3.12 and Figure 3.13. For information on 
the benchmark run names, see Table 3.6.) This was followed by MIRANDAs and 
MIRANDA, then TARGETSPYs and TARGETSPY, MIRMAP, HITSENSORs 
and HITSENSOR, then other methods. Overall, RNAhybrid predictions perform 
quite poorly as a binary classifier, such that its recovery curves straddle the dashed 
random prediction line — with the notable exception of RNAHYBRIDs-P (i.e. 
RNAhybrid with a seed binding constraint, ranked by p-value), which has a 
performance that is better than PITA, although not as good as PITAf. 
 
Figure 3.13 shows the same recovery graph as Figure 3.12, but focusing on the top 
500 ranked predictions for each method. These would be the predictions used most 
as they would be considered most enriched with bona fide miRNA-target 
interactions. This emphasises the difference in performance between TargetScan and 
other methods for top ranked miRNA-target predictions. Note the recovery curve of 
the TargetScan conservation script (i.e. TSCONSERV) above all others. This is 
followed by the TSUNION recovery curve — which unifies the results of the two 
TargetScan scripts — and then by the TargetScan context script (i.e. 
TSCONTEXT). This shows that, at least for the set of known validated miRNA-
target interactions used here, TargetScan is better at identifying known miTIs among 
its top predictions than the other methods being compared. 
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Figure 3.12 Legend:  
The figure on page 244 overleaf shows a graph of known miRNA-target interactions 
recovered as a function of the number of miRNA-target predictions. Except for MicroTar 
(which was included only in the ROC analysis), each miRNA-target prediction run in Figure 
3.11 is represented in this graph in the same colour. An additional curve is included in this 
figure: TSUNION — the averaged results of TSCONSERV and TSCONTEXT — created to 
allow the results of TargetScan as a whole to be compared to those of other methods. 
Recovery curves for RNAhybrid include: RNAhybrid predictions ranked by MFE 
(RNAHYBRID-E), RNAhybrid predictions ranked by p-value (RNAHYBRID-P), 
RNAhybrid predictions constrained by seed binding and ranked by MFE (RNAHYBRIDs-
E), and RNAhybrid predictions constrained by seed binding and ranked by p-value 
(RNAHYBRIDs-P). For all other recovery curve names, see Table 3.6. The dashed grey line 
reflects the expected performance of a random predictor. 
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Figure 3.12: Benchmark recovery rates of 8 miTP programs.  
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Figure 3.13: Benchmark recovery rates among top-ranking microRNA-target predictions.  
Shown is a graph of known miRNA-target interactions recovered as a function of the number of miRNA-target predictions, among the top-ranking predictions 
of 8 of the methods benchmarked (MicroTar having been excluded). Recovery curves are colour-coded as in Figure 3.12. 
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Table 3.8: Summary of miTP benchmark results. 
ROC Graph Recovery Graph 
 
AUC 
 
Sensitivity (Top 500) Sensitivity (Overall) 
HITSENSOR 0.6780  6.69% 92.39% 
HITSENSORs 0.7056  7.47% 95.61% 
MICROTAR 0.5723  N/A N/A 
MIRANDA 0.7101  8.57% 40.70% 
MIRANDAs 0.7161  9.30% 31.78% 
MIRMAP 0.6991  8.68% 72.15% 
MULTIMITAR 0.4610  1.42% 1.42% 
PITA 0.6723  2.42% 77.09% 
PITAf 0.6048  3.07% 29.65% 
RNAHYBRID-E 0.6717  0.96% 99.99% 
RNAHYBRID-P 0.5639  1.56% 99.66% 
RNAHYBRIDs-E 0.6646  1.58% 88.79% 
RNAHYBRIDs-P 0.6628  2.89% 87.34% 
TARGETSPY 0.6627  6.54% 39.68% 
TARGETSPYs 0.6393  8.89% 19.00% 
TSCONSERV 0.7234  13.96% 13.96% 
TSCONTEXT 0.7533  11.84% 41.47% 
TSUNION N/A  13.79% 41.79% 
 
Table 3.8 Legend:  
Shown is a summary of the key results for the miTP benchmark. The AUC column shows 
the area under the ROC curve attained by each method in the ROC analysis. The Sensitivity 
(Top 500) column shows the percentage of known miRNA targets recovered by each miTP 
method in the top 500 miRNA-target predictions. The Sensitivity (Overall) column shows 
the percentage of known targets recovered overall by each miRNA-target prediction method. 
Benchmark runs shown for RNAhybrid include: RNAhybrid predictions ranked by MFE 
(RNAHYBRID-E), RNAhybrid predictions ranked by p-value (RNAHYBRID-P), 
RNAhybrid predictions constrained by seed binding and ranked by MFE (RNAHYBRIDs-
E), and RNAhybrid predictions constrained by seed binding and ranked by p-value 
(RNAHYBRIDs-P). As in the recovery graphs of Figure 3.12 and Figure 3.13, the results of 
TSCONSERV and TSCONTEXT were averaged to produce a TSUNION curve, which 
allows the results of TargetScan as a whole to be compared to those of other methods. For 
other benchmark run names, see Table 3.6.  
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3.5 Discussion	  
With the caveat that the results of this benchmark study are subject to the data and 
methods used, the general ranking of miRNA-target prediction methods was 
consistent across both the ROC and recovery analyses. TargetScan and miRanda 
performed best overall, attaining a higher AUC than other methods in ROC analysis, 
and recovering more known miRNA targets than other methods studied, for a given 
number of predictions. However, both methods were relatively limited in their 
sensitivity: in terms of known positive miRNA targets recovered, TargetScan had 
sensitivity of 41.79%, while miRanda had sensitivity of 40.7%. Of the more sensitive 
methods overall, miRmap and Hitsensor performed best, with overall sensitivity of 
72.15% and 95.61%, respectively, and also high sensitivity among top ranking 
miRNA-target predictions (i.e. 8.68% for miRmap and 7.47% for Hitsensor). 
However, this sensitivity came at some cost to specificity, such that in ROC analysis, 
miRmap had an AUC of 0.6991, while Hitsensor (with increased weighting for seed 
match sites) attained an AUC of 0.7056. Nevertheless, these two methods had 
sensitivity comparable to miRanda among the top-ranked miRNA-target predictions 
(see Figure 3.13 and Table 3.8).  
 
TargetSpy and MultiMiTar — the miTP methods based on machine learning — did 
not perform very well overall. TargetSpy (without seed constraint) attained a 
reasonably good AUC of 0.6627 in ROC analysis, but attained relatively low 
sensitivity of 39.68%. MultiMiTar performed considerably worse, having an AUC of 
0.461 (worse than random) in ROC analysis and maximum sensitivity of 1.42% in 
the recovery graph. Both methods produced a relatively small number of miRNA-
target predictions: approximately 4000 and 288 per miRNA, respectively, compared 
to an average of about 9000 miTPs per miRNA among the other benchmarked 
methods. Whether the low number of predictions is an issue with machine learning 
per se is debatable; perhaps a stringent cutoff is used by these methods because the 
accuracy of the machine learning algorithm was found to deteriorate beyond a certain 
point. It could be argued, at least in some instances, that a reduction in sensitivity is 
acceptable if the miRNA-target predictions that are made have a high degree of 
accuracy. This might be the case for TargetSpy, which achieved a high AUC 
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considering its relatively low sensitivity and, at the limit of its sensitivity, recovered 
almost as many known miRNA targets as the TargetScan context script, (note the 
short green line for TARGETSPYs in the bottom left of Figure 3.12). However, the 
same could not be said for MultiMiTar, which achieved neither a high AUC nor 
appreciable sensitivity.  
 
The miRNA-target prediction methods based primarily on thermodynamic 
considerations — i.e. PITA, RNAhybrid and MicroTar — performed relatively 
poorly at the binary classification of miRNA-target interactions. Among these 
methods, PITA performed best, with an AUC of up to 0.6723 in ROC analysis and 
sensitivity levels of 3.07% (with flank) and 2.42% (without flank) among the top 500 
miRNA-target predictions. RNAhybrid had a maximum AUC of 0.6717 in the ROC 
graph, but tracked the random predictor line in the recovery graph, with a maximum 
sensitivity of 2.89% among the top 500 predictions, when seed constrained miRNA-
target predictions were ranked by increasing p-value. MicroTar had the worst 
performance of the three: due to its prohibitive computational cost (e.g. in extreme 
cases, it could take more than 12 hours to test a single miRNA-target interaction), it 
was excluded from the main benchmark study and only tested against the 
comparatively small number of high-quality validated miTIs used to construct the 
ROC graph, achieving an AUC of 0.5723. The inclusion of accessibility in the 
thermodynamic calculations of PITA may account for its improved performance over 
RNAhybrid, which focuses only on the hybridisation energy of the miRNA-target 
duplex. MicroTar similarly focuses on the miRNA-target duplex, but models the 
folding of the target mRNA both before and after hybridisation; this thoroughness is 
associated with considerable computational cost, but is unfortunately not rewarded 
with improved identification of miRNA-target interactions.  
 
In the recovery graph in Figure 3.12, the differences in performance of RNAhybrid 
miRNA-target predictions under different score types and settings can be seen. This 
recovery graph shows that RNAhybrid predictions ranked by increasing MFE (i.e. 
RNAHYBRID-E and RNAHYBRIDs-E in Figure 3.12) are a poor binary classifier 
of miRNA-target interactions, with a recovery performance at or below that of a 
random classifier. In the 'Top-500' predictions, RNAHYBRID and RNAHYBRIDs, 
as ranked by MFE, attained sensitivity levels of only 0.96% and 1.58%, respectively. 
 249 
This compares unfavourably with an average of 6.09% sensitivity among all miTP 
methods benchmarked. Predictions of RNAHYBRID ranked by p-value (i.e. 
RNAHYBRID-P in Figure 3.12) had 'Top-500' sensitivity of 1.56%, reflecting a 
generally poor performance by RNAhybrid. However, one exception was observed: 
when a miRNA seed binding constraint is imposed (i.e. RNAHYBRIDs-P in Figure 
3.12), the overall performance of RNAhybrid improves considerably and with 'Top-
500' sensitivity of 2.89%, is comparable with that of PITA.  
 
Whether the observed differences in performance of miTP methods are statistically 
significant is a non-trivial question. Fortunately, the StAR web utility (Vergara et al. 
2008) integrates statistical analysis of ROC curves, implementing the method 
described by Delong et al. (1988) for comparing the AUC values of different ROC 
curves using a Mann-Whitney U test. The results of this statistical analysis for the 
ROC graph in Figure 3.11 are shown in Table 3.7. These indicate that TargetScan 
has a significantly higher AUC than the majority of methods, including RNAhybrid, 
PITA, TargetSpy, MicroTar and MultiMiTar (0.081 ≤ ΔAUC ≤ 0.214, α = 0.05). 
Similarly, miRanda has significantly higher AUC than TargetSpy, MicroTar and 
MultiMiTar, as well as PITA and RNAhybrid under some settings (0.071 ≤ ΔAUC ≤ 
0.171, α = 0.05). Notably, neither TargetScan nor miRanda have a performance that 
is significantly better than miRmap or Hitsensor at a 5% significance level (see Table 
3.7). This may be due in part to the relatively low number of high-quality positively 
and negatively validated miRNA-target interactions — with 479 positively validated 
miTIs and 45 negatively validated miTIs, there were only 524 high-quality 
validations in the dataset. Perhaps with a larger set of such high-quality miRNA-
target validations, statistical analysis of ROC graphs might allow clearer distinctions 
to be drawn between the performance of different miRNA-target prediction methods. 
 
Aside from its ability to identify and characterise miRNA-target interactions, other 
aspects of miRNA-target prediction software may be of importance. The 
development model of miRmap may present a new way of tackling the problem of 
choosing which miTP method to use from a selection of disparate methods, by 
incorporating the features of different miTP methods within one open source Python 
package. Whether this model will become widely used remains to be seen, but does 
depend on continuing active development by the authors of the miRmap Python 
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package (Vejnar and Zdobnov 2012) and by its community of users. Python is 
(arguably) highly suited to open source development, since its design philosophy 
emphasises readability and maintainability. Without such active maintenance, the 
feature set implemented in miRmap will inevitably lag behind those used by other 
actively developed miRNA-target prediction software. For example, the miRmap 
package at time of publication by Vejnar and Zdobnov (2012) lacked the target 
abundance and seed-pairing stability features implemented in TargetScan by Garcia 
et al. (2011). Furthermore, newly discovered miRNA-target site types such as bulge 
sites (Chi et al. 2012) and centred pairing sites (Shin et al. 2010) are yet to be 
included in miRmap or indeed any miRNA-target prediction method. 
 
One aspect of concern is the narrow focus of current miRNA-target prediction 
methods on identifying miRNA-target sites within the 3′ UTR sequence; it has been 
suggested that this may have become a self-reinforcing bias (Rigoutsos 2009, Peter 
2010). Indeed, the lack of validated miRNA-target sites localised to the coding 
region of the target gene effectively prevented miRNA-target prediction within the 
CDS from being considered within the benchmark study in this chapter. Recent 
developments will at least alleviate concerns of a bias towards target prediction 
within 3′ UTRs, with the publication of methods that identify miRNA targets within 
coding regions, such as DIANA-microT-CDS (Reczko et al. 2012) and more 
recently PACCMIT-CDS (Marín et al. 2013). This will perhaps allow more miRNA-
target sites to be identified within the coding regions of potential target genes, and in 
turn for such target sites to be validated as functional, since many miTI validation 
experiments are guided by preliminary miRNA-target predictions.  
 
The use of miRNA-target predictions to identify candidate targets for validation in 
itself can pose a problem, since this biases the set of validated miRNA-target 
interactions towards those miTP methods that are most widely used (Sturm et al. 
2010). To some extent such circularity is unavoidable, although large-scale miRNA-
target validation studies such as those of Baek et al. (2008) or Chi et al. (2009) can 
ameliorate this problem.  
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The greatest strength of this benchmark — comparison of miRNA-target prediction 
methods on a consistent dataset — could also be seen as its most limiting weakness, 
since it effectively excluded those miTP methods for which standalone software is 
not currently available. This ruled out a comparison of the software for EIMMo, 
PicTar and DIANA-microT, all of which performed well in previous benchmarks 
(Sethupathy et al. 2006, Baek et al. 2008, Selbach et al. 2008, Alexiou et al. 2009), 
and none of which are available to download. It also prevented an assessment of 
miRanda predictions ranked using mirSVR, which has been reported to improve the 
ranking of miRNA-target predictions produced by miRanda (Betel et al. 2010), but 
which has yet to be integrated into miRanda proper. A benchmark study of miRNA-
target prediction methods remains incomplete without including an assessment of all 
current miTP methods, and the prospect of such a benchmark awaits a time when the 
release of standalone software becomes the norm among the population of miRNA-
target prediction methods. Nevertheless, incomplete as it is, the benchmark described 
here has distinguished those methods that achieve the best balance between precision 
and sensitivity (i.e. TargetScan and miRanda) from those that lack either precision 
(e.g. RNAhybrid), sensitivity (e.g. TargetSpy), or both. 
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Chapter	  4:	  	  	  	  Prediction	  of	  Placenta-­‐Specific	  MicroRNA-­‐Target	  
Interactions	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4.1 Introduction	  
Chapter 2 focused on the role of functional shift of placental genes in the evolution 
of the placenta. However, this inevitably produces an incomplete picture of 
evolutionary change in relation to the emergence of placenta, since there are 
numerous ways in which such novelty can arise (Hughes and Friedman 2010). 
Morphological innovation introduced by genetic novelty is frequently mediated by 
changes in the regulatory regime controlling expression of genes (Davidson and 
Erwin 2006).  
 
MicroRNAs are a potentially valuable source of information on the evolution of gene 
expression regulation, since they more or less continually emerge during evolution, 
tend to be highly conserved and undergo secondary loss only rarely (Wheeler et al. 
2009). MiRNAs have been shown to regulate a broad range of biological processes 
— including insulin secretion (Poy et al. 2004), B-cell differentiation (Chen 2004a) 
and differentiation of adipocytes (Esau et al. 2004) — and are believed to play a role 
in the maintenance of tissue identity (Chang et al. 2004, Girard et al. 2008), and 
more broadly in the evolution of vertebrate complexity (Heimberg et al. 2008, 
Wheeler et al. 2009, Peterson et al. 2009a).  
 
MiRNAs similarly play a key role in placental development. Many miRNAs are 
expressed specifically or exclusively in the placenta (Liang et al. 2007, Landgraf et 
al. 2007), and placental miRNA expression patterns differ over the gestation period 
(Luo et al. 2009), perhaps reflecting a developmental program. MiRNAs have been 
shown to play a role in the regulation of trophoblast proliferation (Chao et al. 2010, 
Luo et al. 2012) and the formation of capillaries at foetal-maternal interface (Sekita 
et al. 2008), while dysregulation of miRNAs has been observed in cases of pre-term 
delivery (Mayor-Lynn et al. 2011) and notably in pre-eclampsia (Poliseno et al. 
2006, Pineles et al. 2007, Hu et al. 2009, Mayor-Lynn et al. 2011).  
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For example, the gene retrotransposon-like 1 (RTL1) is critical for the development 
of placenta in a manner sensitive to its expression levels (Kotzot 2004, Sekita et al. 
2008). Both over-expression and under-expression of RTL1 are associated with 
deleterious phenotypes affecting the growth and development of the young in human 
(Kotzot 2004) and in mouse (Sekita et al. 2008). Several miRNAs are transcribed 
from the antisense strand of the RTL1 locus (Seitz et al. 2003); these miRNAs 
regulate the expression of their host gene, maintaining its expression levels 
temporally within the optimal range (Davis et al. 2005).  
 
Another example of the influence of miRNA in placenta is furnished by the 
chromosome 19 miRNA cluster (C19MC) first identified by Bentwich et al. (2005); 
this remains the largest miRNA cluster observed in human (Flor and Bullerdiek 
2012). The C19MC cluster comprises 46 miRNA precursors, many of which share 
similarities with the neighbouring cluster of miRNAs containing mir-371, mir-372 
and mir-373. This similarity has led to suggestions that the C19MC cluster may have 
originated in a duplication of one of these three neighbouring miRNAs (Bentwich et 
al. 2005, Zhang et al. 2008).  
 
MiRNAs homologous to those in the C19MC have not been identified in any non-
primate genome, and it is believed to be a primate-specific cluster (Bentwich et al. 
2005, Zhang et al. 2008). A clue to its rapid expansion in the primate lineage has 
been offered by the presence of Alu elements (Batzer and Deininger 2002), 
interspersed among the miRNAs in C19MC; Alu-mediated expansion has been 
suggested to account for the emergence of such a large number of miRNAs in a 
comparatively short period of time (Zhang et al. 2008, Lehnert et al. 2009).  
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There is some debate as to whether the members of C19MC are transcribed by RNA 
polymerase II or III (Borchert et al. 2006, Bortolin-Cavaille et al. 2009), but there is 
little controversy about where it is expressed. Expression of C19MC miRNAs has 
been observed in placenta (Bentwich et al. 2005, Liang et al. 2007) and particularly 
in embryonic stem cells (Bar et al. 2008, Cao et al. 2008, Ren et al. 2009), but has 
not been observed in adult tissues (Liang et al. 2007, Landgraf et al. 2007). The 
C19MC cluster is genomically imprinted, such that only the paternally inherited gene 
is expressed in placenta (Tsai et al. 2009, Noguer-Dance et al. 2010), while both 
alleles are methylated (and therefore not expressed) in normal adult tissues such as 
muscle or brain (Noguer-Dance et al. 2010). However, despite considerable progress 
in determining its evolutionary history and expression patterns, relatively little is 
known about the function of the miRNAs in the C19MC cluster, although for 
example, 23 members of this cluster have been shown to have a tumour suppressive 
function, an oncogenic role, or both (Flor and Bullerdiek 2012).  
 
Taken together, these studies demonstrate that miRNAs have played a key role in the 
evolution and development of placenta through the regulation of their target genes. 
In this chapter we have performed evolutionary analyses of miRNA-target 
interactions for a set of 114 placental genes (from Chapter 2) and 141 placental 
miRNAs assembled specifically for this chapter. For each placental miRNA and 
gene, miRNA-target prediction was performed in 20 different species, to identify 
miRNA-target pairs that have a predicted functional interaction that is conserved 
across species and to assess the prevalence of such interactions and the nature of 
their emergence, whether they emerge soon after the emergence of the miRNA itself 
or more slowly over time. 
 
 256 
4.2 Materials	  
A set of placental miRNAs was assembled, including those miRNAs known to be 
important to the development and/or function of the placenta, and those miRNAs 
with placenta-specific expression patterns. The placental genes analysed in Chapter 2 
were used again in this chapter. The species of interest in this chapter are also 
identical to those in Chapter 2, as the same requirements of good genome coverage, 
genome quality and taxon sampling remain. The genomic nucleotide sequence data 
for each species of interest was obtained from the Ensembl genomic database server 
(Flicek et al. 2012), while the sequences of placental miRNA and target gene 3′ 
UTRs were downloaded from Ensembl through the BioMart interface (Smedley et al. 
2009). Placental miRNA sequences were obtained from a local copy of the miRBase 
database (Griffiths-Jones 2004, Griffiths-Jones 2006, Griffiths-Jones et al. 2008, 
Kozomara and Griffiths-Jones 2011). All scripts used during this process can be 
accessed from the following location in the electronic appendix: Appendix / home / 
code / scripts.html. 
4.2.1 Placental	  MicroRNA	  Set	  Assembly	  
The set of placenta-specific miRNAs is composed of miRNAs from seven different 
data sources. Each placental miRNA has a placenta-specific expression pattern, or its 
dysregulation is associated with a disease state. Each data source is listed in Table 
4.1. Before being merged into one non-redundant data set, each miRNA (whether 
precursor or mature miRNA) was mapped to a common standard nomenclature — in 
this case that of miRBase release 18. Where a study specified a precursor, all 
corresponding mature miRNAs that could not be ruled out were included. 
Correspondingly, where a study specified a mature miRNA, all corresponding 
miRNA precursors that could not be ruled out were included. The result was a set of 
159 mature miRNAs with 141 corresponding miRNA precursors. Of the 141 
precursor miRNAs, 127 were human miRNAs and 14 were mouse miRNAs. 
Information on each of the 141 precursor miRNAs is given in Table 4.2, and the 
process itself is summarised in Figure 4.1. 
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Figure 4.1: Placental microRNA set assembly pipeline.  
Shown is a bioinformatics pipeline depicting the steps involved in placental miRNA set 
assembly. Arrows indicate the direction of process flow. For information on symbols used, 
see Figure 2.2.  
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Table 4.1: Placental microRNA dataset sources. 
miRNA Dataset # miRNAs Details References 
Bentwich 43 Original discovery of chromosome 19 miRNA cluster (C19MC) Bentwich et al. (2005) 
Ensembl64 C19MC 46 C19MC miRNAs annotated in Ensembl release 64 Flicek et al. (2011) 
Landgraf 8 Expression profile showing 100% normalised tissue enrichment in placenta Landgraf et al. (2007) 
Liang 51 MicroRNAs over-expressed in placenta; of which 40 are in C19MC Liang et al. (2007) 
Hu 7 MicroRNAs over-expressed in placenta of patients with pre-eclampsia Hu et al. (2009) 
Luo 72 High expression in placenta: in first trimester, at term or throughout gestation Luo et al. (2009) 
Prieto 14 MicroRNAs with functional effects in normal and disease states of placenta Prieto and Markert (2011)  
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Table 4.2: Placenta-specific microRNAs. 
miRNA ID miRBase Accession Ensembl Gene ID Mature miRNAs 
hsa-let-7a-1 MI0000060 ENSG00000199165 hsa-let-7a-5p 
hsa-let-7a-2 MI0000061 ENSG00000198975 hsa-let-7a-5p 
hsa-let-7a-3 MI0000062 ENSG00000198986 hsa-let-7a-5p 
hsa-let-7b MI0000063 ENSG00000207875 hsa-let-7b-5p 
hsa-let-7d MI0000065 ENSG00000199133 hsa-let-7d-3p 
hsa-mir-1-2 MI0000437 ENSG00000207694 hsa-miR-1 
hsa-mir-1-1 MI0000651 ENSG00000199017 hsa-miR-1 
hsa-mir-15b MI0000438 ENSG00000207779 hsa-miR-15b-5p,                     hsa-miR-15b-3p 
hsa-mir-16-1 MI0000070 ENSG00000208006 hsa-miR-16-5p,                      hsa-miR-16-1-3p 
hsa-mir-16-2 MI0000115 ENSG00000198987 hsa-miR-16-5p,                      hsa-miR-16-2-3p 
hsa-mir-21 MI0000077 ENSG00000199004 hsa-miR-21-5p 
hsa-mir-23a MI0000079 ENSG00000207980 hsa-miR-23a-3p 
hsa-mir-24-1 MI0000080 ENSG00000207617 hsa-miR-24-3p 
hsa-mir-24-2 MI0000081 ENSG00000209707 hsa-miR-24-3p 
hsa-mir-25 MI0000082 ENSG00000207547 hsa-miR-25-3p 
hsa-mir-26a-1 MI0000083 ENSG00000199075 hsa-miR-26a-5p 
hsa-mir-26b MI0000084 ENSG00000199121 hsa-miR-26b-5p,                    hsa-miR-26b-3p 
hsa-mir-26a-2 MI0000750 ENSG00000207789 hsa-miR-26a-5p 
hsa-mir-27a MI0000085 ENSG00000207808 hsa-miR-27a-3p 
hsa-mir-27b MI0000440 ENSG00000207864 hsa-miR-27b-3p 
hsa-mir-29b-1 MI0000105 ENSG00000207748 hsa-miR-29b-3p,                    hsa-miR-29b-1-5p 
hsa-mir-29b-2 MI0000107 ENSG00000207790 hsa-miR-29b-3p,                    hsa-miR-29b-2-5p 
hsa-mir-30c-2 MI0000254 ENSG00000199094 hsa-miR-30c-5p 
hsa-mir-30d MI0000255 ENSG00000199153 hsa-miR-30d-5p 
hsa-mir-30b MI0000441 ENSG00000207582 hsa-miR-30b-5p 
hsa-mir-30c-1 MI0000736 ENSG00000207962 hsa-miR-30c-5p 
hsa-mir-30e MI0000749 ENSG00000198974 hsa-miR-30e-5p 
hsa-mir-31 MI0000089 ENSG00000199177 hsa-miR-31-5p 
hsa-mir-34a MI0000268 ENSG00000207865 hsa-miR-34a-5p 
hsa-mir-34b MI0000742 ENSG00000207811 hsa-miR-34b-5p,                        hsa-miR-34b-3p 
hsa-mir-34c MI0000743 ENSG00000207562 hsa-miR-34c-5p 
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Table 4.2: Placenta-specific  microRNAs. (continued) 
miRBase 18 ID miRBase Accession Ensembl Gene ID Mature miRNAs 
hsa-mir-92b MI0003560 ENSG00000208011 hsa-miR-92b-3p 
hsa-mir-93 MI0000095 ENSG00000207757 hsa-miR-93-5p,                     hsa-miR-93-3p 
hsa-mir-99a MI0000101 ENSG00000207638 hsa-miR-99a-5p 
hsa-mir-99b MI0000746 ENSG00000207550 hsa-miR-99b-5p,                    hsa-miR-99b-3p 
hsa-mir-100 MI0000102 ENSG00000207994 hsa-miR-100-5p 
hsa-mir-106b MI0000734 ENSG00000208036 hsa-miR-106b-5p 
hsa-mir-122 MI0000442 ENSG00000207778 hsa-miR-122-5p 
hsa-mir-125b-1 MI0000446 ENSG00000207971 hsa-miR-125b-5p 
hsa-mir-125b-2 MI0000470 ENSG00000207863 hsa-miR-125b-5p,                  hsa-miR-125b-2-3p 
hsa-mir-140 MI0000456 ENSG00000208017 hsa-miR-140-5p 
hsa-mir-141 MI0000457 ENSG00000207708 hsa-miR-141-3p 
hsa-mir-143 MI0000459 ENSG00000208035 hsa-miR-143-3p 
hsa-mir-151a MI0000809 ENSG00000207792 hsa-miR-151a-3p 
hsa-mir-154 MI0000480 ENSG00000207978 hsa-miR-154-5p,                   hsa-miR-154-3p 
hsa-mir-181a-2 MI0000269 ENSG00000207595 hsa-miR-181a-5p,                  hsa-miR-181a-2-3p 
hsa-mir-181a-1 MI0000289 ENSG00000207759 hsa-miR-181a-5p,                    hsa-miR-181a-3p 
hsa-mir-184 MI0000481 ENSG00000207695 hsa-miR-184 
hsa-mir-191 MI0000465 ENSG00000207605 hsa-miR-191-5p 
hsa-mir-196b MI0001150 ENSG00000207584 hsa-miR-196b-5p 
hsa-mir-199a-1 MI0000242 ENSG00000207752 hsa-miR-199a-3p 
hsa-mir-199a-2 MI0000281 ENSG00000208024 hsa-miR-199a-3p 
hsa-mir-199b MI0000282 ENSG00000207581 hsa-miR-199b-5p,                 hsa-miR-199b-3p 
hsa-mir-200c MI0000650 ENSG00000207713 hsa-miR-200c-3p 
hsa-mir-205 MI0000285 ENSG00000207623 hsa-miR-205-5p,                   hsa-miR-205-3p 
hsa-mir-210 MI0000286 ENSG00000199038 hsa-miR-210 
hsa-mir-214 MI0000290 ENSG00000207949 hsa-miR-214-3p 
hsa-mir-221 MI0000298 ENSG00000207870 hsa-miR-221-3p 
hsa-mir-222 MI0000299 ENSG00000207725 hsa-miR-222-5p,                       hsa-miR-222-3p 
hsa-mir-224 MI0000301 ENSG00000207621 hsa-miR-224-5p,                    hsa-miR-224-3p 
hsa-mir-324 MI0000813 ENSG00000199053 hsa-miR-324-3p 
 261 
Table 4.2: Placenta-specific  microRNAs. (continued) 
miRNA ID miRBase Accession Ensembl Gene ID Mature miRNAs 
hsa-mir-331 MI0000812 ENSG00000199172 hsa-miR-331-3p 
hsa-mir-335 MI0000816 ENSG00000199043 hsa-miR-335-5p,       hsa-miR-335-3p 
hsa-mir-342 MI0000805 ENSG00000199082 hsa-miR-342-3p,       hsa-miR-342-5p 
hsa-mir-361 MI0000760 ENSG00000199051 hsa-miR-361-5p 
hsa-mir-371a MI0000779 ENSG00000199031 hsa-miR-371a-5p,      hsa-miR-371a-3p 
hsa-mir-372 MI0000780 ENSG00000199095 hsa-miR-372 
hsa-mir-373 MI0000781 ENSG00000199143 hsa-miR-373-5p,       hsa-miR-373-3p 
hsa-mir-377 MI0000785 ENSG00000199015 hsa-miR-377-5p,       hsa-miR-377-3p 
hsa-mir-381 MI0000789 ENSG00000199020 hsa-miR-381 
hsa-mir-424 MI0001446 ENSG00000199097 hsa-miR-424-5p,        hsa-miR-424-3p 
hsa-mir-449a MI0001648 ENSG00000198983 hsa-miR-449a 
hsa-mir-450a-1 MI0001652 ENSG00000199132 hsa-miR-450a-5p 
hsa-mir-450a-2 MI0003187 ENSG00000207755 hsa-miR-450a-5p,      hsa-miR-450a-3p 
hsa-mir-451a MI0001729 ENSG00000207794 hsa-miR-451a 
hsa-mir-483 MI0002467 ENSG00000207805 hsa-miR-483-3p 
hsa-mir-491 MI0003126 ENSG00000207609 hsa-miR-491-5p,       hsa-miR-491-3p 
hsa-mir-497 MI0003138 ENSG00000207791 hsa-miR-497-5p 
hsa-mir-498 MI0003142 ENSG00000207869 hsa-miR-498 
hsa-mir-503 MI0003188 ENSG00000208005 hsa-miR-503 
hsa-mir-512-1 MI0003140 ENSG00000207645 hsa-miR-512-5p,       hsa-miR-512-3p 
hsa-mir-512-2 MI0003141 ENSG00000207644 hsa-miR-512-5p,       hsa-miR-512-3p 
hsa-mir-515-1 MI0003144 ENSG00000207616 hsa-miR-515-5p,       hsa-miR-515-3p 
hsa-mir-515-2 MI0003147 ENSG00000207615 hsa-miR-515-5p,        hsa-miR-515-3p 
hsa-mir-516b-2 MI0003167 ENSG00000207925 hsa-miR-516b-5p,       hsa-miR-516b-3p 
hsa-mir-516b-1 MI0003172 ENSG00000207946 hsa-miR-516b-5p,      hsa-miR-516b-3p 
hsa-mir-516a-1 MI0003180 ENSG00000207767 hsa-miR-516a-5p,      hsa-miR-516a-3p 
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Table 4.2: Placenta-specific  microRNAs. (continued) 
miRNA ID miRBase Accession Ensembl Gene ID Mature miRNAs 
hsa-mir-516a-2 MI0003181 ENSG00000207620 hsa-miR-516a-5p,    hsa-miR-516a-3p 
hsa-mir-517a MI0003161 ENSG00000207734 hsa-miR-517-5p,     hsa-miR-517a-3p 
hsa-mir-517b MI0003165 ENSG00000207837 hsa-miR-517-5p,     hsa-miR-517b-3p 
hsa-mir-517c MI0003174 ENSG00000207838 hsa-miR-517-5p,     hsa-miR-517c-3p 
hsa-mir-518f MI0003154 ENSG00000207706 hsa-miR-518f-5p,    hsa-miR-518f-3p 
hsa-mir-518b MI0003156 ENSG00000207862 hsa-miR-518b 
hsa-mir-518c MI0003159 ENSG00000207553 hsa-miR-518c-5p,     hsa-miR-518c-3p 
hsa-mir-518e MI0003169 ENSG00000207987 hsa-miR-518e-5p,    hsa-miR-518e-3p 
hsa-mir-518a-1 MI0003170 ENSG00000207803 hsa-miR-518a-5p,    hsa-miR-518a-3p 
hsa-mir-518d MI0003171 ENSG00000207747 hsa-miR-518d-5p,    hsa-miR-518d-3p 
hsa-mir-518a-2 MI0003173 ENSG00000207699 hsa-miR-518a-5p,    hsa-miR-518a-3p 
hsa-mir-519e MI0003145 ENSG00000207810 hsa-miR-519e-5p,    hsa-miR-519e-3p 
hsa-mir-519c MI0003148 ENSG00000207788 hsa-miR-519c-5p,    hsa-miR-519c-3p 
hsa-mir-519b MI0003151 ENSG00000207825 hsa-miR-519b-5p,    hsa-miR-519b-3p 
hsa-mir-519d MI0003162 ENSG00000207981 hsa-miR-519d 
hsa-mir-519a-1 MI0003178 ENSG00000207992 hsa-miR-519a-5p,    hsa-miR-519a-3p 
hsa-mir-519a-2 MI0003182 ENSG00000207723 hsa-miR-519a-3p 
hsa-mir-520e MI0003143 ENSG00000207599 hsa-miR-520e 
hsa-mir-520f MI0003146 ENSG00000207555 hsa-miR-520f 
hsa-mir-520a MI0003149 ENSG00000207594 hsa-miR-520a-5p,    hsa-miR-520a-3p 
hsa-mir-520b MI0003155 ENSG00000207722 hsa-miR-520b 
hsa-mir-520c MI0003158 ENSG00000207738 hsa-miR-520c-5p,    hsa-miR-520c-3p 
hsa-mir-520d MI0003164 ENSG00000207735 hsa-miR-520d-5p,   hsa-miR-520d-3p 
hsa-mir-520g MI0003166 ENSG00000207799 hsa-miR-520g 
hsa-mir-520h MI0003175 ENSG00000207861 hsa-miR-520h 
hsa-mir-521-1 MI0003176 ENSG00000207634 hsa-miR-521 
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Table 4.2: Placenta-specific  microRNAs. (continued) 
miRNA ID miRBase Accession Ensembl Gene ID Mature miRNAs 
hsa-mir-521-2 MI0003163 ENSG00000207549 hsa-miR-521 
hsa-mir-522 MI0003177 ENSG00000207806 hsa-miR-522-5p,     hsa-miR-522-3p 
hsa-mir-523 MI0003153 ENSG00000208016 hsa-miR-523-5p,      hsa-miR-523-3p 
hsa-mir-524 MI0003160 ENSG00000207977 hsa-miR-524-5p,        hsa-miR-524-3p 
hsa-mir-525 MI0003152 ENSG00000207711 hsa-miR-525-5p,      hsa-miR-525-3p 
hsa-mir-526b MI0003150 ENSG00000207580 hsa-miR-526b-5p,      hsa-miR-526b-3p 
hsa-mir-526a-1 MI0003157 ENSG00000207629 hsa-miR-526a 
hsa-mir-526a-2 MI0003168 ENSG00000211532 hsa-miR-526a 
hsa-mir-527 MI0003179 ENSG00000207979 hsa-miR-527 
hsa-mir-532 MI0003205 ENSG00000207758 hsa-miR-532-3p 
hsa-mir-584 MI0003591 ENSG00000207714 hsa-miR-584-5p,     hsa-miR-584-3p 
hsa-mir-1283-1 MI0003832 ENSG00000221421 hsa-miR-1283 
hsa-mir-1283-2 MI0006430 ENSG00000221548 hsa-miR-1283 
hsa-mir-1323 MI0003786 ENSG00000221017 hsa-miR-1323 
mmu-mir-136 MI0000162 ENSMUSG00000070129 mmu-miR-136-5p 
mmu-mir-144 MI0000168 ENSMUSG00000065401 mmu-miR-144-3p 
mmu-mir-467a-1 MI0002402 ENSMUSG00000076162 mmu-miR-467a-5p 
mmu-mir-467d MI0005513 ENSMUSG00000077021 mmu-miR-467d-5p 
mmu-mir-467e MI0006128 ENSMUSG00000076948 mmu-miR-467e-5p 
mmu-mir-467a-2 MI0014053 ENSMUSG00000076161 mmu-miR-467a-5p 
mmu-mir-467a-3 MI0014056 ENSMUSG00000076160 mmu-miR-467a-5p 
mmu-mir-467a-4 MI0014059 ENSMUSG00000076159 mmu-miR-467a-5p 
mmu-mir-467a-5 MI0014062 ENSMUSG00000076158 mmu-miR-467a-5p 
mmu-mir-467a-6 MI0014065 ENSMUSG00000076157 mmu-miR-467a-5p 
mmu-mir-467a-7 MI0014069  mmu-miR-467a-5p 
mmu-mir-467a-8 MI0014072 ENSMUSG00000076155 mmu-miR-467a-5p 
mmu-mir-467a-9 MI0014074  mmu-miR-467a-5p 
mmu-mir-467a-10 MI0014076 ENSMUSG00000077033 mmu-miR-467a-5p 
 
Table 4.2 Legend:  
Shown on pages 259 to 263 inclusive are tables of information for all 141 placenta-specific  
miRNAs studied in this thesis. For each miRNA ID, the corresponding miRBase accession, 
Ensembl Gene ID and mature miRNAs are listed.  
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4.2.2 Placental	  Gene	  Set	  Assembly	  
The set of placental genes used here is the same as that used in Chapter 2. Because 
miRNA-target prediction analysis did not impose the same constraints, in terms of 
number of species, as the selective pressure analysis conducted in Chapter 2, the 
following genes — excluded in that chapter — were reintroduced here: pregnancy 
specific beta-1-glycoprotein 7 (PSG7), X antigen family members 2 and 3 (XAGE2 
and XAGE3), and insulin-like 4 (INSL4). For each gene family member, the same 
representative transcript used in Chapter 2 was used again here.  
4.2.3 Obtaining	  Genome	  Sequence	  Data	  
The complete genome assemblies of the 22 species of interest were manually 
downloaded from the Ensembl server (Flicek et al. 2012). All genome assemblies 
comprised nucleotide FASTA files: in 17 species these were arranged into 
chromosomes, while in the remaining 5 genome assemblies were non-chromosomal 
(see Table 2.1). For the human genome assembly GRCh37.p5, the genome assembly 
files included 114 genomic patch files, representing 40 fix patches, 65 novel patches 
and 9 haplotype sequence patches. 
4.2.4 Obtaining	  Placental	  MicroRNA	  Sequence	  Data	  
The precursor sequence of each placental miRNA was obtained using the Perl script 
GetMirbaseSequences.pl on a local copy of miRBase. The resulting FASTA 
sequence file contained the precursor sequence of 141 miRNAs — 127 in human and 
14 in mouse. 
4.2.5 Obtaining	  Placental	  Gene	  Family	  3′	  UTR	  Sequence	  Data	  
Target gene 3′ UTR sequences were obtained as follows. The set of representative 
Transcript Ensembl IDs for each placental gene and its homologs (as obtained in 
Chapter 2) were used as a filter for a series of Ensembl BioMart 'Sequences' queries 
— one per species — with the attributes 'Ensembl Gene ID' and '3′ UTR'. The output 
from each such query was a file containing a FASTA entry for each representative 
transcript. If the representative transcript had an annotated 3′ UTR, the FASTA entry 
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contained its 3′ UTR sequence. Otherwise, it contained one of the non-sequence 
strings 'Sequence unavailable' or 'No UTR is annotated for this transcript'. These 
non-sequence entries were not removed, as they were to be used later on to 
distinguish between cases where a species contained no homologs from those where 
a species contained one or more homologs but none had an annotated 3′ UTR. The 
resulting 3′ UTR sequences and non-sequence entries for each species were then 
concatenated into a single FASTA file.  
 
This complete sequence file was then filtered to create a sequence file that only 
contained annotated 3′ UTR sequences, using the script FilterSequencesFASTA.pl. 
Non-sequences were filtered out, as were all genes for which the annotated 3′ UTR 
was shorter than 37 nucleotides. The minimum 3′ UTR length was set to 37, as this is 
the sum of the average length of a mature miRNA (i.e. 22 bases) and the distance 
downstream of the open reading frame (i.e. 15 bases), in which miRNA-target 
interactions have been found to have reduced effectiveness (Grimson et al. 2007). As 
used in this thesis, a non-sequence is placeholder text that is used by databases such 
as Ensembl to indicate that no sequence is present (e.g. 'Sequence unavailable'). 
 
The result was two FASTA sequence files: one containing a FASTA entry — either 
sequence or non-sequence — for all 2495 representative transcripts, the other 
containing FASTA sequence entries for the 1050 representative transcripts with an 
annotated 3′ UTR sequence of sufficient length to perform miRNA-target prediction. 
Figure 4.2 shows the number of placental genes in each species and the proportion of 
these genes with an annotated 3′ UTR sequence. Note the complete absence of 
annotated 3′ UTR sequences for these genes in elephant and lizard. Because of this, 
elephant and lizard were effectively excluded from the gene family miRNA-target 
prediction analysis in this chapter. 
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Figure 4.2 Legend:  
The figure on page 267 overleaf depicts the heterogeneous levels of 3′ UTR sequence 
annotation for the 2495 gene family members of 114 placental genes across 22 species. Each 
column indicates the total number of placental genes of interest in the given genome; the 
filled section indicates the number of genes for which there is an annotated 3′ UTR 
nucleotide sequence in Ensembl that is at least 37 nucleotides in length (the minimum 3′ 
UTR length required for miRNA-target prediction) (Flicek et al. 2012), while the section 
outlined by a dashed line indicates the number of genes lacking an annotated 3′ UTR in 
Ensembl. Columns marked by an asterisk (*) denote that the species in question had almost 
no usable 3′ UTR sequences for the genes of interest, while columns marked by a double 
asterisk (**) denote that those species completely lacked annotated 3′ UTR sequence for the 
genes of interest.  
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Figure 4.2: Levels of 3′ UTR annotation for 114 placental genes and their homologs in 22 species.  
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4.3 Methods	  
In order to identify whether a given miRNA-target interaction is conserved across 
species, it is first necessary to identify the respective homologs of the cognate 
miRNA and target. The gene family miRNA-target prediction therefore involves two 
steps: (i) identifying miRNA and target gene homologs in each species of interest, 
and (ii) predicting miRNA-target interactions between each miRNA and its target 
gene across all species in which they are present. The placental gene homologs were 
previously obtained from the Ensembl database (Flicek et al. 2012) in Chapter 2, so 
it only remained to identify the homologs of the placental miRNAs.  
4.3.1 Identifying	  MicroRNA	  Homologs	  
This section describes the procedures followed to identify the homologs of 141 
placental miRNAs in 22 species. It is important for a miRNA search to be as 
comprehensive as possible (Shomron et al. 2009). To ensure that miRNA gene 
families were as complete as possible, homology information was (I) extracted from 
miRBase, (II) downloaded from Ensembl, (III) obtained through a miRNA homolog 
search in all 22 species of interest, and (IV) integrated from these three sources into 
one dataset. The process undertaken is outlined below and summarised in Figure 4.3. 
All scripts used during this process can be accessed from the following location in 
the electronic appendix: Appendix / home / code / scripts.html. 
I.	  miRBase	  Gene	  Family	  Data	  Download	  
With the set of miRNAs in human and mouse, homologs were obtained for the 18 
species represented in miRBase using CreateMirbaseGeneFamilyTable.pl with the 
141 miRNA precursor miRBase accessions. (See Table 4.3.) This script queries a 
local copy of miRBase using a set of user-defined filters and creates a gene family 
table for the miRNA precursors and/or miRNA gene families that pass those 
filters, in which each row contains the members of a particular miRNA gene 
family across different species, and each column contains the miRNAs of a 
particular species across different miRNA gene families.  
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Figure 4.3: Placental microRNA homolog identification pipeline.  
Shown is a bioinformatics pipeline depicting the steps involved in placental miRNA homolog identification. Arrows indicate the direction of process flow. For 
information on symbols used, see the pipeline key in Figure 2.2. 
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Table 4.3: miRBase data for the species studied in this thesis. 
Species Scientific Name miRBase Entries 
miRBase 
Genome 
Assembly 
Ensembl 
Genome 
Assembly 
Bat Myotis lucifugus 0 N/A myoLuc2 
Chicken Gallus gallus 499 WASHUC2 WASHUC2 
Chimp Pan troglodytes 600 PanTro2.1 CHIMP2.1.4 
Cow Bos taurus 662 BTAU4.0 UMD3.1 
Dog Canis familiaris 323 CanFam2.0 CanFam2.0 
Elephant Loxodonta africana 0 N/A loxAfr3 
Frog Xenopus tropicalis 188 JGI4.1 JGI_4.2 
Fugu Takifugu rubripes 264 N/A FUGU4.0 
Gorilla Gorilla gorilla 85 N/A gorGor3.1 
Guinea Pig Cavia porcellus 0 N/A cavPor3 
Horse Equus caballus 341 N/A EquCab2 
Human Homo sapiens 1527 GRCh37 GRCh37.p5 
Lizard Anolis carolinensis 282 N/A AnoCar2.0 
Macaque Macaca mulatta 479 MMUL1.0 MMUL_1.0 
Marmoset Callithrix jacchus 0 N/A C_jacchus3.2.1 
Mouse Mus musculus 741 NCBIM37 NCBIM37 
Opossum Monodelphis domestica 156 MONDOM5 monDom5 
Orangutan Pongo abelii 581 N/A PPYG2 
Platypus Ornithorhynchus anatinus 337 N/A OANA5 
Rat Rattus norvegicus 408 RGSC3.4 RGSC3.4 
Zebra Finch Taeniopygia guttata 224 N/A taeGut3.2.4 
Zebrafish Danio rerio 344 Zv9 Zv9 
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II.	  Ensembl	  Gene	  Family	  Data	  Download	  
With the set of miRNAs in human and mouse, homologs were obtained for all 22 
species using a set of Ensembl BioMart 'Homologs' queries to obtain a paralog 
table and ortholog table as in Chapter 2. The Perl script named 
CreateEnsemblGeneFamilyTable.pl was then used to create a gene family table 
from the orthology and paralogy data.  
III.	  miRNAminer(Emulator)	  Homolog	  Search	  
miRNAminer (Artzi et al. 2008) is software that takes, as input, a precursor and 
mature miRNA sequence and searches for homologs in a target genome sequence 
database. After an initial BLAST search (Camacho et al. 2009, Altschul et al. 
1997, Altschul et al. 1990) performed with the query miRNA precursor sequence 
against the target genome, the miRNAminer algorithm filters BLAST hits by E-
value per chromosome (set to 0.05 by default); remaining matches are then 
extended by genomic context of the BLAST hit by examining 50 bases upstream 
and downstream of the start and end, respectively, of the BLAST hit. 
 
All possible extensions of each match within user-specified threshold lengths — 
by default, these are set to a minimum of 70 and maximum of 180 bases — are 
then filtered according to the following criteria: (i) RNA minimum free energy 
(MFE), (ii) minimum precursor intramolecular base-pairing, (iii) requirement for 
hairpin loop, (iv) minimum precursor alignment identity, (v) minimum mature 
sequence alignment identity, (vi) maximum mature sequence mismatches, (vii) 
seed conservation, and (viii) maximum overlap of mature sequence and hairpin 
loop. Putative homologs that satisfy these filters are returned by miRNAminer. 
 
In addition to BLAST, miRNAminer makes use of JAligner (Moustafa 2005) — 
an open-source Java implementation of the Smith-Waterman algorithm (Smith 
and Waterman 1981) — for alignment of the query miRNA to each target, as well 
as RNAfold from the ViennaRNA package (Gruber et al. 2008, Hofacker 2003, 
Hofacker et al. 1994) to estimate RNA folding energy (Artzi et al. 2008). 
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Some aspects of the standard implementation of the miRNAminer algorithm 
rendered it less applicable to this miRNA homolog search. It only accepts input of 
one mature miRNA per query, but many of the placenta-specific miRNAs had two 
annotated mature miRNAs. The standard implementation uses the Smith-
Waterman algorithm for local alignment of the query miRNA with its putative 
homolog sequences, but it was felt that this would not distinguish well between 
candidate homolog sequences with the same local alignment score to a query but 
with different overall lengths. Additionally, miRNAminer filters E-values by 
chromosome. Because of the proportional relationship of E-value to database size 
(see Equation 4.1), the difference in chromosome lengths would result in 
differences of BLAST search sensitivity across a target genome. For example, one 
would expect to see more BLAST hits by chance in chromosome 1 than 
chromosome 19, simply due to its much greater length (i.e. 249Mb in the former 
and 59Mb in the latter, in Ensembl release 65).  
 
€ 
E = lq ⋅ lD ⋅ 2− ʹ′ S  
Equation 4.1: Calculation of BLAST E-value.  
The E-value of a BLAST hit (E) is shown in terms of the length of the query sequence 
(lq), the length of the database sequence (lD), and the normalised score of the BLAST hit 
(S′). See Altschul et al. (1997). 
 
For these reasons, a modified form of the miRNAminer algorithm was 
implemented by this author in Perl for use with the placenta-specific miRNA 
dataset. The resulting Perl script, miRNAminerEmulator.pl, emulates the 
functionality of miRNAminer but incorporates the following changes to the 
algorithm:  
 
 Two mature miRNAs can be included in a query miRNA precursor.  
 
 E-values are estimated for the entire target genome.  
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 Each query is aligned with putative homologs using the Needleman-
Wunsch global alignment algorithm (Needleman and Wunsch 1970), 
as implemented in EMBOSS Needle (Rice et al. 2000).  
 
 A flank length can be specified to set the length of the BLAST hit 
context sequence, such that context sequences are only evaluated if 
they are of a length within one flank length of the query sequence.  
 
The introduction of a flank length parameter ensures that candidate homologs are 
only evaluated if they are of similar length to the query, which markedly reduces 
the number of context sequences that must be evaluated. While greater lengths of 
genomic context sequence are possible in principle, those most similar in length to 
the query are favoured in any case by both alignment and structural filters, so that 
in practice it is not worthwhile to assess context sequences of very different length 
to the query pre-miRNA. 
 
Sample output for both the standard implementation and the emulator described 
here are shown in Figure 4.4. The Perl script miRNAminerEmulator.pl uses 
BLAST+ (Camacho et al. 2009) and ViennaRNA RNAfold (Gruber et al. 2008, 
Hofacker 2003, Hofacker et al. 1994) in the same way as the standard 
miRNAminer. However, instead of using JAligner for alignment of each query 
miRNA to its putative homolog match, miRNAminerEmulator.pl uses EMBOSS 
Needle (Rice et al. 2000) — an implementation of the global alignment 
Needleman-Wunsch algorithm (Needleman and Wunsch 1970). Needleman-
Wunsch was used in miRNAminerEmulator.pl because this alignment algorithm 
favours sequences with high similarity across the entire alignment over those with 
high similarity only in local regions — a desirable property in this case, since 
well-defined homologous regions were sought. 
 
Each miRNA of interest was input to miRNAminerEmulator.pl, which searched 
each genome in turn for homologs of that miRNA, which were then output to a 
table showing information about sequence, position and other attributes for each 
homolog. The settings used were varied depending on the evolutionary distance 
between query and target species. Some example settings are shown in Table 4.4.
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Figure 4.4: miRNAminer/Emulator output.  
Shown are samples of output from (A) miRNAminer (Artzi et al. 2008) in HTML format, 
and (B) miRNAminerEmulator.pl in TSV format. In the miRNAminerEmulator output, the 
Query column gives the precursor miRNA query identifier; the Subject column gives the 
name of the subject sequence in the target genome (e.g. chromosome 9); the Start, End and 
Strand columns give the putative homolog's chromosomal start position, chromosomal end 
position, and chromosomal strand, respectively; the Precursor Sequence and Precursor 
Structure columns give the sequence and predicted secondary structure, respectively, of the 
putative homolog; and subsequent columns give the values of the various miRNAminer 
parameters for the putative homolog. 
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Table 4.4: miRNAminerEmulator settings used. 
Genome flank maxDG minBP maxPG minPI maxOL minMI minL maxMM maxE minSI 
Bat 20 -23.60 0.53 9 0.750 7 0.92 55 1 0.002 6 
Chicken 20 -23.59 0.53 21 0.635 7 0.79 27 5 0.071 5 
Chimp 20 -23.59 0.53 26 0.620 7 0.80 23 5 0.052 5 
Cow 20 -23.59 0.53 9 0.750 7 0.92 55 1 0.002 6 
Dog 20 -23.59 0.53 9 0.750 7 0.92 55 1 0.002 6 
Elephant 20 -23.60 0.53 9 0.750 7 0.92 55 1 0.002 6 
Frog 20 -23.59 0.53 33 0.595 7 0.80 23 5 0.104 5 
Fugu 20 -23.59 0.53 40 0.570 7 0.76 22 7 0.170 6 
Gorilla 20 -23.59 0.53 26 0.620 7 0.80 23 5 0.052 5 
Horse 20 -23.59 0.53 9 0.750 7 0.92 55 1 0.002 6 
Lizard 20 -23.59 0.53 21 0.635 7 0.79 27 5 0.071 5 
Macaque 20 -23.59 0.53 26 0.620 7 0.80 23 5 0.052 5 
Marmoset 20 -23.59 0.53 26 0.620 7 0.80 23 5 0.052 5 
Mouse 20 -23.59 0.53 11 0.770 7 0.88 52 3 0.120 6 
Opossum 20 -23.59 0.53 23 0.600 7 0.79 23 5 0.242 7 
Orangutan 20 -23.59 0.53 26 0.620 7 0.80 23 5 0.052 5 
Platypus 20 -23.59 0.53 35 0.560 7 0.69 22 8 0.071 2 
Rat 20 -23.59 0.53 11 0.770 7 0.88 52 3 0.120 6 
Zebrafish 20 -23.59 0.53 40 0.570 7 0.76 22 7 0.170 6 
 
Table 4.4 Legend:  
Shown are example miRNAminerEmulator settings used in this chapter. Parameters include the flank, to set genome context sequence length, maximum 
thermodynamic ΔG of precursor (maxDG), minimum proportion of intramolecular base pairs (minBP), maximum number of gaps in precursor alignment 
(maxPG), minimum proportion of identical sites in precursor alignment (minPI), maximum overlap between mature region and hairpin loop (maxOL), 
minimum proportion of identical sites in mature sequence alignment (minMI), minimum BLAST hit length (minL), maximum number of mismatches in 
mature sequence alignment (maxMM), maximum BLAST E-value (maxE), and minimum number of identical sites in the miRNA seed alignment (minSI). 
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In parallel with the whole-genome miRNA homolog search, homologous 
microsyntenic regions were searched. In order to improve the sensitivity of the 
miRNA homolog search while maintaining high specificity, genes lying 
immediately upstream and downstream of each miRNA of interest were used to 
establish the boundaries of that miRNA's microsyntenic region. Homologous 
microsyntenic regions were obtained for each miRNA in each species using the 
Perl script GetSyntenicRegions.pl. The narrower search space presented by these 
microsyntenic regions — typically less than 1 million bases, compared to more 
than 3 billion nucleotides in, for example, the human genome — allowed for a 
small marginal gain in sensitivity that improved recovery of homologous miRNAs 
in these regions (e.g. 2% more miRNA homologs in macaque). 
miRNAminerEmulator.pl was run as before (see Table 4.4) but with an additional 
argument specifying the microsyntenic region(s) to be searched.  
 
In the human genome assembly, regions of the reference sequence that coincide 
with a genome fix patch were also searched for putative homologs. Putative 
homologs found on a fix patch were reported from the reference sequence only if 
the corresponding sequence on the fix patch was unchanged. If the fix patch 
appeared to have affected the DNA sequence of a homolog (i.e. if the number of 
putative homologs in the fix patch differed from the reference sequence, or if the 
set of sequences in the fix patch did not match those in the reference sequence), 
the match was taken from the fix patch and the corresponding match in the 
patched region of the reference sequence was ignored. 
IV.	  Integrating	  Homology	  Data	  
Having obtained homology data from miRBase, Ensembl and from a 
miRNAminerEmulator.pl search, this homology information was integrated using 
the Perl script GetIntegratedMirnaGeneFamilyInfo.pl, which took the homology 
information from these three sources and combined them into one integrated 
miRNA gene family table and associated miRNA sequence file.  
 
Where a homolog was present in miRBase, the miRBase accession was given in 
the output gene family table. Where a homolog was absent from miRBase but 
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present in Ensembl, the Ensembl Gene ID was used. Further, if a homolog was 
identified by miRNAminerEmulator.pl and present in Ensembl, but absent from 
miRBase, mature regions of the homolog as inferred by miRNAminerEmulator.pl 
were mapped onto the Ensembl miRNA precursor sequence. In cases where a 
miRNA homolog was absent from both miRBase and Ensembl, a provisional 
miRNA ID was used, based on the miRNA ID of the relevant query miRNA (e.g. 
with query hsa-miR-1-1, a homolog in elephant might be laf-miR-1-P1). This 
allowed the provenance of each homolog to be determined from its identifier in 
the integrated miRNA gene family table.  
4.3.2 Identifying	  MicroRNA	  Targets	  
This section describes the procedures followed to identify the target genes of 141 
placental miRNAs and their homologs in 22 species. MiRNA-target prediction for 
the gene families of each placenta-specific miRNA and placental gene required a 
number of steps: (I) obtaining estimates of target abundance for each species of 
interest, (II) preparing TargetScan input files, (III) performing miRNA-target 
prediction with TargetScan, and (IV) processing TargetScan output files. The 
processes involved are outlined below and summarised in Figure 4.5. All scripts used 
during this process can be accessed from the following location in the electronic 
appendix: Appendix / home / code / scripts.html. 
I.	  Estimating	  Target	  Abundance	  
As described in Section 3.3.1, TargetScan TA/SPS files had previously been 
obtained for human, chicken, cow, mouse, rat and zebrafish. Representative 3′ 
UTRs had also been obtained during the miTP benchmark for a further 9 species. 
For 7 of these species, target abundance (TA) estimates were obtained using the 
Perl script GetTargetAbundance.pl, taking that species' representative 3′ UTRs as 
input. However, fugu and guinea pig had 727 and 232 representative 3′ UTRs, 
respectively. Given such a small pool of representative 3′ UTRs, it was unlikely 
that accurate TA estimates could be obtained for these species. Because of this, 
fugu and guinea pig TA estimates were taken from those of zebrafish and mouse, 
respectively. 
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Figure 4.5: Placental microRNA target prediction pipeline.  
Shown is a bioinformatics pipeline depicting the steps involved in placental miRNA target prediction. Arrows indicate the direction of process flow. For 
information on symbols used, see the pipeline key in Figure 2.2. 
 279 
For the 5 species not in the TargetScan phylogeny, representative 3′ UTRs were 
obtained for the first time. These sets of representative 3′ UTRs were then used to 
generate TA estimates for each of the 5 non-TargetScan species. The 18 sets of 
TA estimates were then used to create 20 species-specific TA/SPS files for all 
species except elephant and lizard (see Figure 4.2).  
II.	  Preparing	  TargetScan	  Input	  
With the integrated miRNA gene family table and associated precursor sequence 
file, the Perl script GetMatureMirnaGeneFamilyInfo.pl was used to obtain a 
mature miRNA gene family table and its corresponding mature miRNA sequence 
file. For every miRNA precursor in the original miRNA gene family table, the 
mature miRNA gene family table contained any mature miRNAs corresponding 
to that miRNA precursor. For precursor miRNAs derived from miRBase, the 
corresponding mature miRNA accession and sequence were obtained directly 
from a local copy of miRBase. For Ensembl Gene IDs and miRNAminer hits, a 
provisional mature miRNA ID was obtained by appending '-5p' or '-3p' to the 
mature miRNA, depending on its position within the precursor sequence. For 
Ensembl miRNAs that lack a demarcated mature region, no corresponding mature 
miRNA could be output. 
 
Five of the species under study — bat, gorilla, orangutan, marmoset and zebra 
finch — are absent from the phylogeny included with TargetScan, so it was not 
possible to run the TargetScan conservation script on any miRNA-target pairs in 
these species. For these species, only the target gene 3′ UTR sequence was 
required, as an alignment of orthologs is not required by the TargetScan context 
script. These were obtained by filtering the set of genes in each such species to 
retain only those with a corresponding annotated 3′ UTR sequence. 
 
For all other species, ortholog alignments were obtained for all target genes with 
one or more annotated orthologous 3′ UTR sequences. This was done using the 
ortholog table created in Chapter 2. This ortholog table showed human genes and 
their orthologs in all other species, but for each other species, an ortholog table 
would be required from the perspective of that species. The human oriented 
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ortholog table was reoriented to the perspective of each respective species using 
the Perl script ReorientEnsemblOrthologTable.pl.  
 
Using each species-specific ortholog table along with the sequence file containing 
annotated 3′ UTRs, a representative ortholog table was obtained using the Perl 
script GetRepresentativeOrthologs.pl. This script removed those orthologs 
without an annotated sequence, and chose a representative ortholog where 
multiple orthologs were present, by taking the ortholog that aligned best to the 
gene of interest. For alignment, this script uses EMBOSS Needle (Rice et al. 
2000), an implementation of the global alignment Needleman-Wunsch algorithm 
(Needleman and Wunsch 1970). Selection of a representative ortholog was 
necessary because TargetScan only accepts one target gene ortholog per species.  
 
An ortholog sequence file was obtained for each gene of interest, containing the 
sequences of the gene itself and each of its representative orthologs. There were 
16 genes without an ortholog sequence (e.g. pregnancy-specific beta-1-
glycoprotein 9, or PSG9). For those genes with one or more orthologs (e.g. lectin, 
galactoside-binding, soluble, 14, or LGALS14), a guide tree was created for each 
gene of interest using CreateGuideTree.pl with the species tree discussed in 
Chapter 2, based on that of Benton and Donoghue (2007). The ortholog sequences 
and guide tree were input to PRANK v.100802, which output an MSA of 
orthologs for each gene of interest. In the TargetScan phylogeny species, 838 
genes were readied for miTP with TargetScan: 822 ortholog alignments, 16 gene 
sequences. No annotated 3′ UTRs were available for lizard or elephant.  
 
The Perl script PrepGeneFamilyMITP.pl was used to prepare TargetScan input 
files across the 20 species with both miRNA and target gene homolog sequences, 
including miRNA seed and sequence files and target gene alignment files in the 
TSV format expected by TargetScan, arranged in an ordered directory structure 
by species. Lizard and elephant were excluded due to lack of target gene data, 
while the five non-TargetScan species were excluded from TargetScan miRNA-
target prediction using the conservation script, and the gene family of tachykinin 3 
(TAC3) was excluded because this gene does not itself have an available 3′ UTR 
sequence.  
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III.	  MicroRNA-­Target	  Prediction	  with	  TargetScan	  
TargetScan was run without error on the ICHEC Stokes HPC cluster using one 
ICHEC taskfarm for each of the four TargetScan scripts: the standard TargetScan 
script, the branch length bins script, the TargetScan context script and the 
TargetScan conservation script. The standard TargetScan script was run in parallel 
with the branch length bins script, followed by a parallel run of the TargetScan 
context and conservation scripts. See Figure 4.6 for a visual summary of this 
process. The complete set of taskfarm runs used approximately 250 core hours to 
test ~220,000 miRNA-target interactions with the four TargetScan scripts — 
taking less than 4 seconds to test each miTI, on average.  
IV.	  Processing	  TargetScan	  Output	  
The Perl script ProcGeneFamilyMITP.pl was used to process the gene family 
miTP output. For both the human and mouse miRNA gene families, mature and 
precursor miRNA gene family tables and associated miRNA info files were 
included in post-processing. Both the annotated and original target gene tables 
were also included. This made it easier to distinguish cases where there was no 
miRNA or gene homolog from those in which there are miRNA and gene 
homologs but not necessarily available sequences. Although they were not 
included in the TargetScan analysis, the species elephant and lizard were included 
in post-processing for completeness. 
 
The final processed output comprised 277 TSV files showing gene family miTP 
results: one for each of 141 key miRNAs, 114 key genes and 22 species, as well 
as 2 TSV files showing gene family miTP results specifically for key miRNAs 
and genes in human and mouse, respectively.  
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Figure 4.6: TargetScan script pipeline.  
Shown is a bioinformatics pipeline depicting the steps involved in running the TargetScan Perl scripts. Arrows indicate the direction of process flow. The 
dashed grey rounded rectangle encompasses the NCBI Taxonomy ID of the reference species and the TargetScan phylogeny, both of which are used as input 
by the TargetScan branch length bins and conservation scripts. For information on other symbols used, see the pipeline key in Figure 2.2.  
 283 
4.4 Results	  
Sections 4.4.1 and 4.4.2 outline the results of the miRNA homolog search and gene 
family miRNA-target prediction, respectively.  
4.4.1 MicroRNA	  Homologs	  
MiRNA homologs were identified in the 22 species of interest. Figure 4.7 and Figure 
4.8 show gene family presence/absence diagrams for placental miRNAs in human 
and mouse, respectively. In both figures, each row corresponds to a placental 
miRNA, each column corresponds to a species, and the colour of each cell indicates 
whether homologs of the given miRNA are present in the given species: light grey 
indicates that a homolog is present, while dark grey indicates that a homolog is 
absent. These figures integrate homology data from three sources: the miRBase 
miRNA database (Griffiths-Jones 2004, Griffiths-Jones 2006, Griffiths-Jones et al. 
2008, Kozomara and Griffiths-Jones 2011), the Ensembl genomic database (Flicek et 
al. 2012) and the results of a homolog search against the Ensembl genomic 
sequences by the script miRNAminerEmulator.pl, which emulates the functionality 
of miRNAminer (Artzi et al. 2008). Note that the integrated miRNA gene family 
dataset is accessible in the electronic appendix at the following file path: Appendix / 
home / projects / placenta / pipelines / microrna-homologs / integrated-microrna-
gene-family-info.html. 
 
In these presence/absence diagrams, the clade in which each miRNA can be seen, 
and the lineage of origin of each miRNA may therefore be inferred from the clades 
in which it is present. It can be seen, for example, that the members of the C19MC 
miRNA cluster (i.e. hsa-mir-512-1 to hsa-mir-527) are broadly primate-specific.   
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Figure 4.7: Presence/absence of placental microRNAs in 22 species. 
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Figure 4.7: Presence/absence of placental microRNAs in 22 species. (continued) 
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Figure 4.7: Presence/absence of placental microRNAs in 22 species. (continued) 
Shown on pages 284 to 286 inclusive are patterns of presence and absence in 22 vertebrate 
species of homologs for 127 human placental miRNAs. Each row shows the homologs of a 
specific miRNA, while each column shows miRNA homologs in a particular species. 
Presence is denoted by a light grey cell, while absence is denoted by a dark grey cell. 
Homolog information was obtained from three sources: miRBase (Griffiths-Jones 2004, 
Griffiths-Jones 2006, Griffiths-Jones et al. 2008, Kozomara and Griffiths-Jones 2011), 
Ensembl (Flicek et al. 2012), and an implementation of the miRNAminer algorithm (Artzi et 
al. 2008). 
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Figure 4.8: Presence/absence of mouse microRNAs in 22 species.  
The figure above shows patterns of presence and absence in 22 vertebrate species of 
homologs for 14 human placental miRNAs. Each row shows the homologs of a specific 
miRNA, while each column shows miRNA homologs in a particular species. Presence is 
denoted by a light grey cell, while absence is denoted by a dark grey cell. Homolog 
information was obtained from three sources: miRBase (Griffiths-Jones 2004, Griffiths-
Jones 2006, Griffiths-Jones et al. 2008, Kozomara and Griffiths-Jones 2011), Ensembl 
(Flicek et al. 2012), and an implementation of the miRNAminer algorithm (Artzi et al. 
2008). 
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4.4.2 MicroRNA	  Targets	  
Gene family miRNA-target predictions were performed for 127 and 14 placental 
miRNAs in human and mouse, respectively, against 114 human placental genes. Of a 
possible 14,478 miRNA-target pairs in human, 2,856 were predicted by TargetScan 
to have a functional interaction. Given 1,596 possible miRNA-target pairs in mouse, 
214 were predicted to have a functional interaction by TargetScan. Full gene family 
miRNA-target prediction results are accessible in the electronic appendix at the 
following file path: Appendix / home / projects / placenta / pipelines / microrna-
targets / microrna-target-predictions.html. 
 
The clades in which miRNA-target interactions are predicted to act are shown for 
human in Figure 4.9 and Figure 4.10, and mouse in Figure 4.11 and Figure 4.12. For 
example, the 'Primates' column of Figure 4.9 shows 834 predicted miRNA-target 
interactions that are conserved across primates; the vast majority of these (i.e. 663) 
are from miRNA-target pairs that began to co-exist within the genome of the 
ancestral primate, while only 171 primate-specific miRNA-target interactions are 
predicted between miRNAs and target genes that co-existed in the genome prior to 
the emergence of primates. MiRNAs and targets that have co-existed since the 
ancestral primate were also predicted to interact in the ape clade (153) and even 
specifically in human (73). This large proportion of primate-specific miRNA-target 
interactions is not necessarily unexpected, since the miRNAs in the C19MC cluster 
are primate-specific and it would be expected that the miRNAs in this cluster would 
have acquired targets among those genes responsible for placental development in 
the primate clade.  
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Figure 4.9: Origin of human placental microRNAs and their target sites.  
Each stacked column above represents the number of miRNA-target predictions for the given clade, and each differently coloured column within the 
stacked column represents a clade of origin (i.e. the clade in which both the miRNA and target gene were present). The clade colour code used here 
is identical to that used in Figure 1.6. 
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Figure 4.10: Phylogeny depicting origin of human microRNAs and their target sites.  
Shown is a phylogeny of all 22 species, overlaid with pie charts, such that the area of each pie chart represents the number of miRNA-target 
predictions for the given clade, and each differently coloured segment within the pie chart represents a clade of origin. The clade colour code used 
here is identical to that used in Figure 1.6. 
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Figure 4.11: Origin of mouse placental microRNAs and their target sites.  
Each stacked column above represents the number of miRNA-target predictions for the given clade, and each differently coloured column within the 
stacked column represents a clade of origin (i.e. the clade in which both the miRNA and target gene were present). The clade colour code used here 
is identical to that used in Figure 1.6. 
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Figure 4.12: Phylogeny depicting origin of mouse microRNAs and their target sites.  
Shown is a phylogeny of all 22 species, overlaid with pie charts, such that the area of each pie chart represents the number of miRNA-target 
predictions for the given clade, and each differently coloured segment within the pie chart represents a clade of origin (i.e. the clade in which both 
the miRNA and target gene were present). The clade colour code used here is identical to that used in Figure 1.6. 
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Figure 4.13 shows a heatmap diagram of the miRNA-target predictions made for the 
C19MC cluster against the set of 114 placental genes (the 24 genes for which no 
miRNA-target prediction was made are not included in Figure 4.13). Each column 
shows miRNA-target predictions for a specific placental gene, while each row shows 
predicted miRNA-target interactions for a specific miRNA. Each cell is divided into 
two triangles: the red triangle in the upper-left of each cell gives the miRNA-target 
prediction result for the TargetScan context script, while the blue triangle to the 
lower-right of each cell gives the miRNA-target prediction result for the TargetScan 
conservation script. Brighter values indicate a stronger miRNA-target prediction — 
stronger miRNA-target repression in the case of the TargetScan context script, 
stronger miRNA-target conservation in the case of the TargetScan conservation 
script.  
 
Figure 4.13 shows that no preferentially conserved miRNA-target interactions were 
predicted by the TargetScan conservation script for any of the miRNAs in the 
C19MC cluster. This is not unexpected, since the cluster itself is not conserved 
across an appreciable branch length on the TargetScan vertebrate phylogeny and the 
TargetScan conservation script tends to make a relatively small number of high-
confidence miRNA-target predictions. A trend that is noticeable among the miRNA-
target predictions made by the TargetScan context script is the numerous patterns of 
multiple miRNAs being predicted to interact with the same gene, or of multiple 
genes predicted to interact with the same miRNA. These can be seen as small 
columns or rows (respectively) of miRNA-target predictions within the heatmap 
diagram. These might be indicative of coordinated regulation of a gene by multiple 
miRNAs — as observed by, for example, Wu et al. (2010) — or of the regulation by 
a single miRNA of the expression of multiple genes in a coordinated manner. 
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Figure 4.13: MicroRNA-target predictions for C19MC microRNAs in human.  
The above figure shows predicted miRNA-target interactions for the chromosome 19 microRNA cluster (C19MC) among the set of placental genes. Each 
column shows results for a particular gene, while each row shows predictions for a given miRNA. Each red triangle represents a miRNA-target prediction 
made by the TargetScan Context+ script (Garcia et al. 2011, Grimson et al. 2007). 
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4.5 Discussion	  
The patterns of homology identified for each of the miRNAs in this chapter are in 
broad agreement with the hypothesis that once a miRNA emerges, substitutions 
within functionally important regions are rare and secondary loss of the miRNA is 
rarer still (Sperling and Peterson 2009). Similarly, patterns of miRNA-target 
prediction, involving homologous miRNAs and target genes, are also observed 
across clades, so that for many monophyletic groups of miRNAs, interactions 
between the miRNA and its target genes evolved relatively rapidly after the 
evolution of the miRNA itself. Furthermore, miRNA targeting patterns form a 
complex regulatory network, with coordinated regulation of genes by multiple 
miRNAs and of parallel control by one miRNA of many genes.  
 
The patterns of miRNA homology can be seen in Figure 4.7. For example, hsa-mir-
517a is conserved in primate species but found in no other genome, while the let-7 
miRNA family is conserved throughout all vertebrate species studied. Some 
exceptions to this trend are noticeable in Figure 4.7. For example, many miRNAs 
otherwise conserved throughout Eutheria appear to be absent from bat (e.g. hsa-mir-
23a, hsa-mir-26b). This may indicate lineage-specific loss of these miRNAs; 
alternatively it may reflect the level of sequence coverage or quality in the genome in 
question, or possibly a false-negative prediction by the homolog search method used. 
The apparent homology of a frog sequence to hsa-mir-520e may similarly indicate a 
distant homology, or it may possibly be more reflective of a false-positive prediction 
by the homolog search method. Although both implementations take account of 
BLAST E-values, it should be noted that those E-values apply to the sequence 
alignment only and not to the miRNA homology prediction as a whole. For example, 
neither miRNAminer or the emulator described in this chapter estimate E-values for 
miRNA homology that take account of the expected frequency of hairpin structure or 
other miRNA features in addition to that of a high-scoring sequence alignment (Artzi 
et al. 2008). Such a comprehensive statistic would be highly desirable, and would 
facilitate more accurate estimation of the extent of false-positive and false-negative 
homology predictions.  
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The patterns of emergence of miRNA-target interactions can be seen in Figure 4.9, 
Figure 4.10, Figure 4.11, and Figure 4.12, while the patterns of predicted human 
miRNA-target interactions involving C19MC miRNAs are shown in Figure 4.13. 
False-positive prediction rates among miRNA-target prediction methods remain 
quite high, with estimates ranging from 28% (Lewis et al. 2005) to 67% (Baek et al. 
2008). Even with the most accurate method, a set of miRNA-target predictions might 
be better seen as being enriched for miRNA-target interactions rather than 
constituting a set of miTIs per se. Nevertheless, even if only a fraction of the 
predicted miRNA-target interactions presented in Figure 4.13 are functional in vivo, 
it is difficult to imagine that the picture presented — of coordinated regulation of 
genes by multiple miRNAs and of parallel control by one miRNA of many genes — 
would not remain. The validation of an interaction between, say, a placenta-critical 
gene such as leptin (LEP) or a placenta-specific gene such as isthmin 2 (ISM2) with 
multiple miRNAs in the C19MC cluster would constitute compelling evidence that 
the expression of these genes is finely controlled by the miRNAs of the C19MC.  
 
Some of these common miRNA-target predictions reflect a shared miRNA seed 
sequence across multiple miRNAs, although this is not always the case. For example, 
the mir-517 miRNAs predicted to target LEP share a seed with each other, as do the 
mir-518 miRNAs — except for hsa-mir-518e, which appears to have undergone a 
seed shift in the 3′ direction — but the seed sequences of these two sets of miRNAs 
differ from each other. Furthermore, miRNAs hsa-mir-518d, hsa-mir-518e and hsa-
mir-518f are all predicted by TargetScan to target LEP with both arms of the miRNA 
hairpin (i.e. both mature miRNAs). That the expression of this gene would be tightly 
regulated is not unexpected, given its key role in pregnancy in Eutheria and 
especially among primates; leptin is known to play a key role in implantation, 
trophoblast development and placental function throughout pregnancy in a time-
dependent manner (Henson and Castracane 2006, Maymó et al. 2011). Its expression 
at optimal levels and at the right time would therefore be critical for healthy placental 
development. If validated, the regulation of LEP by the mir-517 miRNAs, and the 
nature of its response to each of the individual miRNAs, would augment current 
knowledge of how this key protein is regulated in placenta. 
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With those miRNAs that share a seed sequence, it has been proposed that it would be 
possible to distinguish which member of a miRNA family is most likely to represent 
a functional regulator of a given target by taking account of the level of Watson-
Crick complementarity of the 3′ region of the miRNA to the target gene sequence 
(Brennecke et al. 2005).  
 
In Figure 4.9 and Figure 4.10, the overall high proportion of primate-specific 
miRNAs with miRNA-target interactions conserved throughout primates is likely 
affected by the presence of the 46 miRNAs from the primate-specific C19MC 
cluster. Nevertheless, this indicates that many of these primate-specific miRNAs 
acquired miRNA-target interactions in a relatively short space of time after their 
emergence, which supports the argument by Chen and Rajewsky (2007) and 
Shomron et al. (2009) that miRNA-target sites can emerge quite rapidly in 
evolutionary terms. Their tissue-specific origin is also congruent with the hypothesis 
of miRNA and miRNA-target emergence posited by Chen and Rajewsky (2007) — 
see Section 1.9.6 — although broader expression patterns have not yet been 
observed. Whether the C19MC cluster will be found to act in tissues other than the 
placenta remains to be seen, but in any case, there is little doubt that this cluster of 
small miRNAs has made a big impact on the placenta (Flor and Bullerdiek 2012). 
  
In summary, this chapter has shown that many — though not all — placental 
miRNAs are conserved throughout Eutheria but confined to that clade, and that for 
many of these miRNAs — though not all — interactions with target genes evolved 
relatively rapidly after the emergence of the miRNA itself. This pattern is 
recapitulated by the miRNAs in the C19MC — conserved throughout primates but 
also confined to that lineage — for which many miRNA-target interactions arose 
almost as soon as the miRNAs themselves. 
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In a critique of the widespread use of selective pressure analysis, with codon based 
methods using maximum likelihood, to identify instances of positive selection and 
associated functional shift, Hughes and Friedman (2010) argue that an excess of non-
synonymous substitutions over synonymous substitutions does not necessarily imply 
positive selection, that in any case such an excess will be masked by more recent 
synonymous substitutions over time, and that positive selection by sequence 
substitution is just one of many possible mechanisms of functional shift. The authors 
list several alternative mechanisms by which novelty can arise in the evolution of a 
protein-coding gene: substitution at a single amino acid site, sequence insertion or 
deletion, gene fusion, loss of splice signals with consequent loss of exons, and 
regulatory changes that alter the expression of the gene (Hughes and Friedman 
2010). Hughes and Friedman (2010) go on to argue that such alternative 
mechanisms, although less readily analysed by bioinformatic methods, "almost 
certainly account for the overwhelming majority of cases of positive selection on 
duplicate genes" (Hughes and Friedman 2010, p.88).  
 
This issue is akin to the well-known metaphor of the drunk under the streetlight, 
searching for his lost keys only in the small area lit by the streetlight, because that is 
the easiest place to search. While it is arguably the case that statistical methods for 
identifying positive selection by comparison of models of codon substitution have a 
longer history and are better developed than methods to identify positive selection 
mediated by other mechanisms such as gene fusion, exon shuffling and regulatory 
innovation, there has been progress in development of such methods. Bioinformatics 
approaches and resources are available for identifying gene fusion events (Kim et al. 
2010) and cases of exon shuffling (Cancherini et al. 2010). While indels have not 
been used to analyse the selective pressure acting on a gene, the explicit treatment of 
alignment gaps as evolutionary events has been used to improve multiple sequence 
alignment (Löytynoja and Goldman 2008), and there is certainly potential for 
alignment gaps to inform phylogenetic analyses (Dessimoz and Gil 2010). In terms 
of regulatory innovation, challenges remain in computational prediction of 
transcription factor binding sites (Wasserman and Sandelin 2004, Tompa et al. 
2005), but considerable progress has been made during the last decade in the 
development of miRNA-target prediction methods (Reyes-Herrera and Ficarra 
2012). Thus, the set of methods for identifying and characterising evolutionary 
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novelty progress at different rates in different areas, so the methods available will 
inevitably be incomplete until sufficient progress is made in all areas. However, this 
should not be used as an argument against using those methods that are currently 
amenable to bioinformatics analysis. In the metaphor of the drunk under the 
streetlight, as progress in bioinformatics sheds new light on an ever expanding space, 
we can explore the newly elucidated areas while acknowledging that our search is far 
from exhaustive.  
 
In this thesis, we have sought to make use of complementary approaches to estimate 
the extent of functional shift in placental genes in the Eutherian lineage: in Chapter 
2, a selective pressure analysis based on codon substitution models, and in Chapter 4, 
an analysis of miRNA-target interactions within the gene families of each placental 
gene. This aims to address two of the mechanisms of evolutionary novelty listed by 
Hughes and Friedman (2010). The former looked at the changes made directly to 
placental gene sequences, while the latter examined putative changes to the 
regulation of placental gene expression.  
 
Care was taken in both major strands of the project to ensure that the methodology 
used would minimise errors and false-positive predictions. In Chapter 2, the 
placental gene homologs used were those identified by the Ensembl Compara 
pipeline (Vilella et al. 2009), currently the only genome-scale homology resource 
that uses tree reconciliation (Altenhoff and Dessimoz 2009); the sequences of each 
gene family were aligned using an alignment method that has performed well as a 
preparatory step for selective pressure analysis (Fletcher and Yang 2010, Markova-
Raina and Petrov 2011); and selective pressure analysis itself was performed using 
software that is both accurate and powerful (Anisimova et al. 2001, Yang et al. 2009, 
Zhai et al. 2012) and whose predictions of positive selection have been validated in 
vitro (Levasseur et al. 2006, Huang et al. 2012, Loughran et al. 2012). Although 
false-positive rates were not explicitly estimated during selective pressure analysis, 
in a comparable analysis by Fletcher and Yang (2010) false-positive estimates 
ranged from 2% to 29%.  
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In Chapter 4, placental miRNA homologs were obtained from three sources — 
Ensembl, miRBase and a homolog search using miRNAminerEmulator.pl (an 
implementation of the miRNAminer algorithm); and the miRNA-target prediction 
method used was chosen in a performance benchmark of currently available miRNA-
target prediction methods, which found TargetScan to be the best-performing of the 
methods compared — this was the subject of Chapter 3.  
 
Despite the steps taken to minimise errors, positive selection was inferred due to an 
alignment error in at least one instance (see Section 2.4.2), and there are likely to be 
some errors in miRNA homology prediction (see Section 4.4.1) and miRNA-target 
prediction, for which false-positive rates are known to be high (Bartel 2009, Peter 
2010) — for example, the ratio of predicted targets to estimated false-positives was 
7:2 in a study by Lewis et al. (2005), and even the most accurate methods were 
found to have false discovery rates of approximately 67% by Baek et al. (2008). 
Nevertheless, such errors are unlikely to be so prevalent as to substantially affect the 
broad conclusions derived from these analyses.  
 
The results of Chapter 2 are in broad agreement with those of Hou et al. (2009), with 
higher estimates of positive selection at the Eutherian stem in this thesis — 44.1% as 
opposed to the 27.9% observed by Hou et al. (2009) — perhaps reflecting the 
presence of multi-gene families (gene families with one-to-many homologs). When 
the results in Chapter 2 for the subset of gene families with one-to-one orthologs are 
compared with the results of Hou et al. (2009), the trend is less marked: estimated 
rates of positive selection in Chapter 2 drop to 36.1%, higher than those of Hou et al. 
(2009), but not significantly so (α = 0.05). Whether the different results in this thesis 
are due to the choice of alignment method is debatable, but since the alignment 
method used was one of the key methodological differences between this study and 
that of Hou et al. (2009), it is likely that the alignment method used had — and can 
have — a considerable impact on the detection of positive selection.  
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In Chapter 4, a combination of miRNA homology search and miRNA-target 
prediction identified placental miRNA homologs and their targets. The results of 
these analyses showed that many miRNAs evolved targets relatively soon after their 
own emergence. This was especially apparent in the case of the C19MC miRNAs, a 
cluster of miRNAs identified by (Bentwich et al. 2005) that are primate-specific 
(Bentwich et al. 2005) (Zhang et al. 2008). As the results of Chapter 4 indicate, these 
miRNAs also have many miRNA-target interactions that are predicted to occur 
throughout primates; subject to in vitro validation, this would confirm that these 
miRNAs acquired targets relatively swiftly following the emergence and expansion 
of the C19MC cluster.  
 
The miRNA-target predictions for miRNAs specific to placental mammals broadly 
recapitulated the pattern of the C19MC cluster, with an initial burst of new miRNA-
target interactions shortly after their emergence, followed by a more or less 
continuous acquisition of targets throughout subsequent evolution (see Figure 4.9 
and Figure 4.10). 
 
The omission from the miRNA-target prediction benchmark in Chapter 3 of PicTar, 
EIMMo and DIANA-microT is unfortunate, especially considering the good 
performance of these three methods in previous benchmark studies (Sethupathy et al. 
2006, Baek et al. 2008, Selbach et al. 2008, Alexiou et al. 2009). Nevertheless, many 
— though not all — of the features exploited by these methods are also used by at 
least one of the methods compared in Chapter 3.  
 
Active development continues of both new and existing miRNA-target prediction 
methods, and as new mechanisms and features of miRNA-target interactions are 
uncovered experimentally, it is reasonable to expect that these will be employed in 
future iterations of miRNA-target prediction software. Recently identified miRNA-
target site types such as bulge sites (Chi et al. 2012) and centred pairing sites (Shin et 
al. 2010) may be incorporated in future miRNA-target prediction methods.  
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For identification of miRNA-target sites within coding regions, contextual features 
that could potentially be discriminative of functional target sites might include repeat 
sequences, since at least one miRNA has been observed to target repeat-rich coding 
regions enriched for miRNA target sites (Schnall-Levin et al. 2011), or the presence 
of rare codons for the given organism that induce ribosome stalling and allow the 
miRNA to bind to its target site, as achieved in an experiment by Gu et al. (2009). 
(Whether these features are characteristic of miRNA-target interactions in coding 
regions in vivo remains to be seen, but they do present an avenue for investigation.)  
 
As experimental evidence sheds further light on these mechanisms, this expands the 
space that can be explored by bioinformatics, which may in turn point to promising 
avenues for further experimentation. To follow the metaphor that introduced this 
discussion, while we may be restricted to looking within the extent of the streetlight, 
we can at least work to expand the reach of its illumination. 
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6.1 Conclusion	  
In conclusion, in the first selective pressure analysis of placental genes that includes 
multi-gene families, estimated levels of positive selection in placental genes were 
found to be higher than previous estimates, with nearly half of such genes 
undergoing positive selection in the ancestral Eutherian lineage. By comparison with 
available functional annotation, it has been possible to establish in this thesis that at 
least some of these are attributable to functional shift in these genes at the time of the 
Eutherian ancestor.  
 
Similarly, 14 placental miRNAs arose in the Eutherian clade and remain conserved 
throughout Eutheria (or nearly so), as did their miRNA-target interactions (although 
the individual sites may differ); this pattern has also been followed by the C19MC 
cluster of placental miRNAs. Whether the miRNA-target interactions predicted in 
this thesis are confirmed to be bona fide awaits experimental validation, but in any 
case great care was taken to choose the miRNA-target prediction method with the 
highest specificity for a reasonable level of sensitivity.  
 
Of the 9 miRNA-target prediction methods benchmarked here, this was found to be 
TargetScan, although it should be noted that its performance in ROC analysis was 
not significantly better, at the 5% significance level, than miRanda, miRmap or 
Hitsensor. It is debatable whether TargetScan would perform better than these three 
other methods with a different set of validated miRNA-target interactions. In any 
case, there can be little doubt that as the set of validated miRNA-target interactions 
increases in size, our ability to distinguish the performance of existing miRNA-target 
prediction methods will grow too.  
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6.2 Future	  Work	  
In any future comparison of miRNA-target prediction methods, the notable omission 
of miRNA-target prediction methods such as PicTar (Chen et al. 2006, Lall et al. 
2006, Grün et al. 2005, Krek et al. 2005), EIMMo (Gaidatzis et al. 2007), and 
DIANA-microT (Reczko et al. 2012, Reczko et al. 2011, Maragkakis et al. 2009a, 
Maragkakis et al. 2009b), should be remedied. One possible way of including these 
methods would be to perform automated queries to the web interface of each method. 
However, this will not provide a remedy in all cases, since many such web query 
systems simply provide access to precalculated miRNA-target predictions, rather 
than allowing novel predictions with user-specified miRNA and target sequences.  
 
A second avenue for improvement of the miRNA-target prediction benchmark would 
be to filter validated miRNA-target interactions to identify only those for which a 
miRNA-target prediction method was not used in the process of selecting validation 
candidates. This subset of validated miTIs would facilitate the exclusion of that 
potential source of bias, as was done by Sethupathy et al. in 2006, with the smaller 
set of validations available at that time. 
 
In relation to the placenta-specific miRNA-target interactions, in vitro validation of 
predicted miRNA-target interactions would be of benefit in confirming the accuracy 
of those miRNA-target predictions. Further benefit may be obtained through analysis 
of the predicted miRNA-target interactions from the perspective of the miRNA-
target interaction network, to tease apart the patterns of parallel regulation by one 
miRNA of many genes and coordinated control of genes by multiple miRNAs.  
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of positive selection at functionally significant
positions
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Heather J Ruskin2,3 and Mary J O’Connell1,2*Abstract
Background: Cancer, much like most human disease, is routinely studied by utilizing model organisms. Of these
model organisms, mice are often dominant. However, our assumptions of functional equivalence fail to consider
the opportunity for divergence conferred by ~180 Million Years (MY) of independent evolution between these
species. For a given set of human disease related genes, it is therefore important to determine if functional
equivalency has been retained between species. In this study we test the hypothesis that cancer associated genes
have different patterns of substitution akin to adaptive evolution in different mammal lineages.
Results: Our analysis of the current literature and colon cancer databases identified 22 genes exhibiting colon
cancer associated germline mutations. We identified orthologs for these 22 genes across a set of high coverage
(>6X) vertebrate genomes. Analysis of these orthologous datasets revealed significant levels of positive selection.
Evidence of lineage-specific positive selection was identified in 14 genes in both ancestral and extant lineages.
Lineage-specific positive selection was detected in the ancestral Euarchontoglires and Hominidae lineages for
STK11, in the ancestral primate lineage for CDH1, in the ancestral Murinae lineage for both SDHC and MSH6 genes
and the ancestral Muridae lineage for TSC1.
Conclusion: Identifying positive selection in the Primate, Hominidae, Muridae and Murinae lineages suggests an
ancestral functional shift in these genes between the rodent and primate lineages. Analyses such as this, combining
evolutionary theory and predictions - along with medically relevant data, can thus provide us with important clues
for modeling human diseases.
Keywords: Positive selection, Colon cancer, Adaptive evolution, Protein functional shift, Selective pressure,
Evolutionary medicineBackground
Mouse models are currently used to research many
human cancers including colon cancer. On a genome
wide scale, mouse protein sequences share 78.5% se-
quence identity with human counterparts [1]. With such
high levels of sequence identity it may seem reasonable
to expect that many orthologs between mouse and* Correspondence: mary.oconnell@dcu.ie
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reproduction in any medium, provided the orhuman would have conserved functions. However, in the
~180 Million Years (MY) of independent evolution [2],
it is possible that certain proteins have functionally
diverged. One example of ortholog divergence between
human and mouse is the TDP1 gene, required in Topo1-
DNA complex repair, protein sequence similarity of 81%.
A point mutation from an adenine to a guanine at pos-
ition 1478 in human TDP1 is linked with a disorder
known as SCAN1 that results in cerebellar atrophy and
peripheral neuropathy. However, this mutation in mouse
does not result in the same condition/phenotype [3].
Specific mutations in any of the following genes in
human result in disease: BCL10, PKLR and SGCA, but
the same mutations in the mouse homologs do notl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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BRCA1 is heavily implicated in breast cancer in humans,
with BRCA1+/− women having a 50% risk of developing
breast cancer, while BRCA+/− mice do not exhibit
increased susceptibility to cancer [5]. These observed
differences in phenotype could potentially be the result
of protein functional shifts in cancer-associated genes
between human and mouse. While the analysis of the
mouse lineage versus human is important from an evo-
lutionary medicine perspective to determine/predict
those specific cases where mouse may not effectively
model the human disease phenotype, the analysis of all
other lineages frames these results in the context of all
mammals. Therefore, in this study we have not only
examined the human and mouse lineages but all lineages
leading to extant species in our dataset. This allows us
to gain a greater understanding of the level of lineage-
specific functional shift that has occurred in colon can-
cer associated genes.
Positive selection is the retention and spread of advan-
tageous mutations throughout a population and has long
been considered synonymous with protein functional
shift. There are a number of driving forces for positive
selection including external mechanisms such as adapta-
tion to different ecological niches and response to dis-
ease and internal mechanisms such as co-evolution and
compensatory mutations [6], all of which are relevant to
the data and species we are analyzing. At the molecular
level, the ratio of nonsynonymous substitutions per non-
synonymous site (dN) to synonymous substitutions per
synonymous site (dS) is known as ω, and indicates the
selective pressure at work in that sequence. If ω> 1 it
signifies positive selective pressure, ω= 1 signifies neutral
evolution, while ω< 1 indicates purifying selective pres-
sure. Previous work assessed the level of positive selec-
tion present in mammal genomes and estimated 5%-9%
of genes in mammals are under positive selection under
a Bayesian framework, and thus provides us with a
reference or expected level of positive selection for our
analysis [7,8].
Here we have applied a Maximum Likelihood method
based on codon models of evolution to assess the select-
ive pressures across our dataset [9]. These methods are
far more robust than alternatives such as the sliding
window approach [10], nonetheless they do suffer from
limitations and have strict criteria in terms of dataset
size for statistical robustness [11,12]. Another feature of
sequence evolution that can negatively impact on a se-
lective pressure analysis is recombination [13]. To evalu-
ate the robustness of the Likelihood Ratio Tests (LRTs),
simulations have been performed that show that type 1
error rates can be up to 90% with relatively high rates of
recombination in protein coding sequences resulting
in the misinterpretation of recombination as positiveselection [13]. We have incorporated a test for recom-
bination for all genes in the dataset prior to the ML se-
lective pressure analysis. Recent studies using these
codon models of evoluton in an ML framework have
combined evolutionary predictions of positive selection
with biochemical verification of functional affects of
these substitutions [14-16], and thus support the link be-
tween positive selection and protein functional shift.
We have taken colon cancer as an example for our
study given the large amount of mutation and epigenetic
data available for this form of cancer [17]. Lineage-
specific positive selection in genes associated with colon
cancer is strongly suggestive of functional shift and
could have serious implications in the use of certain
lineages for modeling colon cancer.
Colorectal cancer (CRC) is the third most commonly
diagnosed cancer in males and second in females and we
have focused on this in our study [18]. CRC arises
through the accumulation of multiple genetic and epi-
genetic changes. Genetic changes consist of both som-
atic and germline (i.e. heritable) mutations. The genes in
which there are germline mutations that are highly asso-
ciated with the development of colon cancer are ana-
lyzed here (22 genes in total) and are referred to
throughout this manuscript as “colon cancer associated
genes”. Colon cancer associated genes work in conjunc-
tion with other proteins and pathways and can be
thought of as contributing to, rather than being the sin-
gle cause of colon cancer (note: these genes also have
other functions outside of their association that may
contribute to selective pressure variation in different
lineages). Epigenetic changes such as hypermethylation
of certain genes, loss of imprinting and acetylation/phos-
phorylation/methylation of particular histones are also
implicated in cancer. Detailed information on colon can-
cer epigenetics have been made available to the commu-
nity through the StatEpigen biomedical resource [17].
Other events such as loss of heterozygosity, microsatel-
lite instability and CpG island methylator phenotype can
also play an important role.
Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
is a hereditary predisposition for the development of
colorectal cancer, and accounts for 3% of all colon cancer
cases [19]. The 22 genes we have analyzed were selected
based on the presence of known germline mutations
associated with colon cancer. What follows is a brief de-
scription of each gene in the study. The genes linked
with HNPCC are: MLH1, PMS2, MSH2, MSH6, and
PMS1, all of which are members of the MMR DNA re-
pair pathway [19].
MLH1 (mutL homologue 1) is a mismatch repair gene
and is commonly associated with HNPCC. Missense
mutations in MLH1 occur in the C-terminal domain,
which is responsible for constitutive dimerization with
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have also shown that microsatellite instability (MSI) is
the molecular fingerprint of a deficient mismatch repair
system. It is estimated that some 15% of colorectal can-
cers display MSI owing to the epigenetic silencing of
MLH1, and/or germline mutation in any one of the fol-
lowing mismatch repair genes: PMS2, MLH1, MSH2,
and MSH6 [21]. The mismatch repair endonuclease
PMS2 is known to interact with MLH1 and is a compo-
nent of the post-replicative DNA mismatch repair sys-
tem (MMR). PMS2 is recruited to cleave damaged DNA
this recruitment is triggered by the binding of MSH2
and MSH6 proteins to dsDNA mismatches followed by
the recruitment of MLH1 (Figure 1). PMS1 is also
involved in the repair of DNA mismatches, and it can
form heterodimers with MLH1. Additional genes in our
study include the tumor suppressor gene TP53, CDH1,Figure 1 Phylogeny of animal species used in this study. The ancestra
names as used throughout the text. Those lineages where positive selectio
selection is denoted with an empty circle.MUTYH, and APC. TP53 is a hub protein in the cellular
DNA damage response pathway known as the P53 sig-
naling pathway [22], it is linked with colorectal cancer
and many other cancers. The genes CDH1, MUTYH,
and APC also interact with one another in addition to
their involvement in the MMR pathway described above.
For example, CDH1 and APC combine to act as a ubi-
quitin ligase, which is involved in glycolysis regulation
during the cell cycle [23]. In fact, most of the colon can-
cer associated genes in this study can be grouped into
critical pathways, such as apoptosis, DNA damage con-
trol, and cell cycle signaling [24].
To assess if there is evidence for protein functional
shift from the patterns of substitution in colon cancer
associated genes we have carried out selective pressure
analyses using codon models of lineage-specific rate
heterogeneity.l lineages tested in the analysis are labeled with their corresponding
n was detected are labeled with filled circles, no evidence of positive
Morgan et al. BMC Evolutionary Biology 2012, 12:114 Page 4 of 16
http://www.biomedcentral.com/1471-2148/12/114Methods
Sequence data assembled
The colon cancer gene dataset used in this study con-
sists of 22 genes taken from the Cancer Gene Census at
the Sanger Institute [25]. All 22 genes have reported
cases of germline mutations that are associated with
colon cancer (See Table 1 for summary of data, detail on
the complete dataset is available in Additional file 1).
Using Compara data from Ensembl [26,27], single gene
orthologs were identified for each gene across the verte-
brate genomes chosen. The 21 species were selected
based on genome coverage. These included representa-
tives from 3 of the 4 main lineages of Eutheria, namely
Afrotheria, Euarchontoglires, and Laurasiatheria, as well
as outgroup species including platypus, zebrafish, and
zebra finch (see Additional file 1).
Multiple sequence alignment
The coding DNA sequences of the single gene orthologs
were translated and the resulting amino acid sequences
were aligned using the default parameters in ClustalW
2.0.12 [30,31]. We mapped gaps from the amino acid
multiple sequence alignment (MSA) to the corre-
sponding nucleotide sequences to produce a nucleo-
tide alignment. All alignments were reviewed for
quality and any poorly aligned regions were manually
edited using Se-Al [32]. All alignments are available
in Additional file 2.
Alignment criteria for selective pressure analysis
It has been shown through computer simulations that
sequence length has an impact on the power to infer
positive selection [33]. Power was also found to increase
with greater taxonomic representation and greater diver-
gence, although extreme levels of divergence were found
to cause a reduction in power. Simulations have shown
that the presence of longer foreground branches also
increased the power of the test statistic, but extremely
long foreground branches reduced the power [34]. To
increase the statistical power of the analyses performed
here we have therefore only considered single gene fam-
ilies containing 6 or more taxa, and alignment lengths of
greater than 500 amino acids.
Recombination analysis
Recombination events can result in the incorrect detec-
tion of positive selection. To reduce the detection of po-
tential false positives from our analyses, we have
implemented GENECONV (version 1.81a) [35]. GENE-
CONV detects gene conversion events between ances-
tors of sequences in a multiple sequence alignment.
Default parameters where employed, and 10,000 ran-
domly permuted datasets were generated for each SingleGene Orthologous family and global inner fragments
were listed if P-value <= 0.05 or smaller.
Selective pressure analysis using codon models of
evolution
Selective pressure analyses were performed using
Codeml from PAML version 4.4 [36,37]. Because each
gene family analyzed was composed of single gene
orthologs, pruned species phylogenies were used as per
previous publications [2,38]. Codeml implements a num-
ber of codon-based models in a Maximum Likelihood
framework that can be used to test alternative and
nested evolutionary hypotheses. Three different types of
codon model were used in this study: (i) a homogeneous
model (Model 0) - a single ω-value is estimated for the
entire alignment; (ii) site-heterogeneous models - the
sites of the gene sequence are grouped into two or more
site classes, each with its own ω-value; and (iii) lineage-
specific heterogeneous models - a different ω parameter
is estimated for different site classes in combination with
different lineages [9,36,39].
Seven site-heterogeneous models were used, we have
retained conventional annotations for these models:
Model 1a (Nearly Neutral), Model 2a (Selection), Model
3 Discrete (k = 2), Model 3 Discrete (k = 3), Model 7,
Model 8 and Model 8a. Two lineage-specific heteroge-
neous models were used: Model A and Model A Null.
These models have been applied similarly elsewhere [40].
The goodness-of-fit of the different models was
assessed statistically using a likelihood ratio test (LRT).
The LRT compares the log-likelihoods of a null model
with the alternative model. For hierarchically nested
models, the test statistic of an LRT approximates the χ2
distribution with degrees of freedom equal to the num-
ber of additional free parameters in the alternative
model compared to the null model. Because of this, the
critical value of the test statistic can be determined from
standard statistical tables. If the p-value of the test statis-
tic exceeds that critical value (i.e. if the alternative model
fits the data significantly better than the null model),
then the null model can be rejected. For example, if the
test statistic of an LRT comparing Model 1a (Nearly
Neutral) with Model 2a (Selection) is greater than the
critical value determined from the χ2 distribution, Model
1 a can be rejected. If ω1> 1 under Model 2a, positive
selection may be inferred. Additional file 3 shows the set
of LRTs used for selective pressure analysis.
In cases where positive selection is inferred, the pos-
terior probability of a site belonging to the positively
selected class is estimated using two calculations: Naïve
Empirical Bayes (NEB) or Bayes Empirical Bayes (BEB).
If both BEB and NEB are predicted, we will preferen-
tially use the BEB results as these have been shown to be
more robust [37].
Table 1 Colon Cancer Gene Set analyzed in this study
Gene
(HGNC
code)
Ensembl
Identifier
Taxa
Number2
Alignment
Length3
Syndrome Tumor Types
Observed
Pathway(s) References4
APC ENSG00000134982 20 9177 Familial adenomatous
polyposis (FAP)
Colon, thyroid,
stomach, intestine
APC [19,24]
ATM ENSG00000149311 18 9189 Ataxia telangiectasia (A-T) Leukemia, lymphoma,
colorectal
CIN [24],
[17]
BHD ENSG00000154803 20 1737 Birt-Hogg-Dube syndrome Renal, colon AMPK, mTOR,
STAT
[24]
BMPR1A ENSG00000107779 19 1596 Juvenile polyposis Gastrointestinal SMAD [24]
CDH1 ENSG00000039068 15 2649 Familial gastric carcinoma Stomach AP [[24,28]
(E-cadherin)]
MADH4 ENSG00000141646 16 1656 Juvenile polyposis Gastrointestinal SMAD [[24], (SMAD4)]
MET ENSG00000105976 21 4146 Hereditary papillary
renal cell carcinoma (HPRCC)
Kidney, colorectal RAS, PI3K, STAT,
Beta-catenin, Notch
[24]
MLH1 ENSG00000076242 19 2274 Hereditary non-polyposis
colon cancer (HNPCC)
Colon, uterus MMR [24]
MSH2 ENSG00000095002 18 2802 Hereditary non-polyposis
colon cancer (HNPCC)
Colon, uterus MMR [24]
MSH6 ENSG00000116062 19 4101 Hereditary non-polyposis
colon cancer (HNPCC)
Colon, uterus MMR [24]
MUTYH ENSG00000132781 21 1569 Attenuated Polyposis Colon BER [24]
NF1 ENSG00000196712 17 8523 Neurofibromatosis type I Neurofibroma,
colon
RTK [24]
PMS1 ENSG00000064933 20 2799 Hereditary non-polyposis
colon cancer (HNPCC)
Colon, uterus MMR
PMS2 ENSG00000122512 21 2592 Hereditary non-polyposis
colon cancer (HNPCC)
Colon, uterus MMR [24]
PTEN ENSG00000171862 18 1209 Cowden syndrome Hamartoma, glioma,
colorectum
PI3K [24],
[17]
SDHB ENSG00000117118 18 840 Hereditary paraganglioma,
Carney–Stratakis
Paragangliomas,
pheochromocytomas,
gastrointestinal
HIF1 [24]
SDHC ENSG00000143252 16 507 Hereditary
paraganglioma,
Carney–Stratakis
Paragangliomas,
pheochromocytomas,
gastrointestinal
HIF1 [24]
STK11 ENSG00000118046 18 1320 Peutz-Jeghers
syndrome
Intestinal, ovarian,
pancreatic, colorectal
PI3K [24,29]
TP53 ENSG00000141510 16 1185 Li-Fraumeni
syndrome/sarcoma
Breast, sarcoma,
adrenal, brain,
colorectal
p53 [24,29]
TSC1 ENSG00000165699 18 3495 Tuberous sclerosis Hamartoma, kidney,
colorectal
PI3K [24,29]
TSC2 ENSG00000103197 19 5436 Tuberous sclerosis Hamartoma, kidney,
colorectal
PI3K [24,29]
VHL ENSG00000134086 18 639 Von Hippel-Lindau syndrom Kidney, colorectal HIF1 [24]
Each of the 22 genes analyzed in this study are detailed, including their HGNC approved gene symbols, and Ensembl gene IDs. The total number of species
analyzed for each gene and the overall length of alignment in base pairs are also given. The syndrome, tumor type observed and pathway involved are detailed.
References citing alternative gene names are identified using rounded parentheses.
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for analysis and to process all output. PAML output
files were parsed for parameter estimates and log like-
lihood values, and LRTs were performed (seeAdditional file 3). Where positively selected sites were
inferred under a given model, positively selected sites
were mapped to the sequence (or sequences) of inter-
est and included in the summary file (see Additional
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for human error in setting up and interpreting PAML
analyses and is available from the authors on request.
Functional annotation of sites under positive selection
for each protein was obtained from UniProt [41].
Human population analysis
Selective pressures within the present day human popu-
lation were analyzed for those genes with evidence of
lineage-specific positive selection in the human ancestral
lineages. The online tool SNP@Evolution2 and HapMap
release II source data was used to look at variations
within the East Asian (A), Northern and Western Euro-
pean (C), and African Yoruba (Y) populations. The
“integrated haplotype score” or iHS, described first in
[42], was employed here as a test for directional selec-
tion. The iHS is standardized using genome wide empir-
ical distributions, it has an approximate normal
distribution allowing for direct comparisons of the score
across genes, and it outperforms in comparison to other
available approaches [42]. A derived allele that has been
segregating in the population receives a large iHS (>+ 2)
while a large negative iHS (<−2) indicates that the
derived allele has increased in frequency.
Results and discussion
Starting with a dataset of 22 genes, we identified single
gene orthologs across 21 complete vertebrate genomes.
Ortholog identification resulted in families with between
15 and 21 taxa, and alignment lengths of between 507
and 9,189 base pairs thus satisfying the criteria
described in the materials and methods section. The test
for recombination on all 22 genes is summarized in
Additional file 5. The analysis revealed that only the
TP53 protein showed significant levels of recombination,
the regions where recombination was present were
noted and compared to regions where positive selection
was detected. If these regions overlapped - the positive
selection result was deemed a false positive.
To assess the selective pressure variation, we per-
formed both site- and lineage-specific selective pres-
sure analyses and subsequently assessed the statistical
significance of all results via LRT analyses to ascertain
the codon evolutionary model of best fit. In those
cases where the ω value vastly exceeds 1, we have
simply denoted them as ω >> 1 throughout the
manuscript, as there is no biological significance for
these extremely large ω values (the precise numbers
are shown in the Tables throughout). The lineage-
specific analyses are more pertinent to the main focus
of the paper, i.e. - the identification of species-specific
patterns of substitution in these colon cancer asso-
ciated genes. Therefore the lineage-specific results
have been described in detail in the following section.Site-specific results are briefly summarized on a gene-
by-gene basis. All positively selected sites were
assessed using functional information from the Uni-
prot database [41]. The model of best fit along with
associated parameter estimates are described and a
summary table for each of the 22 genes is given in
Additional file 4.
Lineage-specific selective pressure analyses
Lineage-specific models of codon evolution were
assessed at multiple phylogenetic depths, (i) the ex-
tant lineages within the Euarchontoglires clade, and
(ii), all ancestral lineages leading from the Euarchon-
toglires to modern mouse and human were also
tested independently as depicted in Figure 1. Analysis
of the extant human and mouse lineages did not yield
evidence of positive selection. Conversely, analysis of
the lineages within the Euarchontoglires clade resulted
in significant evidence of lineage-specific positive se-
lection, 6 genes in ancestral lineages and 12 in extant
lineages, see Figure 1. The STK11 gene showed evi-
dence of positive selection in the Euarchontoglires an-
cestral lineage and again in the Hominidae ancestral
lineage. CDH1 showed patterns of substitution condu-
cive with positive selection in the ancestral primate
lineage. In the ancestral Muridae lineage there is evi-
dence for positive selection acting on the TSC1 gene.
The ancestral Murinae lineage showed evidence of
positive selection for both MSH6 and SDHC, see
Table 2 for summary.
In the following section, we have analyzed the posi-
tively selected sites for those genes with evidence of
lineage-specific positive selection in the context of
their potential functional relevance for those genes.
This was carried out for all genes where functional
sites and/or domains have been elucidated. All sites
described were calculated via Bayes Empirical Bayes
(BEB) analysis (unless otherwise specified). In all cases
we are assessing the potential functional importance
of residues based on their sequence position. There
are instances where we identify stretches of protein
sequence under positive selection - there is a possibil-
ity that these sites may have very different functions
despite their sequence position. For a total 16 of the
22 genes there were partial or complete 3D structures
available. However, many of the positively selected
sites identified were located in regions that were not
yet fully resolved at the structural level, and so only
the 3D model for STK11 is given.
Positive selection in the Euarchontoglires Ancestral branch
The most ancestral branch tested was the Euarchon-
toglires ancestral branch, i.e. the ancestor of the Pri-
mate, Rodent and Glires clades as depicted in
Table 2 Summary of parameter estimates and likelihood scores for the model of best fit showing evidence of positive
selection
Gene Model lnL Parameter Estimates Positive
Selection
BEB Positively Selected
Sites
Lineage-Specific Analyses
Euarchontoglires Ancestral Branch
STK11 modelA −8602.921472 p0 = 0.93299, p1 = 0.05633, p2 = 0.01007, p3 = 0.00061
ω0 = 0.03346, ω1 = 1.00000, ω2 = 197.90897
Yes 3> 0.50, 1> 0.95, 0> 0.99
Primate Ancestral Branch
CDH1 modelA −16658.03484 p0 = 0.75454, p1 = 0.23453, p2 = 0.00834, p3 = 0.00259
ω0 = 0.05683, ω1 = 1.00000, ω2 = 10.20516
Yes 9> 0.50, 1> 0.95, 0> 0.99
Hominidae Ancestral Branch
STK11 modelA −8601.056009 p0 = 0.93574, p1 = 0.05920, p2 = 0.00476, p3 = 0.00030
ω0 = 0.03323, ω1 = 1.00000, ω2 = 44.31709
Yes 3> 0.50, 2> 0.95, 1> 0.99
VHL modelA −4263.853291 p0 = 0.73748, p1 = 0.25109, p2 = 0.00853, p3 = 0.00290
ω0 = 0.05985, ω1 = 1.00000, ω2 = 220.34533
Yes 1> 0.50, 0> 0.95, 0> 0.99
Chimpanzee Extant Branch
TSC2 modelA −42659.27711 p0 = 0.90352, p1 = 0.09434, p2 = 0.00194, p3 = 0.00020
ω0 = 0.04404, ω1 = 1.00000, ω2 = 190.09480
Yes 6> 0.50, 2> 0.95, 2> 0.99
VHL modelA −4262.098043 p0 = 0.73571, p1 = 0.25251, p2 = 0.00877, p3 = 0.00301
ω0 = 0.05976, ω1 = 1.00000, ω2 = 262.72662
Yes 3> 0.50, 0> 0.95, 0> 0.99
Gorilla Extant Branch
MSH2 modelA −19485.4338 p0 = 0.92233, p1 = 0.06298, p2 = 0.01375, p3 = 0.00094
ω0 = 0.06427, ω1 = 1.00000, ω2 = 999.00000
Yes 46> 0.50, 34> 0.95, 18> 0.99
TSC2 modelA −42569.22884 p0 = 0.89862, p1 = 0.08796, p2 = 0.01222, p3 = 0.00120
ω0 = 0.04339, ω1 = 1.00000, ω2 = 999.00000
Yes 27> 0.50, 14> 0.95, 12> 0.99
MSH6 modelA −34009.90221 p0 = 0.78382, p1 = 0.18418, p2 = 0.02591, p3 = 0.00609
ω0 = 0.06974, ω1 = 1.00000, ω2 = 999.00000
Yes 46> 0.50, 34> 0.95, 18> 0.99
ATM modelA −69374.08393 p0 = 0.80673, p1 = 0.17971, p2 = 0.01109, p3 = 0.00247
ω0 = 0.09745, ω1 = 1.00000, ω2 = 999.00000
Yes 48> 0.50, 23> 0.95, 19> 0.99
Orangutan Extant Branch
TSC1 modelA −24068.71106 p0 = 0.79963, p1 = 0.18828, p2 = 0.00978, p3 = 0.00230
ω0 = 0.08020, ω1 = 1.00000, ω2 = 999.00000
Yes 13> 0.50, 6> 0.95,5> 0.99
TSC2 modelA −42673.92339 p0 = 0.90414, p1 = 0.09295, p2 = 0.00263, p3 = 0.00027
ω0 = 0.04433, ω1 = 1.00000, ω2 = 40.47366
Yes 9> 0.50, 0> 0.95, 0> 0.99
Marmoset Extant Branch
TSC2 modelA −42616.04524 p0 = 0.89841, p1 = 0.09019, p2 = 0.01035, p3 = 0.00104
ω0 = 0.04325, ω1 = 1.00000, ω2 = 235.10448
Yes 38> 0.50, 9> 0.95
MSH6 modelA −34009.90221 p0 = 0.78382, p1 = 0.18418, p2 = 0.02591, p3 = 0.00609
ω0 = 0.06974, ω1 = 1.00000, ω2 = 999.00000
Yes 45> 0.50, 16> 0.95, 12> 0.99
VHL modelA −4262.443441 p0 = 0.72045, p1 = 0.22453, p2 = 0.04195, p3 = 0.01307
ω0 = 0.05886, ω1 = 1.00000, ω2 = 90.26952
Yes 10> 0.50, 0> 0.95, 0> 0.99
ATM modelA −69583.23068 p0 = 0.81640, p1 = 0.18148, p2 = 0.00173, p3 = 0.00038
ω0 = 0.09939, ω1 = 1.00000, ω2 = 46.82466
Yes 2> 0.50, 0> 0.95, 0> 0.99
Muridae Ancestral Branch
TSC1 modelA −24126.17894 p0 = 0.80995, p1 = 0.18416, p2 = 0.00481, p3 = 0.00109
ω0 = 0.08293, ω1 = 1.00000, ω2 = 999.00000
Yes 1> 0.59, 0> 0.95, 0> 0.99
Murinae Ancestral Branch
SDHC modelA −3846.690164 p0 = 0.87666, p1 = 0.08131, p2 = 0.03846, p3 = 0.00357
ω0 = 0.15340, ω1 = 1.00000, ω2 = 253.61375
Yes 9> 0.50, 2> 0.95, 1> 0.99
MSH6 modelA −34190.13821 p0 = 0.79911, p1 = 0.19671, p2 = 0.00335, p3 = 0.00082
ω0 = 0.07057, ω1 = 1.00000, ω2 = 126.22513
Yes 3> 0.50, 1> 0.95, 0> 0.99
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Table 2 Summary of parameter estimates and likelihood scores for the model of best fit showing evidence of positive
selection (Continued)
Rat Extant Branch
MADH4 modelA −6092.186945 p0 = 0.93360, p1 = 0.01536, p2 = 0.05021, p3 = 0.00083
ω0 = 0.01379, ω1 = 1.00000, ω2 = 102.33013
Yes 24> 0.50, 11> 0.95, 10> 0.99
NF1 modelA −37750.29866 p0 = 0.96609, p1 = 0.02476, p2 = 0.00892, p3 = 0.00023
ω0 = 0.02265, ω1 = 1.00000, ω2 = 999.00000
Yes 39> 0.50, 10> 0.95, 10> 0.99
Guinea pig Extant Branch
TSC1 modelA −24116.58577 p0 = 0.80206, p1 = 0.18611, p2 = 0.00961, p3 = 0.00223
ω0 = 0.08093, ω1 = 1.00000, ω2 = 284.22603
Yes 9> 0.50, 4> 0.95, 0> 0.99
NF1 modelA −37849.50819 p0 = 0.97375, p1 = 0.02506, p2 = 0.00116, p3 = 0.00003
ω0 = 0.02414, ω1 = 1.00000, ω2 = 171.64068
Yes 3> 0.50, 1> 0.95, 0> 0.99
Rabbit Extant Branch
MLH1 modelA −19516.63525 p0 = 0.80595, p1 = 0.18541, p2 = 0.00703, p3 = 0.00162
ω0 = 0.05262, ω1 = 1.00000, ω2 = 7.52747
Yes 5> 0.05, 3> 0.95, 0> 0.99
MUTYH modelA −15911.6175 p0 = 0.61027, p1 = 0.37605, p2 = 0.00846, p3 = 0.00522
ω0 = 0.07703, ω1 = 1.00000, ω2 = 998.99697
Yes 5> 0.50, 4> 0.95, 3> 0.99
SDHC modelA −3822.683246 p0 = 0.57771, p1 = 0.06636, p2 = 0.31926, p3 = 0.03667
ω0 = 0.12047, ω1 = 1.00000, ω2 = 3.59059
Yes 51> 0.50, 10> 0.95, 8> 0.99
ATM modelA −69582.95152 p0 = 0.81572, p1 = 0.18045, p2 = 0.00313, p3 = 0.00069
ω0 = 0.09930, ω1 = 1.00000, ω2 = 7.41594
Yes 6> 0.50, 0> 0.95, 0> 0.99
BHD modelA −13523.51719 p0 = 0.90728, p1 = 0.05930, p2 = 0.03137, p3 = 0.00205
ω0 = 0.02817, ω1 = 1.00000, ω2 = 6.50017
Yes 10> 0.50, 7> 0.95, 1> 0.99
Site-specific Analyses
CDH1 m8 −16589.88768 p = 0.21848, p0 = 0.99291, p1 = 0.00709,
q = 0.80842 ω=4.53766
Yes 15> 0.5, 1> 0.95, 0> 0.99
PMS1 m8 −26480.39761 p = 0.61337, p0 = 0.93580, p1 = 0.06420,
q = 1.93110 ω=1.32691
Yes 25> 0.50, 1> 0.95, 0> 0.99
PMS2 m8 −27449.3651 p = 0.29104, p0 = 0.91064, p1 = 0.08936,
q = 1.31619 ω=1.28855
Yes 37> 0.50, 1> 0.95, 0> 0.99
MUTYH m8 −15797.6226 p = 0.37255, p0 = 0.97242, p1 = 0.02758,
q = 1.00900 ω=2.44412
Yes 18> 0.5, 1> 0.95, 0> 0.99
TP53 m8 −8688.19126 p = 0.40362, p0 = 0.94645, p1 = 0.05355,
q = 1.77507 ω=1.97385
Yes 13> 0.5, 3> 0.95, 0> 0.99
The model of best fit is summarized below for those genes with evidence of positive selection. The lineage-specific results for each lineage tested from the
Euarchontoglires ancestor to modern lineages are shown in the top panel and the site-specific results are shown in the bottom panel. The model abbreviations
are as per main text. P refers to the number of free parameters estimated in that model. BEB = Bayes Empirical Bayes estimations. The number of positively
selected sites identified can be found the final column, sites are separated by the posterior probability cutoffs of 0.50, 0.95, and 0.99.
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and was the only gene that showed evidence of posi-
tive selection in this ancestral lineage. STK11 (Serine/
Threonine-protein kinase 11) plays an essential role
in G1 cell cycle arrest and acts as a tumor suppres-
sor. It phosphorylates and activates members of the
AMPK-related subfamily of protein kinases [43,44],).
Mutations in STK11 cause Peutz-Jeghers syndrome
(PJS), this is a rare autosomal dominant disorder
characterized by multiple gastrointestinal hamartoma-
tous polyps and an increased risk of various neo-
plasms including gastrointestinal cancer [45,46]. From
the literature we currently know of 17 sites across
this gene that when mutated are associated with
colon-cancer. The Euarchontoglires ancestral lineage has1.1% of sites under positive selection (ω >> 1).
The positively selected residues were located on the 3D
structure of this enzyme (See Figure 1 inset). Position
206 with a Posterior Probability (PP) = 0.889 is a hydro-
phobic Alanine or Valine in Euarchontoglires species and
is a negatively charged Glutamic acid or positively
charged Lysine in non-Euarchontoglires species. This
residue also lies in close proximity to sporadic cancer site
A205T and colorectal cancer site D208N in Human [47].
Positively selected position 301 in Euarchontoglires
(P = 0.885) is present in Euarchontoglires species as an
Arginine residue and all non-Euarchontoglires as an
uncharged Glutamine residue. Site 301 is close to
R297K and region 303–306 both of which have been
implicated in PJS [48].
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The branch leading from the Euarchontoglires ancestor
towards the primates was analyzed, we have termed
this branch the ancestral Primate branch as depicted in
Figure 1. The CDH1 dataset consists of 15 taxa and fol-
lowing LRT analyses showed evidence of lineage-specific
positive selection in 1.1% of sites in the Primate Ances-
tor (ω=10.21). Positively selected sites were compared to
human Swiss-Prot entry (P12830) and it was found that
position 604, with a PP of 0.549, falls in close proximity
to gastric cancer variant R598Q [49]. At position 604
Primates have a negatively charged Glutamic acid while
non-primates have a polar uncharged Glutamine.
Positive selection in the Hominidae Ancestral branch
The next branch in the primate clade is that leading
to modern great apes, i.e. Hominidae, as depicted in
Figure 1. This lineage also showed evidence of posi-
tive selection again in the STK11 gene in 0.51% of
sites, with ω >> 1. See Figure 2(a) and Table 2. The
positively selected positions were compared to the
human Swiss-Prot sequence (Q15831). Position 347
represents a radical substitution, as the Hominidae codeFigure 2 Positive selection analysis for 4 genes: (a) STK11, (b) CDH1,
end of alignment. The Y-axis is the posterior probability. The vertical red ba
from human populations. The black dots on each graph represent the posfor an Alanine (a small hydrophobic residue) whereas
the Murinae lineage encode an Arginine at this position
(a basic, hydrophilic, and positively charged residue).
For positively selected site 378, the ancestral Hominidae
lineage encodes the polar residue Serine, while the
closely related species studied encode the small amphi-
philic Glycine. The functions of these specific sites have
not been reported thus far in the literature but are likely
to be of considerable interest as they mark adaptations
unique to the ancestral Hominidae.
A second gene showing evidence of positive selec-
tion in the Hominidae ancestral branch is the VHL
dataset consisting of 18 taxa. The VHL gene encodes
Von Hippel-Lindaue tumour suppressor protein.
Mutations occurring in this gene can result in von
Hippel-Lindau disease (VHDL) - a dominantly inher-
ited familial cancer syndrome [50]. VHL exhibited
weak evidence of positive selection with 1.1% of sites
in the ancestral Hominidae lineage under positive se-
lection. There was one amino acid that had low
coverage in the alignment (present only in 6/18 spe-
cies), as this is a very weak results we have not
expanded upon it any further.(c) MUTYH, and (d) TP53. The x-axis depicts the gene from start to
rs on each graph represent the known cancer causing variants
itively selected sites identified in this study.
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Analysis of modern non-human primates also identified
positive selection in a number of genes. In VHL positive
selection was detected in the Chimpanzee lineage where
1.2% of sites have ω >> 1, and also in the Marmoset
lineage where 5.5% sites have ω >> 1. Sites under posi-
tive selection were compared against human Swiss-Prot
entry (P40337), however the region (1–60) was only
represented by 11/18 species in the alignment and there-
fore we do not have sufficient confidence in these posi-
tions to explore these sites in more detail.
The MSH6 gene dataset contained 19 taxa and showed
evidence of positive selection in both the Gorilla and
Marmoset lineages each displaying 3.2% of sites with
ω >> 1. Gorilla and Marmoset extant lineages were
compared against human (P52701) Swiss-Prot entry. No
relevant functional information could be extracted from
positively selected sites in Gorilla, however 2/45 posi-
tively selected sites in Marmoset fall in close proximity
to cancer variants. In marmoset, positively selected site
803 (PP = 0.551) coincides with Human colorectal cancer
variants D803G [51] and V800A [52]. Position 803 in
Marmoset is a negatively charged Glutamic acid while in
all other mammals it is a small negatively charged
Aspartic acid. Positively selected site 1099 in Marmoset
(PP = 0.614) is located between human colorectal cancer
variants R1095H [53] and T1110C [54].
MSH2 alignment consists of 18 taxa. The function of
the MSH2 protein is in post-replicative DNA mismatch
repair system (MMR). Mutations in MSH2 result in
hereditary non-polyposis colorectal cancer type 1
(HNPCC1) [55]. Lineage-specific positive selection was
identified in 1.5% of sites within the extant Gorilla
lineage with ω >> 1. Positively selected sites were com-
pared against human Swiss-Prot sequence (P43246). All
15 of the BEB identified sites occur between amino acid
position 124–142 which overlaps with the region con-
taining variants N127S, N139S and I145M associated
with HNPCC1 [55].
Tuberous sclerosis 2 protein (TSC2) interacts with
TSC1 protein and mutations in this gene can cause tu-
berous sclerosis type 2 [56]. The alignment of TSC2
consisted of 19 taxa. Lineage-specific positive selection
was identified in the following extant lineages, the per-
centage of sites under positive selection in each lineage
is shown in brackets, in all cases ω >> 1: Chimpanzee
lineage (0.2%), Gorilla (1.3%), Orangutan (0.29%), and,
Marmoset (1.1%). Positively selected sites were com-
pared against human Swiss-Prot sequence (P49815)
however the functional information was not available to
contextualize these results.
ATM acts as a DNA checkpoint sensor by activating
checkpoint signaling upon double strand breaks [57].
The alignment of ATM consisted of 18 taxa and positiveselection was detected in the following lineages (again
the percentage of the alignment under positive selection
is shown in brackets): Gorilla (1.4%, ω >> 1), Marmoset
(0.21%, ω >> 1), and Rabbit (0.38%, ω = 7.42). BEB sig-
nificant sites were compared to human (Q13315) and
mouse (Q62388) Swiss-Prot entries to determine the
functional relevance of selected sites. In the Gorilla
lineage positively selected site 2067 (PP = 0.787), where
in humans a substitution of Alanine to Aspartate in this
same position can result in Ataxia telangiectasia (AT)
which is a severe disease that causes weakened immune
function and greater predisposition to cancer [57]. No
other functionally relevant information was found upon
comparison of Swiss-Prot information against either
Marmoset or Rabbit.
The extant Orangutan lineage also showed evidence of
positive selection in the TSC1 gene for 1.2% of its align-
ment (ω >> 1). Positively selected sites were compared
against human Swiss-Prot sequence (Q92574) and
mouse Swiss-Prot sequence (Q9EP53) however there
was insufficient information to extrapolate the potential
functional impact of these sites.
Human population level analysis using HapMap data
Genes displaying evidence of positive selection in
lineages leading to Homo sapiens, i.e. the primate and
Hominidae lineages (STK11, CDH1 and VHL), were fur-
ther analyzed to determine if there is evidence for on-
going positive directional selection in modern day
human populations. The integrated haplotype score, iHS
[42], was calculated for each SNP in STK11, CDH1 and
VHL genes across African Yorubu (Y), East Asian (A)
and European (C) populations. One intronic SNP in the
SDK11 gene, had an iHS score of +2.0385 in European
populations. In the CDH1 gene, two intronic SNPs with
iHS scores of +2.0433 and +2.5838 respectively were
identified in the East Asian populations. iHS scores of
greater than +2 indicate that these alleles are segregating
at a significant rate within their given populations. No
population level directional selection was identified in
the VHL gene in modern humans.
Positive selection in the Ancestral Muridae branch
The ancestral Muridae branch marks the most recent
common ancestor of modern mouse, rat and guinea pig
species and is depicted in Figure 1. Tuberous sclerosis 1
protein (TSC1) interacts with TSC2 and acts as a
tumour suppressor gene [56]. Defects in TSC1 cause tu-
berous sclerosis type 1 which is an autosomal dominant
multi-system disorder. There were a total of 18 taxa ana-
lysed in for the TSC1 gene and 0.59% of sites in the
Muridae ancestral lineage were identified with ω >> 1.
As before for TSC1: positively selected sites were com-
pared against human Swiss-Prot sequence (Q92574) and
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was insufficient information to extrapolate potential
functional impacts of these sites.
Positive selection in the Ancestral Murinae branch
The ancestral Murinae branch defines the most recent
common ancestor of mouse and rat. In total there were
two genes identified as being under positive selection in
the Murinae lineage. The first is the MSH6 gene that
acts as a DNA mismatch repair protein and is a compo-
nent of the post–replicative DNA mismatch repair sys-
tem [58]. MSH6 also heterodimerizes with MSH2 to
form MutS-alpha, a protein complex that functions by
binding to DNA mismatches and initiating DNA repair
[59]. Mutations in MSH6 have been reported to cause
HNPCC type 5 [60], atypical HNPCC, and familial colo-
rectal cancers (suspected or incomplete HNPCC) [61].
The MSH6 dataset consists of 19 taxa. Lineage-specific
analysis of the ancestral Murinae lineage revealed 0.42%
of the sites (3 residues) in MSH6 under positive selec-
tion, ω >> 1 (see Table 2). The corresponding Swiss-
Prot sequence (P54276) lacked functional details for
these positions, therefore, potential functional effects re-
main unknown. However, examination of the alignment
at this position revealed the substitution of residues with
unrelated biochemical properties at these positions. At
positively selected site 374 (numbered as per Swiss-Prot
entry), the Murinae lineage has a Proline whereas
remaining species tested encode either Glutamic acid,
Aspartic acid, or Lysine. As Proline produces “kinks” in
the α-helical regions of proteins, such a substitution
could alter the protein structure substantially. Positively
selected site 759 is a Leucine in the Murinae, all other
non-outgroup species encode aliphatic residues (Isoleu-
cine or Valine). The ancestral Murinae has a Cysteine at
Swiss-Prot position 1259 while all other species have an
Alanine at this position. These residues are of specific
interest for further in vitro functional assaying given
their uniqueness to the rodent clade and their retention
in all modern rodents tested.
The second gene with evidence of positive selection on
the ancestral Murinae lineage is the SDHC (Succinate de-
hydrogenase cytochrome b 560 subunit, mitochondrial)
gene. The SDHC function is to act as a membrane-
anchoring subunit for the SDH protein. Defects in this
protein are reported in paragangliomas and gastric stro-
mal sarcomas [62]. The dataset for the SDHC consists of
16 taxa. Lineage-specific positive selection was detected
in the ancestral Murinae lineage with 4.2% of sites (9
residues) in this protein with ω >> 1 (Table 2). Com-
parison with the human sequence from Swiss-Prot
(Q99643) and mouse sequence (Q9CZB0) placed 8 of
these sites either in transmembrane or topological
domains across the gene, with the additional positivelyselected residue (position 128) neighboring a metal bind-
ing site at position 127.Positive selection in the Extant Rabbit branch
The SDHC gene again showed evidence of positive selec-
tion, this time in the extant Rabbit lineage with 35.59% of
sites under positive selection (ω = 3.59). 15/51 positively
selected sites were identified as occurring within 10
amino acid positions of the metal binding site 127, also
mentioned in the ancestral Murinae analysis. While there
are extremely high levels of positive selection identified
in the rabbit lineage, no other relevant functional infor-
mation could be gleaned from the databases at this point.
The MUTYH alignment consisted of 21 taxa and
showed evidence of lineage-specific positive selection in
1.4% of sites in the extant Rabbit lineage (ω >> 1). Posi-
tively selected sites were compared to human (Q9UIF7)
and mouse (Q99P21) Swiss-Prot entries, however no
relevant functional information could be extrapolated.
Radical substitutions occurred in all 5 BEB sites in the
extant Rabbit lineage, three of which are at positions
485–487 in the Nudix hydrolase domain.
The MLH1 gene codes for a critical protein involved
with the post-replicative DNA mismatch repair system.
Defects in this gene result in hereditary non-polyposis
colorectal cancer type 2 (HNPCC2) [63]. The alignment
of MLH1 consists of 19 taxa and again positive selection
was detected in the extant rabbit lineage in 0.87% of
sites (ω = 7.53). Positively selected sites were compared
against human Swiss-Prot sequence (P40692) and mouse
Swiss-Prot sequence (Q9JK91). At amino acid position
120, Rabbit has a polar uncharged Serine residue while
all other species tested have a hydrophobic Alanine resi-
due. This positively selected site falls in a region dense
with HNPCC2 variants at positions A111V, T116K,
T117M, Y126N, A128P [63-65]. Positively selected resi-
dues in Rabbit: 209, 478 and 514, each fall within 8
amino acid positions of HNPCC2 variants: V213M,
R474Q and V506A [66]. And position 478 identified as
under positive selection also lies in close proximity to a
colorectal cancer variant R472I [67].
Finally, the BHD gene showed evidence of positive se-
lection in the extant Rabbit lineage. The function of the
BHD gene is still largely unknown, however it is thought
that it may be a tumour suppressor and it may be
involved in colorectal tumorigenesis [68]. The alignment
consisted of 20 taxa and positive selection was detected
in 3.34% of sites (ω = 6.5), again unique to the Rabbit
lineage. BEB significant sites were compared to human
(Q8NFG4) and mouse (Q8QZS3) Swiss-Prot entries to
determine their functional relevance. All 10 of the posi-
tively selected sites in Rabbit occur in a small region
from position 61–83 and border a known human cancer
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Tryptophan results in sporadic colorectal carcinoma.
Positive selection in the Extant Rodent and
Guinea Pig branches
MADH4 is the co-activator and mediator of signal trans-
duction by TGF-beta. Defects in MADH4 result in pan-
creatic, colorectal, juvenile polyposis syndrome, juvenile
intestinal polyposis and primary pulmonary hypertension
[69,70]. The Rat lineage has lineage-specific positive se-
lection in the MADH4 gene where 5.1% of sites are
evolving with ω >> 1 (number of taxa = 16). Positively
selected sites were compared to human (Q13485) and
mouse (P97471) Swiss-Prot entries. The majority of
positively selected residues in this protein are sequential
with 18/24 sites under positive selection in the rat
lineage within 10 amino acid positions of the natural
human variant 493. When position 493 is mutated from
Aspartate to Histidine pancreatic carcinoma is induced
[71].
NF1 is thought to be a regulator of RAS activity [72].
Defects in NF1 can cause colorectal carcinoma and
breast cancer [70]. The NF1 dataset consists of 17 taxa.
Lineage-specific positive selection was identified in 0.92%
of sites in Rat (ω >> 1) and 0.12% of sites in guinea pig
(ω >> 1). BEB significant sites were compared to
human (P21359) and mouse (Q04690) Swiss-Prot
sequences, however there was no functionally relevant
information available.
TSC1 also shows evidence of positive selection in
the extant guinea pig lineage where 1.2% of the sites have
ω >> 1. As before, the positively selected sites were
compared against human Swiss-Prot sequence (Q92574)
and mouse Swiss-Prot sequence (Q9EP53) however there
was insufficient information to extrapolate potential func-
tional impacts of these sites.
Results of site-specific selective pressure analyses
The site-specific results may be beneficial to those work-
ing on rational mutagenesis and/or the identification of
functionally important regions in these colon cancer
associated genes and so these results have been summar-
ized. We have identified five genes that have signatures
of site-specific positive selection, namely: CDH1,
MUTYH, PMS1, PMS2 and TP53, representing ~23% of
the dataset. For each of these five genes, the model of
best fit was the site-heterogeneous model “model 8”, see
Table 2 for summary.
Defects in the CDH1 member of the Cadherin family
are linked to hereditary diffuse gastric cancer [24,28].
The CDH1 alignment contained 15 taxa and site-specific
analyses revealed 0.71% sites evolving under strong posi-
tive selection, ω = 4.54, see Table 2. We compared these
sites to the human Swiss-Prot entry (P12830) to obtainrelevant functional information, see Figure 2(b). The vast
majority of positively selected sites (12 sites) in the pro-
tein are within the extracellular topological domain
(positions 155–709). Many of these positively selected
sites are in close proximity to natural cancer variants.
For example, position 421 is under position selection
and resides within a region (418–423) known to be miss-
ing in gastric carcinoma samples [73]. Positions 457,
465, and 467 are under positive selection and map in
close proximity to natural variant E463Q found in gas-
tric carcinoma samples [49]. Position 700 resides within
the metalloproteinase cleavage site (700–701) of CDH1.
Position 735 is in close proximity to a gamma-secretase
/PS1 cleavage site (731–732) [74], and position 553 is in
close proximity to a glycosylation site (558), essential for
the posttranslational modification of proteins [75]. In
the CDH1 gene, the majority of species tested (8/15)
have hydrophobic residues (Isoleucine, Valine, Leucine)
at position 553, the glires group (mouse, rat, guinea pig
and rabbit) have small residues (Alanine, Serine, Threo-
nine), but human, gorilla, and dog have large aromatic
residues (Phenylalanine) that could significantly alter the
protein structure and may affect binding at the glycosy-
lation site at position 558.
The MUTYH dataset consisted of 21 taxa and site-
specific analysis identified 18 sites under positive selec-
tion (ω = 2.44), representing 2.8% of the MUTYH protein
(Table 2). A total of 10 unique sites are reported as nat-
ural cancer variants in human (Q9UIF7), see Figure 2(c).
Positively selected sites 406 and 412 are in close proxim-
ity to natural cancer variants at positions 402 and 411.
Positively selected sites 521, 528 and 538 also map in
close proximity to natural variants, 526 and 531 respect-
ively. Also of note are the replacement substitutions
observed at Swiss-Prot positions 406 and 412, these are
radical with potential effects on protein structure. At
position 406 there is a large aromatic Trytophan in Pri-
mates, and a hydrophobic Leucine and Valine present in
the Glires. At position 412 there is an hydrophobic Leu-
cine in Primates and a positively charged Histidine in
the Glires.
PMS1 (postmeiotic segregation increased 1) encodes a
DNA mismatch repair protein and this dataset consists
of 20 taxa. Defects in PMS1 are reported to cause heredi-
tary non-polyposis colorectal cancer type 3 (HNPCC3)
[76]. Analysis of PMS1 identified site-specific model of
codon evolution model 8 as best fit, estimating 25 posi-
tively selected sites (6.4% of the alignment) with ω = 1.33
(Table 2). We compared these sites against human
Swiss-Prot sequence P54277. Positively selected site 387
resides in close proximity to position 394 - a natural vari-
ant (M394T) reported in incomplete HNPCC and
HNPCC3 [77]. Due to limited functional data it was un-
feasible to study the remaining 24 sites. However, due to
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selected sites could prove ideal as candidates for muta-
genesis studies in the future.
Mismatch repair endonuclease PMS2 (postmeiotic
segregation increased 2) is a component of the post-
replicative DNA mismatch repair system [78]. Defects in
PMS2 are reported in HNPCC [76]. The PMS2 dataset
contained 21 taxa and site-specific analysis identified
8.9% of sites under positive selection in this PMS2 pro-
tein, ω = 1.29 (Table 2). Functional relevance of these
sites was determined by comparison to Human Swiss-
Prot sequence (P54278). The vast majority of sites (32)
reside within the 430–645 region of the alignment. This
region of the alignment is highly variable and could not
be not improved manually. Functional characterization
for this region is also lacking and therefore we could not
assess functional relevance. Outside this region, two
positively selected sites, 402 and 406 (PP = 0.632 and
0.728 respectively) flank a phosphoserine modification
site (403) [79]. Both substitutions are radical and could
affect the function at position 403.
TP53 (cellular tumor antigen p53) acts as a tumor
suppressor by inducing apoptosis or arresting growth
depending on the physiological circumstances and cell
type [80]. The TP53 protein (P04637) is 393 residues in
length with 343 of these sites reported as natural var-
iants that cause/lead to cancer including but not lim-
ited to colorectal and gastric cancers [41,81,82]. In our
analysis of TP53 we have 16 taxa. Mutations in this
gene radically affect function and therefore we would
expect to find evidence of strong purifying selection
across sites and lineages. However, results indicate that
site specific positive selection is at work with 13 sites
under positive selection, ω = 1.97. See Figure 2(d) and
Table 2 for detailed analyses. On inspection of these 14
sites, we determine that 11 are located within the first
region of the protein (positions 1–83), a region respon-
sible for interaction with the methyltransferase
HRMT1L2 and the recruiting of promoters to the TP53
gene [83]. We identified a cluster of positively selected
sites, namely positions 46 and 47, along with an add-
itional 7 sites within ten residues 39, 52, 53, 54, 55, 56,
and 59 (see Additional file 4). Mutation of position 46
can abolish phosphorylation by HIPK2 and acetylation
of K-382 by CREBBP [84]. Region 66–110 of TP53 is
involved in interaction with WWOX protein and we
have identified two sites (Swiss-Prot positions: 72 and
81), under positive selection within this region. Positively
selected position 129, is located within a region reported
to interact with HIPK1 (100–370) and AXIN1 (116–
292), and in addition is also located within a region
(positions 113–236) that is required for interaction with
FBX042. Positively selected residue 355 is located within
the CARM1 interaction region (300–393), the HIPK2interacting region (319–360), and the oligomerization
region (325–356).
Conclusion
The results we have presented are indicative of selective
pressures acting in a lineage-specific manner. The posi-
tively selected sites we have identified in this study fre-
quently reside in regions of functional importance, such
as glycosylation sites, protease cleavage sites, and sites
known to interact with proteins involved in DNA dam-
age repair pathways. Also of note, positively selected
residues are frequently located at, or in close proximity
to, known cancer associated sites although the statistical
significance of these coincidences cannot be concluded
with such a small sample sizes. Larger sample sizes and
more complete functional information will be hugely
beneficial in resolving whether these positively selected
residues are most likely positioned to or at variants asso-
ciated with cancer.
In using the mouse as a model organism for colon
cancer, we are making an assumption that the orthologs
in both species are functioning in precisely the same
way despite ~ 180 MY of independent evolution. We
found no evidence of functional divergence in the extant
human and mouse lineages for the genes analyzed. How-
ever, upon testing the lineages leading from the MRCA
of mouse and human, i.e. Euarchontoglires, positive se-
lection has occurred on certain ancestral branches and
in specific extant lineages. In the ancestral lineages of
primates, rodents and glires there is evidence of positive
selection in 6 of the 22 genes tested (this includes the
VHL result but as from Table 2 it is clear that this is a
weak result). In total, considering all lineages analyzed
including extant lineages, we have detected lineage-
specific positive selection in 64% of the genes analyzed
(i.e. 14/22 genes). Studies on the levels of polymorphism
observed in Drosophila species indicate that positive se-
lection is pervasive in this species with positive selection
present in ~25% of the genes [85]. Previous studies on
the levels of positive selection in primates compared to
rodents and in the Hominidae reveal much lower levels
of positive selection in the range of 5-9% of genes in the
genome [7,8]. If these previous analyses were to act as a
measurement of expectation then we should have identi-
fied only 1 gene under positive selection in this dataset
that is comprised of mammals for the most part (taking
the Drosophila data as the upper bound we would ex-
pect in the region of 6 genes with evidence of positive
selection).
On grouping the cancer associated genes according to
their involvement in functional pathways we determined
that the MMR DNA damage response pathway has evi-
dence of positive selection in 3 components of the path-
way – 2 of which are site-specific and one of which is
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specific selective pressure in this clade for this process.
The site-specific analyses identified a total of 5 genes that
are positively selected: CDH1, MUTYH, PMS1, PMS2
and TP53. These results are important for contributing
to our understanding of fundamental functions of these
proteins and have provided potential targets for rational
mutagenesis.
Overall, these results indicate that the function of cer-
tain proteins associated with colon cancer display dis-
tinct lineage-specific patterns of substitution indicative
of positive selection in the ancestral human and mouse
lineages. There are a number of selective pressures on
any given protein that can contribute to patterns of sub-
stitution that are “falsely” indicative of positive selection.
The necessity to continue to interact with protein part-
ners may be a strong driving force in the evolution of
the proteins in this study as many form functional com-
plexes with one another or other proteins [86]. Compen-
satory mutations may also contribute to elevated levels
of ω [87]. The effective population size (Ne) of the spe-
cies tested vary enormously, with estimations for mod-
ern human populations in the range of Ne= 7,500 to
3,100 [88], while estimations for modern mouse popula-
tions range from Ne= 58,000 to 25,000 [89] and this
large difference in Ne may also contribute to detection
of false positives. We have also detected weak evidence
for ongoing selective pressure in the human genome on
the STK11 and CDH1, but these signals of selection may
be artifacts of the very small effective population size of
modern humans. Smaller Ne values are associated with
increased fixation of slightly deleterious substitutions
and subsequent elevated ω values [90]. Such slightly
deleterious mutations in turn can lead to additional
compensatory substitutions that become fixed. Teasing
apart substitutions that have become fixed due to posi-
tive selection from slightly deleterious substitutions fixed
due to small Ne [91] will aid in a more complete under-
standing of protein evolution in the future.Additional files
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essential sites and disease-implicated regions of
mammalian reproductive proteins
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Abstract
Background: Reproductive proteins are central to the continuation of all mammalian species. The evolution of
these proteins has been greatly influenced by environmental pressures induced by pathogens, rival sperm, sexual
selection and sexual conflict. Positive selection has been demonstrated in many of these proteins with particular
focus on primate lineages. However, the mammalia are a diverse group in terms of mating habits, population sizes
and germ line generation times. We have examined the selective pressures at work on a number of novel
reproductive proteins across a wide variety of mammalia.
Results: We show that selective pressures on reproductive proteins are highly varied. Of the 10 genes analyzed in
detail, all contain signatures of positive selection either across specific sites or in specific lineages or a combination
of both. Our analysis of SP56 and Col1a1 are entirely novel and the results show positively selected sites present in
each gene. Our findings for the Col1a1 gene are suggestive of a link between positive selection and severe disease
type. We find evidence in our dataset to suggest that interacting proteins are evolving in symphony: most likely to
maintain interacting functionality.
Conclusion: Our in silico analyses show positively selected sites are occurring near catalytically important regions
suggesting selective pressure to maximize efficient fertilization. In those cases where a mechanism of protein
function is not fully understood, the sites presented here represent ideal candidates for mutational study. This work
has highlighted the widespread rate heterogeneity in mutational rates across the mammalia and specifically has
shown that the evolution of reproductive proteins is highly varied depending on the species and interacting
partners. We have shown that positive selection and disease are closely linked in the Col1a1 gene.
Background
Reproductive proteins are essential for success of sexu-
ally reproducing species and indeed for the emergence
of new species. In the past it has been observed that
reproductive proteins tend to be under positive selective
pressure to change, i.e. adaptive evolution, a trend found
in a variety of animal species from abalone to primates
[1,2]. Adaptive evolution or positive selection is a selec-
tive pressure placed on a protein by a change in envir-
onment in order to improve the fitness of the organism
in that environment.
With changes in environment, that can include mating
system, there is a subsequent selective pressure on the
protein sequences related to those functions to adapt
accordingly. This variation can be detected using the
well-known measurements of the rate of non-synon-
ymous substitutions per non-synonymous site (Dn) and
synonymous substitutions per synonymous site (Ds) and
their ratio ω = Dn/Ds. The detection of adaptive evolu-
tion, where the ratio exceeds unity, is referred to as
positive Darwinian selection. Detecting positive Darwi-
nian selection in a region of a protein, or indeed in a
lineage of a phylogeny, indicates that there is a selective
advantage in changing the amino acid sequence in this
region. These signals are essential for our understanding
of functionally important residues in a protein sequence
and protein functional shift.
In general, the rate of mutation that a gene undergoes
is contingent on a number of factors including; protein
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structure, presence of gene duplicates, location in the
genome, effective population size, germ line generation
time, and composition of the sequence (for review see
[3]). It has recently been shown that the number of phy-
sical interactions of a particular protein also influences
the intrinsic rate of evolution [4]. Evidence for the gen-
eration time effect has come from studies on various
proteins and species including analyses of substitution
rates in higher primates and rodents [5], substitution
rates in higher grasses and in palms [6], in mammalian
genomes [7] and in chloroplast and sex mutation rate
ratios [5,6]. With recent advances in sequencing we
have an opportunity to examine these effects using a
wider selection of proteins and species. Documented
selective pressures associated with positive selection in
reproductive proteins include: (i) intense sperm compe-
tition whereby sperm from numerous males, ejaculated
into the female reproductive tract, compete with one
another for the prized fertilization of the egg [8]; (ii)
evasion of the immune system, whereby surface layer
reproductive proteins evolve to evade destruction by the
host’s immune system [8]; and finally (iii) selective pres-
sures enforced by mating system, related of course to
point (i) above. Species that are more promiscuous have
increased levels of selective pressure acting on reproduc-
tive proteins than species that are monogamous. This
later point is illustrated in the study of SEMG2, where
adaptive evolution was found to correlate with mating
system in primates [9].
In order to determine the variation in selective pres-
sure in these proteins, there are a number of criteria
that the data must meet. Firstly, the data must have a
robust phylogenetic signal. Secondly, systematic biases
that may exist in the data must be minimized, these
include but are not limited to: long branch attraction
(LBA), amino acid composition bias, base composition
bias and unqualified ortholog predictions, all of which
may lead to inaccurate estimates of phylogeny. Thirdly,
sensitivity to taxa number is a known limitation of
methods for detecting positive selection, therefore more
than 6 taxa are needed to gain accurate estimations of
selective pressure using the maximum likelihood (ML)
method applied here [10].
In this study we have selected a subset of proteins that
have roles to play in reproduction. Our dataset was
composed of three major datatypes, (i) previously pub-
lished reproductive proteins, (ii) interacting proteins,
here we identified proteins shown to interact with (i),
and finally (iii), genes identified from microarray experi-
ments as being highly expressed in reproductive tissues.
For group (iii) we assume that those proteins highly
expressed in reproductive tissues are important for the
function of that tissue. The previously untested repro-
ductive proteins analysed here are from data types (ii)
and (iii) outlined above. These novel proteins are SP56,
Porimin and Col1a1. SP56 is sperm binding protein
number 56, this protein is a representative of the inter-
acting protein subset of sequences analysed. SP56 has
been shown to interact with ZP3 - a well-studied repro-
ductive protein. Both Porimin and Col1a1 have been
identified from published microarray experiments on
normal human tissue [11], and were selected for analysis
due to their high levels of expression in reproductive tis-
sues in that study. Porimin is a transmembrane protein
that is highly expressed in the uterus, prostate and pla-
centa and Col1a1 is highly expressed in the uterus.
Further evidence for the link between Porimin and
reproduction was not available in the literature and
therefore results from this particular gene are taken
with caution until this protein is further characterized.
Col1a1 plays an important role during spermatogenesis
where it mediates the detachment and migration of
germ cells, thus adding further support for its role in
reproduction [12].
We have analyzed these data with an approach sensi-
tive to all the systematic biases and limitations of meth-
ods given above. A number of genes in our dataset have
been analyzed previously but have not taken these lim-
itations and considerations into account. We have
expanded these datasets to include a greater number of
taxa, we have analyzed all of these genes for evidence of
systematic biases and we have used improved models of
codon evolution. In this paper we have included models
that allow for rate variation across the sequence and
across the phylogeny.
Results and Discussion
We performed phylogenetic analyses on all 11 datasets.
The resultant gene trees were found to conflict with the
canonical phylogeny species ([13], as adapted in Figure
1. The only exception was the Catsper1 mammalian
dataset. We postulate the following causes for this con-
flict: (1) amino acid and/or base composition bias, (2)
lack of phylogenetic signal in the data, and finally (3),
LBA caused by mixtures of long and short germ line
generation times (see Figure 2 for a sample of species
and their germ line generation times from our dataset).
What follows is a summary of the results of the tests of
data quality and bias we performed, see Table 1 for
synopsis. We carried out these tests to determine in
each case whether these conflicting phylogenies are
accurate descriptions of history or whether the data are
subject to these known issues listed 1-3 above. Subse-
quent statistical comparison of the gene trees and spe-
cies phylogeny using the Shimodaira Hasegawa (SH) test
[14] revealed that there is no statistical difference
between the gene and species trees in each case, see
Table 2 for results of SH tests. The only exceptions
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were Prkar2a and ZP3 where the presence of polytomies
in the gene trees caused the preference of the unre-
solved nodes over the resolved nodes.
1. Tests of Data Quality and Bias
(i) Test for amino acid and base composition biases
We tested all multiple sequence alignments (MSAs) for
evidence of significant levels of amino acid composition
bias and base composition bias in each lineage using the
TreePuzzle software [15]. We found that all alignments
passed the significance test with p-values < 0.05, see
Table 1 for summary. For full set of amino acid and
base composition bias test results, see Additional Files 1
and 2 respectively. In summary the discordance between
each of the gene trees and the canonical species phylo-
geny is not a result of amino acid or base composition
biases providing evidence of false relationships.
(ii) Test for phylogenetic signal
We performed the likelihood mapping procedure imple-
mented in the TreePuzzle software [15,16] to determine
the level of phylogenetic signal/conflict present in each
alignment, for more detail see the Methods section. Our
initial dataset consisted of 27 genes, we used this filter-
ing step to reduce our dataset to contain only those
genes with phylogenetic signal. We categorized the
results from the likelihood mapping analysis into 3 main
categories of signal: category 1 had strong phylogenetic
signal (see Figure 3a), category 2 had medium level of
phylogenetic signal (see Figure 3b) and category 3 had
low/no levels of phylogenetic signal (see Figure 3c). The
results of the test for phylogenetic signal are summar-
ized in Table 1 and in total 9 out of the 27 genes had
strong phylogenetic signal (category 1), with an addi-
tional 2 genes with moderate levels of phylogenetic sig-
nal (category 2). The complete set of results for the
likelihood mapping process is given in Additional File 3.
The remaining 17 genes failed the test (category 3). The
category 3 genes (with low or no levels of phylogenetic
signal) were subsequently removed from the analysis,
only 10 genes were retained for further analysis.
(iii) Long Branch Attraction (LBA) analysis
We assessed the data for evidence of LBA which would
manifest itself in the data by drawing species with a
greater number of mutations in the gene of interest
together erroneously on the phylogenetic tree. The
method applied uses the MSA and the corresponding
phylogeny to categorise rates amongst sites, using an
Table 1 Summary of the analysis of quality and bias present in the data
GENE DATA QUALITY PHYLOGENETIC ANALYSIS
LM Category AA Comp Bias Base Comp Bias Substitution
Model
Gene v Species Tree LBA
Artifact
Adam2 1 Pass Pass JTT+G Unresolved No
Catsper1 Exon1 1 Pass Pass JTT+I+G+F Unresolved No
Catsper1 Mammals 1 Pass Pass JTT+G+F Unresolved No
Col1a1 1 Pass Pass JTT+G Unresolved No
Ph20 1 Pass Pass JTT+G+F Resolved Yes
Porimin 1 Pass Pass JTT+G+F Unresolved No
Prkar2a 2 Pass Pass JTT+I+G Unresolved No
Semg2 1 Pass Pass JTT+G+F Unresolved No
Sp56 2 Pass Pass JTT+I+G Unresolved No
Zp2 1 Pass Pass JTT+G Unresolved No
Zp3 1 Pass Pass JTT+G+F Unresolved No
Genes with significant signal are given in the Likelihood mapping, or, L.M. Category column, see text for explanation of the category 1 and 2 in this column.
Results of the amino acid composition and nucleotide base composition bias tests, are shown in the A.A. Comp Bias and Base Comp Bias columns respectively.
The phylogenetic trees for each gene are drawn using the substitution model described where G = gamma distributed rates across sites, I = invariable sites, F =
frequency of amino acids, JTT = Jones Taylor Thornton model. In the case of LBA analysis, No = no evidence of LBA in the gene analysed, Yes = evidence of LBA
in the gene analysed.
Table 2 Summary of SH tests for complete gene datasets
Gene SH - gene SH - ideal Best-fit Tree
Adam2 1.0000 0.1200 NS
Catsper1 Exon1 1.0000 0.1460 NS
Catsper1 mammals 0.5020 1.0000 NS
Col1a1 1.0000 0.2650 NS
Ph20 1.0000 0.3220 NS
Porimin 0.4040 1.0000 NS
Prkar2a 1.0000 0.0490 gene
Semg2 1.0000 0.1010 NS
Sp56 1.0000 0.2380 NS
Zp2 0.1620 1.0000 NS
Zp3 1.0000 0.0050 gene
For each gene, the likelihood of estimated Bayesian phylogeny (gene) and
corresponding ideal species tree (ideal) to fit the dataset were determined
with the SH test at a 5% significance level. Values equal to 1.0000 represent
the tree with the lowest log likelihood, values less than 0.05 refer to those
cases where there is a significant difference between the two topologies, and
the gene tree is a significantly better fit to the data. NS = No Statistical
significance between gene and species tree, in these cases the species tree
was used.
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approach we have previsouly published for mammalian
data [17], as described in detail the Methods section. In
this method of site-stripping we apply the phylogenetic
tree (estimated ab initio in this software) and the MSA
to classify all sites in the alignment into one of eight
categories of mutation rate. These are arbitrary cate-
gories from 1-8; with 1 being the most highly conserved
sites and 8 being the most highly variable. Essentially,
these estimates allow us to select only the most con-
served sites for phylogeny reconstruction. Sites are
sequentially stripped from the alignments based on their
rate of evolution and phylogenies are created based on
slower evolving sites. These site-stripped phylogenies are
then compared to the species tree. Using two indepen-
dent methods of comparison we determined whether
the resultant stripped trees had topologies significantly
similar to the species phylogeny. The “root mean
squared deviation”, or RMSD, method is restricted to
binary trees [18], see Additional File 4 for full set of
results. Therefore we also employed the SH method of
Figure 1 Canonical mammalian species phylogeny. Shown here is a representation of the agreed relationships amongst the mammalia for
the species used in this analysis. The “?” on the lineage leading to horse indicates controversy over the position of this lineage on the
phylogeny.
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comparing phylogenies [14], see Additional File 5 for
full set of results. For a full description of the RMSD
statistic used here [18], see the corresponding section in
the Methods. Using this approach we could identify the
signature of LBA in the Ph20 dataset alone, see Table 1
for summary.
2. Analysis of selective pressures using codon models of
evolution
Following analysis of the phylogenies of these reproduc-
tive genes, we determined the selective forces at work
on these 10 genes (11 datasets). Only those genes pas-
sing the data quality tests were analyzed here (i.e. 10
genes), see Table 1. In the case of Catsper1, we have
analyzed the gene at two different evolutionary distances
because it contains high levels of insertion and deletion
events. The two datasets for Catsper1 are: exon 1 from
the primates only, and, the entire gene from only distant
mammalian groups. Hence the number of datasets is 11,
and the number of genes tested is 10. The alignments in
all cases reached significant levels following randomiza-
tion tests (z-scores > 1000 in all cases, a z-score of
greater than 5 is typically taken as significant).
In those cases where the genes had already been ana-
lyzed in previous studies, we expand upon the data in
these studies and use more sophisticated models of evo-
lution. ML methods are sensitive to sample size with a
minimum of 6 taxa recommended from simulation stu-
dies [10]. For a summary of the site-specific and line-
age-specific results, see Table 3 and Table 4
Figure 2 Selection of mammalia used in the analysis and the time to reproductive age in months. Species are shown on the X-axis in
alphabetical order. On the Y-axis is the number of months it takes for each species to reach reproductive age.
Figure 3 Example of likelihood mapping categories. (a), category 1 genes with strong phylogenetic signal the example given here is the
ZP2 gene, (b) category 2 genes with intermediate levels of phylogenetic signal, the example given here is the Prkar2a gene, and (c), category
3 genes with low/no phylogenetic signal, the example given here is the CD9 gene.
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respectively. For a summary of all likelihood ratio tests
(LRTs) performed in the analyses of these genes see
Table A9. In general the lineages tested in the lineage
specific analysis for each gene were as follows: modern
human; the primate ancestor; modern mouse, and the
rodent ancestor, these are indicated in Figure 4(a-k). For
certain datasets the species tested varied depending on
those species for which high quality sequence data
existed for that gene, these are discussed on a gene-by-
gene basis below. In summary, for each of the 11 data-
sets tested, positive selection was detected. In the site-
specific test between 7 and 94 sites per gene were iden-
tified as positively selected. In the lineage-specific ana-
lyses there were up to 2 lineages per gene identified as
having evidence of positive selection. Below is a brief
description of the results on a gene-by-gene basis, the
complete set of all parameters, likelihood values and
LRTs are given in Additional File 6.
Col1a1
Possibly the most intriguing result from our entire ana-
lysis is that from the Col1a1 protein. According to the
microarray study employed here [11], Col1a1 is highly
expressed in the uterus tissue. It is also found in most
structural tissues including cartilage, bone, tendon, skin
and part of the eye (sclera). It is a member of the group
1 collagen proteins involved in the development of the
uterine fibroids [19]. There are two propeptide regions
to the Col1a1 gene, denoted N- and C-terminal propep-
tides. According to studies on Col1a1 function, a role
has been established for Col1a1 in spermatogenesis [12].
Our site-specific analysis shows 66 sites evolving with
an ω value of 4.09, see Table 3. In summary 35/66 of
our positively selected sites fall in the N-terminal pro-
peptide region (23-161) and 9/66 positively selected sites
fall in the C-terminal propeptide region (1219-1464),
this can be seen clearly in Figure 5a. Position 162 in
Table 3 Summary of the results of the site-specific analysis: in each case the most significant model was M8
Gene n Parameter estimates # Positively selected Sites
Adam2 12 p0 = 0.92632 p = 0.37637
q = 0.60688
p1 = 0.07368 ω = 3.94326
45>0.50
15>0.95
5>0.99
Catsper1_Exon1 (primates only) 16 p0 = 0.82736 p = 0.13661
q = 0.03850
p1 = 0.17264 ω = 3.13071
95>0.50
7>0.95
1>0.99
Catsper1_Mammals
(non-primate mammals only)
8 p0 = 0.83315 p = 0.34233
q = 0.51278
p1 = 0.16685 ω = 3.26879
124>0.50
30>0.95
8>0.99
Col1a1 10 p0 = 0.98023 p = 0.04796
q = 0.32286
p1 = 0.01977 ω = 4.09285
66>0.50
21>0.95
8>0.99
Ph20 11 p0 = 0.87658 p = 0.56141
q = 0.83349
p1 = 0.12342 ω = 2.20500
39>0.50
3>0.95
0>0.99
Porimin 10 p0 = 0.85067 p = 0.41864
q = 0.32952
p1 = 0.14933 ω = 12.21841
30>0.50
13>0.95
5>0.99
Prkar2a 17 p0 = 0.95102 p = 0.16339
q = 0.98823
p1 = 0.04898 ω = 2.60992
19>0.50
4>0.95
0>0.99
Semg2 12 p0 = 0.97236 p = 0.01163
q = 0.00500
p1 = 0.02764 ω = 12.26405
41>0.50
5>0.95
2>0.99
Sp56 14 p0 = 0.98807 p = 0.16114
q = 1.12262
p1 = 0.01193 ω = 3.81710
8>0.50
2>0.95
2>0.99
Zp2 18 p0 = 0.87339 p = 0.63945
q = 0.75356
p1 = 0.12661 ω = 2.04655
52>0.50
9>0.95
6>0.99
Zp3 13 p0 = 0.91489 p = 0.30029
q = 0.77328
p1 = 0.08511 ω = 1.92305
48>0.50
0>0.95
0>0.99
Following LRT analysis M8 was chosen in each case as the most significant model. n refers to the number of taxa in each dataset. The proportion of sites (p),
evolving under each corresponding selective pressures (ω) are shown. For example, p0 refers to the proportion of the protein evolving under the selective
pressure value given by ω0. The parameters p and q describe the beta distribution. The final column gives the number of sites with posterior probability (PP) of
0.50, 0.95 and 0.99 that belong in the positively selected category or sites. The number before the “>“ refers to the number of sites with a specific PP value.
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Col1a1 is cleaved and modified by an endopeptidase,
position 162 is also modified by pyrrolidone carboxcylic
acid (Swiss-Prot PO2452). A positively selected site at
position 163 is neighboring this multifunctional site,
suggesting that there has been an evolutionary effort to
improve cleavage and/or modification in this protein.
Variations in Col1a1 are linked with Osteogenesis
Imperfecta (OI), an autosomal dominant disease, result-
ing in an inability to make the correct collagen protein.
There are a spectrum of OI conditions, the most severe
is OI type 2 (OI-II) leading to death in the perinatal
period. A recent extensive study of the Single Nucleo-
tide Polymorphisms (SNPs) associated with OI has
revealed a number of substitutions of glycine residues
within the triple helical domains of the Col1a1 protein
[20]. The total number of disease implicated sites in the
Swiss-Prot entry P02452 for Col1a1 is 99: 4 of these are
OI non-specific, 4 are OI-I, 59 are OI_II, 14 are OI-IV
and 15 are SNPs (2 are associated with another disease).
One third of the mutations that result in substitutions
for glycine in Col1a1 are lethal whereas those between
the start codon and position 200 are non-lethal. Only 1
of the sites we have identified as positively selected is in
the non-lethal domain from position 1-200, this is site
195. This positively selected site is neighboring the SNP
position 197 that causes a mild OI phenotype. In Table
5 we show a list of 11 positively selected sites that fall
in close proximity to sites associated with disease and
are located between 280 and 1456, spanning the impor-
tant triple helix region. These positions are all within 1
to 5 amino acid residues of known disease variants, 8 of
these disease variants are the severe/lethal OI-II disease
form. Two exclusively lethal regions, helix positions
691-823 and 910-964 aligned with major binding regions
[20] and we find a positively selected site in this region.
Following a randomization test for the positively
selected sites and disease implicated sites (as denoted by
Swiss-Prot entry PO2452), we have found that the pat-
tern we observe, i.e. finding positively selected sites in
close proximity to disease implicated sites is significant
in 3 out of the 11 cases examined here (at P < 0.05).
Lineage-specific analysis shows evidence for positive
selection in this protein in the rodent ancestor. In total,
2.2% of the sites in the rodent ancestor have ω = 72.73,
while the rest of the species are evolving under purifying
selection, ω = 0.013. For a summary of site and lineage
specific results for Col1a1, see Table 3 and 4. For com-
plete set of results see Additional File 6(d).
Prkar2a (interacts with SEMG2)
Prkar2a is a cAMP dependent protein kinase that is
attached to the sperm flagella via regulatory subunit
(RII) [21]. Protein tyrosine phosphorylation has been
linked with successful fertilization due to hyper-acti-
vated sperm motility [22]. This increase in phosphoryla-
tion is part of a cAMP dependent pathway that activates
protein kinase A [22].
Table 4 Summary of lineage-specific positive selection detected.
Species tested as Foreground Significant LRT Parameter estimates
P Fwd ω Bck ω
Adam2
Macaque ModelA v M1 9.57% 1.71 0.10/1
Catsper1 Mammals
Ferungulata ModelA v M1 4.46% 998.99 0.09/1
Rodents ModelA v M1 5.45% 999.00 0.084/1
ModelB v m3Discrtk2 4.47% 999.00 0.12/1.38
Col1a1
Rodents ModelA v M1 2.17% 72.73 0.013/1
ModelB v m3Discrtk2 1.93% 72.77 0.02/1.35
PH-20
Guinea Pig ModelA v M1 6.3% 11.48 0.13/1
ModelB v m3Discrtk2 6.14% 12.57 0.14/1.10
Prkar2a
Macaque ModelA v M1 2.37% 999.00 0.04/1
ModelB v m3Discrtk2 2.53 999.00 0.04/1.22
Sp56
Human ModelB v m3Discrtk2 100% 62.40015 0.02/0.55
Glires ModelB v m3Discrtk2 2.56% 1.03 0.02/0.55
Summary table of significant results for lineages specific analyses following LRT analyses. Lineages tested as foreground (Fwd) are shown in the first column.
Only those lineages with significant LRT values for Model B or Model A and ω >1 are shown here. Parameter estimates are given for the LRT values highlighted
in bold. P is the proportion of sites under selection the corresponding selective pressure as measured by ω. Fwd ω and Bck ω scores for the foreground species
and background species respectively are given in the final column.
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The PRKA families were previously tested for positive
selection using 3 to 4 taxa and site-specific model M8
with no significant results for positive selection reported.
With our 17 taxa dataset, we were able to detect that
4.7% of sites were evolving at a rate of ω = 2.60, see
Table 3 for summary of details.
Positively selected sites detected in the site-specific
analysis of Prkar2a were compared to the human Swiss-
Prot sequence (P13861). In total 18 sites were predicted
to be positively selected, 17 of these sites occur in the
region of the protein associated with dimerization and
phosphorylation (2-138), see Figure 5(c). In the Swiss-
Prot entry there are a number of residues listed as being
modified by phosphoserine. These are positions 58, 78,
80, 99 and phosphothreonine at position 54. The sites
estimated to be positively selected from our analysis are:
58, 59, 61, 62, 63, 64, 65, 68, 70, 74, 75, these sites are
at or in close proximity to these modified residues.
The regulatory subunit alpha 2 of Prkar2a has been
shown in vitro to interact with Semg2. The phosphory-
lation of Semg2 may lead to its activation into forming
a gel matrix in the female reproductive tract. From our
analysis it is shown that while Semg2 has positively
selected sites dispersed throughout its sequence,
whereas the positively selected sites for Prkar2a are loca-
lized to the N-terminus region, and the remainder of the
gene is under strong purifying selection. Literature has
so far not specified an exact phosphorylation site for
Semg2, which prevents us from commenting further on
its interactions with Prkar2a.
Lineage-specific analysis shows that Prkar2a in the
macaque has undergone a greater selective pressure to
change when compared with other mammalia in the
dataset, with 2.53% of sites evolving at ω = 1.22, see
Table 4 for summary of results. For complete set of
results for Prkar2a, see Additional File 6(g).
Ph20 (interacts with ZP2 and ZP3)
Ph20 is expressed in the testis and found in the acro-
some of the sperm. It is also codes for a receptor that is
involved in the sperm to zona pellucida (ZP) adhesion
[23].
Previous analysis conducted on this protein involved 6
taxa [24]. Here we have increased the number of taxa to
11. We have omitted the carnivores from our analysis of
Ph20 as the sequences were spurious. We found evi-
dence for LBA in the Ph20 dataset. By removing fast
evolving sites a fully resolved gene phylogeny is
obtained. This gene tree now is in agreement with the
ideal species phylogeny ([13].
Lineage-specific analysis shows that guinea pig is
under positive selection, with 6.1% of sites with ω =
12.57 while all other species in the background are evol-
ving at ω = 0.14 or neutrally, see Table 4. The 39 posi-
tively selected sites were then compared to the human
Swiss-Prot sequence (P38567), see Figure 5(b) for
results. Catalytically important resides 146, 148, 211 284
and 287 when mutated result in a reduction in, or loss
of, activity [25]. It has been shown experimentally that
mutations in the region of this active site significantly
reduce or completely block the function of this protein
[25]. Our results show that 3 of the positively selected
sites, 155, 272, 273, are in close proximity to these
regions. Another 5 positively selected sites: 83, 155, 252,
353 and 391 are close to glycosylation sites, see Figure 5
(b). These sites when modified are known to change the
structure and function of the Ph20 protein. For com-
plete set of results for Ph20 see Additional File 6(e).
These results are of significance as the Ph20 protein
changes position in the sperm during the different
stages of the fertilization process. In guinea pig Ph20
protein is known to migrate from the post acrosomal
membrane to the inner acrosomal membrane [26]. Thus
finding these positively selected sites in close proximity
to these glycosylation sites in guinea pig suggests that
these sites have been selected to modify the Ph20 struc-
ture more effectively thus increasing the chance of
capacitation.
SP56 (interacts with ZP2 and ZP3)
The binding of sperm to the zona pellucida (ZP) is cru-
cial for gamete formation to take place. The exact
mechanisms of this process are still to be uncovered
therefore any predictions on important residues will
greatly improve knowledge by directing mutational stu-
dies. SP56 has been shown through photoaffinity cross-
linking experiments to have a specific binding affinity
for ZP3 [27]. Therefore it is believed to play an impor-
tant role in the binding of sperm to the ZP matrix.
Experiments have shown that during capacitation SP56
is released from the acrosomal matrix and becomes situ-
ated in the sperm head membrane, enabling it to act as
a ZP3 binding protein [28].
Here we have found 8 positions in the SP56 protein
that are under positive selection (ω = 3.82) following
site-specific analysis. These sites were compared to the
human SP56 entry in Swiss-Prot (Q13228) to determine
possible links to function. One of these 8 positively
selected sites is position 122, regarded as a SNP number
(rs35396382) in dbSNP database [29]. Although further
experimental work needs to be conducted to decipher
the clinical association of this position, it is extremely
interesting that our most significant positively selected
site also displays variation in the population, especially
given the overall high level of conservation in this gene.
For summary of results see Tables 3 and 4, and for full
set of results for this gene see Additional File 6(i).
ZP2
Zona pellucida (ZP) proteins form the complex glyco-
protein coat that surrounds the oocyte [30]. These ZP
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proteins have been shown to be under strong pressure
to change, and results have been published on both site
and lineage analyses [31]. Here we have expanded the
analysis of ZP2 to include 18 taxa (maximum previously
tested = 8 [31]). We have also applied more complex
models of evolution and have sampled deeper branches
on the phylogeny including a representative of the
Afrotheria - elephant.
In this case, the results of our larger dataset and
more complex models show that the values of ω deter-
mined here vary slightly when compared to previous
analyses [31]. This previous test showed 4.7% of sites to
have ω = 2.5, increasing the size of the dataset in this
study results in 52 sites in ZP2 that have an ω value of
2.05. See Additional File 6(j) for complete results.
Positively selected sites were compared to the human
Swiss-Prot entry for ZP2 (Q05996) to identify possible
function for these sites, see Figure 5(d). ZP2 contains 7
carbohydrate chains situated between sites 87-462, these
are important for the sperm to bind to the ZP of the
egg coat [32]. Of the 46 sites identified to be under
positive selection, 23 fall between positions 66-257, this
region contains 5 of the binding domains of the carbo-
hydrate chains. The clustering can be seen more clearly
Figure 4 Results of lineage specific positive selection analysis on 11 datasets. The phylogeny used for each gene is a reduced version of
the species phylogeny. The lineages labeled as foreground in the analysis are denoted in the diagram with asterix symbols. These are the results
following LRT analysis. Those lineages where positive selection was determined are represented by red pentagons.
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in Figure 5(d). Another cluster of positively selected
sites (10 sites in total) occurs in the propeptide region
(641-745). It has been suggested that upon the cleavage
of the propeptide region, the mature ZP2 protein plays
a role in the prevention of polyspermy [33].
ZP3
Analysis of site-specific evolution in ZP3 identified 48
positively selected sites. Of specific interest are positively
selected positions 329, 330, 332, 336, 338, 339, as these
sites were in close proximity to identified sperm binding
sites (329-334) [34], see Table 3. The furin cleavage site
is identified at position (350-353), and the propeptide
domain at position (351-424). When cleavage takes
place the ZP3 undergoes a conformational change that
inhibits any further sperm binding to the coat thus pre-
venting polyspermy [35]. Of the 48 positively selected
sites identified, 10 fall within the propeptide domain,
with an additional 12 occurring close to the vicinity of
the furin cleavage and sperm binding sites, thus
suggesting that there is a pressure to improve binding
and prevent polyspermy. For complete set of results for
ZP3, see Additional File 6(k).
Adam2 (Fertilin b)
Adam2 is a cell adhesion molecule that plays a funda-
mental role in the final binding of sperm to the oocyte
membrane [36]. Indirect interactions have been shown
with female proteins CD9 [37]. (We have not continued
further analysis on CD9, as it failed the likelihood map-
ping test).
Previous results have been published reporting posi-
tive selection using site-specific analysis on 6 taxa [24].
Here we have included 12 taxa for Adam2 and we have
investigated the possible functional implications of posi-
tively selected sites found. In the site-specific analysis
we find 7.3% of sites with ω = 3.94, this corresponds to
45 sites in total, see Table 3. Comparison of these posi-
tions to human Swiss-Prot Adam2 sequence (Q99965),
we determine that 39/45 positively selected sites are
Figure 5 Results of positive selection analysis for 4 genes. Each of the four graphs represents the CDS of a gene from position 1 to the
stop codon (X-axis). The Y-axis is the posterior probability of each of the sites belonging to the positively selected category. The dark blue data
points are sites estimated to be under positive selection. Alternative pale blue and white regions depict alternative domains in the protein, this
data is taken from Swiss-Prot. The vertical red bars in each case represent functionally important sites, these are specific to each gene as follows:
(a) Col1a1, (i) Cleavage site by procollagen N-endopeptidase, (ii) O-linked Gylcosylation site, (iii) Cell attachment site, (iv) Cell Attachment site,
and (v) O-linked Glycosylation site. (b) PH20, (i) active site, proton donor, (ii) and (iii) are positions when mutated result in loss of activity, and
(iv) N-linked Glycosylation site, (c) Prkar2a, (i) and is a Phosphothreoinine modified residue, (d) ZP2, (i), (iii) and (iv) are N-linked Glycosylation
sites, and (ii) is the cleavage site.
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situated in the C-terminus region. On closer investiga-
tion of these sites we find that 12/45 positively selected
sites occur in the disintegrin domain (position 384-473).
The disintegrin domain has been shown to be involved
in the binding of Adam2 to the oocyte [38]. A cysteine-
rich domain occurs between (477-606), 16/45 positively
selected sites fall in this region. It has been suggested
for Adam12, (another member of the Adam family of
proteins), that the cysteine-rich domain plays a role in
mediating the cellular interactions via syndecans and
integrin [39], a similar role for this domain in Adam2
can be postulated. Overall the results for Adam2 suggest
a selective pressure for increased binding of Adam2 to
the oocyte regardless of species of origin. For a complete
set of results and LRTs for Adam2, see Additional File 6
(a).
Catsper1
Catsper1 is involved in regulating the calcium cation
channel in sperm flagella, the result of which is
movement of sperm [40]. Previous studies on Catsper1
exon 1 have been performed [41]. We intended to
expand our analysis to span all exons and expand the
data set to include a variety of mammalia. However, the
exon 1 of non-primate mammalia is so highly variable
that an accurate alignment cannot be constructed. The
remaining exons were highly conserved across all spe-
cies. We therefore split our catsper1 dataset into two
sections each of which produced a good quality align-
ment for analysis, (1) exon1 of catsper1 for the primates,
and (2) entire catsper1 gene for non-primate mammalia.
(a) Catsper1 Exon 1 primatesSite-specific analysis of
this protein identified 17% of the protein under positive
selection with ω = 3.13. Previous analysis of this exon
showed positive selection on indel substitutions in this
gene [41]. The positively selected sites are situated
throughout exon1, little is known about the functional
significance of these sites. However, it is known that
exon 1 has a significant role to play in altering the rate
Table 5 Summary of the positively selected sites in the col1a1 gene, their clinical relevance, and, the probability of
being located within distance “d” from the nearest disease-implicated site.
Positively
selected sites
Posterior
Probability
Human Variant:
SNP position
Distance
(d)
Probability of
being d
from nearest
disease-
implicated site
Genetic code distances between
observed character states
Clinical
Association
195 0.926 197 2 0.04 A-N = 2 G ®
C
mild
phenotype
280 0.588 275 5 0.26 A-S = 1; S-T = 1; T-A = 1 G ®
D
OI-II
478 0.959 476 2 0.128 A-S = 1; S-T = 1; T-A = 1 G ®
R
OI-II
784 0.968 776 8 0.396 A-S = 1; S-T = 1; T-A = 1 G ®
S
OI-II
1032 0.535 1025 7 0.364 A-P = 1 G ®
R
OI-II
1063 0.826 1061 2 0.128 N-S = 1 G ®
D
OI-II
1061 2 0.032 N-S = 1 G ®
S
OI-IV
1149 0.623 1151 2 0.032 A-S = 1 G ®
S
OI-III
1151 2 0.128 A-S = 1 G ®
V
OI-II
1194 0.675 1195 1 0.076 A-G = 1; G-S = 1; S-A = 1 G ®
C
OI-II mild
form
1196 0.972 A-F = 2; F-Y = 1; Y-A = 2
1316 0.928 1312 4 0.24 K-N = 1; N-P = 2; P-K = 2 W ®
C
OI-II
1456 0.997 1460 4 0.1 C-F = 1; C-L = 2; C-M = 2; F-L = 1; F-M
= 2; L-M = 1
P ®
H
dbSNP:
rs17853657
The sites under positive selection in the col1a1 protein and their associated posterior probabilities (PP) are shown. The third column shows variant positions
(SNPs) as determined using Swiss-Prot human (PO2452) sequence. The fourth and fifth columns show the residue distance “d” of the positively selected site from
its nearest genetic variant, and the probability of being located “d” residues from any disease implicated site by random chance alone. The sixth column uses
single-letter amino acid symbols to show the genetic code distances between all observed character states at each positively selected site. “Clinical Association”
show the replacement substitution at the human variant position and its clinical association with that human variant. OI = Osteolysis imperfecta, OI-I to -IV. The
final entry for dbSNP is database entry number rs17853657 and as yet has not been associated with OI although it is in the same domain as the other disease-
causing SNPs.
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of calcium ion channel inactivation. Different lengths in
the N-terminus result in different rates of channel inac-
tivation, where a long terminus results in a longer time
to activation than the shorter terminus. This is
described most effectively by the ball and chain mechan-
ism described in [41]. See Additional File 6(b) for com-
plete results. These results show the importance of this
protein, and specifically the first exon, for reproductive
success.
(b) Catsper1 entire gene non-primate mammalsOur
site-specific analysis identified 16.7% of the sites under
positive selection with an ω = 3.27, see Table 3. These
sites all cluster in exon 1. While the rodent ancestor
appears to be under positive selection with 4.47% of its
sites evolving at ω = 999, see Additional File 6(c) for
complete set of results. A previous study of 9 rodent
species, including Mus musculus individuals from 4 dif-
ferent populations, has shown that within the rodent
order there has been a continued pressure to evolve,
with positive selection for indel substitutions in exon1
of the Catsper1 gene [43].
Semg2
A member of the family of semenogelin genes, Semg2 is
involved in the formation of a postcopulatory plug [44].
Previously, positive selection has been reported for both
site-specific and lineage-specific analysis for Semg2
[9,45]. We have expanded the data set from previous
analyses to incorporate more species.
In our site-specific analysis, we found that 2.7% of our
sites had an ω value of 12.26, see Table 3.
We have performed a novel functional analysis of
these positively selected sites by comparing them to the
human Semg2 sequence (Q02383) in the Swiss-Prot
database. This is a step not previously taken by other
studies of Semg2. A striking pattern emerged - all
known domains of this protein have several positively
selected sites. There is a probable glycosylation site at
position 272, which is located close to a large stretch of
positively selected sites (positions 262 to 289). It is so
far unknown how significant this glycosylation site is in
Semg2 and whether it plays a role in modifying the pro-
tein to form a copulatory plug. However, the results
indicate that this protein, and in particular the region
around the glycosylation site, has been under significant
pressure to change.
A complete set of results for Semg2 is given in
Additional File 6(h). The lineage-specific results are
not described here in detail as lineage analyses have
been carried out previously on the primate Semg2
gene [9,45]. It has been shown recently that the rate
of evolution for this protein varies depending on the
level of sperm competition [9]. Our results are in
agreement with this finding, thus further verifying our
approach.
Porimin
Two isoforms of this protein have been identified; we
have focused on isoform 1 in the mammalia, as isoform
2 contains an additional human specific region between
residues 34-52. To date the exact mechanisms of this
transmembrane receptor are unknown. This protein is
not well characterized biochemically and its function
cannot be verified as reproduction related, therefore we
only discuss the results briefly below.
On site-specific analysis of this protein we determined
that 30 of the sites are under positive selection (ω =
12.22), see Table 3. From analysis of the sites on the
Swiss-Prot entry for human Porimin (Q8N131), we
could determine that two positively selected sites (146
and 147), were found in a highly conserved region and
fall in close proximity to the N-linked glycosylation site.
For complete set of results for Porimin, see Additional
File 6(f).
Conclusion
Testing for phylogenetic signal and biases, such as
amino acid composition bias and LBA, indicated that
there was adequate phylogenetic signal for 10 of the
genes and in general no evidence of systematic biases.
On testing for LBA, Ph20 was the only protein in this
dataset that displayed the typical signature of this bias
with gene and species tree agreement being maximized
with the removal of the fastest evolving categories. This
would suggest that while germ line generation times
vary greatly in the dataset, the effect of the resultant
LBA does not impact on the sequence data to any great
extent (1/11datasets).
Selective pressures for the reproductive proteins stu-
died here are heterogeneous. All proteins exhibited
regions of strong conservation proving the importance
of maintaining structural stability and overall function
in these proteins. All but 1 protein (Adam2) exhibited
evidence of positive selection in specific lineages, and
all proteins without exception exhibited positive selec-
tion in regions of catalytic/functional importance. For
SP56 and Col1a1 the site-specific results are entirely
novel. The lineage-specific results described here for
Prkar2a and Catsper1 exon 1 in primates, are also
novel. We have shown that, in the case of Catsper1,
there is a fundamental protein functional shift between
new world monkeys and old world monkeys. The Dn/
Ds measurement applied here assumes that neutral
substitution rate is akin to Ds, therefore no selection
on silent sites. There have been many publications of
late to the contrary therefore we are mindful of exam-
ining the rate of silent substitution in all our analyses
[46,47].
For the reproductive genes in our dataset, we show
that lineages evolve at unique rates and at functionally
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crucial sites, specifically those involved in phosphoryla-
tion. We have also shown that a number of these pro-
teins (Col1a1 and Catsper1) show positive selection for
example in the ancestral rodent lineage and evidence of
purifying selection in the subsequent divergent species.
Overall our analyses of these reproductive proteins
show how important it is to carefully examine data for
systematic biases prior to testing for lineage and/or
site specific positive selection. We have also demon-
strated the importance of including large numbers of
taxa/lineages in these analyses. This finding was high-
lighted in our analysis of Prkar2a where previous ana-
lysis of this protein had included only 4 taxa and
therefore reported a negative result. We do not
observe any large-scale effect of germ line generation
time in our dataset, with only 1 protein (Ph20) with
evidence of long branch attraction. The results of
Col1a1 indicate that the positively selected sites may
have been of such importance for this protein that
neighboring mutated sites may have been maintained
in the population despite their propensity for causing
disease. The location of positively selected sites deter-
mined using this approach and in regions of functional
importance in the proteins in this dataset, provides us
with further evidence of the link between functional
shift and positive selection.
Methods
The data analyzed in this study consist of homologous
reproductive genes from a variety of mammalian gen-
omes. Genes were identified as being reproduction
related from literature searches, analysis of protein
interaction networks (iHOP) [48] and expression
(microarray) data [11]. The microarray expression data
used is from normal human tissues. We have also
included a more in-depth analysis of previously identi-
fied cases of positive selection in reproductive proteins.
A list of all data used in this study are available in
Additional File 7, the total number of genes analyzed
was 10. Homologs of all 10 reproduction related genes
were identified in mammalian genomes that span the
entire phylogeny of mammals, see Figure 1. For each
of the reproduction related genes, the alignment of
homologs contained between 10 and 18 species, and
the alignment length varied between 351 and 4374
base pairs.
Sequence Data
Protein coding sequences for the reproductive proteins
were retrieved by the combination of two methods;
Ensembl and Blast searches. Orthologous coding
sequences from all available completed mammalian gen-
omes were retrieved from the Ensembl database [49].
These orthologs had been identified previously by
performing a genome-wide reciprocal WUBlastp
+SmithWaterman search of each gene across all com-
pleted genomes. To include those mammalia that were
not present in Ensembl a BlastP search was conducted
on all the human amino acid sequences from each gene
against the Swiss-Prot database.
Mammalian Species
Primates: Human (Homo sapiens), Chimp (Pan troglo-
dytes), Bonobo (Pan paniscus), Bornean Orangutan
(Pongo pygmaeus), Sumatran Orangutan (Pongo abelii),
Gorilla (Gorilla gorilla), Rhesus Macaque (Macaca
mulatta), Crab eating Macaque (Macaca fascicularis),
Pigtailed Macaque (Macaca nemestrina), Bonnet mon-
key (Macaca radiata), Baboon (Papio hamadryas),
Mantled Guereza (Colobus guereza), Vervet Monkey
(Cercopithecus aethiops), Angolan Talapoin (Miopithe-
cus talapoin), Squirrel Monkey (Saimiri sciureus), Cot-
ton top tamarin (Saguinus oedipus), Common
Marmoset (Callithrix jacchus), Marmoset/Callithrix
(Callithrix-jacchus), Spider Monkey (Ateles geoffroyi),
Bushbaby (Otolemur garnettii), Common woolly mon-
key (Lagothrix lagotricha), Ringtailed lemurs (Lemur
catta), Kloss Gibbon (Hylobates klossii), Common/Lar
Gibbon (Hylobates lar), Night/owl Monkey (Aotus tri-
virgatus boliviensis). Scandentia: Treeshrew (Tupaia
belangeri). Rodents: Mouse (Mus musculus), Rat (Rat-
tus norvegicus), Guinea pig (Cavia porcellus), Ground
Squirrel/Squirrel (Spermophilus tridecemlineatus).
Lagomorpha: Rabbit (Oryctolagus cuniculus), Pika
(Ochotona princes). Eulipotyphila: Hedgehog (Erinaceus
europaeus), Shrew (Sorex araneus). Carnivores: Cat
(Felis catus), Dog (Canis familiaris). Artiodactyla: Cow
(Bos taurus), Pig (Sus scrofa). Perisodactyla: Horse
(Equus caballus). Proboscidea: Elephant (Loxodonta
africana). Monotremata: Platypus (Ornithorhynchus
anatinus). Didelphimorphia: Opossum (Monodelphis
domestica).
Multiple Sequence Alignment (MSA)
All coding sequences were translated into their corre-
sponding amino acid sequences using in-house transla-
tion software. Gene family alignments were generated at
protein level using ClustalX 1.83.1 using default para-
meter settings [50]. The corresponding nucleotide gene
family datasets were aligning based on their protein
alignments using in-house software. Each gene family
alignment was manually edited using Se-Al [51] to
remove any ambiguous regions.
Nucleotide composition bias, amino acid composition
bias and likelihood mapping tests
TreePuzzle 5.2 [15] performs a chi-square test that
compares the amino acid composition of each
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sequence to the frequency distribution assumed in the
General Time Reversible (GTR) and Jones Taylor
Thornton (JTT) models [52]. Ideally no species should
fail this test, however, where two species fail and are
thus drawn together on a tree, these sequences are
excluded. Using the likelihood mapping method, each
tree is disassembled into its constituent quartets and
the support for each possible quartet is assessed. If the
data contains phylogenetic signal then the likelihood of
all three possible relationships for that quartet will be
equally likely, these are represented by the three tips
of the triangle, and the majority of the signal will be in
these tip regions. Otherwise, the vertices and central
region will be most heavily populated by supporting
quartets.
Phylogeny Reconstruction
Phylogenetic trees were constructed using MrBayes
v3.2.1 [53] and the amino acid sequences. Amino acid
sequences were used in order to vitiate the effects of
base and codon compositional biases. The substitution
model was selected following model testing using Mod-
elgenerator version 85 [54]. The selected model was
JTT, the GTR rate model was implemented and the first
20000 trees for each gene were discarded as “burnin”. A
majority rule consensus tree from the remaining trees
sampled was constructed for each gene. The parameter
settings for each gene phylogeny are summarized in
Additional File 8.
Site-stripping for significance
To test for long branch attraction (LBA) we applied the
slow-fast approach of Brinkman and Phillipe [55]. We
implemented the rate categorisation in a maximum like-
lihood framework in TreePuzzle 5.2 [15]. This software
takes the alignment as input and generates ab initio
phylogenetic trees. It then calculates the rate of muta-
tion for each site in the alignment. The software speci-
fies 8 arbitrary categories of site: each one of these
categories contains some portion of the alignment. In
this manuscript 8 is the most rapidly evolving (for
example every lineage has a different character state for
that character), and category 1 is the most slowly evol-
ving (for example each lineage has the same/identical
character state for that character). Sites are then pro-
gressively removed from the protein MSA according to
their evolutionary rate, and at each stage a new phyloge-
netic tree is constructed based on this slightly reduced
dataset. The difference between the new topology cre-
ated on a reduced alignment and the original topology
reconstructed based on the entire alignment are then
compared in a statistical framework to determine which
fits the data best (SH Test 2, see below) or which is
most similar to the species phylogeny (RMSD Test 1,
see below). At each stage we employ MrBayes [56] to
perform the phylogenetic reconstruction using the afore-
mentioned settings.
Tests of the difference between two trees
Test 1: Nodal distance calculation
TOPD/FMTS v 3.3 [18] calculates the distance
between the site-stripped trees and the ‘ideal’ tree. The
‘ideal’ tree used for each gene was a pruned version of
the canonical species tree as seen in Figure 1. A dis-
tance matrix is derived by counting the number of
nodes that separate each of the taxa in a tree. A dis-
tance matrix is calculated for each site-stripped tree as
compared to the ideal species tree. The nodal distance
score is obtained by calculating the RMSD of the
matrices. If both trees are identical the RMSD value
would be 0, indicating no distance between them. This
figure increases the more distance there is between the
two trees.
Test 2: Shimodaira-Hasegawa (SH) statistical test of two
trees
For each gene MSA, complete and site-stripped, a com-
parison of the likelihood of the estimated Bayesian phy-
logeny for that alignment with the likelihood of its
corresponding ‘ideal’ species tree was carried out using
the SH test [14] implemented in TreePuzzle 5.2 [15] to
determine which tree was significantly the best-fit tree
for the alignment.
Selective Pressure Analysis
PAML 4.3 [57,58] uses a ML method of calculating ω
for site-specific and lineage-site specific changes.
Codeml, part of the PAML 4.3 package [57,58], applies
a series of models to our data, with each model differ-
ing from the previous with the addition of more com-
plex parameters. The simplest model is M0, and it
calculates an ω value over the entire alignment. This
model assumes that all sites and all lineages are evol-
ving at the same rate. Model M3 is an extension of
M0 and allows all ω values to vary freely. There are
two variations of the M3 model, m3(k = 2) discrete
which allows two variable classes of sites and m3(k =
3) which allows three classes of site. M1 is a neutral
model that allows two parameter estimates for propor-
tion of sites where ω = 0 or ω = 1. M2 is the selection
model, it allows three parameters where ω = 0 or ω =
1 or ω is estimated and free to be greater than 1. M7,
is the beta model, it allows ten different site classes for
ω between 0 and 1. M7 is compared against the more
parameter rich M8 (beta &omega >1). M8 allows 10
different site classes but contains an additional para-
meter whereby the 11th ω is free to vary between 0
and >1. M8a(beta &omega = 1) is null hypothesis of
model 8. Model A & Model B are models that allow
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testing of ω variation in lineage-site analyses. Model A
is an extension of M1 and Model B is a more para-
meter rich extension of m3(k = 2). We have also
implemented model A null which is denoted as mod-
elA1 elsewhere. Model A null is compared to model A
in an LRT as per Additional File 9. Only statistically
significant models for the data are taken into account.
Statistically significant results were decided by calculat-
ing the difference in log likelihood or, lnL, scores
between models and their more parameter rich exten-
sions in a likelihood ratio test (LRT) as described pre-
viously in [17,58]. If the likelihood score was exceeded
the critical c2 values, then the result was significant.
See Additional File 9 for full set of LRTs performed.
In silico analysis of positively selected sites
Sites under positive selection (ω > 1) were estimated
using the empirical Bayes methods in the site-specific
and lineage specific analysis performed. The methods
used were naúve empirical Bayes (NEB) and Bayes
empirical Bayes (BEB) [58]. Swiss-Prot is a protein
sequence database that provides description of the func-
tion of a protein, the domain structures, post-transla-
tional modifications and variants. Significant sites,
verified through close examination of the MSAs and
codeml output using alignment visualisation software
Se-AL [51], were compared with unaligned human
amino acid sequence taken from Swiss-Prot. These sites
were examined to see whether or not they lay in cataly-
tically important regions of the protein.
Additional file 1: Additional Table 1 - Results of amino acid
composition bias per gene. Results of the amino acid composition bias
test and shown here on a per gene basis. We would expect that if two
species have similarly and significantly (P < 0.05) biased amino acid
composition that they would be drawn together on the phylogeny.
Those with P < 0.05 scores are highlighted but are dispersed throughout
different genes. The frequency distribution assumed in the maximum
likelihood model calculated by Tree-Puzzle (5% chi-square p-values) was
used. N/A = species not represented in the gene dataset.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2148-10-
39-S1.DOC ]
Additional file 2: Additional Table 2 - Results of base composition
bias per gene. Results of the base composition bias test and shown
here on a per gene basis. We would expect that if two species have
similarly and significantly (P < 0.05) biased base composition that they
would be drawn together on the phylogeny. Those with P < 0.05 scores
are highlighted but are dispersed throughout different genes. The
frequency distribution assumed in the maximum likelihood model
calculated by Tree-Puzzle (5% chi-square p-values) was used. N/A =
species not represented in the gene dataset.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2148-10-
39-S2.DOC ]
Additional file 3: Additional Table 3 - Results of likelihood mapping
test for phylogenetic support and conflict estimated for each gene.
Results of Likelihood mapping test are shown here on a gene-by-gene
basis. This table summarizes the amount of phylogenetic signal and
conflict in each alignment. The three possible topologies for each
quartet of species are represented by the corners of the triangle, these
corners represent strong support for phylogenetic signal. Quartets
present on the vertices represent incongruence in the phylogenetic
signal. Quartets at the centre of the triangle represents those quartets
where all three topologies are equally likely, i.e. phylogenetic signal
completely lacking. Each gene is subsequently given a category based
on the quality of the data, only categories 1 and 2 were used.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2148-10-
39-S3.DOC ]
Additional file 4: Additional Table 4 - Results of root mean squared
deviation (RMSD) analysis for comparing binary trees. This table
summarizes the results of comparing the site stripped phylogenies with
the ideal species phylogeny. In the first column is the gene name. Each
of the subsequent columns represents a category of site variation that is
removed (1 is the slowest evolving, 8 the most rapid). The values given
for each category removed is the RMSD statistic and represents how
similar the resultant site stripped topology is to the canonical species
phylogeny. NB - non-binary tree, N/A - not applicable (site category not
estimated for alignment).
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2148-10-
39-S4.DOC ]
Additional file 5: Additional Table 5 - Results of the SH test for site-
stripped gene versus ideal species phylogeny. This table summarizes
the results of comparing the site stripped phylogenies with the ideal
species phylogeny using the SH test, this is a more statistically robust
approach and more suited to multi-furcating topologies such as those in
the dataset. Each of the rows represents a category of site variation that
is removed. For each site stripped site dataset the resultant gene tree is
compared to the species phylogeny. The values given for each category
removed denotes whether there is a significant difference between the
site stripped tree and the species phylogeny, values of less than 0.05
represent those cases where there is a significant difference between the
phylogenies. NS = No Statistical significance between gene and species
tree, the species tree was taken in these cases.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2148-10-
39-S5.DOC ]
Additional file 6: Additional Table 6(a-k) - Complete results of
Maximum likelihood analysis for selective pressure variation per
gene. For each gene analyzed (a-k) the results are shown in full on a
gene-by-gene basis (in alphabetical order). The layout of each table is
identical for each gene. The corresponding LRTs performed and all
scores and values computed are shown below. The models used are
given in the left-most column (Model), followed by the number of
parameters associated with that model (P). The Log Likelihood or each
model is given in the column (L), and the estimates of the parameters
for the proportion of sites (p) and the ratio of Dn/Ds (ω) are given. Sites
identified by each model as being positively selected are shown in the
final column.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2148-10-
39-S6.DOC ]
Additional file 7: Additional Table 7 - Summary of data used in the
analysis. Species names, unique identifiers and sequence lengths
are given for all data. Summary of data used in the analysis. Species
names, unique identifiers for Ensembl (ENS) or Swiss-Prot and database
versions are given. The sequence length per species are given for all
genes.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2148-10-
39-S7.DOC ]
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Additional file 8: Additional Table 8 - Parameters for Phylogeny
Reconstruction per gene. The parameters used to reconstruct each
gene tree in MrBayes are shown. The model of rate heterogeneity for
each gene is shown, along with the number of generations required,
and the number of markov chains (these values vary based on the size
of the dataset).
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2148-10-
39-S8.DOC ]
Additional file 9: Additional Table 9 - Likelihood ratio tests (LRTs)
performed using all evolutionary models used in selection analysis.
Details on all likelihood ratio tests performed in the analysis. The models
are denoted by their abbreviated names, Model A1 is denoted as Model
A null throughout the manuscript. The number of degrees of freedom
(df) are shown, this is relevant for the chi-squared test for significance,
the critical values in each instance are given in the final column.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2148-10-
39-S9.DOC ]
Abbreviations
A.A.: Amino Acid; Bck: Background lineage/s; BEB: Bayes Empirical Bayes; CDS:
Coding DNA sequence; Dn: Non-synonymous substitution per non-
synonymous site; Ds: Synonymous substitution per synonymous site; F:
Frequency of amino acids; Fwd: Foreground lineage/s; G: gamma distributed
sites rates across sites; GTR: General Time Reversible; I: invariable; JTT: Jones,
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